Scientific Publications

Amemiya K, Dankmeyer JL, Bernhards RC, et al. Activation of toll-like receptors by live gram-negative bacterial pathogens reveals mitigation of TLR4 responses and activation of TLR5 by flagella. Front Cell Infect Microbiol. 2021;11:745325. https://doi.org/10.3389/fcimb.2021.745325

Arnold CE, Shoemaker CJ, Smith DR, et al. Host response transcriptomic analysis of Crimean-Congo hemorrhagic fever pathogenesis in the cynomolgus macaque model. Sci Rep. 2021;11(1):19807. https://doi.org/10.1038/s41598-021-99130-1

Bachert BA, Richardson JB, Mlynek KD, et al. Development, phenotypic characterization and genomic analysis of a Francisella tularensis panel for tularemia vaccine testing. Front Microbiol. 2021;12:725776. https://doi.org/10.3389/fmicb.2021.725776

Beitzel BF, Radoshitzky SR, Di Paola N, et al. On‐demand patient‐specific phenotype‐to‐genotype Ebola virus characterization. Viruses. 2021;13(10):2010. https://doi.org/10.3390/v13102010

Biryukov S, Dankmeyer JL, Shamsuddin Z, et al. Impact of toll-like receptor-specific agonists on the host immune response to the Yersinia pestis plague rF1V vaccine. Front Immunol. 2021;12:726416. https://doi.org/10.3389/fimmu.2021.726416

Blair PW, Kortepeter MG, Downey LG, et al. Intensive care unit-like care of nonhuman primates with Ebola virus disease. J Infect Dis. 2021;224(4):632-642. https://doi.org/10.1093/infdis/jiaa781

Boonyalai N, Thamnurak C, Sai-Ngam P, et al. Plasmodium falciparum phenotypic and genotypic resistance profile during the emergence of Piperaquine resistance in Northeastern Thailand. Sci Rep. 2021;11(1):13419. https://doi.org/10.1038/s41598-021-92735-6

Bowling PA, Bencivenga MA, Leyva ME, et al. Effects of a heated anesthesia breathing circuit on body temperature in anesthetized rhesus macaques (macaca mulatta). J Am Assoc Lab Anim Sci. 2021;60(6):675-680. https://doi.org/10.30802/aalas-jaalas-21-000058

Brocato RL, Altamura LA, Carey BD, et al. Comparison of transcriptional responses between pathogenic and nonpathogenic hantavirus infections in Syrian hamsters using NanoString. PLoS Negl Trop Dis. 2021;15(8):e0009592. https://doi.org/10.1371/journal.pntd.0009592

Brocato RL, Kwilas SA, Josleyn MD, et al. Small animal jet injection technique results in enhanced immunogenicity of hantavirus DNA vaccines. Vaccine. 2021;39(7):1101-1110. https://doi.org/10.1016/j.vaccine.2021.01.002

Brocato RL, Kwilas SA, Kim RK, et al. Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters. NPJ Vaccines. 2021;6(1):16. https://doi.org/10.1038/s41541-020-00279-z

Cai Y, Yu S, Chi X, Radoshitzky SR, Kuhn JH, Berger EA. An immunotoxin targeting Ebola virus glycoprotein inhibits Ebola virus production from infected cells. PLoS One. 2021;16(1):e0245024. https://doi.org/10.1371/journal.pone.0245024

Cai Y, Yu S, Fang Y, et al. Development and characterization of a cdna-launch recombinant simian hemorrhagic fever virus expressing enhanced green fluorescent protein: ORF 2b' is not required for in vitro virus replication. Viruses. 2021;13(4):632. https://doi.org/10.3390/v13040632

Chapman NS, Zhao H, Kose N, et al. Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition. Proc Natl Acad Sci U S A. 2021;118(14):e2025642118. https://doi.org/10.1073/pnas.2025642118

Chen Y, Toth EA, Ruan B, et al. Engineering subtilisin proteases that specifically degrade active RAS. Commun Biol. 2021;4(1):299. https://doi.org/10.1038/s42003-021-01818-7

Chiang CY, Zhong Y, Ward MD, et al. Proteomic analysis of non-human primate peripheral blood mononuclear cells during Burkholderia mallei infection reveals a role of ezrin in glanders pathogenesis. Front Microbiol. 2021;12:625211. https://doi.org/10.3389/fmicb.2021.625211

Clayton NP, Jain A, Halasohoris SA, et al. In vitro and in vivo characterization of tebipenem (TBP), an orally active carbapenem, against biothreat pathogens. Antimicrob Agents Chemother. 2021;65(5):e02385-20. https://doi.org/10.1128/aac.02385-20

Cote CK, Biryukov SS, Klimko CP, et al. Protection elicited by attenuated live Yersinia pestis vaccine strains against lethal infection with virulent Y. pestis. Vaccines (Basel). 2021;9(2):161. https://doi.org/10.3390/vaccines9020161

Cote CK, Weidner JM, Klimko C, et al. Biological validation of a chemical effluent decontamination system. Appl Biosaf. 2021;26(1):23-32. https://doi.org/10.1089/apb.21.937967

Crooks CM, Weiler AM, Rybarczyk SL, et al. African-lineage Zika virus replication dynamics and maternal-fetal interface infection in pregnant rhesus macaques. J Virol. 2021;95(16):e0222020. https://doi.org/10.1128/jvi.02220-20

Davis S, Milechin L, Patel T, et al. Detecting pathogen exposure during the non-symptomatic incubation period using physiological data: proof of concept in non-human primates. Front Physiol. 2021;12:691074. https://doi.org/10.3389/fphys.2021.691074

De Luca E, Álvarez-Narváez S, Maboni G, et al. Comparative genomics analyses support the reclassification of bisgaard taxon 40 as Mergibacter gen. nov., with Mergibacter septicus sp. nov. as type species: novel insights into the phylogeny and virulence factors of a Pasteurellaceae family member associated with mortality events in seabirds. Front Microbiol. 2021;12:667356. https://doi.org/10.3389/fmicb.2021.667356

Dixon BC, Culbreth MJ, Kumsher DM, Carbaugh CM, Fetterer DP, Reiter CP. Mid-tibiofibular amputation as a method of terminal blood collection in xenopus laevis. J Am Assoc Lab Anim Sci. 2021;60(5):582-586. https://doi.org/10.30802/aalas-jaalas-21-000005

Downs I, Johnson JC, Rossi F, et al. Natural history of aerosol-induced Ebola virus disease in rhesus macaques. Viruses. 2021;13(11):2297. https://doi.org/10.3390/v13112297

Engdahl TB, Kuzmina NA, Ronk AJ, et al. Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection. Cell Rep. 2021;35(5):109086. https://doi.org/10.1016/j.celrep.2021.109086

Evans TS, Myat TW, Hom NS, et al. Seroepidemiologic survey of Crimean-Congo hemorrhagic fever virus in logging communities, Myanmar. Emerg Infect Dis. 2021;27(6):1709-1713. https://doi.org/10.3201/eid2706.203223

Fall G, Diallo D, Soumaila H, et al. First detection of the West Nile virus Koutango lineage in sandflies in Niger. Pathogens. 2021;10(3):257. https://doi.org/10.3390/pathogens10030257

Fels JM, Maurer DP, Herbert AS, et al. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever. Cell. 2021;184(13):3486-3501.e3421. https://doi.org/10.1016/j.cell.2021.05.001

Franz DR, Le Duc JW. Technology advances, high-risk research, and a safe way forward. mBio. 2021;12(5):e0237321. https://doi.org/10.1128/mbio.02373-21

Frick OM, Livingston VA, Whitehouse CA, et al. The natural history of aerosolized Francisella tularensis infection in cynomolgus macaques. Pathogens. 2021;10(5):597. https://doi.org/10.3390/pathogens10050597

Garcia-Rodriguez C, Yan S, Geren IN, et al. A four-monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotypes C and D. Toxins (Basel). 2021;13(9):641. https://doi.org/10.3390/toxins13090641

Golden JW, Zeng X, Cline CR, et al. Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease. J Gen Virol. 2021;102(5):001599. https://doi.org/10.1099/jgv.0.001599

Grund ME, Kramarska E, Choi SJ, et al. Predictive and experimental immunogenicity of burkholderia collagen‐like protein 8‐derived antigens. Vaccines. 2021;9(11). https://doi.org/10.3390/cells10030495

Grund ME, Soo JC, Cote CK, Berisio R, Lukomski S. Thinking outside the bug: targeting outer membrane proteins for Burkholderia vaccines. Cells. 2021;10(3). https://doi.org/10.3390/cells10030495

Guito JC, Prescott JB, Arnold CE, et al. Asymptomatic infection of Marburg virus reservoir bats is explained by a strategy of immunoprotective disease tolerance. Curr Biol. 2021;31(2):257-270.e255. https://doi.org/10.1016/j.cub.2020.10.015

Gupta Y, Kumar S, Zak SE, et al. Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach. Bioorg Med Chem. 2021;47:116393. https://doi.org/10.1016/j.bmc.2021.116393

Gupta Y, Maciorowski D, Zak SE, et al. Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays. Methods. 2021;195:57-71. https://doi.org/10.1016/j.ymeth.2021.01.003

Gupta Y, Maciorowski D, Zak SE, et al. Heparin: a simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy. Int J Biol Macromol. 2021;183:203-212. https://doi.org/10.1016/j.ijbiomac.2021.04.148

Haddow AD, Clarke SC. Inaccuracies in Google's health-based knowledge panels perpetuate widespread misconceptions involving infectious disease transmission. Am J Trop Med Hyg. 2021;104(6):2293-2297. https://doi.org/10.4269/ajtmh.21-0216

Haddow AD, Rowland TE, Norris SL, et al. No evidence of rVSV-Ebola virus vaccine replication or dissemination in the sand fly Phlebotomus papatasi. Am J Trop Med Hyg. 2021;104(3):1093-1095. https://doi.org/10.4269/ajtmh.20-0951

Haddow, AD, Watt, TR, Bloomfield, HA, Fetterer, DP, & Harbourt, DE. Modeling the stability of SARS-CoV-2 on personal protective equipment (PPE). Am J Trop Med Hyg. 2021;104(2):549-551. https://doi.org/10.4269/ajtmh.20-1508

Halasohoris SA, Scarff JM, Pysz LM, et al. In vitro and in vivo activity of GT-1, a novel siderophore cephalosporin, and GT-055, a broad-spectrum β-lactamase inhibitor, against biothreat and ESKAPE pathogens. J Antibiot (Tokyo). 2021;74(12):884-892. https://doi.org/10.1038/s41429-021-00472-9

Haslwanter D, Dieterle ME, Wec AZ, et al. A combination of receptor-binding domain and n-terminal domain neutralizing antibodies limits the generation of SARS-CoV-2 spike neutralization-escape mutants. mBio. 2021;12(5):e0247321. https://doi.org/10.1128/mbio.02473-21

Herring S, Oda JM, Wagoner J, et al. Erratum for Herring et al., "Inhibition of Arenaviruses by combinations of orally available approved drugs". Antimicrob Agents Chemother. 2021;65(6):e00653-21. https://doi.org/10.1128/aac.00653-21

Herring S, Oda JM, Wagoner J, et al. Inhibition of Arenaviruses by combinations of orally available approved drugs. Antimicrob Agents Chemother. 2021;65(4):e01146-20. https://doi.org/10.1128/aac.01146-20

Hierweger MM, Koch MC, Rupp M, et al. Novel filoviruses, hantavirus, and rhabdovirus in freshwater fish, Switzerland, 2017. Emerg Infect Dis. 2021;27(12):3082-3091. https://doi.org/10.3201/eid2712.210491

Hollidge BS, Cohen CA, Akuoku Frimpong J, Badger CV, Dye JM, Schmaljohn CS. Toll-like receptor 4 mediates blood-brain barrier permeability and disease in C3H mice during Venezuelan equine encephalitis virus infection. Virulence. 2021;12(1):430-443. https://doi.org/10.1080/21505594.2020.1870834

Hulseberg CE, Kumar R, Di Paola N, et al. Molecular analysis of the 2012 Bundibugyo virus disease outbreak. Cell Rep Med. 2021;2(8):100351. https://doi.org/10.1016/j.xcrm.2021.100351

Jelacic TM, Ribot WJ, Tobery SA, Chabot DJ, Friedlander AM. Poly-γ-Glutamic acid encapsulation of Bacillus anthracis inhibits human dendritic cell responses. Immunohorizons. 2021;5(2):81-89. https://doi.org/10.4049/immunohorizons.2100004

Jiang J, Ramos SJ, Bangalore P, et al. Multivalent DNA vaccines as a strategy to combat multiple concurrent epidemics: mosquito-borne and hemorrhagic fever viruses. Viruses. 2021;13(3):382. https://doi.org/10.3390/v13030382

Johnston SC, Ricks KM, Jay A, et al. Development of a coronavirus disease 2019 nonhuman primate model using airborne exposure. PLoS One. 2021;16(2):e0246366. https://doi.org/10.1371/journal.pone.0246366

Johnston SC, Wilhelmsen CL, Shamblin J, et al. Delayed disease in cynomolgus macaques exposed to Ebola virus by an intranasal route. Front Immunol. 2021;12:709772. https://doi.org/10.3389/fimmu.2021.709772

Keasey SL, Zhao BM, Ulrich RG, Suh MJ. Proteomic analysis of antibiotic susceptibility in Enterobacteriaceae. Methods Mol Biol. 2021;2296:381-392. https://doi.org/10.1007/978-1-0716-1358-0_22

Kijek TM, Bozue JA, Panchal RG, Litosh VA, Woodard RW, Ahmed SA. A direct spectropolarimetric assay of arabinose 5-phosphate isomerase. Anal Biochem. 2021;622:114116. https://doi.org/10.1016/j.ab.2021.114116

King HAD, Gordon Joyce M, Lakhal-Naouar I, et al. Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques. Proc Natl Acad Sci U S A. 2021;118(38):e2106433118. https://doi.org/10.1073/pnas.2106433118

Kinganda-Lusamaki E, Black A, Mukadi DB, et al. Integration of genomic sequencing into the response to the Ebola virus outbreak in Nord Kivu, Democratic Republic of the Congo. Nat Med. 2021;27(4):710-716. https://doi.org/10.1038/s41591-021-01302-z

Kuehnert PA, Stefan CP, Badger CV, Ricks KM. Crimean-Congo hemorrhagic fever virus (CCHFV): a silent but widespread threat. Curr Trop Med Rep. 2021:1-7. https://doi.org/10.1007/s40475-021-00235-4

Kuhn JH, Adkins S, Agwanda BR, et al. 2021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales. Arch Virol. 2021;166(12):3513-3566. https://doi.org/10.1007/s00705-021-05143-6

Kuhn JH, Adkins S, Agwanda BR, et al. Correction to: 2021 Taxonomic update of phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales. Arch Virol. 2021;166(12):3567-3579. https://doi.org/10.1007/s00705-021-05266-w

Kumar S, Gupta Y, Zak SE, et al. A novel compound active against SARS-CoV-2 targeting uridylate-specific endoribonuclease (NendoU/NSP15): in silico and in vitro investigations. RSC Med Chem. 2021;12(10):1757-1764. https://doi.org/10.1039/d1md00202c

Larson PA, Bartlett ML, Garcia K, et al. Genomic features of humoral immunity support tolerance model in Egyptian rousette bats. Cell Rep. 2021;35(7):109140. https://doi.org/10.1016/j.celrep.2021.109140

Legler PM, Little SF, Senft J, et al. Treatment of experimental anthrax with pegylated circularly permuted capsule depolymerase. Sci Transl Med. 2021;13(623):eabh1682. https://doi.org/10.1126/scitranslmed.abh1682

Li T, Chung HK, Pireku PK, et al. Rapid high-throughput whole-genome sequencing of SARS-CoV-2 by using one-step reverse transcription-pcr amplification with an integrated microfluidic system and next-generation sequencing. J Clin Microbiol. 2021;59(5):e02784-20. https://doi.org/10.1128/jcm.02784-20

Lin JT, Waltmann A, Moser KA, et al. Selection of cytochrome b mutants is rare among plasmodium falciparum patients failing treatment with atovaquone-proguanil in Cambodia. Antimicrob Agents Chemother. 2021;65(3):e01249-20. https://doi.org/10.1128/aac.01249-20

Liu JL, Webb EM, Zabetakis D, et al. Stabilization of a broadly neutralizing anti-Chikungunya virus single domain antibody. Front Med (Lausanne). 2021;8:626028. https://doi.org/10.3389/fmed.2021.626028

Luban J, Sattler RA, Mühlberger E, et al. The DHODH inhibitor PTC299 arrests SARS-CoV-2 replication and suppresses induction of inflammatory cytokines. Virus Res. 2021;292:198246. https://doi.org/10.1016/j.virusres.2020.198246

Maccio U, Zinkernagel AS, Shambat SM, et al. SARS-CoV-2 leads to a small vessel endotheliitis in the heart. EBioMedicine. 2021;63:103182. https://doi.org/10.1016/j.ebiom.2020.103182

Martchenko Shilman M, Bartolo G, Alameh S, et al. In vivo activity of repurposed amodiaquine as a host-targeting therapy for the treatment of anthrax. ACS Infect Dis. 2021;7(8):2176-2191. https://doi.org/10.1021/acsinfecdis.1c00190

McCurdy S, Duffy E, Hickman M, Halasohoris S, Zumbrun SD. Efficacy of delafloxacin against the biothreat pathogen Burkholderia pseudomallei. Antimicrob Agents Chemother. 2021;65(10):e0073621. https://doi.org/10.1128/aac.00736-21

Montgomery VA, Lindsey CY, Smith LA, Webb RP. Development of an o-pthalaldehyde (OPA) assay to measure protein content in Ricin Vaccine E. coli (RVEc™). Vaccine. 2021;39(3):564-570. https://doi.org/10.1016/j.vaccine.2020.12.008

Mou S, Jenkins CC, Okaro U, Dhummakupt ES, Mach PM, DeShazer D. The Burkholderia pseudomallei hmqA-G locus mediates competitive fitness against environmental gram-positive bacteria. Microbiol Spectr. 2021;9(1):e0010221. https://doi.org/10.1128/spectrum.00102-21

Newman CM, Tarantal AF, Martinez ML, et al. Early embryonic loss following intravaginal Zika virus challenge in rhesus macaques. Front Immunol. 2021;12:686437. https://doi.org/10.3389/fimmu.2021.686437

Niemuth NA, Fallacara D, Triplett CA, et al. Natural history of disease in cynomolgus monkeys exposed to Ebola virus Kikwit strain demonstrates the reliability of this non-human primate model for Ebola virus disease. PLoS One. 2021;16(7):e0252874. https://doi.org/10.1371/journal.pone.0252874

Ohrman C, Sahl JW, Sjodin A, et al. Reorganized genomic taxonomy of Francisellaceae enables design of robust environmental PCR assays for detection of Francisella tularensis. Microorganisms. 2021; 9(1):146. https://doi.org/10.3390/microorganisms9010146

Okaro U, George S, Anderson B. What Is in a Cat Scratch? Growth of Bartonella henselae in a Biofilm. Microorganisms. 2021;9(4):835. https://doi.org/10.3390/microorganisms9040835

Osorio-Guarín JA, Gopaulchan D, Quanckenbush C, Lennon AM, Umaharan P, Cornejo OE. Comparative transcriptomic analysis reveals key components controlling spathe color in Anthurium andraeanum (Hort.). PLoS ONE. 2021;16(12):e0261364. https://doi.org/10.1371/journal.pone.0261364

Papp-Wallace KM, Shapiro AB, Becka SA, et al. In vitro antibacterial activity and in vivo efficacy of sulbactam-durlobactam against pathogenic Burkholderia species. Antimicrob Agents Chemother. 2021;65(3):e01930-20. https://doi.org/10.1128/aac.01930-20

Paquin-Proulx D, Gunn BM, Alrubayyi A, et al. Associations between antibody Fc-mediated effector functions and long-term sequelae in Ebola virus survivors. Front Immunol. 2021;12:682120. https://doi.org/10.3389/fimmu.2021.682120

Pérez-Sautu U, Wiley MR, Prieto K, et al. Novel viruses in hard ticks collected in the Republic of Korea unveiled by metagenomic high-throughput sequencing analysis. Ticks Tick Borne Dis. 2021;12(6):101820. https://doi.org/10.1016/j.ttbdis.2021.101820

Phelps AL, O’brien LM, Ulaeto DO, et al. Cross-strain neutralizing and protective monoclonal antibodies against EEEV or WEEV. Viruses. 2021;13(11):2231. https://doi.org/10.3390/v13112231

Pierson BC, Cardile AP, Okwesili AC, et al. Safety and immunogenicity of an inactivated eastern equine encephalitis virus vaccine. Vaccine. 2021;39(20):2780-2790. https://doi.org/10.1016/j.vaccine.2021.03.030

Pinky L, Burke CW, Russell CJ, Smith AM. Quantifying dose-, strain-, and tissue-specific kinetics of parainfluenza virus infection. PLoS Comput Biol. 2021;17(8):e1009299. https://doi.org/10.1371/journal.pcbi.1009299

Rappazzo CG, Tse LV, Kaku CI, et al. Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody. Science. 2021;371(6531):823-829. https://doi.org/10.1126/science.abf4830

Robie ER, Zemke JN, Toh TH, et al. Chikungunya and Zika viruses not detected among patients with dengue-like illness, Sarawak, Malaysia. Asia Pac J Public Health. 2021;33(8):995-996. https://doi.org/10.1177/10105395211007631

Rosario-Acevedo R, Biryukov SS, Bozue JA, Cote CK. Plague prevention and therapy: Perspectives on current and future strategies. Biomedicines. 2021;9(10):1421. https://doi.org/10.3390/biomedicines9101421

Saikh KU. MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity. Immunol Res. 2021;69(2):117-128. https://doi.org/10.1007/s12026-021-09188-2

Saikh KU, Ranji CM. Cells stimulated with more than one toll-like receptor-ligand in the presence of a myd88 inhibitor augmented interferon-β via MyD88-independent signaling pathway. Viral Immunol. 2021;34(9):646-652. https://doi.org/10.1089/vim.2021.0020

Sen E, Kota KP, Panchal RG, Bavari S, Kiris E. Screening of a focused ubiquitin-proteasome pathway inhibitor library identifies small molecules as novel modulators of Botulinum Neurotoxin Type A toxicity. Front Pharmacology. 2021;12:763950. https://doi.org/10.3389/fphar.2021.763950

Shoudy LE, Namjoshi P, Giordano G, et al. The O-Ag antibody response to Francisella is distinct in rodents and higher animals and can serve as a correlate of protection. Pathogens. 2021;10(12):1646. https://doi.org/10.3390/pathogens10121646

Shrestha B, Shah Z, Morgan AP, et al. Distribution and temporal dynamics of Plasmodium falciparum chloroquine resistance transporter mutations associated with piperaquine resistance in Northern Cambodia. J Infect Dis. 2021;224(6):1077-1085. https://doi.org/10.1093/infdis/jiab055

Shu Q, Kenny T, Fan J, Lyon CJ, Cazares LH, Hu TY. Species-specific quantification of circulating ebolavirus burden using VP40-derived peptide variants. PLoS Pathogens. 2021;17(11):e1010039. https://doi.org/10.1371/journal.ppat.1010039

Stefan CP, Arnold CE, Shoemaker CJ, et al. Transcriptomic analysis reveals host mirnas correlated with immune gene dysregulation during fatal disease progression in the Ebola virus cynomolgus macaque disease model. Microorganisms. 2021;9(3):665. https://doi.org/10.3390/microorganisms9030665

Strange DP, Jiyarom B, Sadri-Ardekani H, et al. Paracrine IFN response limits ZIKV infection in human sertoli cells. Front Microbiol. 2021;12:667146. https://doi.org/10.3389/fmicb.2021.667146

Suschak JJ, Golden JW, Fitzpatrick CJ, et al. A CCHFV DNA vaccine protects against heterologous challenge and establishes GP38 as immunorelevant in mice. NPJ Vaccines. 2021;6(1):31. https://doi.org/10.1038/s41541-021-00293-9

Trefry JC, Rossi FD, Accardi MV, et al. The utilization of advance telemetry to investigate critical physiological parameters including electroencephalography in cynomolgus macaques following aerosol challenge with eastern equine encephalitis virus. PLoS Negl Trop Dis. 2021;15(6):e0009424. https://doi.org/10.1371/journal.pntd.0009424

Trevino SR, Dankmeyer JL, Fetterer DP, et al. Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model. PLoS Negl Trop Dis. 2021;15(2):e0009125. https://doi.org/10.1371/journal.pntd.0009125

Turell MJ, Dohm DJ, Fernandez R, Klein TA. Vector competence of peruvian mosquitoes for two Orthobunyaviruses isolated from mosquitoes captured in Peru. J Med Entomol. 2021;58(3):1384-1388. https://doi.org/10.1093/jme/tjaa252

Vaughan JA, Hinson J, Andrews ES, Turell MJ. Pre-existing microfilarial infections of American Robins (Passeriformes: Turdidae) and Common Grackles (Passeriformes: Icteridae) have limited impact on enhancing dissemination of West Nile virus in Culex pipiens Mosquitoes (Diptera: Culicidae). J Med Entomol. 2021;58(3):1389-1397. https://doi.org/10.1093/jme/tjaa261

Vietri NJ, Tobery SA, Chabot DJ, et al. Clindamycin protects nonhuman primates against inhalational anthrax but does not enhance reduction of circulating toxin levels when combined with ciprofloxacin. J Infect Dis. 2021;223(2):319-325. https://doi.org/10.1093/infdis/jiaa365

Voss WN, Hou YJ, Johnson NV, et al. Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes. Science. 2021;372(6546):1108-1112. https://doi.org/10.1126/science.abg5268

Waag DM, Chance TB, Trevino SR, et al. Comparison of three non-human primate aerosol models for glanders, caused by Burkholderia mallei. Microb Pathog. 2021;155:104919. https://doi.org/10.1016/j.micpath.2021.104919

Wang Y, Howell KA, Brannan J, et al. Prominent neutralizing antibody response targeting the Ebolavirus glycoprotein subunit interface elicited by immunization. J Virol. 2021;95(8):e01907-20. https://doi.org/10.1128/jvi.01907-20

Warren TK, Kane CD, Wells J, et al. Remdesivir is efficacious in rhesus monkeys exposed to aerosolized Ebola virus. Sci Rep. 2021;11(1):19458. https://doi.org/10.1038/s41598-021-98971-0

White LE, Holland RL, Scruggs JL. What is your diagnosis? A scrotal lesion in a cynomolgus macaque. Vet Clin Pathol. 2021;50(2):302-304. https://doi.org/10.1111/vcp.12961

Wirchnianski AS, Wec AZ, Nyakatura EK, et al. Two distinct lysosomal targeting strategies afford Trojan horse antibodies with pan-filovirus activity. Front Immunol. 2021;12:729851. https://doi.org/10.3389/fimmu.2021.729851

Wuertz KMG, Barkei EK, Chen WH, et al. A SARS-CoV-2 spike ferritin nanoparticle vaccine protects hamsters against Alpha and Beta virus variant challenge. NPJ Vaccines. 2021;6(1):129. https://doi.org/10.1038/s41541-021-00392-7

Yee JL, Prongay K, Van Rompay KKA, et al. Tuberculosis detection in nonhuman primates is enhanced by use of testing algorithms that include an interferon-γ release assay. Am J Vet Res. 2021;83(1):15-22. https://doi.org/10.2460/ajvr.21.08.0124

Abudurexiti A, Adkins S, Alioto D, et al. Taxonomy of the order Bunyavirales: update 2019. Arch Virol. 2019;164(7):1949-1965. https://doi.org/10.1007/s00705-019-04253-6

Amarasinghe GK, Ayllón MA, Bào Y, et al. Taxonomy of the order Mononegavirales: update 2019. Arch Virol. 2019;164(7):1967-1980. https://doi.org/10.1007/s00705-019-04247-4

Arnold CE, Guito JC, Altamura LA, et al. Transcriptomics reveal antiviral gene induction in the Egyptian rousette bat is antagonized in vitro by Marburg virus infection. Viruses. 2018;10(11):607. https://doi.org/10.3390/v10110607

Atre T, Phillips RL, Modjarrad K, Regules JA, Bergmann-Leitner ES. Development and characterization of a Zaire Ebola (ZEBOV) specific IgM ELISA. J Immunol Methods. 2019;468:29-34. https://doi.org/10.1016/j.jim.2019.03.008

Bachert BA, Biryukov SS, Chua J, et al. A Francisella novicida mutant, lacking the soluble lytic transglycosylase slt, exhibits defects in both growth and virulence. Front Microbiol. 2019;10:1343. https://doi.org/10.3389/fmicb.2019.01343

Bazzill JD, Stronsky SM, Kalinyak LC, et al. Vaccine nanoparticles displaying recombinant Ebola virus glycoprotein for induction of potent antibody and polyfunctional T cell responses. Nanomedicine. 2019;18:414-425. https://doi.org/10.1016/j.nano.2018.11.005

Blair PW, Keshtkar-Jahromi M, Psoter KJ, et al. Virulence of Marburg virus Angola compared to Mt. Elgon (Musoke) in macaques: a pooled survival analysis. Viruses. 2018;10(11):658. https://doi.org/10.3390/v10110658

Blair PW, Kuhn JH, Pecor DB, et al. An emerging biothreat: Crimean-Congo hemorrhagic fever virus in Southern and Western Asia. Am J Trop Med Hyg. 2019;100(1):16-23. https://doi.org/10.4269/ajtmh.18-0553

Bocan TM, Basuli F, Stafford RG, et al. Synthesis of [ 18 F] favipiravir and biodistribution in C3H/HeN mice as assessed by positron emission tomography. Sci Rep. 2019;9(1):1785. https://doi.org/10.1038/s41598-018-37866-z

Bornholdt ZA, Herbert AS, Mire CE, et al. A two-antibody pan-Ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates. Cell Host Microbe. 2019;25(1):49-58.e45. https://doi.org/10.1016/j.chom.2018.12.005

Bose ME, Shrivastava S, He J, et al. Sequencing and analysis of globally obtained human parainfluenza viruses 1 and 3 genomes. PLoS One. 2019;14(7):e0220057. https://doi.org/10.1371/journal.pone.0220057

Brannan JM, He S, Howell KA, et al. Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates. Nat Commun. 2019;10(1):105. https://doi.org/10.1038/s41467-018-08040-w

Brocato RL, Hooper JW. Progress on the prevention and treatment of hantavirus disease. Viruses. 2019;11(7):610. https://doi.org/10.3390/v11070610

Bruhn M, Schindler D, Kemter FS, et al. Functionality of two origins of replication in vibrio cholerae strains with a single chromosome. Front Microbiol. 2018;9:2932. https://doi.org/10.3389/fmicb.2018.02932

Caì Y, Iwasaki M, Beitzel BF, et al. Recombinant Lassa virus expressing green fluorescent protein as a tool for high-throughput drug screens and neutralizing antibody assays. Viruses. 2018;10(11):655. https://doi.org/10.3390/v10110655

Caì Y, Yú S, Jangra RK, et al. Human, nonhuman primate, and bat cells are broadly susceptible to tibrovirus particle cell entry. Front Microbiol. 2019;10:856. https://doi.org/10.3389/fmicb.2019.00856

Cai YY, Iwasaki M, Beitzel BF, et al. Recombinant Lassa virus expressing green fluorescent protein as a tool for high-throughput drug screens and neutralizing antibody assays. Viruses. 2018;10(11):655. https://doi.org/10.3390/v10110655

Cashman KA, Wilkinson ER, Zeng X, et al. Immune-mediated systemic vasculitis as the proposed cause of sudden-onset sensorineural hearing loss following Lassa virus exposure in cynomolgus macaques. mBio. 2018;9(5):e01896-18. https://doi.org/10.1128/mBio.01896-18

Chua J, Bozue JA, Klimko CP, et al. Formaldehyde and glutaraldehyde inactivation of bacterial tier 1 select agents in tissues. Emerg Infect Dis. 2019;25(5):919-926. https://doi.org/10.3201/eid2505.180928

Clements TL, Rossi CA, Irish AK, et al. Chikungunya and O'nyong-nyong viruses in Uganda: implications for diagnostics. Open Forum Infect Dis. 2019;6(3): ofz001. https://doi.org/10.1093/ofid/ofz001

Conrad TA, Lo CC, Koehler JW, et al. Diagnostic targETEd seQuencing adjudicaTion (DETEQT) algorithms for adjudicating targeted infectious disease next-generation sequencing panels. J Mol Diagn. 2019;21(1):99-110. https://doi.org/10.1016/j.jmoldx.2018.08.008

Cooper TK, Huzella L, Johnson JC, et al. Author Correction: histology, immunohistochemistry, and in situ hybridization reveal overlooked Ebola virus target tissues in the Ebola virus disease guinea pig model. Sci Rep. 2019;9(1):15013. https://doi.org/10.1038/s41598-019-51386-4

DeShazer D. A novel contact-independent T6SS that maintains redox homeostasis via Zn2+ and Mn2+ acquisition is conserved in the Burkholderia pseudomallei complex. Microbiol Res. 2019;226:48-54. https://doi.org/10.1016/j.micres.2019.05.007

DeShazer D, Lovett S, Richardson J, et al. Bacteriophage-associated genes responsible for the widely divergent phenotypes of variants of Burkholderia pseudomallei strain MSHR5848. J Med Microbiol. 2019;68(2):263-278. https://doi.org/10.1099/jmm.0.000908

Diagne MM, Ndione MHD, Di Paola N, et al. Usutu virus Isolated from rodents in Senegal. Viruses. 2019;11(2):181. https://doi.org/10.3390/v11020181

Fan Y, Stronsky SM, Xu Y, et al. Multilamellar vaccine particle elicits potent immune activation with protein antigens and protects mice against Ebola virus infection. ACS Nano. 2019;13(10): 11087-11096. https://doi.org/10.1021/acsnano.9b03660

Fukuda H, Li S, Sardo L, et al. Structural determinants of the APOBEC3G N-terminal domain for HIV-1 RNA association. Front Cell Infect Microbiol. 2019;9:129. https://doi.org/10.3389/fcimb.2019.00129

Garrison AR, Smith DR, Golden JW. Animal models for Crimean-Congo hemorrhagic fever human disease. Viruses. 2019;11(7):590. https://doi.org/10.3390/v11070590

Golden JW, Shoemaker CJ, Lindquist ME, et al. GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection. Sci Adv. 2019;5(7):eaaw9535. https://doi.org/10.1126/sciadv.aaw9535

Grubaugh ND, Saraf S, Gangavarapu K, et al. Travel Surveillance and genomics uncover a hidden Zika outbreak during the waning epidemic. Cell. 2019;178(5):1057-1071.e1011. https://www.sciencedirect.com/science/article/pii/S0092867419307834?via%3Dihub

Happi AN, Happi CT, Schoepp RJ. Lassa fever diagnostics: past, present, and future. Curr Opin Virol. 2019;37:132-138. https://doi.org/10.1016/j.coviro.2019.08.002

Haston JC, Rostad CA, Jerris RC, et al. Prospective cohort study of next-generation sequencing as a diagnostic modality for unexplained encephalitis in children. J Pediatric Infect Dis Soc. 2019: piz032. https://doi.org/10.1093/jpids/piz032

Hogan M, Bahta M, Tsuji K, et al. Targeting protein-protein interactions of tyrosine phosphatases with microarrayed fragment libraries displayed on phosphopeptide substrate scaffolds. ACS Comb Sci. 2019;21(3):158-170. https://doi.org/10.1021/acscombsci.8b00122

Hulseberg CE, Fénéant L, Szymanska-De Wijs KM, et al. Arbidol and other low-molecular-weight drugs that inhibit Lassa and Ebola viruses. J Virol. 2019;93(8): e02185-18. https://doi.org/10.1128/JVI.02185-18

Jangra RK, Herbert AS, Li R, et al. Protocadherin-1 is essential for cell entry by New World hantaviruses. Nature. 2018;563(7732):559-563. https://doi.org/10.1038/s41586-018-0702-1

Jasenosky LD, Cadena C, Mire CE, et al. The FDA-approved oral drug nitazoxanide amplifies host antiviral responses and inhibits Ebola virus. iScience. 2019;19:1279-1290. https://doi.org/10.1016/j.isci.2019.07.003

Jiang JJ, Banglore P, Cashman KA, et al. Immunogenicity of a protective intradermal DNA vaccine against Lassa virus in cynomolgus macaques. Hum Vaccin Immunother. 2019;15(9):2066-2074. https://doi.org/10.1080/21645515.2019.1616499

Katawera V, Kohar H, Mahmoud N, et al. Enhancing laboratory capacity during Ebola virus disease (EVD) heightened surveillance in Liberia: lessons learned and recommendations. Pan Afr Med J. 2019;33(suppl 2):8. https://doi.org/10.11604/pamj.supp.2019.33.2.17366

Keasey SL, Smith JL, Fernandez S, Durbin AP, Zhao BM, Ulrich RG. Impact of Dengue virus serotype 2 strain diversity on serological immune responses to Dengue. ACS Infect Dis. 2018;4(12):1705-1717. https://doi.org/10.1021/acsinfecdis.8b00185

Keasey SL, Suh MJ, Das S, et al. Decreased antibiotic susceptibility driven by global remodeling of the klebsiella pneumoniae proteome. Mol Cell Proteomics. 2019;18(4):657-668. https://doi.org/10.1074/mcp.RA118.000739

Kende M, Paragas J, Salazar AM. The efficacy of poly-ICLC against Ebola-Zaire virus (EBOV) infection in mice and cynomolgus monkeys. Antiviral Res. 2019;163:179-184. https://doi.org/10.1016/j.antiviral.2018.12.020

Khan M, Miller C, Hale M. Development of an assay for antimicrobial susceptibility testing of Coxiella burnetii. Abstr Pap Am Chem Soc. 2019;257. https://mdsoar.org/handle/11603/13530

Kijek TM, Mou S, Bachert BA, et al. The D-alanyl-D-alanine carboxypeptidase enzyme is essential for virulence in the Schu S4 strain of Francisella tularensis and a dacD mutant is able to provide protection against a pneumonic challenge. Microb Pathog. 2019;137. https://doi.org/10.1016/j.micpath.2019.103742

Kim AS, Austin SK, Gardner CL, et al. Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein. Nat Microbiol. 2019;4(1):187-197+. https://doi.org/10.1038/s41564-018-0286-4

Kinoshita Y, Cloutier AK, Rozak DA, et al. A novel selective medium for the isolation of Burkholderia mallei from equine specimens. BMC Vet Res. 2019;15(1). https://doi.org/10.1186/s12917-019-1874-0

Ko SY, Akahata W, Yang ES, et al. A virus-like particle vaccine prevents equine encephalitis virus infection in nonhuman primates. Sci Transl Med. 2019;11(492). https://doi.org/10.1126/scitranslmed.aav3113

Koehler JW, Douglas CE, Minogue TD. A highly multiplexed broad pathogen detection assay for infectious disease diagnostics. PLoS Negl Trop Dis. 2018;12(11). https://doi.org/10.1371/journal.pntd.0006889

Krakauer T. Staphylococcal superantigens: Pyrogenic toxins induce toxic shock. Toxins (Basel). 2019;11(3):178. https://doi.org/10.3390/toxins11030178

Krishnamurthy M, Lemmon MM, Falcinelli EM, et al. Enhancing the antibacterial activity of polymyxins using a nonantibiotic drug. Infect Drug Resist. 2019;12:1393-1405. https://doi.org/10.2147/IDR.S196874

Kuhn JH, Amarasinghe GK, Basler CF, et al. ICTV virus taxonomy profile: Filoviridae. J Gen Virol. 2019;100(6):911-912. https://doi.org/10.1099/jgv.0.001252

Lindquist ME, Hicar MD. B Cells and antibodies in Kawasaki disease. Int J Mol Sci. 2019;20(8). https://doi.org/10.3390/ijms20081834

Liu J, Coffin KM, Johnston SC, et al. Nipah virus persists in the brains of nonhuman primate survivors. JCI Insight. 2019;4(14). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675545/

Maes P, Adkins S, Alkhovsky SV, et al. Taxonomy of the order Bunyavirales: second update 2018. Arch Virol. 2019;164(3):927-941. https://doi.org/10.1007/s00705-018-04127-3

Maes P, Amarasinghe GK, Ayllón MA, et al. Taxonomy of the order Mononegavirales: second update 2018. Arch Virol. 2019;164(4):1233-1244. https://doi.org/10.1007/s00705-018-04126-4

Martins KA, Gregory MK, Valdez SM, et al. Neutralizing antibodies from convalescent Chikungunya virus patients can cross-neutralize Mayaro and Una viruses. Am J Trop Med Hyg. 2019;100(6):1541-1544. https://doi.org/10.4269/ajtmh.18-0756

Maxson T, Blancett CD, Graham AS, Stefan CP, Minogue TD. Rapid antibiotic susceptibility testing from blood culture bottles with species agnostic real-time polymerase chain reaction. PLoS One. 2018;13(12):e0209042. https://doi.org/10.1371/journal.pone.0209042

Mbala-Kingebeni P, Aziza A, Di Paola N, et al. Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri provinces of the Democratic Republic of the Congo: a rapid genomic assessment. Lancet Infect Dis. 2019;19(6):648-657. https://doi.org/10.1016/S1473-3099(19)30118-5

Mbala-Kingebeni P, Pratt CB, Wiley MR, et al. 2018 Ebola virus disease outbreak in Équateur Province, Democratic Republic of the Congo: a retrospective genomic characterisation. Lancet Infect Dis. 2019;19(6):641-647. https://doi.org/10.1016/S1473-3099(19)30124-0

McCall S, Kreindl G, Kastinger T, et al. Rudolf Hess - The Doppelganger conspiracy theory disproved. Forensic Sci Int Genet2019;40:18-22. https://doi.org/10.1016/j.fsigen.2019.01.004

Minogue TD, Koehler JW, Stefan CP, Conrad TA. Next-generation sequencing for biodefense: biothreat detection, forensics, and the clinic. Clin Chem. 2019;65(3):383-392. https://doi.org/10.1373/clinchem.2016.266536

Mohamed YF, Scott NE, Molinaro A, et al. A general protein O-glycosylation machinery conserved in Burkholderia species improves bacterial fitness and elicits glycan immunogenicity in humans. J Biol Chem. 2019;294(36):13248-13268. https://doi.org/10.1074/jbc.RA119.009671

Morazzani EM, Compton JR, Leary DH, et al. Proteolytic cleavage of host proteins by the group IV viral proteases of Venezuelan equine encephalitis virus and Zika virus. Antiviral Res. 2019;164:106-122. https://doi.org/10.1016/j.antiviral.2019.02.001

Morwitzer MJ, Tritsch SR, Cazares LH, et al. Identification of RUVBL1 and RUVBL2 as novel cellular interactors of the Ebola virus nucleoprotein. Viruses. 2019;11(4):pii: E372. https://doi.org/10.3390/v11040372

Nalca A, Totura A, Livingston V, Frick O, Dyer D. African green monkey model of Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Int J Infect Dis. 2019;79(suppl 1):99-100. https://doi.org/10.1016/j.ijid.2018.11.249

Natesan M, Wu SW, Chen CI, et al. A smartphone-based rapid telemonitoring system for Ebola and Marburg isease surveillance. ACS Sens. 2019;4(1):61-68. https://doi.org/10.1021/acssensors.8b00842

Nimo-Paintsil SC, Fichet-Calvet E, Borremans B, et al. Rodent-borne infections in rural Ghanaian farming communities [published correction appears in PLoS One. 2019;14(6): e0218271]. PLoS One. 2019;14(4): e0215224. https://doi.org/10.1371/journal.pone.0215224

Nunes MRT, de Souza WM, Savji N, et al. Oropouche orthobunyavirus: genetic characterization of full-length genomes and development of molecular methods to discriminate natural reassortments. Infect Genet Evol. 2019;68:16-22. https://doi.org/10.1016/j.meegid.2018.11.020

Obregon-Perko V, Parodi L, Hodara V, et al. Adaptation of SIV to baboon PBMC or isolated CD4 cells: insights into cell types required for baboon resistance to SIV infection. J Med Primatol. 2018;47(5)(Special Issue: 35th Annual Symposium on Nonhuman Primate Models for AIDS):323-323. https://doi.org/10.1111/jmp.12383

Oliveira DBL, Durigon GS, Mendes É, et al. Persistence and intra-host genetic evolution of Zika virus infection in symptomatic adults: a special view in the male reproductive system. Viruses. 2018;10(11). https://doi.org/10.3390/v10110615

Olson MA. Conformational selection of a polyproline peptide by Ebola virus VP30. Proteomics. 2018;18(21-22):e1800081. https://doi.org/10.1002/pmic.201800081

Olson MA, Legler PM, Zabetakis D, Turner KB, Anderson GP, Goldman ER. Sequence tolerance of a single-domain antibody with a high thermal stability: comparison of computational and experimental fitness profiles. ACS Omega. 2019;4(6):10444-10454. https://doi.org/10.1021/acsomega.9b00730

Pandya UM, Egbuta C, Norman TMA, et al. The biophysical interaction of the danger-associated molecular pattern (DAMP) calreticulin with the pattern-associated molecular pattern (PAMP) lipopolysaccharide. Int J Mol Sci. 2019;20(2):408. https://doi.org/10.3390/ijms20020408

Perez-Sautu U, Wiley MR, Iglesias-Caballero M, et al. Target-independent high-throughput sequencing methods provide evidence that already known human viral pathogens play a main role in respiratory infections with unexplained etiology. Emerg Microbes Infect. 2019;8(1):1054-1065. https://doi.org/10.1080/22221751.2019.1640587

Perley CC, Brocato RL, Kwilas SA, et al. Three asymptomatic animal infection models of hemorrhagic fever with renal syndrome caused by hantaviruses. PLoS One. 2019;14(5):e0216700. https://doi.org/10.1371/journal.pone.0216700

Pessi A, Bixler SL, Soloveva V, et al. Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo. Antiviral Res. 2019;171:104592. https://doi.org/10.1016/j.antiviral.2019.104592

Pleet ML, DeMarino C, Stonier SW, et al. Extracellular vesicles and Ebola virus: a new mechanism of immune evasion. Viruses. 2019;11(5):pii E40. https://doi.org/10.3390/v11050410

Rajamani S, Sandy R, Kota K, et al. Robust biofilm assay for quantification and high throughput screening applications. J Microbiol Methods. 2019;159:179-185. https://doi.org/10.1016/j.mimet.2019.02.018

Ramirez de Arellano E, Sanchez-Lockhart M, Perteguer MJ, et al. First evidence of antibodies against Lloviu virus in Schreiber's bent-winged insectivorous bats demonstrate a wide circulation of the virus in Spain. Viruses. 2019;11(4):pii E60. https://doi.org/10.3390/v11040360

Ricks KM, Koehler J, Shoemaker C, Voorhees M, Schoepp R. Development of a sustainable diagnostic toolbox for serosurveillance of West African infectious diseases. Int J Infect Dis. 2019(suppl 1);79:24-25. https://doi.org/10.1016/j.ijid.2018.11.074

Ricks KM, Shoemaker CJ, Dupuy LC, et al. Development of a bead-based immunoassay using virus-like particles for detection of alphaviral humoral response. J Virol Methods. 2019;270:12-17. https://doi.org/10.1016/j.jviromet.2019.04.013

Rusnak JM, Dupuy LC, Niemuth NA, Glenn AM, Ward LA. Comparison of aerosol- and percutaneous-acquired Venezuelan equine encephalitis in humans and nonhuman primates for suitability in predicting clinical efficacy under the animal rule. Comp Med. 2018;68(5):380-395. https://doi.org/10.30802/AALAS-CM-18-000027

Rusnak JM, Glass PJ, Weaver SC, et al. Approach to strain selection and the propagation of viral stocks for Venezuelan equine encephalitis virus vaccine efficacy testing under the animal rule. Viruses. 2019;11(9):pii E807. https://doi.org/10.3390/v11090807

Saikh KU, Dankmeyer JL, Zeng X, Ulrich RG, Amemiya K. An increase in intracellular p62/NBR1 and persistence of Burkholderia mallei and B. pseudomallei in infected mice linked to autophagy deficiency. Immun Inflamm Dis. 2019;7(1):7-21. https://doi.org/10.1002/iid3.239

Salami K, Gouglas D, Schmaljohn C, Saville M, Tornieporth N. A review of Lassa fever vaccine candidates. Curr Opin Virol. 2019;37:105-111. https://doi.org/10.1016/j.coviro.2019.07.006

Samsa MM, Dupuy LC, Beard CW, et al. Self-amplifying RNA vaccines for Venezuelan equine encephalitis virus induce robust protective immunogenicity in mice. Mol Ther. 2019;27(4):850-865. https://doi.org/10.1016/j.ymthe.2018.12.013

Scarff JM, Waidyarachchi SL, Meyer CJ, et al. Aminomethyl spectinomycins: a novel antibacterial chemotype for biothreat pathogens. J Antibiot (Tokyo). 2019;72(9):693-701. https://doi.org/10.1038/s41429-019-0194-8

Schmaljohn C, Safronetz D. Editorial overview: Lassa virus. Curr Opin Virol. 2019;37:vii-ix. https://doi.org/10.1016/j.coviro.2019.09.001

Selakovic Ž, Tran JP, Kota KP, et al. Second generation of diazachrysenes: protection of Ebola virus infected mice and mechanism of action. Eur J Med Chem. 2019;162:32-50. https://doi.org/10.1016/j.ejmech.2018.10.061

Si LL, Meng K, Tian ZY, et al. Triterpenoids manipulate a broad range of virus-host fusion via wrapping the HR2 domain prevalent in viral envelopes. Sci Adv. 2018;4(11):eaau8408. https://doi.org/10.1126/sciadv.aau8408

Sichtig H, Minogue T, Yan Y, et al. FDA-ARGOS is a database with public quality-controlled reference genomes for diagnostic use and regulatory science. Nat Commun. 2019;10(1):3313. https://doi.org/10.1038/s41467-019-11306-6

Siddharthan V, Miao J, Van Wettere AJ, et al. Human polyclonal antibodies produced from transchromosomal bovine provides prophylactic and therapeutic protections against Zika virus infection in STAT2 KO Syrian hamsters. Viruses. 2019;11(2):pii E92. https://doi.org/10.3390/v11020092

Smith D, Shoemaker CJ, Garrison A, et al. The pathogenesis of genetically diverse strains of Crimean-Congo hemorrhagic fever virus in the cynomolgus macaque model. Int J Infect Dis. 2019;79(suppl 1):16. https://doi.org/10.1016/j.ijid.2018.11.056

Smith DR, Shoemaker CJ, Zeng X, et al. Persistent Crimean-Congo hemorrhagic fever virus infection in the testes and within granulomas of non-human primates with latent tuberculosis. PLoS Pathog. 2019;15(9):e1008050. https://doi.org/10.1371/journal.ppat.1008050

Sobarzo A, Stonier SW, Radinsky O, et al. Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors. EBioMedicine. 2019;46:215-226. https://doi.org/10.1016/j.ebiom.2019.07.021

Steger CL, Brown ML, Sullivan OM, et al. In vitro double-stranded RNA synthesis by rotavirus polymerase mutants with lesions at core shell contact sites. J Virol. 2019;93(20):pii e01049. https://doi.org/10.1128/JVI.01049-19

Totura AL, Bavari S. Broad-spectrum coronavirus antiviral drug discovery. Expert Opin Drug Discov. 2019;14(4):397-412. https://doi.org/10.1080/17460441.2019.1581171

Trevino SR, Klimko CP, Reed MC, et al. Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei. PLoS One. 2018;13(11):e0208277. https://doi.org/10.1371/journal.pone.0208277

Turell MJ, Gozalo AS, Guevara C, et al. Lack of evidence of sylvatic transmission of dengue viruses in the Amazon Rainforest near Iquitos, Peru. Vector Borne Zoonotic Dis. 2019;19(9):685-689. https://doi.org/10.1089/vbz.2018.2408

Turner MJ, Cox JK, Spellman AC, Stahl C, Bavari S. Avoidance behavior independent of innate-immune signaling seen in Caenorhabditis elegans challenged with Bacillus anthracis. Dev Comp Immunol. 2020;102:103453. https://doi.org/10.1016/j.dci.2019.103453

Verdonck S, Pu SY, Sorrell FJ, et al. Synthesis and structure-activity relationships of 3,5-disubstituted-pyrrolo 2,3-b pyridines as Inhibitors of adaptor-associated kinase 1 with antiviral activity. J Med Chem. 2019;62(12):5810-5831. https://doi.org/10.1021/acs.jmedchem.9b00136

Voorhees M, Ricks KM, Fulmer A, Quesinberry J, Poli M, Schoepp R. Development of a multiplexed antigen detection immunoassay for detection of viral agents. Int J Infect Dis. 2019;79(suppl 1):106. https://doi.org/10.1016/j.ijid.2018.11.264

Voorhees MA, Padilla SL, Jamsransuren D, et al. Crimean-Congo hemorrhagic fever virus, Mongolia, 2013-2014. Emerg Infect Dis. 2018;24(12):2202-2209. https://doi.org/10.3201/eid2412.180175

Ward MD, Brueggemann EE, Kenny T, et al. Characterization of the plasma proteome of nonhuman primates during Ebola virus disease or melioidosis: a host response comparison. Clin Proteomics. 2019;16. https://doi.org/10.1186/s12014-019-9227-3

Wec AZ, Bornholdt ZA, He S, et al. Development of a human antibody cocktail that deploys multiple functions to confer pan-Ebolavirus protection. Cell Host Microbe. 2019;25(1):39-48.e35. https://doi.org/10.1016/j.chom.2018.12.004

West BR, Wec AZ, Moyer CL, et al. Structural basis of broad ebolavirus neutralization by a human survivor antibody. Nat Struct Mol Biol. 2019;26(3):204-212. https://doi.org/10.1038/s41594-019-0191-4

Williamson LE, Flyak AI, Kose N, et al. Early human B cell response to Ebola virus in four U.S. survivors of infection. J Virol. 2019;93(8):pii e01439-18. https://doi.org/10.1128/JVI.01439-18

Zabetakis D, Shriver-Lake LC, Olson MA, Goldman ER, Anderson GP. Experimental evaluation of single-domain antibodies predicted by molecular dynamics simulations to have elevated thermal stability. Protein Sci. 2019;28(10):1909-1912. https://doi.org/10.1002/pro.3692

Abouelkhair MA, Thompson R, Riley MC, Bemis DA, Kania SA. Complete genome sequences of three staphylococcus pseudintermedius strains isolated from Botswana. Genome Announc. 2018;6(10):e01599-17. https://mra.asm.org/content/6/10/e01599-17.

Amarasinghe GK, Aréchiga Ceballos NG, Banyard AC, et al. Taxonomy of the order Mononegavirales: update 2018. Arch Virol. 2018;163(8):2283-2294. https://link.springer.com/article/10.1007/s00705-018-3814-x.

Arnold CE, Guito JC, Altamura LA, et al. Transcriptomics reveal antiviral gene induction in the Egyptian rousette bat is antagonized in vitro by Marburg virus infection. Viruses. 2018;10(11):E607. https://www.mdpi.com/1999-4915/10/11/607.

Bart SM, Cohen C, Dye JM, Shorter J, Bates P. Enhancement of Ebola virus infection by seminal amyloid fibrils. Proc Natl Acad Sci U S A. 2018;115(28):7410-7415. https://www.pnas.org/content/115/28/7410.

Bazzill JD, Stronsky SM, Kalinyak LC, et al. Vaccine nanoparticles displaying recombinant Ebola virus glycoprotein for induction of potent antibody and polyfunctional T cell responses. Nanomedicine. 2018 Nov 22. [Epub ahead of print]. https://www.sciencedirect.com/science/article/pii/S1549963418305562.

Blair PW, Keshtkar-Jahromi M, Psoter KJ, et al. Virulence of Marburg virus Angola compared to Mt. Elgon (Musoke) in macaques: a pooled survival analysis. Viruses. 2018;10(11):E658. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267608/.

Blitvich BJ, Beaty BJ, Blair CD, et al. Bunyavirus taxonomy: limitations and misconceptions associated with the current ICTV criteria used for species demarcation. Am J Trop Med Hyg. 2018;99(1):11-16. Epub 2018 Apr 19. https://www.ajtmh.org/content/journals/10.4269/ajtmh.18-0038.

Brangel P, Sobarzo A, Parolo C, et al. A serological point-of-care test for the detection of IgG antibodies against Ebola virus in human survivors. ACS Nano. 2018;12(1):63-73. https://pubs.acs.org/doi/10.1021/acsnano.7b07021.

Brocato RL, Wahl V, Hammerbeck CD, et al. Innate immune responses elicited by Sin Nombre virus or type I IFN agonists protect hamsters from lethal Andes virus infections. J Gen Virol. 2018;99(10):1359-1366. https://jgv.microbiologyresearch.org/content/journal/jgv/10.1099/jgv.0.001131.

Brown JF, Dye JM, Tozay S, et al. Anti-Ebola virus antibody levels in convalescent plasma and viral load after plasma infusion in patients with Ebola virus disease. J Infect Dis. 2018;218(4):555-562. https://academic.oup.com/jid/article/218/4/555/4967721.

Bruhn M, Schindler D, Kemter FS, et al. Functionality of two origins of replication in vibrio cholerae strains with a single chromosome. Front Microbiol. 2018;9:2932. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284228/.

Burke CW, Froude JW, Miethe S, et al. Human-like neutralizing antibodies protect mice from aerosol exposure with Western equine encephalitis virus. Viruses. 2018;10(4):E147. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923441/.

Caì Y, Iwasaki M, Beitzel BF, et al. Recombinant Lassa virus expressing green fluorescent protein as a tool for high-throughput drug screens and neutralizing antibody assays. Viruses. 2018;10(11):E655. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266387/.

Callendret B, Vellinga J, Wunderlich K, et al. A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. PLoS ONE. 2018;13(2):e0192312. Erratum in: PLoS ONE. 2018;13(4):e0196546. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819775/.

Cashman KA, Wilkinson ER, Zeng X, et al. Immune-mediated systemic vasculitis as the proposed cause of sudden-onset sensorineural hearing loss following Lassa virus exposure in Cynomolgus macaques. mBio. 2018;9(5):e01896-18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6212830/.

Chang AY, Encinales L, Porras A, et al. Frequency of chronic joint pain following Chikungunya virus infection: a Colombian cohort study. Arthritis Rheumatol. 2018;70(4):578-584. Epub 2018 Mar 2. https://onlinelibrary.wiley.com/doi/abs/10.1002/art.40384.

Chang AY, Lynch R, Martins K, et al. Long-term clinical outcomes of Zika-associated Guillain-Barre syndrome. Emerg Microbes Infect. 2018;7(1):148. https://www.nature.com/articles/s41426-018-0151-9.

Chang AY, Martins KA, Encinales L, et al. Chikungunya arthritis mechanisms in the Americas: a cross-sectional analysis of Chikungunya arthritis patients twenty-two months after infection demonstrating no detectable viral persistence in synovial fluid. Arthritis Rheumatol. 2018;70(4):585-593. Epub 2018 Mar 7. https://onlinelibrary.wiley.com/doi/abs/10.1002/art.40383.

Chang AY, Tritsch S, Reid SP, et al. The cytokine profile in acute Chikungunya infection is predictive of chronic arthritis 20 months post infection. Diseases. 2018;6(4):E95. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313749/.

Chateau A, Lunderberg JM, Oh SY, et al. Galactosylation of the secondary cell wall polysaccharide of Bacillus anthracis and its contribution to anthrax pathogenesis. J Bacteriol. 2018;200(5):e00562-17. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809694/.

Chen R, Mukhopadhyay S, Merits A, et al. ICTV virus taxonomy profile: Togaviridae. J Gen Virol. 2018;99(6):761-762. https://jgv.microbiologyresearch.org/content/journal/jgv/10.1099/jgv.0.001072.

Chiang CY, Uzoma I, Moore RT, et al. Mitigating the impact of antibacterial drug resistance through host-directed therapies: current progress, outlook, and challenges. mBio. 2018;9(1):e01932-17. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790911/.

Coffin KM, Liu J, Warren TK, et al. Persistent Marburg virus Infection in the testes of nonhuman primate survivors. Cell Host Microbe. 2018;24(3):405-416.e3. https://www.sciencedirect.com/science/article/pii/S1931312818304311.

Cooper TK, Huzella L, Johnson JC, et al. Histology, immunohistochemistry, and in situ hybridization reveal overlooked Ebola virus target tissues in the Ebola virus disease Guinea pig model. Sci Rep. 2018;8(1):1250. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5775334/.

de la Fuente C, Pinkham C, Dabbagh D, et al. Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection. PLoS ONE. 2018;13(2):e0191983. Erratum in: PLoS ONE. 2018;13(4): e0194633. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800665/.

Dokubo EK, Wendland A, Mate SE, et al. Persistence of Ebola virus after the end of widespread transmission in Liberia: an outbreak report. Lancet Infect Dis. 2018;18(9):1015-1024. https://www.thelancet.com/journals/lancet/article/PIIS1473-3099(18)30417-1/fulltext.

Dupuy LC, Richards MJ, Livingston BD, Hannaman D, Schmaljohn CS. A multiagent alphavirus DNA vaccine delivered by intramuscular electroporation elicits robust and durable virus-specific immune responses in mice and rabbits and completely protects mice against lethal Venezuelan, Western, and Eastern equine encephalitis virus aerosol challenges. J Immunol Res. 2018; 2018:8521060. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008678/.

Duy J, Honko AN, Altamura LA, et al. Virus-encoded miRNAs in Ebola virus disease. Sci Rep. 2018;8(1):6480. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915558/.

Dyall J, Nelson EA, DeWald LE, et al. Identification of combinations of approved drugs with synergistic activity against Ebola virus in cell cultures. J Infect Dis. 2018;218(suppl_5):S672-S678. https://academic.oup.com/jid/article/218/suppl_5/S672/5043462.

Edri A, Shemesh A, Iraqi M, et al. The Ebola-glycoprotein modulates the function of natural killer cells. Front Immunol. 2018;9:1428. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036185/.

Erasmus JH, Seymour RL, Kaelber JT, et al. Novel insect-specific Eilat virus-based chimeric vaccine candidates provide durable, mono- and multivalent, single-dose protection against lethal alphavirus challenge. J Virol. 2018;92(4):e01274-17. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790933/.

Espy N, Pérez-Sautu U, De Arellano ER, et al. Ribavirin had demonstrable effects on the Crimean-Congo hemorrhagic fever virus (CCHFV) population and load in a patient with CCHF infection. J Infect Dis. 2018;217(12):1952-1956. https://academic.oup.com/jid/article/217/12/1952/4951805.

Eugenia Loureiro M, Zorzetto-Fernandes AL, Radoshitzky S, Chi X, Dallari S, Marooki N, Leger P, Foscaldi S, Harjono V, Sharma S, Zid BM, Lopez N, de la Torre JC, Bavari S, Zuniga E. DDX3 suppresses type I interferons and favors viral replication during Arenavirus infection. PLoS Pathog. 20182;14(7):e1007125. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042795/.

Faye O, Pratt CB, Faye M, et al. Genomic characterisation of human monkeypox virus in Nigeria. Lancet Infect Dis. 2018;18(3):246. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(18)30043-4/fulltext.

Fedewa G, Radoshitzky SR, Chi X, et al. Ebola virus, but not Marburg virus, replicates efficiently and without required adaptation in snake cells. Virus Evol. 2018;4(2):vey034. .

Fernandez-Garcia MD, Volle R, Joffret ML, et al. Genetic characterization of Enterovirus A71 circulating in Africa. Emerg Infect Dis. 2018;24(4):754-757. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875259/.

Franz DR, Nasim A. Responsible life science research: the Pakistani leadership model. Health Secur. 2018;16(1):79-81. https://www.liebertpub.com/doi/10.1089/hs.2018.0006.

Froude JW, Herbert AS, Pelat T, et al. Post-exposure protection in mice against Sudan virus by a two antibody cocktail. Viruses. 2018;10(6):E286. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024315/.

Garcia-Rodriguez C, Razai A, Geren IN, et al. A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype E subtypes. Toxins (Basel). 2018;10(3): E105. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869393/.

Gehling AM, Kuszpit K, Bailey EJ, et al. Evaluation of volume of intramuscular injection into the caudal thigh muscles of female and male BALB/c mice (Mus musculus). J Am Assoc Lab Anim Sci. 2018;57(1):35-43. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875096/.

Ghosal KJ, Patel K, Singh BR, Hale ML. Role of critical elements in botulinum neurotoxin complex in toxin routing across intestinal and bronchial barriers. PLoS ONE. 2018;13(7):e0199524. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033393/.

Gunn BM, Yu WH, Karim MM, et al. A role for Fc function in therapeutic monoclonal antibody-mediated protection against Ebola virus. Cell Host Microbe. 2018;24(2):221-233.e5. https://www.sciencedirect.com/science/article/pii/S1931312818303792.

Haddow AD. The consequences of medically important invasive arthropods: the longhorned tick, Haemaphysalis longicornis. Clin Infectious Dis. 2018 Aug 11. [Epub ahead of print] https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciy695/5071751.

Huttner A, Agnandji ST, Combescure C, et al. Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study. Lancet Infect Dis. 2018;18(7):738-748. https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(18)30165-8/fulltext.

Jangra RK, Herbert AS, Li R, et al. Protocadherin-1 is essential for cell entry by New World hantaviruses. Nature. 2018;563(7732):559-563. https://www.nature.com/articles/s41586-018-0702-1.

Juarez D, Guevara C, Wiley M, et al. Isolation of complete equine encephalitis virus genome from human swab specimen, Peru. Emerg Infect Dis. 2018;24(8):1578-1580. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056129/.

Keasey SL, Smith JL, Fernandez S, et al. Impact of Dengue virus serotype 2 strain diversity on serological immune responses to dengue. ACS Infect Dis. 2018;4(12):1705-1717. https://pubs.acs.org/doi/10.1021/acsinfecdis.8b00185.

Kim WK, No JS, Lee SH, et al. Multiplex PCR−based next-generation sequencing and global diversity of Seoul virus in humans and rats. Emerg Infect Dis. 201824(2):249-257. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782898/.

Koehler JW, Douglas CE, Minogue TD. A highly multiplexed broad pathogen detection assay for infectious disease diagnostics. PLoS Negl Trop Dis. 2018;12(11):e0006889. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6245831/.

Koistinen K, Mullaney L, Bell T, et al. Coccidioidomycosis in nonhuman primates: pathologic and clinical findings. Vet Pathol. 2018;55(6):905-915. https://journals.sagepub.com/doi/10.1177/0300985818787306.

Konduru K, Shurtleff AC, Bavari S, Kaplan G. High degree of correlation between Ebola virus BSL-4 neutralization assays and pseudotyped VSV BSL-2 fluorescence reduction neutralization test. J Virol Methods. 2018;254:1-7. https://www.sciencedirect.com/science/article/pii/S016609341730469X.

Konstantinović J, Kiris E, Kota KP, et al. New steroidal 4-aminoquinolines antagonize botulinum neurotoxin serotype A in mouse embryonic stem cell derived motor neurons in postintoxication model. J Med Chem. 2018;61(4):1595-1608. https://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.7b01710.

Krakauer T. Living dangerously: Burkholderia pseudomallei modulates phagocyte cell death to survive. Med Hypotheses. 2018;121:64-69. https://www.sciencedirect.com/science/article/pii/S0306987718306261 .

Kwon EH, Reisler RB, Cardile AP, et al. Distinguishing respiratory features of category A/B potential bioterrorism agents from community-acquired pneumonia. Health Secur. 2018;16(4):224-238. https://www.liebertpub.com/doi/10.1089/hs.2018.0017.

Lane WC, Dunn MD, Gardner CL, et al. The efficacy of the interferon alpha/beta response versus arboviruses is temperature dependent. mBio. 2018;9(2):e00535-18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915735/.

Lindquist ME, Zeng X, Altamura LA, et al. Exploring Crimean-Congo hemorrhagic fever virus-induced hepatic injury using antibody-mediated type I interferon blockade in mice. J Virol. 2018;92(21):e01083-18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189508/.

Liu J, Kline BA, Kenny TA, et al. A novel sheet-like virus particle array is a hallmark of Zika virus infection. Emerg Microbes Infect. 2018;7:69. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915449/.

Liu PF, Wang Y, Ulrich RG, et al. Leaf-encapsulated vaccines: agroinfiltration and transient expression of the antigen staphylococcal endotoxin B in radish leaves. J Immunol Res. 2018;2018:3710961. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5821973/ .

Losada L, Shea AA, DeShazer D. A MarR family transcriptional regulator and subinhibitory antibiotics regulate type VI secretion gene clusters in Burkholderia pseudomallei. Microbiology. 2018;164(9):1196-1211. https://mic.microbiologyresearch.org/content/journal/micro/10.1099/mic.0.000697.

Lountos GT, Kurussi SR, Zhao BM, et al. High-resolution crystal structures of the D1 and D2 domains of protein tyrosine phosphatase epsilon for structure-based drug design. Acta Crystallogr Sect D Struct Biol. 2018;74(Pt 10):1015-1026. http://scripts.iucr.org/cgi-bin/paper?ni5003.

Loureiro ME, Zorzetto-Fernandes AL, Radoshitzky S, et al. DDX3 suppresses type I interferons and favors viral replication during arenavirus infection. PLoS Pathog. 2018;14(7):e1007125. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042795/.

Lowen RG, Bocan TM, Kane CD, et al. Countering Zika virus: the USAMRIID response. In Hilgenfeld R, Vasudevan S, eds. Dengue and Zika: Control and Antiviral Treatment Strategies. Singapore: Springer Singapore; 2018:303-318. Advances in Experimental Medicine and Biology; vol 1062. https://link.springer.com/chapter/10.1007/978-981-10-8727-1_21.

Luke T, Bennett RS, Gerhardt DM, et al. Fully human Immunoglobulin G from transchromosomic bovines treats nonhuman primates infected with Ebola virus makona isolate. J Infect Dis. 2018;218(suppl 5):S636-S648. https://academic.oup.com/jid/article/218/suppl_5/S636/5054139.

Maes P, AlkhovskySV, Bào Y, et al. Taxonomy of the family arenaviridae and the order Bunyavirales: update 2018. Arch Virol. 2018;163(8):2295-2310. https://link.springer.com/article/10.1007/s00705-018-3843-5.

Mate SE, Wiley MR, Ladner JT, et al. Cross-border transmission of Ebola virus as the cause of a resurgent outbreak in Liberia in April 2016. Clin Infect Dis. 2018;67(7):1147-1149. https://academic.oup.com/cid/article/67/7/1147/4961445.

Maxson T, Blancett CD, Graham AS, Stefan CP, Minogue TD. Rapid antibiotic susceptibility testing from blood culture bottles with species agnostic real-time polymerase chain reaction. PLoS ONE. 2018;13(12):e0209042. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6292663/.

Miller LJ, Fetterer DP, Garza NL, et al. A fixed moderate-dose combination of tiletamine+zolazepam outperforms midazolam in induction of short-term immobilization of ball pythons (Python regius). PLoS ONE. 2018;13(10):e0199339. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195258/.

Miller LJ, Nasar F, Schellhase CW, et al. Zika virus infection in Syrian golden hamsters and strain 13 Guinea pigs. Am J Trop Med Hyg. 2018;98(3):864-867. http://www.ajtmh.org/content/journals/10.4269/ajtmh.17-0686.

Minogue TD, Koehler JW, Stefan CP, Conrad TA. Next-generation sequencing for biodefense: biothreat detection, forensics, and the clinic. Clinical Chem. 2018 Oct 23. [Epub ahead of print]. http://clinchem.aaccjnls.org/content/early/2018/10/23/clinchem.2016.266536.

Mohr EL, Block LN, Newman CM, et al. Ocular and uteroplacental pathology in a macaque pregnancy with congenital Zika virus infection. PLoS ONE. 2018;13(1):e0190617. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5790226/.

Mucker EM, Wollen-Roberts SE, Kimmel A, et al. Intranasal monkeypox marmoset model: prophylactic antibody treatment provides benefit against severe monkeypox virus disease. PLoS Negl Trop Dis. 2018;12(6):e0006581. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029809/.

Mukherjee S, Griffin DH, Horn JR, et al. Engineered synthetic antibodies as probes to quantify the energetic contributions of ligand binding to conformational changes in proteins. J Biol Chem. 2018;293(8):2815-2828. http://www.jbc.org/content/293/8/2815/suppl/DC1.

Nielsen CM, Vekemans J, Lievens M, et al. RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype. Vaccine. 2018;36(12):1637-1642. https://www.sciencedirect.com/science/article/pii/S0264410X18301427.

Nunes MR, de Souza WM, Savji N, et al. Oropouche orthobunyavirus: genetic characterization of full-length genomes and development of molecular methods to discriminate natural reassortments. Infect Genet Evol. 2019;68:16-22. https://www.sciencedirect.com/science/article/pii/S1567134818309316.

Nyakatura EK, Zak SE, Wec AZ, et al. Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteins. J Biol Chem. 2018;293(16):6201-6211. http://www.jbc.org/content/293/16/6201.abstract.

Oliveira DBL, Durigon GS, Mendes É, et al. Persistence and intra-host genetic evolution of Zika virus infection in symptomatic adults: a special view in the male reproductive system. Viruses. 2018;10(11):615. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267439/.

Olson MA. Conformational selection of a polyproline peptide by Ebola virus VP30. Proteomics. 2018;18(21-22):e1800081. https://onlinelibrary.wiley.com/doi/10.1002/pmic.201800081.

Osorio-Guarin JA, Quackenbush CR, Cornejo OE. Ancestry informative alleles captured with reduced representation library sequencing in Theobroma cacao. PLoS One. 2018;13(10):e0203973. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192562/.

Otvos L Jr, Ostorhazi E, Szabo D, et al. Synergy between proline-rich antimicrobial peptides and small molecule antibiotics against selected gram-negative pathogens in vitro and in vivo. Front Chem. 2018;6:309. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102830/.

Pascal KE, Dudgeon D, Trefry JC, et al. Development of clinical-stage human monoclonal antibodies that treat advanced Ebola virus disease in nonhuman primates. J Infect Dis. 2018;218(suppl 5):S612-S626. https://academic.oup.com/jid/article/218/suppl_5/S612/5025816.

Pavlovich SS, Lovett SP, Koroleva G, et al. The Egyptian rousette genome reveals unexpected features of bat antiviral immunity. Cell. 2018;173(5):1098-1110.e1018. https://www.sciencedirect.com/science/article/pii/S0092867418304021.

Pawęska JT, Jansen van Vuren P, Kemp A, et al. Marburg virus infection in Egyptian rousette bats, South Africa, 2013–2014. Emerg Infect Dis. 2018;24(6):1134-1137. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004853/.

Pelin M, Sosa S, Brovedani V, et al. A novel sensitive cell-based immunoenzymatic assay for palytoxin quantitation in mussels. Toxins (Basel). 2018;10(8):E329. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116170/.

Plaut RD, Staab AB, Munson MA, et al. Avirulent bacillus anthracis strain with molecular assay targets as surrogate for irradiation-inactivated virulent spores. Emerg Infect Dis. 2018;24(4):691-699. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875273/.

Pleet ML, Erickson J, DeMarino C, et al. Ebola virus VP40 odulates cell cycle and biogenesis of extracellular vesicles. J Infect Dis. 2018;218(suppl 5):S365-S387. https://academic.oup.com/jid/article/218/suppl_5/S365/5087651.

Poli M, Ruiz-Olvera P, Nalca A, et al. Toxicity and pathophysiology of palytoxin congeners after intraperitoneal and aerosol administration in rats. Toxicon. 2018;150:235-250. https://www.sciencedirect.com/science/article/pii/S0041010118302782.

Pu SY, Wouters R, Schor S, Rozenski J, et al. Optimization of isothiazolo[4,3- b]pyridine-based inhibitors of cyclin G associated kinase (GAK) with broad-spectrum antiviral activity. J Med Chem. 2018;61(14):6178-6192. https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00613.

Rajamani S, Kuszpit K, Scarff JM, et al. Bioengineering of bacterial pathogens for noninvasive imaging and in vivo evaluation of therapeutics. Sci Rep. 2018;8(1):12618. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105664/ .

Reisler RB, Zeng X, Schellhase CW, et al. Ebola virus causes intestinal tract architectural disruption and bacterial invasion in non-human primates. Viruses. 2018;10(10):E513. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213817/.

Richardson JB, Dancy BCR, Horton CL, et al. Exposure to toxic metals triggers unique responses from the rat gut microbiota. Sci Rep. 2018;8(1):6578. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919903/.

Rosenke K, Bounds CE, Hanley PW, et al. Human polyclonal antibodies produced by transchromosomal cattle provide partial protection against lethal Zaire ebolavirus challenge in rhesus macaques. J Infect Dis. 2018;218(suppl 5):S658-S661. https://academic.oup.com/jid/article/218/suppl_5/S658/5059678?searchresult=1.

Ruedas JB, Arnold CE, Palacios G, Connor JH. Growth-adaptive mutations in the Ebola virus makona glycoprotein alter different steps in the virus entry pathway. J Virol. 2018;92(19):e00820-18. https://jvi.asm.org/content/92/19/e00820-18/article-info.

Ruiz SI, Bowen LE, Bailey MM, Berkland C. Pulmonary delivery of Ceftazidime for the treatment of melioidosis in a murine model. Mol Pharm. 2018;15(3):1371-1376. https://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00938.

Rusnak JM, Dupuy LC, Niemuth NA, Glenn AM, Ward LA. Comparison of aerosol- and percutaneous-acquired Venezuelan equine encephalitis in humans and nonhuman primates for suitability in predicting clinical efficacy under the animal rule. Comp Med. 2018;68(5):380-395. https://www.ingentaconnect.com/content/aalas/cm/2018/00000068/00000005/art00008.

Saikh KU, Dankmeyer JL, Zeng X, Ulrich RG, Amemiya K. An increase in intracellular p62/NBR1 and persistence of Burkholderia mallei and B. pseudomallei in infected mice linked to autophagy deficiency. Immun Inflamm Dis. 2018 Dec 19. [Epub ahead of print]. https://onlinelibrary.wiley.com/openurl?rft_id=info:pmid/30569531.

Sanchez-Lockhart M, Reyes DS, Gonzalez JC, et al. Qualitative profiling of the humoral immune response elicited by rVSV-DeltaG-EBOV-GP using a systems serology assay, domain programmable arrays. Cell Rep. 2018;24(4):1050-1059.e1055. https://www.sciencedirect.com/science/article/pii/S2211124718310040.

Sathkumara HD, Merritt AJ, Corea EM, et al. Clinical, bacteriologic, and geographic stratification of melioidosis emerges from the Sri Lankan National Surveillance Program. Am J Trop Med Hyg. 2018;98(2):607-615. http://www.ajtmh.org/content/journals/10.4269/ajtmh.17-0441.

Schafer A, Cheng H, Xiong R, et al. Repurposing potential of 1st generation H1-specific antihistamines as anti-filovirus therapeutics. Antiviral Res. 2018;157:47-56. https://www.sciencedirect.com/science/article/pii/S0166354218303012.

Schuchman R, Kilianski A, Piper A, et al. Comparative characterization of the Sindbis virus proteome from mammalian and invertebrate hosts identifies nsp2 as a component of the virion and sorting nexin 5 as a significant host factor for alphavirus replication. J Virol. 2018;92(14):e00694-18. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026752/.

Selakovic Z, Tran JP, Kota KP, et al. Second generation of diazachrysenes: protection of Ebola virus infected mice and mechanism of action. Eur J Med Chem. 2019;162:32-50. https://www.sciencedirect.com/science/article/pii/S0223523418309383.

Shantha JG, Mattia JG, Goba A, et al. Ebola Virus Persistence in Ocular Tissues and Fluids (EVICT) Study: reverse transcription-polymerase chain reaction and cataract surgery outcomes of Ebola survivors in Sierra Leone. EBioMedicine. 2018;30:217-224. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952345/.

Si L, Meng K, Tian Z, et al. Triterpenoids manipulate a broad range of virus-host fusion via wrapping the HR2 domain prevalent in viral envelopes. Sci Adv. 2018;4(11):eaau8408. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248931/.

Smith DR, Bocan TM. Could PET imaging provide insights into Zika virus neurological sequelae progression? Future Virol. 2018;13(2):75-78. https://www.futuremedicine.com/doi/full/10.2217/fvl-2017-0137.

Smith DR, Johnston SC, Piper A, et al. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates. PLoS Negl Trop Dis. 2018;12(5):e000647. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962102/.

Smith JL, Pugh CL, CisneyED, et al. Human antibody responses to emerging Mayaro virus and cocirculating alphavirus infections examined by using structural proteins from nine New and Old World lineages. mSphere. 2018;3(2):e00003-18. https://msphere.asm.org/content/3/2/e00003-18.

Speranza E, Bixler SL, Altamura LA, et al. A conserved transcriptional response to intranasal Ebola virus exposure in nonhuman primates prior to onset of fever. Sci Transl Med. 2018;10(434):eaaq1016. http://stm.sciencemag.org/content/10/434/eaaq1016.

Stefan CP, Hall AT, Minogue TD. Detection of 16S rRNA and KPC genes from complex matrix utilizing a molecular inversion probe assay for next-generation sequencing. Sci Rep. 2018;8(1):2028. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794912/.

Stidham RA, Freeman DB, von Tersch RL, Sullivan PJ, Tostenson SD. Epidemiological review of Francisella Tularensis: a case study in the complications of dual diagnoses. PLoS Curr. 2018;10: ecurrents.outbreaks.8eb0b55f377abc2d250314bbb8fc9d6d. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5774973/.

Suckling CJ, Alam S, Olson MA, et al. Small molecule analogues of the parasitic worm product ES-62 interact with the TIR domain of MyD88 to inhibit pro-inflammatory signalling. Sci Rep. 2018;8(1):2123. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794923/.

Suschak JJ, Bagley K, Shoemaker CJ, et al. The genetic adjuvants Interleukin-12 and granulocyte-macrophage colony stimulating factor enhance the immunogenicity of an Ebola virus deoxyribonucleic acid vaccine in mice. J Infect Dis. 2018;218(suppl 5):S519-S527. https://academic.oup.com/jid/article/218/suppl_5/S519/5056373.

Suschak JJ, Bagley K, Six C, et al. The genetic adjuvant IL-12 enhances the protective efficacy of a DNA vaccine for Venezuelan equine encephalitis virus delivered by intramuscular injection in mice. Antiviral Res. 2018;159:113-121. https://www.sciencedirect.com/science/article/pii/S0166354218303784.

Trevino SR, Klimko CP, Reed MC, et al. Disease progression in mice exposed to low-doses of aerosolized clinical isolates of Burkholderia pseudomallei. PLoS ONE. 2018;13(11):e0208277. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6267979/.

van Vuren PJ, Allam M, Wiley MR, et al. A novel adenovirus isolated from the Egyptian fruit bat in South Africa is closely related to recent isolates from China. Sci Rep. 2018;8(1):9584. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018157/.

Voorhees MA, Padilla SL, Jamsransuren D, et al. Crimean-Congo hemorrhagic fever virus, Mongolia, 2013-2014. Emerg Infect Dis. 2018;24(12):2202-2209. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256378/.

Wang MK, Ren T, Liu H, et al. Critical role for cholesterol in Lassa fever virus entry identified by a novel small molecule inhibitor targeting the viral receptor LAMP1. PLoS Pathog. 2018;14(9):e1007322. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179309/.

Warfield KL, Howell KA, Vu H, et al. Role of antibodies in protection against Ebola virus in nonhuman primates immunized with three vaccine platforms. J Infect Dis. 2018;218(suppl 5):S553-S564. https://academic.oup.com/jid/article/218/suppl_5/S553/5043486.

Webb RP. Engineering of botulinum neurotoxins for biomedical applications. Toxins (Basel). 2018;10(6):E321. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024800/.

Whitmer SL, Ladner JT, Wiley MR, et al. Active Ebola virus replication and heterogeneous evolutionary rates in EVD Survivors. Cell Rep. 2018;22(5):1159-1168. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809616/.

Agnandji ST, Fernandes JF, Bache EB, Obiang RM, Brosnahan JS, et al. 2017. Safety and immunogenicity of rVSV Delta G-ZEBOV-GP Ebola vaccine in adults and children in Lambarene A, Gabon: A phase I randomised trial. Plos Medicine 14.

Akhvlediani T, Bautista CT, Garuchava N, Sanodze L, Kokaia N, et al. 2017. Epidemiological and Clinical Features of Brucellosis in the Country of Georgia. Plos One 12

Aliota MT, Bassit L, Bradrick SS, Cox B, Garcia-Blanco MA, et al. 2017. Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network. Antiviral Research 144:223-46

Altamura LA, Cazares LH, Coyne SR, Jaissle JG, Jespersen AM, et al. 2017. Inactivation of West Nile virus in serum with heat, ionic detergent, and reducing agent for proteomic applications. Journal of Virological Methods 248:1-6.

Amarasinghe GK, Bao YM, Basler CF, Bavari S, Beer M, et al. 2017. Taxonomy of the order Mononegavirales: update 2017. Archives of Virology 162:2493-504

Andrews CD, Luo Y, Sun M, Yu J, Goff AJ, et al. 2017. In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola Infections. Molecular Therapy-Methods & Clinical Development 7:74-82.

Bam M, Yang X, Zumbrun EE, Ginsberg JP, Leyden Q, et al. 2017. Decreased AGO2 and DCR1 in PBMCs from War Veterans with PTSD leads to diminished miRNA resulting in elevated inflammation. Translational Psychiatry 7.

Bao YM, Amarasinghe GK, Basler CF, Bavari S, Bukreyev A, et al. 2017. Implementation of Objective PASC-Derived Taxon Demarcation Criteria for Official Classification of Filoviruses. Viruses-Basel 9.

Barnes KG, Kindrachuk J, Lin AE, Wohl S, Qu J, et al. 2017. Evidence of Ebola Virus Replication and High Concentration in Semen of a Patient During Recovery. Clinical Infectious Diseases 65:1400-3.

Bartsch SM, McKinnell JA, Mueller LE, Miller LG, Gohil SK, et al. 2017. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Clinical Microbiology and Infection 23.

Bearss JJ, Hunter M, Dankmeyer JL, Fritts KA, Klimko CP, et al. 2017. Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice. Plos One 12.

Bekerman E, Neveu G, Shulla A, Brannan J, Pu SY, et al. 2017. Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects. Journal of Clinical Investigation 127:1338-52.

Bell TM, Shaia CI, Bearss JJ, Mattix ME, Koistinen KA, et al. 2017. Temporal Progression of Lesions in Guinea Pigs Infected With Lassa Virus. Veterinary Pathology 54:549-62.

Bernhards RC, Cote CK, Amemiya K, Waag DM, Klimko CP, et al. 2017. Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia mallei strains potentially associated with persistent infection in mice. Archives of Microbiology 199:277-301.

Blancett CD, Fetterer DP, Koistinen KA, Morazzani EM, Monninger MK, et al. 2017. Accurate virus quantitation using a Scanning Transmission Electron Microscopy (STEM) detector in a scanning electron microscope. Journal of Virological Methods 248:136-44.

Blancett CD, Monninger MK, Nguessan CA, Kuehl KA, Rossi CA, et al. 2017. Utilization of Capsules for Negative Staining of Viral Samples within Biocontainment. Jove-Journal of Visualized Experiments.

Bolton DL, McGinnis K, Finak G, Chattopadhyay P, Gottardo R, Roederer M. 2017. Combined single-cell quantitation of host and SIV genes and proteins ex vivo reveals host-pathogen interactions in individual cells. Plos Pathogens 13.

Bounds CE, Terry FE, Moise L, Hannaman D, Martin WD, et al. 2017. An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice. Human Vaccines & Immunotherapeutics 13:2824-36.

Bowen LE, Bailey MM, Haupt BR, Anderson JB. 2017. Development and characterization of an oro-nasal inhalation plethysmography mask exposure system. Aerosol Science and Technology 51:509-17.

Brahms A, Mudhasani R, Pinkham C, Kota K, Nasar F, et al. 2017. Sorafenib Impedes Rift Valley Fever Virus Egress by Inhibiting Valosin-Containing Protein Function in the Cellular Secretory Pathway. Journal of Virology 91.

Brown JF, Rowe K, Zacharias P, van Hasselt J, Dye JM, et al. 2017. Apheresis for collection of Ebola convalescent plasma in Liberia. Journal of Clinical Apheresis 32:175-81.

Burnouf T, Dye JM, Abayomi A, Consortium GET. 2017. Convalescent Plasma and the Dose of Ebola Virus Antibodies. New England Journal of Medicine 376:1296-7.

Cao LH, Yang D, Wu W, Zeng XK, Jing BY, et al. 2017. Odor-evoked inhibition of olfactory sensory neurons drives olfactory perception in Drosophila. Nature Communications 8.

Cardile AP, Warren TK, Martins KA, Reisler RB, Bavari S. 2017. Will There Be a Cure for Ebola? In Annual Review of Pharmacology and Toxicology, Vol 57, ed. PA Insel, 57:329-48. Number of 329-48 pp.

Cashman KA, Wilkinson ER, Shaia CI, Facemire PR, Bell TM, et al. 2017. A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever. Human Vaccines & Immunotherapeutics 13:2902-11.

Cashman KA, Wilkinson ER, Wollen SE, Shamblin JD, Zelko JM, et al. 2017. DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs. Human Vaccines & Immunotherapeutics 13:3010-9.

Caviness K, Kuhn JH, Palacios G. 2017. Ebola virus persistence as a new focus in clinical research. Current Opinion in Virology 23:43-8

Chance T, Chua J, Toothman RG, Ladner JT, Nuss JE, et al. 2017. A spontaneous mutation in kdsD, a biosynthesis gene for 3 Deoxy-D-manno-Octulosonic Acid, occurred in a ciprofloxacin resistant strain of Francisella tularensis and caused a high level of attenuation in murine models of tularemia. Plos One 12.

Chang A, Encinales L, Porras A, Pacheco N, Reid SP, et al. 2017. Frequency of Chronic Joint Pain Following Chikungunya Infection: A Colombian Cohort Study. Arthritis & Rheumatology 69.

Chang A, Martins K, Encinales L, Reid S, Acuna M, et al. 2017. Cross-Sectional Analysis of Chikungunya Arthritis Patients 22-Months Post-Infection Demonstrates a Lack of Viral Persistence in Synovial Fluid. Arthritis & Rheumatology 69.

Chaudhury S, Ockenhouse CF, Regules JA, Dutta S, Wallqvist A, et al. 2017. THE BIOLOGICAL FUNCTION OF ANTIBODIES INDUCED BY THE RTS,S/AS01 MALARIA VACCINE CANDIDATE IS DETERMINED BY THEIR FINE SPECIFICITY. American Journal of Tropical Medicine and Hygiene 95:503-4.

Chaudhury S, Regules JA, Darko CA, Dutta S, Wallqvist A, et al. 2017. Delayed fractional dose regimen of the RTS, S/AS01 malaria vaccine candidate enhances an IgG4 response that inhibits serum opsonophagocytosis. Scientific Reports 7.

Cheng H, Schafer A, Soloveva V, Gharaibeh D, Kenny T, et al. 2017. Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor. Antiviral Research 145:24-32.

Cheng S, Caviness K, Buehler J, Smithey M, Nikolich-Zugich J, Goodrum F. 2017. Transcriptome-wide characterization of human cytomegalovirus in natural infection and experimental latency. Proceedings of the National Academy of Sciences of the United States of America 114:E10586-E95.

Chua J, Fisher NA, Falcinelli SD, DeShazer D, Friedlander AM. 2017. The Madagascar Hissing Cockroach As an Alternative Non-Mammalian Animal Model to Investigate Virulence, Pathogenesis, and Drug Efficacy. Jove-Journal of Visualized Experiments.

Chua J, Senft JL, Lockett SJ, Brett PJ, Burtnick MN, et al. 2017. pH Alkalinization by Chloroquine Suppresses Pathogenic Burkholderia Type 6 Secretion System 1 and Multinucleated Giant Cells. Infection and Immunity 85.

Cooper CL, Martins KA, Stronsky SM, Langan DP, Steffens J, et al. 2017. T-cell-dependent mechanisms promote Ebola VLP-induced antibody responses, but are dispensable for vaccine-mediated protection. Emerging Microbes & Infections 6.

Costa-da-Silva AL, Ioshino RS, Petersen V, Lima AF, Cunha MDP, et al. 2017. First report of naturally infected Aedes aegypti with chikungunya virus genotype ECSA in the Americas. Plos Neglected Tropical Diseases 11.

Dodson BL, Andrews ES, Turell MJ, Rasgon JL. 2017. Wolbachia effects on Rift Valley fever virus infection in Culex tarsalis mosquitoes. Plos Neglected Tropical Diseases 11.

Dudas G, Carvalho LM, Bedford T, Tatem AJ, Baele G, et al. 2017. Virus genomes reveal factors that spread and sustained the Ebola epidemic. Nature 544:309-+,

ElSherif MS, Brown C, MacKinnon-Cameron D, Li L, Racine T, et al. 2017. Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial. Canadian Medical Association Journal 189:E819-E27.

Erasmus JH, Auguste AJ, Kaelber JT, Luo H, Rossi SL, et al. 2017. A chikungunya fever vaccine utilizing an insect-specific virus platform. Nature Medicine 23:192-9.

Erwin-Cohen RA, Porter AI, Pittman PR, Rossi CA, DaSilva L. 2017. Human transcriptome response to immunization with live-attenuated Venezuelan equine encephalitis virus vaccine (TC-83): Analysis of whole blood. Human Vaccines & Immunotherapeutics 13:169-79.

Falcinelli SD, Shi MC, Friedlander AM, Chua J. 2017. Green tea and epigallocatechin-3-gallate are bactericidal against Bacillus anthracis. Fems Microbiology Letters 364.

Fan YF, Garcia-Rodriguez C, Lou JL, Wen WH, Conrad F, et al. 2017. A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes. Plos One 12.

Fraga M, Vilarino N, Louzao MC, Molina L, Lopez Y, et al. 2017. First Identification of Palytoxin-Like Molecules in the Atlantic Coral Species Palythoa canariensis. Analytical Chemistry 89:7438-46.

Froude JW, Pelat T, Miethe S, Zak SE, Wec AZ, et al. 2017. Generation and characterization of protective antibodies to Marburg virus. Mabs 9:696-703.

Gao D, Cazares LH, Fish EN. 2017. CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis. Bmc Cancer 17.

Garrison AR, Shoemaker CJ, Golden JW, Fitzpatrick CJ, Suschak JJ, et al. 2017. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models. Plos Neglected Tropical Diseases 11.

Gayen M, Gupta P, Morazzani EM, Gaidamakova EK, Knollmann-Ritschel B, et al. 2017. Deinococcus Mn2+-peptide complex: A novel approach to alphavirus vaccine development. Vaccine 35:3672-81.

Golden JW, Beitzel B, Ladner JT, Mucker EM, Kwilas SA, et al. 2017. An attenuated Machupo virus with a disrupted L-segment intergenic region protects guinea pigs against lethal Guanarito virus infection. Scientific Reports 7.

Grossman TH, Anderson MS, Christ D, Gooldy M, Henning LN, et al. 2017. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Francisella tularensis SCHU S4 Infection in BALB/c Mice and Cynomolgus Macaques. Antimicrobial Agents and Chemotherapy 61.

Grubaugh ND, Fauver JR, Ruckert C, Weger-Lucarelli J, Garcia-Luna S, et al. 2017. Mosquitoes Transmit Unique West Nile Virus Populations during Each Feeding Episode. Cell Reports 19:709-18.

Grubaugh ND, Ladner JT, Kraemer MUG, Dudas G, Tan AL, et al. 2017. Genomic epidemiology reveals multiple introductions of Zika virus into the United States. Nature 546:401-+.

Haddow AD, Nalca A, Rossi FD, Miller LJ, Wiley MR, et al. 2017. High Infection Rates for Adult Macaques after Intravaginal or Intrarectal Inoculation with Zika Virus. Emerging Infectious Diseases 23:1274-81.

Haddow AD, Nasar F, Schellhase CW, Moon RD, Padilla SL, et al. 2017. Low potential for mechanical transmission of Ebola virus via house flies (Musca domestica). Parasites & Vectors 10.

Harbourt DE, Johnston SC, Pettitt J, Warren TK, Dorman WR. 2017. Detection of Ebola Virus RNA Through Aerosol Sampling of Animal Biosafety Level 4 Rooms Housing Challenged Nonhuman Primates. Journal of Infectious Diseases 215:554-8.

Harrell WA, Vieira RC, Ensel SM, Montgomery V, Guernieri R, et al. 2017. A matrix-focused structure-activity and binding site flexibility study of quinolinol inhibitors of botulinum neurotoxin serotype A. Bioorganic & Medicinal Chemistry Letters 27:675-8.

Heine HS, Miller L, Halasohoris S, Purcell BK. 2017. In Vitro Antibiotic Susceptibilities of Francisella tularensis Determined by Broth Microdilution following CLSI Methods. Antimicrobial Agents and Chemotherapy 61.

Hoff NA, Morier DS, Kisalu NK, Johnston SC, Doshi RH, et al. 2017. Varicella Coinfection in Patients with Active Monkeypox in the Democratic Republic of the Congo. Ecohealth 14:564-74.

Hofmann D, Zak SE, Nyakatura EK, Mittler E, Bakken RR, et al. 2017. Mechanistic and Fc requirements for inhibition of Sudan virus entry and in vivo protection by a synthetic antibody. Immunology Letters 190:289-95.

Hostler JM, Sheikh KL, Andrada TF, Khramtsov A, Holley PR, Holley AB. 2017. A mobile, web-based system can improve positive airway pressure adherence. Journal of Sleep Research 26:139-46.

Howell KA, Brannan JM, Bryan C, McNeal A, Davidson E, et al. 2017. Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus. Cell Reports 19:413-24.

Huszar S, Singh V, Polcicova A, Barath P, Barrio MB, et al. 2017. N-Acetylglucosamine-1-Phosphate Transferase, WecA, as a Validated Drug Target in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 61.

Kash JC, Walters KA, Kindrachuk J, Baxter D, Scherler K, et al. 2017. Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease. Science Translational Medicine 9.

Kearney BJ, Voorhees MA, Williams PL, Olschner SP, Rossi CA, Schoepp RJ. 2017. Corning HYPERFlask (R) for viral amplification and production of diagnostic reagents. Journal of Virological Methods 242:9-13.

Keasey SL, Pugh CL, Jensen SMR, Smith JL, Hontz RD, et al. 2017. Antibody Responses to Zika Virus Infections in Environments of Flavivirus Endemicity. Clinical and Vaccine Immunology 24.

Khavrutskii IV, Chaudhury S, Stronsky SM, Lee DW, Benko JG, et al. 2017. Quantitative Analysis of Repertoire-Scale Immunoglobulin properties in Vaccine-Induced B-cell Responses. Frontiers in Immunology 8:1-15.

Kopek BG, Paez-Segala MG, Shtengel G, Sochacki KA, Sun MG, et al. 2017. Diverse protocols for correlative super-resolution fluorescence imaging and electron microscopy of chemically fixed samples. Nature Protocols 12:916-46.

Kortepeter MG, Cieslak TJ, Kwon EH, Smith PW, Kratochvil CJ, Hewlett AL. 2017. Comment on "Ebola Virus Infection among Western Healthcare Workers Unable to Recall the Transmission Route". Biomed Research International.

Kortepeter MG, Kwon EH, Christopher GW, Hewlett AL, Cieslak TJ. 2017. Interagency cooperation is the key to an effective pandemic response. Lancet Infectious Diseases 17:21-.

Krishnananthasivam S, Jayathilaka N, Sathkumara HD, Corea E, Natesan M, De Silva AD. 2017. Host gene expression analysis in Sri Lankan melioidosis patients. Plos Neglected Tropical Diseases 11.

Kugelman JR, Wiley MR, Nagle ER, Reyes D, Pfeffer BP, et al. 2017. Error baseline rates of five sample preparation methods used to characterize RNA virus populations. Plos One 12.

Kuhn JH, Bavari S. 2017. Asymptomatic Ebola virus infections-myth or reality? Lancet Infectious Diseases 17:570-1.

Lee DW, Khavrutskii IV, Wallqvist A, Bavari S, Cooper CL, Chaudhury S. 2017. BRILIA: Integrated Tool for High-Throughput Annotation and Lineage tree Assembly of B-Cell Repertoires. Frontiers in Immunology 7.

Legler PM, Compton JR, Hale ML, Anderson GP, Olson MA, et al. 2017. Stability of isolated antibody-antigen complexes as a predictive tool for selecting toxin neutralizing antibodies. Mabs 9:43-57.

Lennemann NJ, Herbert AS, Brouillette R, Rhein B, Bakken RA, et al. 2017. Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice. Journal of Virology 91.

Liang JN, Jangra RK, Bollinger L, Wada J, Radoshitzky SR, et al. 2017. Candidate medical countermeasures targeting Ebola virus cell entry. Future Virology 12:119-40.

Liu C, Zhao Z, Fan J, Lyon CJ, Wu HJ, et al. 2017. Quantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring. Proceedings of the National Academy of Sciences of the United States of America 114:3969-74.

Maxson T, Taylor-Howell CL, Minogue TD. 2017. Semi-quantitative MALDI-TOF for antimicrobial susceptibility testing in Staphylococcus aureus. Plos One 12.

Minogue TD, Koehler JW, Norwood DA. 2017. Targeted Next-Generation Sequencing for Diagnostics and Forensics. Clinical Chemistry 63:450-2.

Mitchell DAJ, Dupuy LC, Sanchez-Lockhart M, Palacios G, Back JW, et al. 2017. Epitope mapping of Ebola virus dominant and subdominant glycoprotein epitopes facilitates construction of an epitope-based DNA vaccine able to focus the antibody response in mice. Human Vaccines & Immunotherapeutics 13:2883-93.

Mott TM, Shoe JL, Hunter M, Woodson AM, Fritts KA, et al. 2017. Comparison of sampling methods to recover germinated Bacillus anthracis and Bacillus thuringiensis endospores from surface coupons. Journal of Applied Microbiology 122:1219-32.

Mucker EM, Hartmann C, Hering D, Giles W, Miller D, et al. 2017. Validation of a pan-orthopox real-time PCR assay for the detection and quantification of viral genomes from nonhuman primate blood. Virology Journal 14.

Muruato LA, Tapia D, Hatcher CL, Kalita M, Brett PJ, et al. 2017. Use of Reverse Vaccinology in the Design and Construction of Nanoglycoconjugate Vaccines against Burkholderia pseudomallei. Clinical and Vaccine Immunology 24.

Nasar F, Matassov D, Seymour RL, Latham T, Gorchakov RV, et al. 2017. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge. Journal of Virology 91.

Natesan M, Corea E, Krishnananthasivam S, Sathkumara HD, Dankmeyer JL, et al. 2017. Calprotectin as a Biomarker for Melioidosis Disease Progression and Management. Journal of Clinical Microbiology 55:1205-10.

Obregon-Perko V, Parodi L, Hodara V, Ladner JT, Wiley MR, et al. 2017. CCR5-binding chemokines contribute to baboon natural resistance to SIV infection. Cytokine 100:72-3.

Olson MA, Lee MS, Yeh IC. 2017. Membrane insertion of fusion peptides from Ebola and Marburg viruses studied by replica-exchange molecular dynamics simulations. Journal of Computational Chemistry 38:1342-52.

Patel MC, Pletneva LM, Boukhvalova MS, Vogel SN, Kajon AE, Blanco JCG. 2017. Immunization with Live Human Rhinovirus (HRV) 16 Induces Protection in Cotton Rats against HRV14 Infection. Frontiers in Microbiology 8.

Pespeni MH, Ladner JT, Moczek AP. 2017. Signals of selection in conditionally expressed genes in the diversification of three horned beetle species. Journal of Evolutionary Biology 30:1644-57.

Pinkham C, Dahal B, de la Fuente CL, Bracci N, Beitzel B, et al. 2017. Alterations in the host transcriptome in vitro following Rift Valley fever virus infection. Scientific Reports 7.

Porter AI, Erwin-Cohen RA, Twenhafel N, Chance T, Yee SB, et al. 2017. Characterization and pathogenesis of aerosolized eastern equine encephalitis in the common marmoset (Callithrix jacchus). Virology Journal 14.

Porter AI, Erwin-Cohen RA, Twenhafel N, Chance T, Yee SB, et al. 2017. Characterization and pathogenesis of aerosolized eastern equine encephalitis in the common marmoset (Callithrix jacchus) (vol 14, 25, 2017). Virology Journal 14.

Postler TS, Clawson AN, Amarasinghe GK, Basler CF, Bavari S, et al. 2017. Possibility and Challenges of Conversion of Current Virus Species Names to Linnaean Binomials. Systematic Biology 66:463-73.

Raabe V, Koehler J. 2017. Laboratory Diagnosis of Lassa Fever. Journal of Clinical Microbiology 55:1629-37.

Raaben M, Jae LT, Herbert AS, Kuehne AI, Stubbs SH, et al. 2017. NRP2 and CD63 Are Host Factors for Lujo Virus Cell Entry. Cell Host & Microbe 22:688-+.

Radinsky O, Edri A, Brusilovsky M, Fedida-Metula S, Sobarzo A, et al. 2017. Sudan ebolavirus long recovered survivors produce GP-specific Abs that are of the IgG1 subclass and preferentially bind Fc gamma RI. Scientific Reports 7.

Rapp-Santos KJ, Altamura LA, Norris SL, Lugo-Roman LA, Rico PJ, Hofer CC. 2017. Comparison of Saliva Collection Methods for the Determination of Salivary Cortisol Levels in Rhesus Macaques (Macaca mulatta), Cynomolgus Macaques (Macaca fascicularis), and African Green Monkeys (Chlorocebus aethiops). Journal of the American Association for Laboratory Animal Science 56:181-9.

Regules JA, Beigel JH, Paolino KM, Voell J, Castellano AR, et al. 2017. A Recombinant Vesicular Stomatitis Virus Ebola Vaccine. New England Journal of Medicine 376:330-41.

Reisler RB, Yu CG, Donofrio MJ, Warren TK, Wells JB, et al. 2017. Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates. Emerging Infectious Diseases 23:1316-24.

Ripoll DR, Mitchell DAJ, Dupuy LC, Wallqvist A, Schmaljohn C, Chaudhury S. 2017. Combinatorial peptide-based epitope mapping from Ebola virus DNA vaccines and infections reveals residue-level determinants of antibody binding. Human Vaccines & Immunotherapeutics 13:2953-66.

Ruedas JB, Ladner JT, Ettinger CR, Gummuluru S, Palacios G, Connor JH. 2017. Spontaneous Mutation at Amino Acid 544 of the Ebola Virus Glycoprotein Potentiates Virus Entry and Selection in Tissue Culture. Journal of Virology 91.

Ryan DA, Degardin M, Alam S, Kissner TL, Hale M, et al. 2017. Rational design of peptide derivatives for inhibition of MyD88-mediated toll-like receptor signaling in human peripheral blood mononuclear cells and epithelial cells exposed to Francisella tularensis. Chemical Biology & Drug Design 90:1190-205.

Saikh KU, Mott TM. 2017. Innate immune response to Burkholderia mallei. Current Opinion in Infectious Diseases 30:297-302.

Samy RP, Stiles BG, Sethi G, Lim LHK. 2017. Melioidosis: Clinical impact and public health threat in the tropics. Plos Neglected Tropical Diseases 11.

Saphire EO, Dye JM, Kobinger GP, Zeitlin L, Chandran K, Garry RF. 2017. How to turn competitors into collaborators. Nature 541:283-5.

Satterly NG, Voorhees MA, Ames AD, Schoepp RJ. 2017. Comparison of MagPix Assays and Enzyme-Linked Immunosorbent Assay for Detection of Hemorrhagic Fever Viruses. Journal of Clinical Microbiology 55:68-78.

Scanlon KM, Snyder YG, Skerry C, Carbonetti NH. 2017. Fatal Pertussis in the Neonatal Mouse Model Is Associated with Pertussis Toxin-Mediated Pathology beyond the Airways. Infection and Immunity 85.

Shah K, Bentley E, Tyler A, Richards KSR, Wright E, et al. 2017. Field-deployable, quantitative, rapid identification of active Ebola virus infection in unprocessed blood. Chemical Science 8:7780-97.

Shea AA, Bernhards RC, Cote CK, Chase CJ, Koehler JW, et al. 2017. Two stable variants of Burkholderia pseudomallei strain MSHR5848 express broadly divergent in vitro phenotypes associated with their virulence differences. Plos One 12.

Siegel D, Hui HC, Doerffler E, Clarke MO, Chun K, et al. 2017. Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo(2,1-f triazin-4-amino Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses. Journal of Medicinal Chemistry 60:1648-61.

Smith DR, Hollidge B, Daye S, Zeng XK, Blancett C, et al. 2017. Neuropathogenesis of Zika Virus in a Highly Susceptible Immunocompetent Mouse Model after Antibody Blockade of Type I Interferon. Plos Neglected Tropical Diseases 11.

Song DH, Kim WK, Gu SH, Lee D, Kim JA, et al. 2017. Sequence-Independent, Single-Primer Amplification Next-Generation Sequencing of Hantaan Virus Cell Culture-Based Isolates. American Journal of Tropical Medicine and Hygiene 96:389-94.

Speranza E, Altamura LA, Kulcsar K, Bixler SL, Rossi CA, et al. 2017. Comparison of Transcriptomic Platforms for Analysis of Whole Blood from Ebola-Infected Cynomolgus Macaques. Scientific Reports 7.

Steenbergen J, Tanaka SK, Miller LL, Halasohoris SA, Hershfield JR. 2017. In Vitro and In Vivo Activity of Omadacycline against Two Biothreat Pathogens, Bacillus anthracis and Yersinia pestis. Antimicrobial Agents and Chemotherapy 61.

Stonier SW, Herbert AS, Kuehne AI, Sobarzo A, Habibulin P, et al. 2017. Marburg virus survivor immune responses are Th1 skewed with limited neutralizing antibody responses. Journal of Experimental Medicine 214:2563-72.

Suh MJ, Keasey SL, Brueggemann EE, Ulrich RG. 2017. Antibiotic-dependent perturbations of extended spectrum beta-lactamase producing Klebsiella pneumoniae proteome. Proteomics 17.

Sunay MME, Foote JB, Leatherman JM, Edwards JP, Armstrong TD, et al. 2017. Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo. International Immunopharmacology 46:112-23.

Suschak JJ, Williams JA, Schmaljohn CS. 2017. Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity. Human Vaccines & Immunotherapeutics 13:2837-48.

Tsai YC, Kotiya A, Kiris E, Yang M, Bavari S, et al. 2017. Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type A intoxication. Proceedings of the National Academy of Sciences of the United States of America 114:E5158-E66.

Tuanyok A, Mayo M, Scholz H, Hall CM, Allender CJ, et al. 2017. Burkholderia humptydooensis sp nov., a New Species Related to Burkholderia thailandensis and the Fifth Member of the Burkholderia pseudomallei Complex. Applied and Environmental Microbiology 83.

van Vuren PJ, Wiley MR, Palacios G, Storm N, Markotter W, et al. 2017. Isolation of a novel orthobunyavirus from bat flies (Eucampsipoda africana). Journal of General Virology 98:935-45.

Vaughan JA, Turell MJ. 2017. Brugia malayi microfilariae transport alphaviruses across the mosquito midgut. Plos One 12.

Vergote V, Laenen L, Vanmechelen B, Van Ranst M, Verbeken E, et al. 2017. A lethal disease model for New World hantaviruses using immunosuppressed Syrian hamsters. Plos Neglected Tropical Diseases 11.

Villano JS, Follo JM, Chappell MG, Collins MT. 2017. Personal Protective Equipment in Animal Research. Comparative Medicine 67:203-14.

Warfield KL, Warren TK, Qiu XG, Wells J, Mire CE, et al. 2017. Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo. Antiviral Research 138:22-31.

Webb RP, Smith TJ, Smith LA, Wright PM, Guernieri RL, et al. 2017. Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism. Toxins 9

Wec AZ, Herbert AS, Murin CD, Nyakatura EK, Abelson DM, et al. 2017. Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses. Cell 169:878-+

Williamson CHD, Vazquez AJ, Hill K, Smith TJ, Nottingham R, et al. 2017. Differentiating Botulinum Neurotoxin-Producing Clostridia with a Simple, Multiplex PCR Assay. Applied and Environmental Microbiology 83.

Witkowski PT, Perley CC, Brocato RL, Hooper JW, Jurgensen C, et al. 2017. Gastrointestinal Tract As Entry Route for Hantavirus Infection. Frontiers in Microbiology 8.

Yalamanchili C, Manda VK, Chittiboyina AG, Guernieri RL, Harrell WA, et al. 2017. Utilizing Ayurvedic literature for the identification of novel phytochemical inhibitors of botulinum neurotoxin A. Journal of Ethnopharmacology 197:211-7.

Yi F, Guo J, Dabbagh D, Spear M, He SJ, et al. 2017. Discovery of Novel Small-Molecule Inhibitors of LIM Domain Kinase for Inhibiting HIV-1. Journal of Virology 91.

Zeng XK, Blancett CD, Koistinen KA, Schellhase CW, Bearss JJ, et al. 2017. Identification and pathological characterization of persistent asymptomatic Ebola virus infection in rhesus monkeys. Nature Microbiology 2.

Zhang X, Basuli F, Shi ZD, Bocan T, Swenson R. 2017. An Improved Automated Synthesis of F-18 FIAU on a GE FX-N Pro Module. Journal of Nuclear Medicine 58

Zhao XL, Howell KA, He SH, Brannan JM, Wec AZ, et al. 2017. Immunization-Elicited Broadly Protective Antibody Reveals Ebolavirus Fusion Loop as a Site of Vulnerability. Cell 169:891-+

Afonso CL, Amarasinghe GK, Banyai K, Bao YM, Basler CF, Bavari S, Bejerman N, Blasdell KR, Briand FX, Briese T, Bukreyev A, Calisher CH, Chandran K, Cheng JS, Clawson AN, Collins PL, Dietzgen RG, Dolnik O, Domier LL, Durrwald R, Dye JM, Easton AJ, Ebihara H, Farkas SL, Freitas-Astua J, Formenty P, Fouchier RAM, Fu YP, Ghedin E, Goodin MM, Hewson R, Horie M, Hyndman TH, Jiang DH, Kitajima EW, Kobinger GP, Kondo H, Kurath G, Lamb RA, Lenardon S, Leroy EM, Li CX, Lin XD, Liu LJ, Longdon B, Marton S, Maisner A, Muhlberger E, Netesov SV, Nowotny N, Patterson JL, Payne SL, Paweska JT, Randall RE, Rima BK, Rota P, Rubbenstroth D, Schwemmle M, Shi M, Smither SJ, Stenglein MD, Stone DM, Takada A, Terregino C, Tesh RB, Tian JH, Tomonaga K, Tordo N, Towner JS, Vasilakis N, Verbeek M, Volchkov VE, Wahl-Jensen V, Walsh JA, Walker PJ, Wang D, Wang LF, Wetzel T, Whitfield AE, Xie JT, Yuen KY, Zhang YZ, Kuhn JH. Taxonomy of the order Mononegavirales: update 2016. Arch Virol. 2016;161(8):2351-60. doi: 10.1007/s00705-016-2880-1

Alves DA, Honko AN, Kortepeter MG, Sun M, Johnson JC, Lugo-Roman LA, Hensley LE. Necrotizing Scleritis, Conjunctivitis, and other pathologic findings in the left eye and brain of an Ebola virus-infected Rhesus Macaque (Macaca mulatta) with apparent recovery and a delayed time of death. J Infect Dis. 2016;213(1):57-60. doi: 10.1093/infdis/jiv357.

Andrews ES, Turell MJ. Effect of holding conditions on the detection of Chikungunya and Venezuelan Equine Encephalitis in mosquito pools. J Am Mosq Control Assoc. 2016;32(1):51-4.

Anthony SM, Rivas SC, Colpitts SL, Howard ME, Stonier SW, Schluns KS. Inflammatory signals regulate IL-15 in response to Lymphodepletion. J Immunol. 2016;196(11):4544-52. doi: 10.4049/jimmunol.1600219.

Bazzill JD, Cooper CL, Fan YC, Bavari S, Moon JJ. Lipid nanoparticles incorporated with Ebola glycoprotein for induction of humoral immunity against Ebola infection. J Immunol. 2016;196:2.

Bell TM, Bunton TE, Shaia CI, Raymond JW, Honnold SP, Donnelly GC, Shamblin JD, Wilkinson ER, Cashman KA. Pathogenesis of Bolivian hemorrhagic fever in guinea pigs. Vet Pathol. 2016;53(1):190-9. doi: 10.1177/0300985815588609.

Bengtsson KL, Song HF, Stertman L, Liu Y, Flyer DC, Massare MJ, Xu RH, Zhou B, Lu HX, Kwilas SA, Hahn TJ, Kpamegan E, Hooper J, Carrion R, Glenn G, Smith G. Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice. Vaccine. 2016;34(16):1927-35. doi: 10.1016/j.vaccine.2016.02.033.

Booth L, Roberts JL, Ecroyd H, Tritsch SR, Bavari S, Reid S, Proniuk S, Zukiwski A, Jacob A, Sepulveda CS, Giovannoni F, Garcia CC, Damonte E, Gonzalez-Gallego J, Tunon MJ, Dent P. AR-12 inhibits multiple chaperones concomitant with stimulating autophagosome formation collectively preventing virus replication. J Cell Physiol. 2016;231(10):2286-302. doi: 10.1002/jcp.25431.

Bornholdt ZA, Turner HL, Murin CD, Li W, Sok D, Souders CA, Piper AE, Goff A, Shamblin JD, Wollen SE, Sprague TR, Fusco ML, Pommert KBJ, Cavacini LA, Smith HL, Klempner M, Reimann KA, Krauland E, Gerngross TU, Wittrup KD, Saphire EO, Burton DR, Glass PJ, Ward AB, Walker LM. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak. Science. 2016;351(6277):1078-83. doi: 10.1126/science.aad5788.

Bozue JA, Chaudhury S, Amemiya K, Chua J, Cote CK, Toothman RG, Dankmeyer JL, Klimko CP, Wilhelmsen CL, Raymond JW, Zavaljevski N, Reifman J, Wallqvist A. Phenotypic characterization of a novel virulence-factor deletion strain of Burkholderia mallei that provides partial protection against inhalational glanders in mice. Front Cell Infect Microbiol. 2016;6:15. doi: 10.3389/fcimb.2016.00021.

Brey RN, Mantis NJ, Pincus SH, Vitetta ES, Smith LA, Roy CJ. Recent advances in the development of vaccines against ricin. Hum Vaccin Immunother. 2016;12(5):1196-201. doi: 10.1080/21645515.2015.1124202.

Brovedani V, Sosa S, Poli M, Forino M, Varello K, Tubaro A, Pelin M. A revisited hemolytic assay for palytoxin detection: Limitations for its quantitation in mussels. Toxicon. 2016;119:225-33. doi: 10.1016/j.toxicon.2016.06.013.

Burk R, Bollinger L, Johnson JC, Wada J, Radoshitzky SR, Palacios G, Bavari S, Jahrling PB, Kuhn JH. Neglected filoviruses. FEMS Microbiol Rev. 2016;40(4):494-519. doi: 10.1093/femsre/fuw010.

Burnouf T, Conton B, Dye JM, Consortium GET. Convalescent plasma for Ebola virus disease. N Engl J Med. 2016;374(25):2498-2500.

Caballero IS, Honko AN, Gire SK, Winnicki SM, Mele M, Gerhardinger C, Lin AE, Rinn JL, Sabeti PC, Hensley LE, Connor JH. In vivo Ebola virus infection leads to a strong innate response in circulating immune cells. Bmc Genomics. 2016;17:13. doi: 10.1186/s12864-016-3060-0.

Cardile AP, Downey LG, Wiseman PD, Warren TK, Bavari S. Antiviral therapeutics for the treatment of Ebola virus infection. Curr Opin Pharmacol. 2016;30:138-43. doi: 10.1016/j.coph.2016.08.016.

Cazares LH, Ward MD, Brueggemann EE, Kenny T, Demond P, Mahone CR, Martins KAO, Nuss JE, Glaros T, Bavari S. Development of a liquid chromatography high resolution mass spectrometry method for the quantitation of viral envelope glycoprotein in Ebola virus-like particle vaccine preparations. Clin Proteomics. 2016;13:18. doi: 10.1186/s12014-016-9119-8.

Chabot DJ, Ribot WJ, Joyce J, Cook J, Hepler R, Nahas D, Chua J, Friedlander AM. Protection of rhesus macaques against inhalational anthrax with a Bacillus anthracis capsule conjugate vaccine. Vaccine. 2016;34(34):4012-6. doi: 10.1016/j.vaccine.2016.06.031.

Chahal JS, Khan OF, Cooper CL, McPartlan JS, Tsosie JK, Tilley LD, Sidik SM, Lourido S, Langer R, Bavari S, Ploegh HL, Anderson DG. Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose. Proc Natl Acad Sci U S A. 2016;113(29):E4133-E42. doi: 10.1073/pnas.1600299113.

Chaudhury S, Ockenhouse CF, Regules JA, Dutta S, Wallqvist A, Jongert E, Waters NC, Lemiale F, Bergmann-Leitner E. The biological function of antibodies induced by the RTS,S/AS01 malaria vaccine candidate is determined by their fine specificity. Malar J. 2016;15:12. doi: 10.1186/s12936-016-1348-9.

Cnops L, van Griensven J, Honko AN, Bausch DG, Sprecher A, Hill CE, Colebunders R, Johnson JC, Griffiths A, Palacios GF, Kraft CS, Kobinger G, Hewlett A, Norwood DA, Sabeti P, Jahrling PB, Formenty P, Kuhn JH, Arien KK. Essentials of filoviral load quantification. Lancet Infect Dis. 2016;16(7):E134-E8. doi: 10.1016/s1473-3099(16)30063-9.

Cnops L, van Griensven J, Honko AN, Bausch DG, Sprecher A, Hill CE, Colebunders R, Johnson JC, Griffiths A, Palacios GF, Kraft CS, Kobinger G, Hewlett A, Norwood DA, Sabeti P, Jahrling PB, Formenty P, Kuhn JH, Arien KK. Overlooking the importance of immunoassays reply. Lancet Infect Dis. 2016;16(10):1110. doi: 10.1016/S1473-3099(16)30339-5.

Cohen CA, Bakken R, Glass PJ. A trivalent alphavirus virus-like replicon particle vaccine induces cell-mediated responses against conserved glycoprotein regions. J Immunol. 2016;196:1.

Cong Y, Dyall J, Hart BJ, DeWald LE, Johnson JC, Postnikova E, Zhou H, Gross R, Rojas O, Alexander I, Josleyn N, Zhang T, Michelotti J, Janosko K, Glass PJ, Flint M, McMullan LK, Spiropoulou CF, Mierzwa T, Guha R, Shinn P, Michael S, Klumpp-Thomas C, McKnight C, Thomas C, Eakin AE, O'Loughlin KG, Green CE, Catz P, Mirsalis JC, Honko AN, Olinger GG, Bennett RS, Holbrook MR, Hensley LE, Jahrling PB. Evaluation of the activity of Lamivudine and Zidovudine against Ebola Virus. PLoS One. 2016;11(11):19. doi: 10.1371/journal.pone.0166318.

Corti D, Misasi J, Mulangu S, Stanley DA, Kanekiyo M, Wollen S, Ploquin A, Doria-Rose NA, Staupe RP, Bailey M, Shi W, Choe M, Marcus H, Thompson EA, Cagigi A, Silacci C, Fernandez-Rodriguez B, Perez L, Sallusto F, Vanzetta F, Agatic G, Cameroni E, Kisalu N, Gordon I, Ledgerwood JE, Mascola JR, Graham BS, Muyembe-Tamfun JJ, Trefry JC, Lanzavecchia A, Sullivan NJ. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science. 2016;351(6279):1339-42. doi: 10.1126/science.aad5224.

Duplantier AJ, Kane CD, Bavari S. Searching for therapeutics against Botulinum neurotoxins: A true challenge for drug discovery. Curr Top Med Chem. 2016;16(21):2330-49. doi: 10.2174/1568026616666160413135630.

Duy J, Koehler JW, Honko AN, Schoepp RJ, Wauquier N, Gonzalez JP, Pitt ML, Mucker EM, Johnson JC, O'Hearn A, Bangura J, Coomber M, Minogue TD. Circulating microRNA profiles of Ebola virus infection. Sci Rep. 2016;6:13. doi: 10.1038/srep24496.

Dye JM, Warfield KL, Wells JB, Unfer RC, Shulenin S, Vu H, Nichols DK, Aman MJ, Bavari S. Virus-like particle vaccination protects nonhuman primates from lethal aerosol exposure with Marburgvirus (VLP vaccination protects Macaques against aerosol challenges). Viruses. 2016;8(4):15. doi: 10.3390/v8040094.

Dye JM, Wu H, Hooper JW, Khurana S, Kuehne AI, Coyle EM, Ortiz RA, Fuentes S, Herbert AS, Golding H, Bakken RA, Brannan JM, Kwilas SA, Sullivan EJ, Luke TC, Smith G, Glenn G, Li WF, Ye L, Yang CL, Compans RW, Tripp RA, Jiao JA. Production of potent fully human polyclonal antibodies against Ebola Zaire virus in transchromosomal cattle. Sci Rep. 2016;6:9. doi: 10.1038/srep24897.

Erukula SV, Srivari Y, Chatterjee P. Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns): Part II. Albumin-bound carbamazepine nanoparticles (ABCns). J Microencapsul. 2016;33(6):524-34. doi: 10.1080/02652048.2016.1222006.

Evans JC, Trujillo C, Wang Z, Eoh H, Ehrt S, Schnappinger D, Boshoff HIM, Rhee KY, Barry CE, Mizrahi V. Validation of CoaBC as a bactericidal target in the coenzyme a pathway of Mycobacterium tuberculosis. ACS Infect Dis. 2016;2(12):70-80. doi: 10.1021/acsinfecdis.6b00150.

Ewers EC, Pratt WD, Twenhafel NA, Shamblin J, Donnelly G, Esham H, Wlazlowski C, Johnson JC, Botto M, Hensley LE, Goff AJ. Natural history of aerosol exposure with Marburg virus in Rhesus Macaques. Viruses. 2016;8(4):16. doi: 10.3390/v8040087.

Farooq F, Beck K, Paolino KM, Phillips R, Waters NC, Regules JA, Bergmann-Leitner ES. Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccine. Sci Rep. 2016;6:9. doi: 10.1038/srep27944.

Folarin OA, Ehichioya D, Schaffner SF, Winnicki SM, Wohl S, Eromon P, West KL, Gladden-Young A, Oyejide NE, Matranga CB, Deme AB, James A, Tomkins-Tinch C, Onyewurunwa K, Ladner JT, Palacios G, Nosamiefan I, Andersen KG, Omilabu S, Park DJ, Yozwiak NL, Nasidi A, Garry RF, Tomori O, Sabeti PC, Happi CT. Ebola virus epidemiology and evolution in Nigeria. J Infect Dis. 2016;214:S102-S9. doi: 10.1093/infdis/jiw190.

Fraga M, Vilarino N, Louzao MC, Fernandez DA, Poli M, Botana LM. Detection of palytoxin-like compounds by a flow cytometry-based immunoassay supported by functional and analytical methods. Anal Chim Acta. 2016;903:1-12. doi: 10.1016/j.aca.2015.09.040.

Frei JC, Nyakatura EK, Zak SE, Bakken RR, Chandran K, Dye JM, Lai JR. Bispecific antibody affords complete post-exposure protection of mice from both Ebola (Zaire) and Sudan viruses. Sci Rep. 2016;6:10. doi: 10.1038/srep19193.

Golden JW, Maes P, Kwilas SA, Ballantyne J, Hooper JW. Glycoprotein-specific antibodies produced by DNA vaccination protect guinea pigs from lethal Argentine and Venezuelan hemorrhagic fever. J Virol. 2016;90(7):3515-29. doi: 10.1128/jvi.02969-15.

Gupta P, Sharma A, Spurgers KB, Bakken RR, Eccleston LT, Cohen JW, Honnold SP, Glass PJ, Maheshwari RK. 1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus. Vaccine. 2016;34(25):2762-5. doi: 10.1016/j.vaccine.2016.04.049.

Haddow AD, Nasar F, Guzman H, Ponlawat A, Jarman RG, Tesh RB, Weaver SC. Genetic characterization of Spondweni and Zika viruses and susceptibility of geographically distinct strains of Aedes aegypti, Aedes albopictus and Culex quinquefasciatus (Diptera: Culicidae) to Spondweni virus. PLoS Negl Trop Dis. 2016;10(10):13. doi: 10.1371/journal.pntd.0005083.

Haddow AD, Woodall JP. Distinguishing between Zika and Spondweni viruses. Bull World Health Organ. 2016;94(10):711-. doi: 10.2471/blt.16.181503.

Hammerbeck CD, Brocato RL, Bell TM, Schellhase CW, Mraz SR, Queen LA, Hooper JW. Depletion of alveolar macrophages does not prevent Hantavirus disease pathogenesis in golden Syrian hamsters. J Virol. 2016;90(14):6200-15. doi: 10.1128/jvi.00304-16.

Hannaman D, Dupuy LC, Ellefsen B, Schmaljohn CS. A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation. Vaccine. 2016;34(31):3607-12. doi: 10.1016/j.vaccine.2016.04.077.

Holley AB, Sobieszczyk M, Perkins M, Cohee BM, Costantoth CB, Mabe DL, Liotta R, Abraham JH, Holley PR, Sherner J. Lung function abnormalities among service members returning from Iraq or Afghanistan with respiratory complaints. Respir Med. 2016;118:84-7. doi: 10.1016/j.rmed.2016.07.014.

Holtsberg FW, Shulenin S, Vu H, Howell KA, Patel SJ, Gunn B, Karim M, Lai JR, Frei JC, Nyakatura EK, Zeitlin L, Douglas R, Fusco ML, Froude JW, Saphire EO, Herbert AS, Wirchnianski AS, Lear-Rooney CM, Alter G, Dye JM, Glass PJ, Warfield KL, Aman MJ. Pan-ebolavirus and Pan-filovirus mouse monoclonal antibodies: Protection against Ebola and Sudan viruses. J Virol. 2016;90(1):266-78. doi: 10.1128/jvi.02171-15.

Hostler DC, Marx ES, Moores LK, Petteys SK, Hostler JM, Mitchell JD, Holley PR, Collen JF, Foster BE, Holley AB. Validation of the International Medical Prevention Registry on Venous Thromboembolism Bleeding Risk Score. Chest. 2016;149(2):372-9. doi: 10.1378/chest.14-2842.

Howell KA, Qiu XG, Brannan JM, Bryan C, Davidson E, Holtsberg FW, Wec AZ, Shulenin S, Biggins JE, Douglas R, Enterlein SG, Turner HL, Pallesen J, Murin CD, He SH, Kroeker A, Vu H, Herbert AS, Fusco ML, Nyakatura EK, Lai JR, Keck ZY, Foung SKH, Saphire EO, Zeitlin L, Ward AB, Chandran K, Doranz BJ, Kobinger GP, Dye JM, Aman MJ. Antibody treatment of Ebola and Sudan virus infection via a uniquely exposed epitope within the glycoprotein receptor-binding site. Cell Rep. 2016;15(7):1514-26. doi: 10.1016/j.celrep.2016.04.026.

Hu X, Compton JR, Leary DH, Olson MA, Lee MS, Cheung J, Ye W, Ferrer M, Southall N, Jadhav A, Morazzani EM, Glass PJ, Marugan J, Legler PM. Kinetic, mutational, and structural studies of the Venezuelan Equine Encephalitis virus nonstructural protein 2 cysteine protease. Biochemistry. 2016;55(21):3007-19. doi: 10.1021/acs.biochem.5b00992.

Keasey SL, Natesan M, Pugh C, Kamata T, Wuchty S, Ulrich RG. Cell-free Determination of binary complexes that comprise extended protein-protein interaction networks of Yersinia pestis. Mol Cell Proteomics. 2016;15(10):3220-32. doi: 10.1074/mcp.M116.059337.

Keck ZY, Enterlein SG, Howell KA, Vu H, Shulenin S, Warfield KL, Froude JW, Araghi N, Douglas R, Biggins J, Lear-Rooney CM, Wirchnianski AS, Lau P, Wang Y, Herbert AS, Dye JM, Glass PJ, Holtsberg FW, Foung SKH, Aman MJ. Macaque monoclonal antibodies targeting novel conserved epitopes within filovirus glycoprotein. J Virol. 2016;90(1):279-91. doi: 10.1128/jvi.02172-15.

Kim WK, Kim JA, Song DH, Lee D, Kim YC, Lee SY, Lee SH, No JS, Kim JH, Kho JH, Gu SH, Jeong ST, Wiley M, Kim HC, Klein TA, Palacios G, Song JW. Phylogeographic analysis of hemorrhagic fever with renal syndrome patients using multiplex PCR-based next generation sequencing. Sci Rep. 2016;6:8. doi: 10.1038/srep26017.

Konduru K, Shurtleff AC, Bradfute SB, Nakamura S, Bavari S, Kaplan G. Ebolavirus glycoprotein Fc fusion protein protects guinea pigs against lethal challenge. PLoS One. 2016;11(9):21. doi: 10.1371/journal.pone.0162446.

Konongoi L, Ofula V, Nyunja A, Owaka S, Koka H, Makio A, Koskei E, Eyase F, Langat D, Schoepp RJ, Rossi CA, Njeru I, Coldren R, Sang R. Detection of dengue virus serotypes 1, 2 and 3 in selected regions of Kenya: 2011-2014. Virol J. 2016;13:11. doi: 10.1186/s12985-016-0641-0.

Koontz JM, Kumsher DM, Kelly R, Stallings JD. Effect of 2 bedding materials on ammonia levels in individually ventilated cages. J Am Assoc Lab Anim Sci. 2016;55(1):25-8.

Kortepeter MG, Kwon EH, Hewlett AL, Smith PW, Cieslak TJ. Containment care units for managing patients with highly hazardous infectious diseases: A concept whose time has come. J Infect Dis. 2016;214:S137-S41. doi: 10.1093/infdis/jiw292.

Krakauer T. Enterotoxins: Microbial proteins and host cell dysregulation. Toxins. 2016;8(1):4. doi: 10.3390/toxins8010017.

Krakauer T, Pradhan K, Stiles BG. Staphylococcal superantigens spark host-mediated danger signals. Front Immunol. 2016;7:14. doi: 10.3389/fimmu.2016.00023.

Krishnamurthy M, Moore RT, Rajamani S, Panchal RG. Bacterial genome engineering and synthetic biology: combating pathogens. BMC Microbiol. 2016;16:11. doi: 10.1186/s12866-016-0876-3.

Kuchuloria T, Imnadze P, Mamuchishvili N, Chokheli M, Tsertsvadze T, Endeladze M, Mshvidobadze K, Gatserelia L, Makhviladze M, Kanashvili M, Mikautadze T, Nanuashvili A, Kiknavelidze K, Kokaia N, Makharadze M, Clark DV, Bautista CT, Farrell M, Fadeel MA, Maksoud MA, Pimentel G, House B, Hepburn MJ, Rivard RG. Hospital-based surveillance for infectious etiologies among patients with acute febrile illness in Georgia, 2008-2011. Am J Trop Med Hyg. 2016;94(1):236-42. doi: 10.4269/ajtmh.15-0400.

Kugelman JR, Rossi CA, Wiley MR, Ladner JT, Nagle ER, Pfeffer BP, Garcia K, Prieto K, Wada J, Kuhn JH, Palacios G. Informing the historical record of experimental nonhuman primate infections with Ebola virus: Genomic characterization of USAMRIID Ebola virus/H.sapiens-tc/COD/1995/Kikwit-9510621 challenge stock "R4368" and its replacement "R4415". PLoS One. 2016;11(3):9. doi: 10.1371/journal.pone.0150919.

Kuhn JH, Lauck M, Bailey AL, Shchetinin AM, Vishnevskaya TV, Bao YM, Ng TFF, LeBreton M, Schneider BS, Gillis A, Tamoufe U, Diffo JL, Takuo JM, Kondov NO, Coffey LL, Wolfe ND, Delwart E, Clawson AN, Postnikova E, Bollinger L, Lackemeyer MG, Radoshitzky SR, Palacios G, Wada J, Shevtsova ZV, Jahrling PB, Lapin BA, Deriabin PG, Dunowska M, Alkhovsky SV, Rogers J, Friedrich TC, O'Connor DH, Goldberg TL. Reorganization and expansion of the nidoviral family Arteriviridae. Arch Virol. 2016;161(3):755-68. doi: 10.1007/s00705-015-2672-z.

Kuhn JH, Wiley MR, Rodriguez SE, Bao YM, Prieto K, da Rosa A, Guzman H, Savji N, Ladner JT, Tesh RB, Wada J, Jahrling PB, Bente DA, Palacios G. Genomic characterization of the Genus Nairovirus (Family Bunyaviridae). Viruses. 2016;8(6):27. doi: 10.3390/v8060164.

Ladner JT, Kuhn JH, Palacios G. Standard finishing categories for high-throughput sequencing of viral genomes. Rev Sci Tech. 2016;35(1):43-52. doi: 10.20506/rst.35.1.2416.

Ladner JT, Wiley MR, Beitzel B, Auguste AJ, Dupuis AP, Lindquist ME, Sibley SD, Kota KP, Fetterer D, Eastwood G, Kimmel D, Prieto K, Guzman H, Aliota MT, Reyes D, Brueggemann EE, John LS, Hyeroba D, Lauck M, Friedrich TC, O'Connor DH, Gestole MC, Cazares LH, Popov VL, Castro-Llanos F, Kochel TJ, Kenny T, White B, Ward MD, Loaiza JR, Goldberg TL, Weaver SC, Kramer LD, Tesh RB, Palacios G. A multicomponent animal virus isolated from mosquitoes. Cell Host Microbe. 2016;20(3):357-67. doi: 10.1016/j.chom.2016.07.011.

Laws TR, Kuchuloria T, Chitadze N, Little SF, Webster WM, Debes AK, Saginadze S, Tsertsvadze N, Chubinidze M, Rivard RG, Tsanava S, Dyson EH, Simpson AJH, Hepburn MJ, Trapaidze N. A comparison of the adaptive immune response between recovered anthrax patients and individuals receiving three different anthrax vaccines. PLoS One. 2016;11(3):16. doi: 10.1371/journal.pone.0148713.

Lee BY, Bartsch SM, Wong KF, McKinnell JA, Slayton RB, Miller LG, Cao CH, Kim DS, Kallen AJ, Jernigan JA, Huang SS. The potential trajectory of carbapenem-resistant enterobacteriaceae, an emerging threat to health-care facilities, and the impact of the Centers for Disease Control and prevention toolkit. M J Epidemiol. 2016;183(5):471-9. doi: 10.1093/aje/kwv299.

Leonardi W, Zilbermintz L, Cheng LW, Zozaya J, Tran SH, Elliott JH, Polukhina K, Manasherob R, Li A, Chi XL, Gharaibeh D, Kenny T, Zamani R, Soloveva V, Haddow AD, Nasar F, Bavari S, Bassik MC, Cohen SN, Levitin A, Martchenko M. Bithionol blocks pathogenicity of bacterial toxins, ricin, and Zika virus. Sci Rep. 2016;6:12. doi: 10.1038/srep34475.

Markwalter CF, Ricks KM, Bitting AL, Mudenda L, Wright DW. Simultaneous capture and sequential detection of two malarial biomarkers on magnetic microparticles. Talanta. 2016;161:443-9. doi: 10.1016/j.talanta.2016.08.078.

Martins KA, Jahrling PB, Bavari S, Kuhn JH. Ebola virus disease candidate vaccines under evaluation in clinical trials. Expert Rev Vaccines. 2016;15(9):1101-12. doi: 10.1080/14760584.2016.1187566.

Martins KAO, Dye JM, Bavari S. Considerations for the development of Zika virus vaccines. Vaccine. 2016;34(33):3711-2. doi: 10.1016/j.vaccine.2016.06.012.

Memisevic V, Kumar K, Zavaljevski N, DeShazer D, Wallqvist A, Reifman J. DBSecSys 2.0: a database of Burkholderia mallei and Burkholderia pseudomallei secretion systems. Bmc Bioinformatics. 2016;17:7. doi: 10.1186/s12859-016-1242-z.

Millar EV, Schlett CD, Law NN, Chen WJ, D'Onofrio MJ, Bennett JW, Tribble DR, Ellis MW. Reduction in acute respiratory infection among military trainees: Secondary effects of a hygiene-based cluster-randomized trial for skin and soft-tissue infection prevention. Infect Control Hosp Epidemiol. 2016;37(9):1118-20. doi: 10.1017/ice.2016.154.

Molohon KJ, Blair PM, Park S, Doroghazi JR, Maxson T, Hershfield JR, Flatt KM, Schroeder NE, Ha T, Mitchell DA. Plantazolicin is an ultranarrow-spectrum antibiotic that targets the Bacillus anthracis membrane. ACS Infect Dis. 2016;2(3):207-20. doi: 10.1021/acsinfecdis.5b00115.

Monninger MK, Nguessan CA, Blancett CD, Kuehl KA, Rossi CA, Olschner SP, Williams PL, Goodman SL, Sun MG. Preparation of viral samples within biocontainment for ultrastructural analysis: Utilization of an innovative processing capsule for negative staining. J Virol Methods. 2016;238:70-6. doi: 10.1016/j.jviromet.2016.10.005.

Mudhasani R, Tran JP, Retterer C, Kota KP, Whitehouse CA, Bavari S. Protein Kinase R Degradation is essential for Rift Valley Fever virus infection and is regulated by SKP1-CUL1-F-box (SCF)(FBXW11-NSs) E3 Ligase. PLoS Pathog. 2016;12(2):27. doi: 10.1371/journal.ppat.1005437.

Natesan M, Jensen SM, Keasey SL, Kamata T, Kuehne AI, Stonier SW, Lutwama JJ, Lobel L, Dye JM, Ulrich RG. Human survivors of disease outbreaks caused by Ebola or Marburg virus exhibit cross-reactive and long-lived antibody responses. Clin Vaccine Immunol. 2016;23(8):717-24. doi: 10.1128/cvi.00107-16.

O'Hearn AE, Voorhees MA, Fetterer DP, Wauquier N, Coomber MR, Bangura J, Fair JN, Gonzalez JP, Schoepp RJ. Serosurveillance of viral pathogens circulating in West Africa. Virol J. 2016;13:6. doi: 10.1186/s12985-016-0621-4.

Olsen ME, Filone CM, Rozelle D, Mire CE, Agans KN, Hensley L, Connor JH. Polyamines and hypusination are required for Ebolavirus gene expression and replication. MBio. 2016;7(4):10. doi: 10.1128/MBio.00882-16.

Olson MA, Legler PM, Goldman ER. Comparison of replica exchange simulations of a kinetically trapped protein conformational state and its native form. J Phys Chem B. 2016;120(9):2234-40. doi: 10.1021/acs.jpcb.6b00233.

Papa A, Vaheri A, LeDuc JW, Kruger DH, Avsic-Zupanc T, Arikawa J, Song JW, Markotic A, Clement J, Liang MF, Li DX, Yashina LN, Jonsson CB, Schmaljohn CS. Meeting report: Tenth International Conference on Hantaviruses. Antiviral Res. 2016;133:234-41. doi: 10.1016/j.antiviral.2016.08.015.

Paronyan L, Zardaryan E, Bakunts V, Gevorgyan Z, Asoyan V, Apresyan H, Hovhannisyan A, Palayan K, Bautista CT, Kuchuloria T, Rivard RG. A retrospective chart review study to describe selected zoonotic and arboviral etiologies in hospitalized febrile patients in the Republic of Armenia. BMC Infect Dis. 2016;16:8. doi: 10.1186/s12879-016-1764-z

Pelin M, Forino M, Brovedani V, Tartaglione L, Dell'Aversano C, Pistocchi R, Poli M, Sosa S, Florio C, Ciminiello P, Tubaro A. Ovatoxin-a, a palytoxin analogue isolated from Ostreopsis cf. ovata Fukuyo: Cytotoxic activity and ELISA detection. Environ Sci Technol. 2016;50(3):1544-51. doi: 10.1021/acs.est.5b04749.

Phan JC, Pettitt J, George JS, Fakoli LS, Taweh FM, Bateman SL, Bennett RS, Norris SL, Spinnler DA, Pimentel G, Sahr PK, Bolay FK, Schoepp RJ. Lateral flow immunoassays for Ebola virus disease detection in Liberia. J Infect Dis. 2016;214:S222-S8. doi: 10.1093/infdis/jiw251.

Pittman PR, McClain D, Quinn X, Coonan KM, Mangiafico J, Makuch RS, Morrill J, Peters CJ. Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans. Vaccine. 2016;34(4):424-9. doi: 10.1016/j.vaccine.2015.12.030.

Pittman PR, Norris SL, Brown ES, Ranadive MV, Schibly BA, Bettinger GE, Lokugamage N, Korman L, Morrill JC, Peters CJ. Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates. Vaccine. 2016;34(4):523-30. doi: 10.1016/j.vaccine.2015.11.078.

Prugar LI, Dye JM, Loughran M, Wrobel JE, Reitz AB, Freedman BD, Harty RN, Herbert AS. Small-molecule probe targeting viral PPxY L-domain inhibits filovirus and arenavirus egress. J Immunol. 2016;196:1.

Pugh C, Brown ES, Quinn XF, Korman L, Dyas BK, Ulrich RG, Pittman PR. Povidone iodine ointment application to the vaccination site does not alter immunoglobulin G antibody response to smallpox vaccine. Viral Immunol. 2016;29(6):361-6. doi: 10.1089/vim.2016.0025.

Radoshitzky SR, Pegoraro G, Chi XL, Dong L, Chiang CY, Jozwick L, Clester JC, Cooper CL, Courier D, Langan DP, Underwood K, Kuehl KA, Sun MG, Cai YY, Yu SQ, Burk R, Zamani R, Kota K, Kuhn JH, Bavari S. siRNA screen identifies trafficking host factors that modulate alphavirus infection. PLoS Pathog. 2016;12(3):30. doi: 10.1371/journal.ppat.1005466.

Regules JA, Cicatelli SB, Bennett JW, Paolino KM, Twomey PS, Moon JE, Kathcart AK, Hauns KD, Komisar JL, Qabar AN, Davidson SA, Dutta S, Griffith ME, Magee CD, Wojnarski M, Livezey JR, Kress AT, Waterman PE, Jongert E, Wille-Reece U, Volkmuth W, Emerling D, Robinson WH, Lievens M, Morelle D, Lee CK, Yassin-Rajkumar B, Weltzin R, Cohen J, Paris RM, Waters NC, Birkett AJ, Kaslow DC, Ballou WR, Ockenhouse CF, Vekemans J. Fractional third and fourth dose of RTS,S/AS01 malaria candidate vaccine: A Phase 2a controlled human malaria parasite infection and immunogenicity study. J Infect Dis. 2016;214(5):762-71. doi: 10.1093/infdis/jiw237.

Riblett AM, Blomen VA, Jae LT, Altamura LA, Doms RW, Brummelkamp TR, Wojcechowskyj JA. A Haploid Genetic Screen Identifies Heparan Sulfate Proteoglycans Supporting Rift Valley Fever Virus Infection. J Virol. 2016;90(3):1414-23. doi: 10.1128/jvi.02055-15.

Ruiz SI, El-Gendy N, Bowen LE, Berkland C, Bailey MM. Formulation and characterization of nanocluster Ceftazidime for the treatment of acute pulmonary melioidosis. J Pharm Sci. 2016;105(11):3399-408. doi: 10.1016/j.xphs.2016.07.029.

Samuel GH, Wiley MR, Badawi A, Adelman ZN, Myles KM. Yellow fever virus capsid protein is a potent suppressor of RNA silencing that binds double-stranded RNA. Proc Natl Acad Sci U S A. 2016;113(48):13863-8. doi: 10.1073/pnas.1600544113.

Shurtleff AC, Bloomfield HA, Mort S, Orr SA, Audet B, Whitaker T, Richards MJ, Bavari S. Validation of the filovirus plaque assay for use in preclinical studies. Viruses. 2016;8(4):20. doi: 10.3390/v8040113.

Sobarzo A, Stonier SW, Herbert AS, Ochayon DE, Kuehne AI, Eskira Y, Fedida-Metula S, Tali N, Lewis EC, Egesa M, Cose S, Lutwama JJ, Yavelsky V, Dye JM, Lobel L. Correspondence of neutralizing humoral immunity and CD4 T cell responses in long recovered Sudan virus survivors. Viruses. 2016;8(5):12. doi: 10.3390/v8050133.

Spengler JR, Estrada-Pena A, Garrison AR, Schmaljohn C, Spiropoulou CF, Bergeron E, Bente DA. A chronological review of experimental infection studies of the role of wild animals and livestock in the maintenance and transmission of Crimean-Congo hemorrhagic fever virus. Antiviral Res. 2016;135:31-47. doi: 10.1016/j.antivira1.2016.09.013.

Stefan CP, Chase K, Coyne S, Kulesh DA, Minogue TD, Koehler JW. Development of real-time reverse transcriptase qPCR assays for the detection of Punta Toro virus and Pichinde virus. Virol J. 2016;13:6. doi: 10.1186/s12985-016-0509-3.

Stefan CP, Koehler JW, Minogue TD. Targeted next-generation sequencing for the detection of ciprofloxacin resistance markers using molecular inversion probes. Sci Rep. 2016;6:12. doi: 10.1038/srep25904.

Stonier SW, James RM, Josleyn NM, Bakken RR, Dye JM. Immune correlates for VEEV replicon vaccine protection against Ebolavirus. J Immunol. 2016;196:2.

Sugiharto VA, Grieco JP, Murphy JR, Olsen CH, Colacicco-Mayhugh MG, Stewart VA, Achee NL, Turell MJ. Effects of preexposure to DEET on the downstream blood-feeding behaviors of Aedes aegypti (Diptera: Culicidae) mosquitoes. J Med Entomol. 2016;53(5):1100-4. doi: 10.1093/jme/tjw066.

Sugiharto VA, Murphy JR, Turell MJ, Olsen CH, Stewart VA, Colacicco-Mayhugh MG, Grieco JP, Achee NL. Dengue virus-1 infection did not alter the behavioral response of Aedes aegypti (Diptera: Culicidae) to DEET. J Med Entomol. 2016;53(3):687-91. doi: 10.1093/jme/tjw030.

Tran EEH, Nelson EA, Bonagiri P, Simmons JA, Shoemaker CJ, Schmaljohn CS, Kobinger GP, Zeitlin L, Subramaniam S, White JM. Mapping of Ebolavirus neutralization by monoclonal antibodies in the ZMapp cocktail using cryo-electron tomography and studies of cellular entry. J Virol. 2016;90(17):7618-27. doi: 10.1128/jvi.00406-16.

Treangen TJ, Schoeler G, Phillippy AM, Bergman NH, Turell MJ. Identification and genomic analysis of a novel group C orthobunyavirus isolated from a mosquito captured near Iquitos, Peru. PLoS Negl Trop Dis. 2016;10(4):13. doi: 10.1371/journal.pntd.0004440.

van der Linden WA, Schulze CJ, Herbert AS, Krause TB, Wirchnianski AA, Dye JM, Chandran K, Bogyo M. Cysteine cathepsin inhibitors as anti-Ebola agents. ACS Infect Dis. 2016;2(3):173-9. doi: 10.1021/acsinfecdis.5b00130.

van Vuren PJ, Wiley M, Palacios G, Storm N, McCulloch S, Markotter W, Birkhead M, Kemp A, Paweska JT. Isolation of a novel fusogenic orthoreovirus from eucampsipoda africana bat flies in South Africa. Viruses. 2016;8(3):25. doi: 10.3390/v8030065.

Wahl-Jensen V, Johnson JC, Lauck M, Weinfurter JT, Moncla LH, Weiler AM, Charlier O, Rojas O, Byrum R, Ragland DR, Huzella L, Zommer E, Cohen M, Bernbaum JG, Cai YY, Sanford HB, Mazur S, Johnson RF, Qin J, Palacios GF, Bailey AL, Jahrling PB, Goldberg TL, O'Connor DH, Friedrich TC, Kuhn JH. Divergent simian arteriviruses cause simian hemorrhagic fever of differing severities in macaques. MBio. 2016;7(1):10. doi: 10.1128/MBio.02009-15.

Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, Siegel D, Perron M, Bannister R, Hui HC, Larson N, Strickley R, Wells J, Stuthman KS, Van Tongeren SA, Garza NL, Donnelly G, Shurtleff AC, Retterer CJ, Gharaibeh D, Zamani R, Kenny T, Eaton BP, Grimes E, Welch LS, Gomba L, Wilhelmsen CL, Nichols DK, Nuss JE, Nagle ER, Kugelman JR, Palacios G, Doerffler E, Neville S, Carra E, Clarke MO, Zhang LJ, Lew W, Ross B, Wang Q, Chun K, Wolfe L, Babusis D, Park Y, Stray KM, Trancheva I, Feng JY, Barauskas O, Xu YL, Wong P, Braun MR, Flint M, McMullan LK, Chen SS, Fearns R, Swaminathan S, Mayers DL, Spiropoulou CF, Lee WA, Nichol ST, Cihlar T, Bavari S. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature. 2016;531(7594):381-+. doi: 10.1038/nature17180.

Warren TK, Whitehouse CA, Wells J, Welch L, Charleston JS, Heald A, Nichols DK, Mattix ME, Palacios G, Kugleman JR, Iversen PL, Bavari S. Delayed time-to-treatment of an antisense morpholino oligomer is effective against lethal Marburg virus infection in Cynomolgus macaques. PLoS Negl Trop Dis. 2016;10(2):18. doi: 10.1371/journal.pntd.0004456.

Watson DC, Bayik D, Srivatsan A, Bergamaschi C, Valentin A, Niu G, Bear J, Monninger M, Sun M, Morales-Kastresana A, Jones JC, Felber BK, Chen XY, Gursel I, Pavlakis GN. Efficient production and enhanced tumor delivery of engineered extracellular vesicles. Biomaterials. 2016;105:195-205. doi: 10.1016/j.biomaterials.2016.07.003.

Wec AZ, Nyakatura EK, Herbert AS, Howell KA, Holtsberg FW, Bakken RR, Mittler E, Christin JR, Shulenin S, Jangra RK, Bharrhan S, Kuehne AI, Bornholdt ZA, Flyak AI, Saphire EO, Crowe JE, Aman MJ, Dye JM, Lai JR, Chandran K. A "Trojan horse" bispecific-antibody strategy for broad protection against ebolaviruses. Science. 2016;354(6310):350-4. doi: 10.1126/science.aag3267.

Weidmann M, Avsic-Zupanc T, Bino S, Bouloy M, Burt F, Chinikar S, Christova I, Dedushaj I, El-Sanousi A, Elaldi N, Hewson R, Hufert FT, Humolli I, van Vuren PJ, Tufan ZK, Korukluoglu G, Lyssen P, Mirazimi A, Neyts J, Niedrig M, Ozkul A, Papa A, Paweska J, Sall AA, Schmaljohn CS, Swanepoel R, Uyar Y, Weber F, Zeller H. Biosafety standards for working with Crimean-Congo hemorrhagic fever virus. J Gen Virol. 2016;97:2799-808. doi: 10.1099/jgv.0.000610.

Williamson CHD, Sahl JW, Smith TJ, Xie G, Foley BT, Smith LA, Fernandez RA, Lindstrom M, Korkeala H, Keim P, Foster J, Hill K. Comparative genomic analyses reveal broad diversity in botulinum-toxin-producing Clostridia. Bmc Genomics. 2016;17:20. doi: 10.1186/s12864-016-2502-z.

Wong KK, Davey RT, Hewlett AL, Kraft CS, Mehta AK, Mulligan MJ, Beck A, Dorman W, Kratochvil CJ, Lai LL, Palmore TN, Rogers S, Smith P, Suffredini AF, Wolcott M, Stroher U, Uyeki TM. Use of postexposure prophylaxis after occupational exposure to Zaire Ebolavirus. Clin Infect Dis. 2016;63(3):376-9. doi: 10.1093/cid/ciw256.

Yu GY, Mate S, Garcia K, Ward MD, Brueggemann E, Hall M, Kenny T, Sanchez-Lockhart M, Lefranc MP, Palacios G. Cynomolgus macaque (Macaca fascicularis) immunoglobulin heavy chain locus description. Immunogenetics. 2016;68(6-7):417-28. doi: 10.1007/s00251-016-0921-2.

Yu SQ, Cai YY, Lyons C, Johnson RF, Postnikova E, Mazur S, Johnson JC, Radoshitzky SR, Bailey AL, Lauck M, Goldberg TL, O'Connor DH, Jahrling PB, Friedrich TC, Kuhn JH. Specific detection of two divergent simian arteriviruses using RNAscope in situ hybridization. PLoS One. 2016;11(3):9. doi: 10.1371/journal.pone.0151313.

Zardaryan E, Paronyan L, Bakunts V, Gevorgyan Z, Asoyan V, Apresyan H, Hovhannisyan A, Palayan K, Kuchuloria T, Rivard RG, Bautista CT. Intestinal infections among febrile hospitalized patients in the Republic of Armenia: A retrospective chart review. J Community Health. 2016;41(5):939-45. doi: 10.1007/s10900-016-0174-x.

Zeitlin L, Geisbert JB, Deer DJ, Fenton KA, Bohorov O, Bohorova N, Goodman C, Kim D, Hiatt A, Pauly MH, Velasco J, Whaley KJ, Altmann F, Gruber C, Steinkellner H, Honko AN, Kuehne AI, Aman MJ, Sahandi S, Enterlein S, Zhan XG, Enria D, Geisbert TW. Monoclonal antibody therapy for Junin virus infection. Proc Natl Acad Sci U S A. 2016;113(16):4458-63. doi: 10.1073/pnas.1600996113.

Amaya M, Keck F, Lindquist M, Voss K, Scavone L, Kehn-Hall K, Roberts B, Bailey C, Schmaljohn C, Narayanan A. The ubiquitin proteasome system plays a role in venezuelan equine encephalitis virus infection. PLoS One. 2015 Apr 30;10(4):e0124792.

Ayithan N, Bradfute SB, Anthony SM, Stuthman KS, Bavari S, Bray M, Ozato K. Virus-like particles activate type I interferon pathways to facilitate post-exposure protection against Ebola virus infection. PLoS One. 2015 Feb 26;10(2):e0118345.

Biron B, Beck K, Dyer D, Mattix M, Twenhafel N, Nalca A. Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax. Antimicrob Agents Chemother. 2015 Apr;59(4):2206-14.

Bradfute SB, Anthony SM, Stuthman KS, Ayithan N, Tailor P, Shaia CI, Bray M, Ozato K, Bavari S. Mechanisms of immunity in post-exposure vaccination against Ebola virus infection. PLoS One. 2015 Mar 18;10(3):e0118434.

Caí Y, Postnikova EN, Bernbaum JG, Yú SQ, Mazur S, Deiuliis NM, Radoshitzky SR, Lackemeyer MG, McCluskey A, Robinson PJ, Haucke V, Wahl-Jensen V, Bailey AL, Lauck M, Friedrich TC, O'Connor DH, Goldberg TL, Jahrling PB, Kuhn JH. Simian hemorrhagic fever virus cell entry is dependent on CD163 and uses a clathrin-mediated endocytosis-like pathway. J Virol. 2015 Jan;89(1):844-56.

Field AE, Jones CL, Kelly R, Marko ST, Kern SJ, Rico PJ. Measurement of fecal corticosterone metabolites as a predictor of the habituation of rhesus macaques (Macaca mulatta) to jacketing. J Am Assoc Lab Anim Sci. 2015 Jan;54(1):59-65.

Garrison AR, Giomarelli BG, Lear-Rooney CM, Saucedo CJ, Yellayi S, Krumpe LR, Rose M, Paragas J, Bray M, Olinger GG Jr, McMahon JB, Huggins J, O'Keefe BR. The cyanobacterial lectin scytovirin displays potent in vitro and in vivo activity against Zaire Ebola virus. Antiviral Res. 2014 Dec;112:1-7.

Haese N, Brocato RL, Henderson T, Nilles ML, Kwilas SA, Josleyn MD, Hammerbeck CD, Schiltz J, Royals M, Ballantyne J, Hooper JW, Bradley DS. Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure. PLoS Negl Trop Dis. 2015 Jun 5;9(6):e0003803

Johnson SL, Bishop-Lilly KA, Ladner JT, Daligault HE, Davenport KW, Jaissle J, Frey KG, Koroleva GI, Bruce DC, Coyne SR, Broomall SM, Li PE, Teshima H, Gibbons HS, Palacios GF, Rosenzweig CN, Redden CL, Xu Y, Minogue TD, Chain PS. Complete genome sequences for 59 burkholderia isolates, both pathogenic and near neighbor. Genome Announc. 2015 Apr 30;3(2). pii: e00159-15.

Johnson SL, Daligault HE, Davenport KW, Coyne SR, Frey KG, Koroleva GI, Broomall SM, Bishop-Lilly KA, Bruce DC, Chertkov O, Freitas T, Jaissle J, Ladner JT, Rosenzweig CN, Gibbons HS, Palacios GF, Redden CL, Xu Y, Minogue TD, Chain PS. Genome sequencing of 18 francisella strains to aid in assay development and testing. Genome Announc. 2015 Apr 30;3(2). pii: e00147-15.

Johnson SL, Daligault HE, Davenport KW, Jaissle J, Frey KG, Ladner JT, Broomall SM, Bishop-Lilly KA, Bruce DC, Coyne SR, Gibbons HS, Lo CC, Munk AC, Rosenzweig CN, Koroleva GI, Palacios GF, Redden CL, Xu Y, Minogue TD, Chain PS. Thirty-Two Complete Genome Assemblies of Nine Yersinia Species, Including Y. pestis, Y. pseudotuberculosis, and Y. enterocolitica. Genome Announc. 2015 Apr 30;3(2). pii: e00148-15.

Johnson SL, Daligault HE, Davenport KW, Jaissle J, Frey KG, Ladner JT, Broomall SM, Bishop-Lilly KA, Bruce DC, Gibbons HS, Coyne SR, Lo CC, Meincke L, Munk AC, Koroleva GI, Rosenzweig CN, Palacios GF, Redden CL, Minogue TD, Chain PS. Complete genome sequences for 35 biothreat assay-relevant bacillus species. Genome Announc. 2015 Apr 30;3(2). pii: e00151-15.

Johnston SC, Briese T, Bell TM, Pratt WD, Shamblin JD, Esham HL, Donnelly GC, Johnson JC, Hensley LE, Lipkin WI, Honko AN. Detailed analysis of the African green monkey model of Nipah virus disease. PLoS One. 2015 Feb 23;10(2):e0117817.

Johnston SC, Johnson JC, Stonier SW, Lin KL, Kisalu NK, Hensley LE, Rimoin AW. Cytokine modulation correlates with severity of monkeypox disease in humans. J Clin Virol. 2015 Feb;63:42-5.

Kamata T, Natesan M, Warfield K, Aman MJ, Ulrich RG. Determination of specific antibody responses to the six species of ebola and marburg viruses by multiplexed protein microarrays. Clin Vaccine Immunol. 2014 Dec;21(12):1605-12.

Krakauer T. Sulfasalazine attenuates staphylococcal enterotoxin B-induced immune responses. Toxins (Basel). 2015 Feb 13;7(2):553-9.

Kugelman JR, Sanchez-Lockhart M, Andersen KG, Gire S, Park DJ, Sealfon R, Lin AE, Wohl S, Sabeti PC, Kuhn JH, Palacios GF. Evaluation of the potential impact of Ebola virus genomic drift on the efficacy of sequence-based candidate therapeutics. MBio. 2015 Jan 20;6(1).

Martins K, Carra JH, Cooper CL, Kwilas SA, Robinson CG, Shurtleff AC, Schokman RD, Kuehl KA, Wells JB, Steffens JT, van Tongeren SA, Hooper JW, Bavari S. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein. Viral Immunol. 2015 Feb;28(1):62-70.

Martins K, Cooper C, Warren T, Wells J, Bell T, Raymond J, Stuthman K, Benko J, Garza N, van Tongeren S, Donnelly G, Retterer C, Dong L, Bavari S. Characterization of clinical and immunological parameters during Ebola virus infection of rhesus macaques. Viral Immunol. 2015 Feb;28(1):32-41.

Mudhasani R, Kota KP, Retterer C, Tran JP, Tritsch SR, Zamani R, Whitehouse CA, Bavari S. High-content image-based screening of a signal transduction pathway inhibitor small-molecule library against highly pathogenic RNA viruses. J Biomol Screen. 2015 Jan;20(1):141-52.

Omotade TO, Bernhards RC, Klimko CP, Matthews ME, Hill AJ, Hunter MS, Webster WM, Bozue JA, Welkos SL, Cote CK. The impact of inducing germination of Bacillus anthracis and Bacillus thuringiensis spores on potential secondary decontamination strategies. J Appl Microbiol. 2014 Dec;117(6):1614-33.

Radoshitzky SR, Báo Y, Buchmeier MJ, Charrel RN, Clawson AN, Clegg CS, DeRisi JL, Emonet S, Gonzalez JP, Kuhn JH, Lukashevich IS, Peters CJ, Romanowski V, Salvato MS, Stenglein MD, de la Torre JC. Past, present, and future of arenavirus taxonomy. Arch Virol. 2015 Jul;160(7):1851-74.

Shurtleff AC, Whitehouse CA, Ward MD, Cazares LH, Bavari S. Pre-symptomatic diagnosis and treatment of filovirus diseases. Front Microbiol. 2015 Feb 20;6:108

Smith TJ, Hill KK, Raphael BH. Historical and current perspectives on Clostridium botulinum diversity. Res Microbiol. 2015 May;166(4):290-302.

Smith TJ, Hill KK, Xie G, Foley BT, Williamson CH, Foster JT, Johnson SL, Chertkov O, Teshima H, Gibbons HS, Johnsky LA, Karavis MA, Smith LA. Genomic sequences of six botulinum neurotoxin-producing strains representing three clostridial species illustrate the mobility and diversity of botulinum neurotoxin genes. Infect Genet Evol. 2015 Mar;30:102-13.

Sozhamannan S, Holland MY, Hall AT, Negrón DA, Ivancich M, Koehler JW, Minogue TD, Campbell CE, Berger WJ, Christopher GW, Goodwin BG, Smith MA. Evaluation of Signature Erosion in Ebola Virus Due to Genomic Drift and Its Impact on the Performance of Diagnostic Assays. Viruses. 2015 Jun 17;7(6):3130-54.

Tree JA, Williamson ED, Rowland CA, Pitt LM. Vaccines and therapies for biodefence agents. J Immunol Res. 2015;2015:537319.

Warfield KL, Dye JM, Wells JB, Unfer RC, Holtsberg FW, Shulenin S, Vu H, Swenson DL, Bavari S, Aman MJ. Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles. PLoS One. 2015 Mar 20;10(3):e0118881.

Welkos SL, Klimko CP, Kern SJ, Bearss JJ, Bozue JA, Bernhards RC, Trevino SR, Waag DM, Amemiya K, Worsham PL, Cote CK. Characterization of Burkholderia pseudomallei Strains Using a Murine Intraperitoneal Infection Model and In Vitro Macrophage Assays. PLoS One. 2015 Apr 24;10(4):e0124667.

Yu GY, Wiley MR, Kugelman JR, Ladner JT, Beitzel BF, Eccleston LT, Morazzani EM, Glass PJ, Palacios GF. Complete coding sequences of eastern equine encephalitis virus and venezuelan equine encephalitis virus strains isolated from human cases. Genome Announc. 2015 Apr 23;3(2).

Bell TM, Shaia CI, Bunton TE, Robinson CG, Wilkinson ER, Hensley LE, et al. Pathology of Experimental Machupo Virus Infection, Chicava Strain, in Cynomolgus Macaques (Macaca fascicularis) by Intramuscular and Aerosol Exposure. Veterinary pathology. 2014.

Bocan TM, Panchal RG, Bavari S. Applications of In Vivo Imaging in the Evaluation of the Pathophysiology of Viral and Bacterial Infections and in Development of Countermeasures to BSL3/4 Pathogens. Molecular imaging and biology. 2014.

Bozue J, Cote CK, Chance T, Kugelman J, Kern SJ, Kijek TK, et al. A Yersinia pestis tat mutant is attenuated in bubonic and small-aerosol pneumonic challenge models of infection but not as attenuated by intranasal challenge. PloS one. 2014;9(8):e104524.

Brocato RL, Hammerbeck CD, Bell TM, Wells JB, Queen LA, Hooper JW. A lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with Sin Nombre virus. Journal of virology. 2014;88(2):811-9.

Brown CS, Lee MS, Leung DW, Wang T, Xu W, Luthra P, et al. In silico derived small molecules bind the filovirus VP35 protein and inhibit its polymerase cofactor activity. Journal of molecular biology. 2014;426(10):2045-58.

Burtnick MN, Brett PJ, DeShazer D. Proteomic Analysis of the Burkholderia pseudomallei Type II Secretome Reveals Hydrolytic Enzymes, Novel Proteins, and the Deubiquitinase TssM. Infection and Immunity. 2014;82(8):3214-26.

Daligault HE, Davenport KW, Minogue TD, Bishop-Lilly KA, Bruce DC, Chain PS, et al. Draft Genome Assembly of Bordetella bronchiseptica ATCC 10580, a Historical Canine Clinical Isolate. Genome announcements. 2014;2(5).

Daligault HE, Davenport KW, Minogue TD, Bishop-Lilly KA, Bruce DC, Chain PS, et al. Complete Genome Assembly of a Quality Control Reference Isolate, Moraxella catarrhalis Strain ATCC 25240. Genome announcements. 2014;2(5).

Dankmeyer JL, Fast RL, Cote CK, Worsham PL, Fritz D, Fisher D, et al. Multiple roles of Myd88 in the immune response to the plague F1-V vaccine and in protection against an aerosol challenge of Yersinia pestis CO92 in mice. Journal of immunology research. 2014;2014:341820.

Dankova V, Balonova L, Straskova A, Spidlova P, Putzova D, Kijek T, et al. Characterization of TPR-like proteins in Francisella tularensis; identification of a novel locus required for virulence. Infection and immunity. 2014.

Davenport KW, Daligault HE, Minogue TD, Bishop-Lilly KA, Bruce DC, Chain PS, et al. Draft Genome Assembly of Delftia acidovorans Type Strain 2167. Genome announcements. 2014;2(5).

Davenport KW, Daligault HE, Minogue TD, Bruce DC, Chain PSG, Coyne SR, et al. Draft Genome Assembly of Acinetobacter baumannii ATCC 19606. Genome announcements. 2014;2(4).

Del Favero G, Sosa S, Poli M, Tubaro A, Sbaizero O, Lorenzon P. In vivo and in vitro effects of 42-hydroxy-palytoxin on mouse skeletal muscle: structural and functional impairment. Toxicology letters. 2014;225(2):285-93.

Dyall J, Coleman CM, Hart BJ, Venkataraman T, Holbrook MR, Kindrachuk J, et al. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrobial agents and chemotherapy. 2014;58(8):4885-93.

Ferreyra GA, Elinoff JM, Demirkale CY, Starost MF, Buckley M, Munson PJ, et al. Late multiple organ surge in interferon-regulated target genes characterizes staphylococcal enterotoxin B lethality. PloS one. 2014;9(2):e88756.

Filone CM, Caballero IS, Dower K, Mendillo ML, Cowley GS, Santagata S, et al. The master regulator of the cellular stress response (HSF1) is critical for orthopoxvirus infection. PLoS pathogens. 2014;10(2):e1003904.

Garamszegi S, Yen JY, Honko AN, Geisbert JB, Rubins KH, Geisbert TW, et al. Transcriptional correlates of disease outcome in anticoagulant-treated non-human primates infected with ebolavirus. PLoS neglected tropical diseases. 2014;8(7):e3061.

Golnar AJ, Turell MJ, LaBeaud AD, Kading RC, Hamer GL. Predicting the mosquito species and vertebrate species involved in the theoretical transmission of rift valley Fever virus in the United States. PLoS neglected tropical diseases. 2014;8(9):e3163.

Haley BJ, Kokashvili T, Tskshvediani A, Janelidze N, Mitaishvili N, Grim CJ, et al. Molecular diversity and predictability of Vibrio parahaemolyticus along the Georgian coastal zone of the Black Sea. Frontiers in microbiology. 2014;5:45.

Han Z, Lu J, Liu Y, Davis B, Lee MS, Olson MA, et al. Small-molecule probes targeting the viral PPxY-host Nedd4 interface block egress of a broad range of RNA viruses. Journal of virology. 2014;88(13):7294-306.

Heine HS, Louie A, Adamovicz JJ, Amemiya K, Fast RL, Miller L, et al. Evaluation of imipenem for prophylaxis and therapy of Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague. Antimicrobial agents and chemotherapy. 2014;58(6):3276-84.

Hokey DA, Wachholder R, Darrah PA, Bolton DL, Barouch DH, Hill K, et al. A nonhuman primate toxicology and immunogenicity study evaluating aerosol delivery of AERAS-402/Ad35 Vaccine: Evidence for transient t cell responses in peripheral blood and robust sustained responses in the lungs. Human vaccines & immunotherapeutics. 2014;10(8).

Holley AB, Petteys S, Mitchell JD, Holley PR, Hostler JM, Clark P, et al. Venous thromboembolism prophylaxis for patients receiving regional anesthesia following injury in Iraq and Afghanistan. The journal of trauma and acute care surgery. 2014;76(1):152-9.

Honnold SP, Bakken RR, Fisher D, Lind CM, Cohen JW, Eccleston LT, et al. Second Generation Inactivated Eastern Equine Encephalitis Virus Vaccine Candidates Protect Mice against a Lethal Aerosol Challenge. PloS one. 2014;9(8):e104708.

Hooper JW, Moon JE, Paolino KM, Newcomer R, McLain DE, Josleyn M, et al. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2014;20 Suppl 5:110-7.

Hughes LJ, Goldstein J, Pohl J, Hooper JW, Lee Pitts R, Townsend MB, et al. A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27. Virology. 2014;464-465:264-73.

Hussainzada N, Lewis JA, Baer CE, Ippolito DL, Jackson DA, Stallings JD. Whole adult organism transcriptional profiling of acute metal exposures in male Zebrafish. BMC Pharmacology & Toxicology. 2014;15:Article No.: 15.

Ip HS, Wiley MR, Long R, Palacios G, Shearn-Bochsler V, Whitehouse CA. Identification and characterization of Highlands J virus from a Mississippi sandhill crane using unbiased next-generation sequencing. Journal of virological methods. 2014;206:42-5.

Jae LT, Raaben M, Herbert AS, Kuehne AI, Wirchnianski AS, Soh TK, et al. Virus entry. Lassa virus entry requires a trigger-induced receptor switch. Science (New York, NY). 2014;344(6191):1506-10.

Jelacic TM, Chabot DJ, Bozue JA, Tobery SA, West MW, Moody K, et al. Exposure to Bacillus anthracis Capsule Results in Suppression of Human Monocyte-Derived Dendritic Cells. Infection and Immunity. 2014;82(8):3405-16.

Johnson JC, Martinez O, Honko AN, Hensley LE, Olinger GG, Basler CF. Pyridinyl imidazole inhibitors of p38 MAP kinase impair viral entry and reduce cytokine induction by Zaire ebolavirus in human dendritic cells. Antiviral research. 2014;107:102-9.

Kamata T, Natesan M, Warfield K, Aman MJ, Ulrich RG. Determination of Specific Antibody Responses to the Six Species of Ebola and Marburg Viruses by Multiplexed Protein Microarrays. Clinical and vaccine immunology : CVI. 2014.

Kiris E, Wang T, Yanpallewar S, Dorsey SG, Becker J, Bavari S, et al. TrkA in vivo function is negatively regulated by ubiquitination. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2014;34(11):4090-8.

Koehler JW, Hall AT, Rolfe PA, Honko AN, Palacios GF, Fair JN, et al. Development and evaluation of a panel of filovirus sequence capture probes for pathogen detection by next-generation sequencing. PloS one. 2014;9(9):e107007.

Kuchuloria T, Imnadze P, Chokheli M, Tsertsvadze T, Endeladze M, Mshvidobadze K, et al. Viral hemorrhagic fever cases in the country of Georgia: Acute Febrile Illness Surveillance Study results. The American journal of tropical medicine and hygiene. 2014;91(2):246-8.

Kwilas S, Kishimori JM, Josleyn M, Jerke K, Ballantyne J, Royals M, et al. A Hantavirus Pulmonary Syndrome (HPS) DNA Vaccine Delivered Using a Spring-powered Jet Injector Elicits a Potent Neutralizing Antibody Response in Rabbits and Nonhuman Primates. Current gene therapy. 2014;14(3):200-10.

Ladner JT, Beitzel B, Chain PSG, Davenport MG, Donaldson EF, Frieman M, et al. Standards for sequencing viral genomes in the era of high-throughput sequencing. mBio. 2014;5(3):e01360-14.

Langel FD, Chiang C-Y, Lane D, Kenny T, Ojeda JF, Zhong Y, et al. Alveolar macrophages infected with Ames or Sterne strain of Bacillus anthracis elicit differential molecular expression patterns. PloS one. 2014;9(2):e87201.

Lee HW, Vaheri A, Schmaljohn CS. Discovery of hantaviruses and of the Hantavirus genus: Personal and historical perspectives of the Presidents of the International Society of Hantaviruses. Virus Research.
2014;187:2-5.

Luther MK, Arvanitis M, Mylonakis E, LaPlante KL. Activity of Daptomycin or Linezolid in Combination with Rifampin or Gentamicin against Biofilm-Forming Enterococcus faecalis or E. faecium in an In Vitro Pharmacodynamic Model Using Simulated Endocardial Vegetations and an In Vivo Survival Assay Using Galleria mellonella Larvae. Antimicrobial Agents and Chemotherapy. 2014;58(8):4612-20.

Martins KAO, Steffens JT, van Tongeren SA, Wells JB, Bergeron AA, Dickson SP, et al. Toll-like receptor agonist augments virus-like particle-mediated protection from Ebola virus with transient immune activation. PloS one. 2014;9(2):e89735.

Maves RC, Tripp MS, Dell TG, Bennett JW, Ahluwalia JS, Tamminga C, et al. Disseminated vaccine-strain varicella as initial presentation of the acquired immunodeficiency syndrome: a case report and review of the literature. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2014;59(1):63-6.

McCoy JB, Mendoza JM, Spik KW, Badger C, Gomez A, Schmaljohn CS, et al. A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skin. Human vaccines & immunotherapeutics. 2014;10(10).

Miloslavski R, Cohen E, Avraham A, Iluz Y, Hayouka Z, Kasir J, et al. Oxygen sufficiency controls TOP mRNA translation via the TSC-Rheb-mTOR pathway in a 4E-BP-independent manner. Journal of molecular cell biology. 2014;6(3):255-66.

Minogue TD, Daligault HA, Davenport KW, Bishop-Lilly KA, Broomall SM, Bruce DC, et al. Whole-genome sequences of 24 Brucella strains. Genome announcements. 2014;2(5).

Minogue TD, Rachwal PA, Trombley Hall A, Koehler JW, Weller SA. Cross-institute evaluations of inhibitor-resistant PCR reagents for direct testing of aerosol and blood samples containing biological warfare agent DNA. Applied and environmental microbiology. 2014;80(4):1322-9.

Mizanur RM, Stafford RG, Ahmed SA. Cleavage of SNAP25 and its shorter versions by the protease domain of serotype A botulinum neurotoxin. PloS one. 2014;9(4):e95188.

Mudhasani R, Kota KP, Retterer C, Tran JP, Whitehouse CA, Bavari S. High content image-based screening of a protease inhibitor library reveals compounds broadly active against Rift Valley fever virus and other highly pathogenic RNA viruses. PLoS neglected tropical diseases. 2014;8(8):e3095.

Nguyen ST, Williams JD, Butler MM, Ding X, Mills DM, Tashjian TF, et al. Synthesis and antibacterial evaluation of new, unsymmetrical triaryl bisamidine compounds. Bioorganic & medicinal chemistry letters. 2014;24(15):3366-72.

Nuss JE, Kehn-Hall K, Benedict A, Costantino J, Ward M, Peyser BD, et al. Multi-Faceted Proteomic Characterization of Host Protein Complement of Rift Valley Fever Virus Virions and Identification of Specific Heat Shock Proteins, Including HSP90, as Important Viral Host Factors. PLoS One. 2014;9(5):Article No.: e93483.

Olson MA, Lee MS. Evaluation of Unrestrained Replica-Exchange Simulations Using Dynamic Walkers in Temperature Space for Protein Structure Refinement. PLoS One. 2014;9(5):Article No.: e96638.

Omotade TO, Bernhards RC, Klimko CP, Matthews ME, Hill AJ, Hunter MS, et al. The impact of inducing germination of Bacillus anthracis and Bacillus thuringiensis spores on potential secondary decontamination strategies. Journal of applied microbiology. 2014.

Page A, Volchkova VA, Reid SP, Mateo M, Bagnaud-Baule A, Nemirov K, et al. Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1. Cell reports. 2014;6(6):1026-36.

Palacios G, Tesh RB, Savji N, da Rosa APAT, Guzman H, Bussetti AV, et al. Characterization of the Sandfly fever Naples species complex and description of a new Karimabad species complex (genus Phlebovirus, family Bunyaviridae). Journal of General Virology. 2014;95(Part 2):292-300.

Panchal RG, Mourich DV, Bradfute S, Hauck LL, Warfield KL, Iversen PL, et al. Induced IL-10 splice altering approach to antiviral drug discovery. Nucleic acid therapeutics. 2014;24(3):179-85.

Paranavitana C, DaSilva L, Vladimirova A, Pittman PR, Velauthapillai M, Nikolich M. Transcriptional profiling of recall responses to Francisella live vaccine strain. Pathog Dis. 2014;70(2):141-52.

Pegoraro G, Eaton BP, Ulrich RL, Lane DJ, Ojeda JF, Bavari S, et al. A high-content imaging assay for the quantification of the Burkholderia pseudomallei induced multinucleated giant cell (MNGC) phenotype in murine macrophages. BMC Microbiology. 2014;14:Article No.: 98.

Petz LN, Turell MJ, Padilla S, Long LS, Reinbold-Wasson DD, Smith DR, et al. Development of Conventional and Real-Time Reverse Transcription Polymerase Chain Reaction Assays to Detect Tembusu Virus in Culex tarsalis Mosquitoes. The American journal of tropical medicine and hygiene. 2014.

Pittman PR, Cavicchia MA, Kingsbury JL, Johnson NA, Barrera-Oro JG, Schmader T, et al. Anthrax vaccine adsorbed: Further evidence supporting continuing the vaccination series rather than restarting the series when doses are delayed. Vaccine. 2014;32(39):5131-9.

Pugh C, Keasey S, Korman L, Pittman PR, Ulrich RG. Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000. Clinical and vaccine immunology : CVI. 2014;21(6):877-85.

Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature. 2014.

Reed DS, Glass PJ, Bakken RR, Barth JF, Lind CM, da Silva L, et al. Combined Alphavirus Replicon Particle Vaccine Induces Durable and Cross-Protective Immune Responses against Equine Encephalitis Viruses. Journal of virology. 2014;88(20):12077-86.

Reid SP, Shurtleff AC, Costantino JA, Tritsch SR, Retterer C, Spurgers KB, et al. HSPA5 is an essential host factor for Ebola virus infection. Antiviral research. 2014;109:171-4.

Samy RP, Kandasamy M, Gopalakrishnakone P, Stiles BG, Rowan EG, Becker D, et al. Wound healing activity and mechanisms of action of an antibacterial protein from the venom of the eastern diamondback rattlesnake (Crotalus adamanteus). PloS one. 2014;9(2):e80199.

Schmaljohn CS, Spik KW, Hooper JW. 0 DNA vaccines for HFRS: laboratory and clinical studies. Virus research. 2014;187:91-6.

Seok SH, Im H, Won HS, Seo MD, Lee YS, Yoon HJ, et al. Structures of inactive CRP species reveal the atomic details of the allosteric transition that discriminates cyclic nucleotide second messengers. Acta Crystallogr D. 2014;70:1726-42.

Stanley DA, Honko AN, Asiedu C, Trefry JC, Lau-Kilby AW, Johnson JC, et al. Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge. Nature medicine. 2014.

Tarquinio K, Confreda K, Shurko J, LaPlante K. Activities of Tobramycin and Polymyxin E against Pseudomonas aeruginosa Biofilm-Coated Medical Grade Endotracheal Tubes. Antimicrobial Agents and Chemotherapy. 2014;58(3):1723-9.

Twenhafel NA, Shaia CI, Bunton TE, Shamblin JD, Wollen SE, Pitt LM, et al. Experimental Aerosolized Guinea Pig-Adapted Zaire Ebolavirus (Variant: Mayinga) Causes Lethal Pneumonia in Guinea Pigs. Veterinary pathology. 2014.

Wanja E, Parker ZF, Odusami O, Rowland T, Davé K, Davé S, et al. Immuno-chromatographic wicking assay for the rapid detection of dengue viral antigens in mosquitoes (Diptera: Culicidae). Journal of medical entomology. 2014;51(1):220-5.

Warfield KL, Goetzmann JE, Biggins JE, Kasda MB, Unfer RC, Vu H, et al. Vaccinating captive chimpanzees to save wild chimpanzees. Proceedings of the National Academy of Sciences of the United States of America. 2014;111(24):8873-6.

Warren TK, Wells J, Panchal RG, Stuthman KS, Garza NL, Van Tongeren SA, et al. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature. 2014;508(7496):402-5.

Yingst SL, Facemire P, Chuvala L, Norwood D, Wolcott M, Alves DA. Pathological findings and diagnostic implications of a rhesus macaque (Macaca mulatta) model of aerosol-exposure melioidosis (Burkholderia pseudomallei). Journal of Medical Microbiology. 2014;63:118-28.

Atanasiu D, Saw WT, Gallagher JR, Hannah BP, Matsuda Z, Whitbeck JC, Cohen GH, Eisenberg RJ. Dual split protein-based fusion assay reveals that mutations to herpes simplex virus (HSV) glycoprotein gB alter the kinetics of cell-cell fusion induced by HSV entry glycoproteins. J Virol. 2013 Nov; 87(21):11332-45

Benton CG, West MW, Hall SM, Marko ST, Johnson JC. Effect of short-term pair housing of juvenile rhesus macaques (Macaca mulatta) on immunologic parameters. J Am Assoc Lab Anim Sci. 2013; 52(3):240-6

Boscolo S, Pelin M, Boscolo S, Poli M, Sosa S, Tubaro A, Florio C. Characterization of palytoxin binding to HaCaT cells using a monoclonal anti-palytoxin antibody. Mar Drugs. 2013 Feb 26; 11(3):584-98

Boscolo S, Pelin M, De Bortoli M, Fontanive G, Barreras A, Berti F, Sosa S, Chaloin O, Bianco A, Yasumoto T, Prato M, Poli M, Tubaro A. Sandwich ELISA Assay for the Quantitation of Palytoxin and Its Analogs in Natural Samples. Environmental Science & Technology 2013 Feb 19, 47(4): 2034-42

Brocato RL, Josleyn MJ, Wahl-Jensen V, Schmaljohn CS, Hooper JW. Construction and Nonclinical Testing of a Puumala Virus Synthetic M Gene-Based DNA Vaccine. Clinical and Vaccine Immunology 2013 Feb, 20(2):218-226

Brudner M, Karpel M, Lear C, Chen L, Yantosca LM, Scully C, Sarraju A, Sokolovska A, Zariffard MR, Eisen DP, Mungall BA, Kotton DN, Omari A, Huang IC, Farzan M, Takahashi K, Stuart L, Stahl GL, Ezekowitz AB, Spear GT, Olinger GG, Schmidt EV, Michelow IC. Lectin-Dependent enhancement of Ebola Virus infection via soluble and transmembrane C-type lectin receptors. PLoS One 2013, 8(4):e60838

Buckheit RW III, Salgado M, Martins KO, Blankson JN. The implications of viral reservoirs on the elite control of HIV-1 infection. Cellular and Molecular Life Sciences 2013 Mar, 70(6):1009-19

Burmester GR, Weinblatt ME, McInnes IB, Porter D, Barbarash O, Vatutin M, Szombati I, Esfandiari E, Sleeman MA, Kane CD, Cavet G, Wang B, Godwood A, Magrini F. EARTH Study Group. Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis. Ann Rheum Dis. 2013 Sep 1; 72(9):1445-52

Byrd, BD, Turell, MJ, Harrison, BA. Potential for populations of Aedes j. japonicus to transmit Rift Valley fever virus in the USA. J Am Mosq Control Assoc 2013 Jun; 29(2):133-7

C. Garcia, S. Yan, I. Geren, J. Lou, W. Wen, F. Conrad, T.J. Smith, J. Brown, J. Skerry, L.A. Smith, J.D. Marks. Human monoclonal antibodies binding botulinum neurotoxin types C, D, and mosaic neurotoxins C-D and D-C. Toxicon Volume 68, 15 June 2013, Pages 86-87

C.B. Shoemaker, J. Mukherjee, J.M. Tremblay, C. Leysath, D. Bedenice, X. Feng, K. Ofori, K. Baldwin, R.P. Webb, P.M. Wright, L.A. Smith, S. Tzipori. A Strategy for rapid development and simplified production of therapeutic antitoxins tested on botulinum neurotoxin. Toxicon Volume 68, 15 June 2013, Page 97

Caí Y, Yú S, Mazur S, Dong L, Janosko K, Zhang T, Müller MA, Hensley LE, Bavari S, Jahrling PB, Radoshitzky SR, Kuhn JH. Nonhuman transferrin receptor 1; is an efficient cell entry receptor for Ocozocoautla de Espinosa virus. J Virol 2013 Dec; 87(24):13930-5.

Cann JA, Jahrling PB, Hensley LE, Wahl-Jensen V. Comparative Pathology of Smallpox and Monkeypox in Man and Macaques. Journal of Comparative Pathology 2013 Jan, 148 (1):6-21

Chang J, Warren TK, Zhao X, Gill T, Guo F, Wang L, Comunale MA, Du Y, Alonzi DS, Yu W, Ye H, Liu F, Guo J-T, Mehta A, Cuconati A, Butters TD, Bavari S, Xu X, Block TM. Small molecule inhibitors of ER a-glucosidases are active against multiple hemorrhagic fever viruses. Antiviral Research 2013 Apr, 98(3): 432-40

Chaudhury S, Abdulhameed MD, Singh N, Tawa GJ, D'haeseleer PM, Zemla AT, Navid A, Zhou CE, Franklin MC, Cheung J, Rudolph MJ, Love J, Graf JF, Rozak DA,Dankmeyer JL, Amemiya K, Daefler S, Wallqvist A. Rapid countermeasure discovery against Francisella tularensis based on a metabolic network reconstruction. PLoS One 2013 May 21; 8(5):e63369

Christova I, Younan R, Taseva E, Gladnishka T, Trifonova I, Ivanova V, Spik K, Schmaljohn C, Mohareb E. Hemorrhagic fever with renal syndrome and Crimean-Congo hemorrhagic fever as causes of acute undifferentiated febrile illness in Bulgaria. Vector-Borne and Zoonotic Diseases 2013 Mar, 13(3): 188-92

Copeland AM, Altamura LA, Van Deusen NM, Schmaljohn CS. Nuclear relocalization of polyadenylate binding protein during rift valley fever virus infection involves expression of the NSs gene. J Virol. 2013 Nov; 87(21):11659-69.

Cote CK, Bozue J, Alem F, Ventura CL, Vergis JM, Welkos SL, O'Brien AD. Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames. Clin Vaccine Immunol. 2013 Jan; 20(1):56-65.

Del Favero G, Beltramo D, Sciancalepore M, Lorenzon P, Coslovich T, Poli M, Testai E, Sosa S, Tubaro A. Toxicity of palytoxin after repeated oral exposure in mice and in vitro effects on cardiomyocytes. Toxicon. 2013 Dec 1; 75:3-15

D'Souza AJM, Mar KD, Huang J, Majumdar S, Ford BM, Dyas B, Ulrich RG, Sullivan VJ. Rapid deamidation of recombinant protective antigen when adsorbed on aluminum hydroxide gel correlates with reduced potency of vaccine. Journal of Pharmaceutical Sciences 2013 Feb, 102 (2): 454-61

Duncan DD, Vogler AJ, Wolcott MJ, Li F, Sarovich DS, Birdsell DN, Watson LM, Hall TA, Sampath R, Housley R, Blyn LB, Hofstadler SA, Ecker DJ, Keim P, Wagner DM, Eshoo MW. Identification and typing of Francisella tularensis with a highly automated genotyping assay. Letters in Applied Microbiology 2013 Feb, 56(2):128-34

Fan Y, Lou J, Garcia C, Zhai W, Dong J, Wen W, Conrad F, Brown J, Skerry J, Smith TJ, Smith LA, Marks JD. Monoclonal antibodies against botulinum neurotoxin serotype F. Toxicon Volume 68, 15 June 2013, Pages 85-86.

Fernández DA, Louzao MC, Vilariño N, Espiña B, Fraga M, Vieytes MR, Román A, Poli M, Botana LM. The kinetic, mechanistic and cytomorphological effects of palytoxin in human intestinal cells (Caco-2) explain its lower-than-parenteral oral toxicity. FEBS J. 2013 Aug; 280(16):3906-19

Fernandez S, Cisney ED, Ulrich RG. Enhancement of serum and mucosal immune responses to a Haemophilus influenzae Type B vaccine by intranasal delivery. Clin Vaccine Immunol. 2013 Nov; 20(11):1690-6.

Filone CM, Hodges EN, Honeyman B, Bushkin GG, Boyd K, Platt A, Ni F, Strom K, Hensley L, Snyder JK, Connor JH. Identification of a broad-spectrum inhibitor of viral RNA synthesis: Validation of a prototype virus-based approach. Chemistry and Biology 2013 Mar, 20(3):424-33

Garrison AR, Radoshitzky SR, Kota KP, Pegoraro G, Ruthel G, Kuhn JH, Altamura LA, Kwilas SA, Bavari S, Haucke V, Schmaljohn CS. Crimean-Congo hemorrhagic fever virus utilizes a clathrin- and early endosome-dependent entry pathway. Virology. 2013 Sep; 444(1-2):45-54.

Grubaugh ND, McMenamy SS, Turell MJ, Lee JS. Multi-gene detection and identification of mosquito-borne RNA viruses using an oligonucleotide microarray. PLoS Negl Trop Dis. 2013 Aug 15; 7(8):e2349.

Grubaugh ND, Petz LN, Melanson VR, McMenamy SS, Turell MJ, Long LS, Pisarcik SE, Kengluecha A, Jaichapor B, O'Guinn ML, Lee JS. Evaluation of a Field-Portable DNA Microarray Platform and Nucleic Acid Amplification Strategies for the Detection of Arboviruses Arthropods and Bloodmeals. American Journal of Tropical Medicine and Hygiene 2013 Feb, 88 (2):245-53

Heffron JD, Jenkins AL, Bozue JA, Kaatz LK, Cote CK, Welkos SL. Phenotypic changes in spores and vegetative cells of Bacillus anthracis associated with BenK. Microbial Pathogenesis 2013 Apr, 57: 41-51

Herbert AS, Kuehne AI, Barth JF, Ortiz RA, Nichols DK, Zak SE, Stonier SW, Muhammad MA, Bakken RR, Prugar LI, Olinger GG, Groebner JL, Lee JS, Pratt WD, Custer M, Kamrud KI, Smith JF, Hart MK, Dye JM. Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus. Journal of Virology 2013 May, 87(9): 4952-64

Hill KK, Smith TJ. Genetic diversity within Clostridium botulinum serotypes, botulinum neurotoxin gene clusters and toxin subtypes. Curr Top Microbiol Immunol. 2013; 364:1-20

Hodge DR, Prentice KW, Ramage JG, Prezioso S, Gauthier C, Swanson T, Hastings R, Basavanna U, Datta S, Sharma SK, Garber EA, Staab A, Pettit D, Drumgoole R, Swaney E, Estacio PL, Elder IA, Kovacs G, Morse BS, Kellogg RB, Stanker L, Morse SA, Pillai SP. Comprehensive laboratory evaluation of a highly specific lateral flow assay for the presumptive identification of ricin in suspicious white powders and environmental samples. Biosecur Bioterror. 2013 Dec; 11(4):237-50. doi: 10.1089/bsp.2013.0053. Epub 2013 Dec 9

Hogan M, Bahta M, Cherry S, Lountos GT, Tropea JE, Zhao BM, Burke TR Jr, Waugh DS, Ulrich RG. Biomolecular interactions of small-molecule inhibitors affecting the YopH protein tyrosine phosphatase. Chemical Biology & Drug Design 2013 Mar, 81(3):323-33

Holley AB, Petteys S, Mitchell JD, Holley PR, Collen JF. Thromboprophylaxis and VTE rates in soldiers wounded in Operation Enduring Freedom and Operation Iraqi Freedom. Chest. 2013 Sep;144(3):966-73.

Hooper JW, Josleyn M, Ballantyne J, Brocato R. A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS). Vaccine. 2013 Sep 13; 31(40):4314-21.

Hu X, Compton JR, Abdulhameed MD, Marchand CL, Robertson KL, Leary DH, Jadhav A, Hershfield JR, Wallqvist A, Friedlander AM, Legler PM. 3-substituted indole inhibitors against Francisella tularensis FabI identified by structure-based virtual screening. J Med Chem. 2013 Jul 11; 56(13):5275-87.

Ismayilova R, Mody R, Abdullayev R, Amirova K, Jabbarova L, Ustun N, Jahanov M, Nasirova E, Powers M, Rivard R, Hepburn M, Bautista CT. Screening of household family members of brucellosis cases and neighboring community members in Azerbaijan. American Journal of Tropical Medicine and Hygiene 2013 May, 88(5): 929-31

Jaiani E, Kokashvili T, Mitaishvili N, Elbakidze T, Janelidze N, Lashkhi N, Kalandadze R, Mikashavidze E, Natroshvili G, Whitehouse CA, Huq A, Tediashvili M. Microbial water quality of recreational lakes near Tbilisi, Georgia. J Water Health. 2013 Jun; 11(2):333-45

Janosi L, Compton JR, Legler PM, Steele KE, Davis JM, Matyas GR, Millard CB. Disruption of the putative vascular leak peptide sequence in the stabilized ricin vaccine candidate RTA1-33/44-198. Toxins 2013 Jan 30, 5(2): 224-48

Johansen LM, Brannan JM, Delos SE, Shoemaker CJ, Stossel A, Lear C, Hoffstrom BG, Dewald LE, Schornberg KL, Scully C, Lehár J, Hensley LE, White JM, Olinger GG. FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection. Sci Transl Med. 2013 Jun 19; 5(190):190ra79.

Kalb SR, Baudys J, Webb RP, Wright P, Smith TJ, Smith LA, Fernández R, Raphael BH, Maslanka SE, Pirkle JL, Barr JR. Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5. FEBS Lett. 2012 Jan 20;586(2):109-15.

Ko KS, Mizanur RM, Jackson JM, Liu L, Pohl NL. A mass-differentiated library strategy for identification of sugar nucleotidyltransferase activities from cell lysates. Anal Biochem. 2013 Oct 1; 441(1):8-12.

Koehler JW, Smith JM, Ripoll DR, Spik KW, Taylor SL, Badger CV, Grant RJ, Ogg MM, Wallqvist A, Guttieri MC, Garry RF, Schmaljohn CS. A fusion-inhibiting peptide against Rift Valley fever virus inhibits multiple, diverse viruses. PLoS Negl Trop Dis. 2013 Sep 12; 7(9):e2430.

Konduru K, Bradfute SB, Jacques J, Manangeeswaran M, Nakamura S, Morshed S, Wood SC, Bavari S, Kaplan GG. Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice. Vaccine. 2011 Apr 5; 29(16):2968-77.

Korva M, Saksida A, Kejžar N, Schmaljohn C, Avšic-Županc T. Viral load and immune response dynamics in patients with haemorrhagic fever with renal syndrome. Clin Microbiol Infect. 2013 Aug; 19(8):E358-66

Kota KP, Eaton B, Lane D, Ulrich M, Ulrich R, Peyser BD, Robinson CG, Jaissle JG, Pegoraro G, Bavari S, Panchal RG. Integrating High-Content Imaging and Chemical Genetics to Probe Host Cellular Pathways Critical for Yersinia Pestis Infection. PLoS One 2013, 8(1): e55167

Krakauer T. Determination of c5a in murine models of staphylococcal enterotoxin B-induced toxic shock. Journal of Immunoassay and Immunochemistry 2013, 34(1): 30-38

Krakauer T. Update on staphylococcal superantigen-induced signaling pathways and therapeutic interventions. Toxins (Basel). 2013 Sep 24; 5(9):1629-54.

Krakauer T, Stiles BG. The staphylococcal enterotoxin (SE) family: SEB and siblings. Virulence. 2013 Nov 15; 4(8):759-73

Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Caí Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, Formenty P, Freiberg AN, Hensley LE, Honko AN, Ignatyev GM, Jahrling PB, Johnson KM, Klenk HD, Kobinger G, Lackemeyer MG, Leroy EM, Lever MS, Lofts LL, Mühlberger E, Netesov SV, Olinger GG, Palacios G, Patterson JL, Paweska JT, Pitt L, Radoshitzky SR, Ryabchikova EI, Saphire EO, Shestopalov AM, Smither SJ, Sullivan NJ, Swanepoel R, Takada A, Towner JS, van der Groen G, Volchkov VE, Wahl-Jensen V, Warren TK, Warfield KL, Weidmann M, Nichol ST. Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Arch Virol. 2013 Jun; 158(6):1425-32.

Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Hensley LE, Honko AN, Jahrling PB, Johnson KM, Kobinger G, Leroy EM, Lever MS, Mühlberger E, Netesov SV, Olinger GG, Palacios G, Patterson JL, Paweska JT, Pitt L, Radoshitzky SR, Saphire EO, Smither SJ, Swanepoel R, Towner JS, van der Groen G, Volchkov VE, Wahl-Jensen V, Warren TK, Weidmann M, Nichol ST. Virus nomenclature below the species level: A standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Archives of Virology 2013 Jan, 158(1): 301-11

Kuhn JH, Bekal S, Caí Y, Clawson AN, Domier LL, Herrel M, Jahrling PB, Kondo H, Lambert KN, Mihindukulasuriya KA, Nowotny N, Radoshitzky SR, Schneider U, Staeheli P, Suzuki N, Tesh RB, Wang D, Wang LF, Dietzgen RG. Nyamiviridae: proposal for a new family in the order Mononegavirales. Arch Virol. 2013 Oct; 158(10):2209-26.

Kuhn JH, Radoshitzky SR, Bavari S, Jahrling PB. The International Code of Virus Classification and Nomenclature (ICVCN): Proposal to delete Rule 3.41. Archives of Virology 2013 Jan, 158(1): 297-99

Ladner JT, Welch TJ, Whitehouse CA, Palacios GF. Genome sequence of Weissella ceti NC36 an Emerging Pathogen of Farmed Rainbow Trout in the United States. Genome Announcements 2013 Jan, 1(1): e00187-12

Ladner JT, Whitehouse CA, Koroleva GI, Palacios GF. Genome sequence of Moraxella macacae 0408225 a novel bacterial species isolated from a Cynomolgus Macaque with epistaxis. Genome Announcements 2013 Jan, 1(1): e00188-12

Leberman M, Lehrer A, Humphreys A, Johns L, Wong TA, Olinger O, Dye J, Carrion R, Patterson J, Marzi A, Feldmann H. Recombinant Ebolavirus antigens from insect cells are potent immunogens inducing cellular and humoral immunity in rodents and non-human primates and provide protection against virus challenge. Journal of Immunology 2013, 190, 123.26

Lee JS, Grubaugh ND, Kondig JP, Turell MJ, Kim HC, Klein TA, O'Guinn ML. Isolation and genomic characterization of Chaoyang virus strain ROK144 from Aedes vexans nipponii from the Republic of Korea. Virology 2013 Jan 20, 435(2):220-24

Lee MS, Olson MA. Comparison of volume and surface area nonpolar solvation free energy terms for implicit solvent simulations. J Chem Phys. 2013 Jul 28; 139(4):

Lindsey CY, Brown JE, Torabazar NR, Smith LA. EL4 cell-based colorimetric toxin neutralization activity assays for determination of neutralizing anti-ricin antibodies. Journal of AOAC International 2013 Jan-Feb, 96(1):147-54

Madrid PB, Chopra S, Manger ID, Gilfillan L, Keepers TR, Shurtleff AC, Green CE, Iyer LV, Dilks HH, Davey RA, Kolokoltsov AA, Carrion R Jr, Patterson JL, Bavari S, Panchal RG, Warren TK, Wells JB, Moos WH, Burke RL, Tanga MJ. A systematic screen of FDA-approved Drugs for inhibitors of biological threat agents. PLoS One 2013, 8(4): e60579

Malhotra S, Yen JY, Honko AN, Garamszegi S, Caballero IS, Johnson JC, Mucker EM, Trefry JC, Hensley LE, Connor JH. Transcriptional profiling of the circulating immune response to Lassa Virus in an aerosol model of exposure. PLoS Neglected Tropical Diseases 2013 Apr 25, 7(4): e2171

Martinez O, Johnson JC, Honko A, Yen B, Shabman RS, Hensley LE, Olinger GG, Basler CF. Ebola virus exploits a monocyte differentiation program to promote its entry. Journal of Virology 2013 Apr, 87(7): 3801-14

McKee CJ, Hines HB, Ulrich RG. Analysis of protein tyrosine phosphatase interactions with microarrayed phosphopeptide substrates using imaging mass spectrometry. Anal Biochem. 2013 Nov 1; 442(1):62-7

Memisevic V, Zavaljevski N, Pieper R, Rajagopala SV, Kwon K, Townsend K, Yu C, Yu X, DeShazer D, Reifman J, Wallqvist A. Novel Burkholderia mallei virulence factors linked to specific host-pathogen protein interactions. Mol Cell Proteomics. 2013 Nov; 12(11):3036-51

Mizanur RM, Frasca V, Swaminathan S, Bavari S, Webb R, Smith LA, Ahmed SA. The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active site. J Biol Chem. 2013 Aug 16; 288(33)

Mucker EM, Goff AJ, Shamblin JD, Grosenbach DW, Damon IK, Mehal JM, Holman RC, Carroll D, Gallardo N, Olson VA, Clemmons CJ, Hudson P, Hruby DE. Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox). Antimicrob Agents Chemother. 2013 Dec; 57(12):6246-53. doi: 10.1128/AAC.00977-13. Epub 2013 Oct 7

Mudhasani R, Tran JP, Retterer C, Radoshitzky SR, Kota KP, Altamura LA, Smith JM, Packard BZ, Kuhn JH, Costantino J, Garrison AR, Schmaljohn CS, Huang IC, Farzan M, Bavari S. IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. J Virol. 2013 Aug;87(15):8451-64

Nablo BJ, Panchal RG, Bavari S, Nguyen TL, Gussio R, Ribot W, Friedlander A, Chabot D, Reiner JE, Robertson JW, Balijepalli A, Halverson KM, Kasianowicz JJ. Anthrax toxin-induced rupture of artificial lipid bilayer membranes. J Chem Phys. 2013 Aug 14; 139(6):065101. doi: 10.1063/1.4816467

Ogg M, Jonsson CB, Camp JV, Hooper JW. Ribavirin protects Syrian hamsters against lethal hantavirus pulmonary syndrome--after intranasal exposure to Andes virus. Viruses. 2013 Nov 8; 5(11):2704-20

O'Guinn ML, Turell MJ, Kengluecha A, Jaichapor B, Kankaew P, Miller RS, Endy TP, Jones JW, Coleman RE, Lee JS. Field detection of Tembusu virus in western Thailand by rt-PCR and vector competence determination of select culex mosquitoes for transmission of the virus. Am J Trop Med Hyg. 2013 Nov; 89(5):1023-8

Okello MO, Mishra S, Nishonov M, Mankowski MK, Russell JD, Wei J, Hogan PA, Ptak RG, Nair V. A novel anti-HIV active integrase inhibitor with a favorable in vitro cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferase metabolism profile. Antiviral Res. 2013 Jun; 98(3):365-72

Okubo BM, Silva ON, Migliolo L, Gomes DG, Porto WF, Batista CL, Ramos CS, Holanda HH, Dias SC, Franco OL, Moreno SE. Evaluation of an antimicrobial L-amino acid oxidase and peptide derivatives from Bothropoides mattogrosensis pitviper venom. PLoS One. 2012; 7(3):e33639

Olson MA, Lee MS. Application of replica exchange umbrella sampling to protein structure refinement of nontemplate models. J Comput Chem. 2013 Jul 30; 34(20):1785-93

Olson MA, Lee MS. Structure refinement of protein model decoys requires accurate side-chain placement. Proteins 2013 Mar, 81(3):469-78

Palacios G, Savji N, Travassos da Rosa A, Guzman H, Yu X, Desai A, Rosen GE, Hutchison S, Lipkin WI, Tesh R. Characterization of the uukuniemi virus group (phlebovirus: bunyaviridae): evidence for seven distinct species. Journal of Virology 2013 Mar, 87(6):3187-95

Omotade TO, Heffron JD, Klimko CP, Marchand CL, Miller LL, Halasahoris SA, Bozue JA, Welkos SL, Cote CK. D-cycloserine or similar physiochemical compounds may be uniquely suited for use in Bacillus anthracis spore decontamination strategies. J Appl Microbiol. 2013 Dec; 115(6):1343-56

Opsenica IM, Tot M, Gomba L, Nuss JE, Sciotti RJ, Bavari S, Burnett JC, Solaja BA. 4-Amino-7-chloroquinolines: probing ligand efficiency provides botulinum neurotoxin serotype A light chain inhibitors with significant antiprotozoal activity. J Med Chem. 2013 Jul 25; 56(14):5860-71

Palacios G, Forrester NL, Savji N, Travassos da Rosa AP, Guzman H, Detoy K, Popov VL, Walker PJ, Lipkin WI, Vasilakis N, Tesh RB. Characterization of Farmington virus, a novel virus from birds that is distantly related to members of the family Rhabdoviridae. Virol J. 2013 Jul 1;10:219

Palacios G, Savji N, Travassos da Rosa A, Desai A, Sanchez-Seco MP, Guzman H, Lipkin WI, Tesh R. Characterization of the Salehabad virus species complex of the genus Phlebovirus (Bunyaviridae). J Gen Virol. 2013 Apr; 94(Pt 4):837-42

Palacios G, Savji N, Travassos da Rosa A, Guzman H, Yu X, Desai A, Rosen GE, Hutchison S, Lipkin WI, Tesh R. Characterization of the Uukuniemi virus group (Phlebovirus: Bunyaviridae): evidence for seven distinct species. J Virol. 2013 Mar; 87(6):3187-95

Panchal RG, Lane D, Boshoff HI, Butler MM, Moir DT, Bowlin TL, Bavari S. Bis-imidazolinylindoles are active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Mycobacterium tuberculosis. Journal of Antibiotics 2013 Jan, 66 (1):47-9

Pelin M, Boscolo S, Poli M, Sosa S, Tubaro A, Florio C. Characterization of palytoxin binding to HaCaT cells using a monoclonal anti-palytoxin antibody. Marine Drugs 2013 Feb 26, 11(3):584-98

Pettitt J, Zeitlin L, Kim do H, Working C, Johnson JC, Bohorov O, Bratcher B, Hiatt E, Hume SD, Johnson AK, Morton J, Pauly MH, Whaley KJ, Ingram MF, Zovanyi A, Heinrich M, Piper A, Zelko J, Olinger GG. Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. Sci Transl Med. 2013 Aug 21; 5(199)

Pittman PR, Fisher D, Quinn X, Schmader T, Barrera-Oro JG. Effect of delayed anthrax vaccine dose on Bacillus anthracis protective antigen IgG response and lethal toxin neutralization activity. Vaccine. 2013 Oct 17; 31(44):5009-14

Priola SA, Ward AE, McCall SA, Trifilo M, Choi YP, Solforosi L, Williamson RA, Cruite JT, Oldstone MB. Lack of prion infectivity in fixed heart tissue from patients with Creutzfeldt-Jakob disease or amyloid heart disease. J Virol. 2013 Sep; 87(17):9501-10

Raphael BH, Choudoir MJ, Lúquez C, Fernández R, Maslanka SE. Sequence diversity of genes encoding botulinum neurotoxin type F. Appl Environ Microbiol. 2010 Jul; 76(14):4805-12

Reed C, Lin K, Wilhelmsen C, Friedrich B, Nalca A, Keeney A, Donnelly G, Shamblin J, Hensley LE, Olinger G, Smith DR. Aerosol exposure to Rift Valley Fever Virus causes earlier and more severe neuropathology in the Murine model, which has important implications for therapeutic development. PLoS Neglected Tropical Diseases 2013 Apr 4, 7(4):e2156

Schiffer JM, Maniatis P, Garza I, Steward-Clark E, Korman LT, Pittman PR, Mei JV, Quinn CP. Quantitative assessment of anthrax vaccine immunogenicity using the dried blood spot matrix. Biologicals 2013 Mar, 41(2):98-103

Shoemaker CJ, Schornberg KL, Delos SE, Scully C, Pajouhesh H, Olinger GG, Johansen LM, White JM. Multiple Cationic Amphiphiles Induce a Niemann-Pick C Phenotype and Inhibit Ebola Virus Entry and Infection. PLoS One 2013, 8(2):e56265

Smith LM, Hensley LE, Geisbert TW, Johnson J, Stossel A, Honko A, Yen JY, Geisbert J, Paragas J, Fritz E, Olinger G, Young HA, Rubins KH, Karp CL. Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever. J Infect Dis. 2013 Jul 15; 208(2):310-8

Smither SJ, Lear-Rooney C, Biggins J, Pettitt J, Lever MS, Olinger GG Jr. Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity. J Virol Methods. 2013 Nov; 193(2):565-71

Sobarzo A, Groseth A, Dolnik O, Becker S, Lutwama JJ, Perelman E, Yavelsky V, Muhammad M, Kuehne AI, Marks RS, Dye JM, Lobel L. Profile and persistence of the virus-specific neutralizing humoral immune response in human survivors of Sudan ebolavirus (Gulu). J Infect Dis. 2013 Jul 15; 208(2):299-309

Sobarzo A, Ochayon DE, Lutwama JJ, Balinandi S, Guttman O, Marks RS, Kuehne AI, Dye JM, Yavelsky V, Lewis EC, Lobel L. Persistent immune responses after Ebola virus infection. N Engl J Med. 2013 Aug 1; 369(5):492-3

Spurgers KB, Hurt CR, Cohen JW, Eccelston LT, Lind CM, Lingappa VR, Glass PJ. Validation of a cell-based ELISA as a screening tool identifying anti-alphavirus small-molecule inhibitors. J Virol Methods. 2013 Oct; 193(1):226-31

Taylor SL, Wahl-Jensen V, Copeland AM, Jahrling PB, Schmaljohn CS. Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system. PLoS Pathog. 2013; 9(7):e1003470

Thomassen HA, Fuller T, Asefi-Najafabady S, Shiplacoff JA, Mulembakani PM, Blumberg S, Johnston SC, Kisalu NK, Kinkela TL, Fair JN, Wolfe ND, Shongo RL, LeBreton M, Meyer H, Wright LL, Muyembe JJ, Buermann W, Okitolonda E, Hensley LE, Lloyd-Smith JO, Smith TB, Rimoin AW. Pathogen-host associations and predicted range shifts of human monkeypox in response to climate change in central Africa. PLoS One. 2013 Jul 31;8(7):e66071

Tomic M, Garcia C, Lou J, Geren IN, Meng Q, Conrad F, Wen W, Smith TJ, Brown J, Smith LA, Wajid A, Dadson AC Jr, Horwitz AH, Freeberg J, Marks JD. Recombinant monoclonal-antibody-based antitoxins for treatment of types A, B, and E botulism. Toxicon Volume 68, 15 June 2013, Pages 99-100

Tot M, Opsenica DM, Mitric M, Burnett JC, Gomba L, Bavari S, Solaja BA. New 9-aminoacridine derivatives as inhibitors of botulinum neurotoxins and P. falciparum malaria. J of Serbian Chem Soc 78, 12; 1847-64

Tretyakova I, Lukashevich I,S, Glass P, Wang E, Weaver S, Pushko P. Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine. Vaccine 2013 Feb 4, 31(7): 1019-25

Trombley Hall A, McKay Zovanyi A, Christensen DR, Koehler JW, Devins Minogue T. Evaluation of inhibitor-resistant real-time PCR methods for diagnostics in clinical and environmental samples. PLoS One. 2013 Sep 9;8(9):e73845

Turell MJ, Britch SC, Aldridge RL, Kline DL, Boohene C, Linthicum KJ. Potential for mosquitoes (Diptera: Culicidae) from Florida to transmit Rift Valley fever virus. J Med Entomol. 2013 Sep;50(5):1111-7

Turell MJ, Byrd BD, Harrison BA. Potential for populations of Aedes j. japonicus to transmit Rift Valley fever virus in the USA. J Am Mosq Control Assoc. 2013 Jun;29(2):133-7

Twenhafel NA, Mattix ME, Johnson JC, Robinson CG, Pratt WD, Cashman KA, Wahl-Jensen V, Terry C, Olinger GG, Hensley LE, Honko AN. Pathology of experimental aerosol Zaire Ebolavirus infection in Rhesus Macaques. Veterinary Pathology 2013 May, 50(3):514-29

Ulrich RL, Deshazer D, Kenny TA, Ulrich MP, Moravusova A, Opperman T, Bavari S, Bowlin TL, Moir DT, Panchal RG. Characterization of the Burkholderia thailandensis SOS response by using whole-transcriptome shotgun sequencing. Appl Environ Microbiol. 2013 Oct; 79(19):5830-43

Ulrich R, Pugh C, Keasey S, Pittman P. A proteome-wide comparison of human antibody responses to the standard polyclonal vaccine for smallpox prevention and the monoclonal replacement ACAM2000 (P4321). Journal of Immunology 2013, 190, 123.24

Vergis JM, Cote CK, Bozue J, Alem F, Ventura CL, Welkos SL, O'Brien AD. Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames. Clinical and Vaccine Immunology 2013 Jan, 20(1):56-65

Webb RP, Smith LA. What next for botulism vaccine development? Expert Rev Vaccines. 2013 May;12(5):481-92

Williams JD, Nguyen ST, Gu S, Ding X, Butler MM, Tashjian TF, Opperman TJ, Panchal RG, Bavari S, Peet NP, Moir DT, Bowlin TL. Potent and broad-spectrum antibacterial activity of indole-based bisamidine antibiotics: synthesis and SAR of novel analogs of MBX 1066 and MBX 1090. Bioorg Med Chem. 2013 Dec 15;21(24):7790-806

Zuniga J, Hammill J, Drory O, Nuss J, Burnett J, Gussio R, Wipf P, Bavari S, Brunger AT. Structural basis for the inhibition of botulinum neurotoxin serotype A by potent peptidomimetics. Toxicon Volume 68, 15 June 2013, Pages 103-4

Ahmed SA, Awosika J, Baldwin C, Bishop-Lilly KA, Biswas B, Broomall S, Chain PSG, Chertkov O, Chokoshvili O, Coyne S, Davenport K, Detter JC, Dorman W, Erkkila TH, Folster JP, Frey KG, George M, Gleasner C, Henry M, Hill KK, Hubbard K, Insalaco J, Johnson S, Kitzmiller A, Krepps M, Lo CC, Luu T, McNew LA, Minogue T, Munk CA, Osborne B, Patel M, Reitenga KG, Rosenzweig CN, Shea A, Shen XH, Strockbine N, Tarr C, Teshima H, van Gieson E, Verratti K, Wolcott M, Xie G, Sozhamannan S, Gibbons HS. Genomic comparison of Escherichia coli O104:H4 isolates from 2009 and 2011 reveals plasmid and prophage heterogeneity including Shiga Toxin encoding phage stx2. PLoS One 2012, 7(11): e48228

Akhvlediani T, Chitadze N, Laws TR, Makharadze M, Chubinidze M, Tsanava S, Commander NJ, Perkins SD, Dyson EH, Rivard RG, Hepburn MJ, Simpson AJH, Imnadze P, Trapaidze N. Comparison of total antibody and interferon-? T-cell responses in patients following infection with brucellosis in Georgia. Journal of Infection and Public Health 2012 Oct, 5(5): 321-331

Arrigo NC, Briese T, Calisher CH, Drebot MA, Fljelle B, LeDuc JW, Powers AM, Repik PM, Roehrig JT, Schmaljohn CS, Tesh RB, Weaver SC. Recommendations for Publication of Viral Genetic Data and Sample Access for Novel Viruses and Strains American Journal of Tropical Medicine and Hygiene 2012 Feb, 86(2): 189-191

Bale S, Dias JM, Fusco ML, Hashiguchi T, Wong AC, Liu T, Keuhne AI, Li S, Woods VL Jr, Chandran K, Dye JM, Saphire EO. Structural basis for differential neutralization of ebolaviruses. Viruses. 2012 Apr, 4(4): 447-70

Boudreau EF, Josleyn M, Ullman D, Fisher D, Dalrymple L, Sellers-Myers K, Loudon P, Rusnak J, Rivard R, Schmaljohn C, Hooper JW. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome. Vaccine 2012 Mar 2; 30(11): 1951-1958

Bozue J, Cote CK, Webster W, Bassett A, Tobery S, Little S, Swietnicki W. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice. FEMS Microbiology Letters 2012 July, 332(2): 113-121

Bozue J, Powell BS, Cote CK, Moody KL, Gelhaus HC, Vietri NJ, Rozak DA. Disrupting the luxS quorum sensing gene does not significantly affect Bacillus anthracis virulence in mice or guinea pigs. Virulence 2012 Oct, 3(6): 504-509

Brocato R, Josleyn M, Ballantyne J, Vial P, Hooper JW. DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS). PLoS One 2012, 7(4): e35996

Bryce L, Koenig M, Jerke KH. A large-scale study of respiratory virus infection over 2 years using the Luminex xTAGRVP assay. Military Medicine 2012 Dec, 177(12): 1533-1538

Buzard GS, Baker D, Wolcott MJ, Norwood DA, Dauphin LA. Multi-platform comparison of ten commercial master mixes for probe-based real-time polymerase chain reaction detection of bioterrorism threat agents for surge preparedness. Forensic Science International 2012 Nov, 223 (1-3): 292-297

Byers DM, Gorbet JC, Irwin LN. Disialogangliosides and TNFα alter gene expression for cytokines and chemokines in primary brain cell cultures. Neurochemical Research 2012 Jan, 37(1): 214-222

Cardellina JH, Roxas-Duncan VI, Montgomery V, Eccard V, Campbell Y, Hu X, Khavrutskii I, Tawa GJ, Wallqvist A, Gloer JB, Phatak NL, Hoeller U, Soman AG, Joshi BK, Hein SM, Wicklow DT, Smith LA. Fungal bis-Naphthopyrones as Inhibitors of Botulinum Neurotoxin Serotype A. ACS Medicinal Chemistry Letters 2012 May, 3(5): 387-391

Chabot DJ, Joyce J, Caulfield M, Cook J, Hepler R, Wang S, Vietri NJ, Ruthel G, Shoop W, Pitt L, Leffel E, Ribot W, Friedlander AM. Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys Vaccine Jan 20, 30(5): 846-52

Chaudhury S, Olson MA, Tawa G, Wallqvist A, Lee MS. Efficient Conformational Sampling in Explicit Solvent Using a Hybrid Replica Exchange Molecular Dynamics Method. Journal of Chemical Theory and Computation 2012 Feb, 8(2): 677-687

Cisney ED, Fernandez S, Hall SI, Krietz GA, Ulrich RG. Examining the role of nasopharyngeal-associated lymphoreticular tissue (NALT) in mouse responses to vaccines. Journal of Visualized Experiments 2012 Aug 1, (66): 3960

Cote CK, Kaatz L, Reinhardt J, Bozue J, Tobery SA, Bassett AD, Sanz P, Darnell SC, Alem F, O'Brien AD, Welkos SL. Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia. Journal of Medical Microbiology 2012 Oct, 61(10): 1380-92

Dabisch P, Yeager J, Kline J, Klinedinst K, Welsch A, Pitt ML. Comparison of the efficiency of sampling devices for aerosolized Burkholderia pseudomallei. Inhalation Toxicology 2012 Apr, 24(5): 247-254

Del Favero G, Florio C, Codan B, Sosa S, Poli M, Sbaizero O, Molgó J, Tubaro A, Lorenzon P. The stretch-activated channel blocker Gd 3+ reduces palytoxin toxicity in primary cultures of skeletal muscle cells. Chemical Research in Toxicology 2012 Sept 17, 25(9): 1912-1920

Del Favero G, Sosa S, Pelin M, D'Orlando E, Florio C, Lorenzon P, Poli M, Tubaro A. Sanitary problems related to the presence of Ostreopsis spp, in the Mediterranean Sea: A multidisciplinary scientific approach. Annali dell�Istituto Superiore di Sanita 2012, 48(4): 407-414

Do Y, Didierlaurent AM, Ryu S, Koh H, Park CG, Park S, Perlin DS, Powell BS, Steinman RM. Induction of pulmonary mucosal immune responses with a protein vaccine targeted to the DEC-205/CD205 receptor. Vaccine. 2012 Oct 5, 30(45): 6359-67

Dower K, Filone CM, Hodges EN, Bjornson ZB, Rubins KH, Brown LE, Schaus S, Hensley LE, Connor JH. Identification of a Pyridopyrimidinone Inhibitor of Orthopoxviruses from a Diversity-Oriented Synthesis Library. Journal of Virology 2012 Mar, 86(5): 2632-2640

Dupuy LC, Reed DS. Nonhuman primate models of encephalitic alphavirus infection: historical review and future perspectives. Current Opinion in Virology 2012 June 2012, 2(3): 363-7

Dye JM, Herbert AS, Kuehne AI, Barth JF, Muhammad MA, Zak SE, Ortiz RA, Prugar LI, Pratt WD. Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. Proceedings of the National Academy of Sciences of the USA 2012 Mar 27, 109(13): 5034-5039

Edupuganti OP, Ovsepian SV, Wang J, Zurawski TH, Schmidt JJ, Smith L, Lawrence GW, Dolly JO. Targeted delivery into motor nerve terminals of inhibitors for SNARE-cleaving proteases via liposomes coupled to an atoxic botulinum neurotoxin. FEBS Journal 2012 July, 279(14): 2555-2567

Eppinger M, Radnedge L, Andersen G, Vietri N, Severson G, Mou S, Ravel J, Worsham PL. Novel Plasmids and Resistance Phenotypes in Yersinia pestis: Unique Plasmid Inventory of Strain Java 9 Mediates High Levels of Arsenic Resistance. PLoS One 2012, 7(3): e32911

Erwin-Cohen RA, Porter AI, Pittman PR, Rossi CA, DaSilva L. Host responses to live-attenuated Venezuelan equine encephalitis virus (TC-83): Comparison of naïve, vaccine responder and nonresponder to TC-83 challenge in human peripheral blood mononuclear cells. Human Vaccines and Immunotherapeutics 2012 Aug, 8(8): 1053-1065

Fenimore PW, Muhammad MA, Fischer WM, Foley BT, Bakken RR, Thurmond JR, Yusim K, Yoon H, Parker M, Hart MK, Dye JM, Korber B, Kuiken C. Designing and Testing Broadly-Protective Filoviral Vaccines Optimized for Cytotoxic T-Lymphocyte Epitope Coverage. PLoS One 2012, 7(10): e44769

Fisher NA, Ribot WJ, Applefeld W, Deshazer D. The Madagascar hissing cockroach as a novel surrogate host for Burkholderia pseudomallei, B. mallei and B. thailandensis. BMC Microbiology 2012 June 22, 12: 117

Forsberg LS, Abshire TG, Friedlander A, Quinn CP, Kannenberg EL, Carlson RW. Localization and structural analysis of a conserved pyruvylated epitope in Bacillus *anthracis* secondary cell wall polysaccharides and characterization of the galactose-deficient wall polysaccharide from avirulent B-*anthracis* CDC 684. Glycobiology 2012 Aug, 22(8): 1103-1117

Friedrich BM, Trefry JC, Biggins JE, Hensley LE, Honko AN, Smith DR, Olinger GG. Potential vaccines and post-exposure treatments for filovirus infections. Viruses 2012 Sept, 4(9): 1619-1650

Fuller T, Thomassen HA, Mulembakani PM, Johnston SC, Lloyd-Smith JO, Kisalu NK, Lutete TK, Blumberg S, Fair JN, Wolfe ND, Shongo RL, Formenty P, Meyer H, Wright LL, Muyembe JJ, Buermann W, Saatchi SS, Okitolonda E, Hensley L, Smith TB, Rimoin AW. Using Remote Sensing to Map the Risk of Human Monkeypox Virus in the Congo Basin. Ecohealth 2012 Mar 5, 8(1):14-25

Gaidamakova EK, Myles IA, McDaniel DP, Fowler CJ, Valdez PA, Naik S, Gayen M, Gupta P, Sharma A, Glass PJ, Maheshwari RK, Datta SK, Daly MJ. Preserving immunogenicity of lethally irradiated viral and bacterial vaccine epitopes using a radio-protective Mn2+-Peptide complex from Deinococcus. Cell Host & Microbe 2012 July 19, 12(1): 117-24

Golden JW, Josleyn M, Mucker EM, Hung C-F, Loudon PT, Wu TC, Hooper JW. Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates. PLoS One 2012 7(7): e42353

Grant-Klein RJ, Van Deusen NM, Badger CV, Hannaman D, Dupuy LC, Schmaljohn CS. A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge. Human Vaccines & Immunotherapeutics 2012 Nov, 8(11): 1703-1706

Hale M. Near infrared whole body imaging. Botulinum Journal 2012, 2(2): 168-172

Hale ML, Cai S, Ahmed SA. Medical applications of clostridia and clostridial toxins. Journal of Toxicology 2012, 2012: 678963

Hart MK, Saviolakis GA, Welkos SL, House RV. Advanced Development of the rF1V and rBV A/B Vaccines: Progress and Challenges. Advances in Preventive Medicine 2012 2012: 731604

Higa MM, Petersen J, Hooper J, Doms RW. Efficient production of Hantaan and Puumala pseudovirions for viral tropism and neutralization studies. Virology 2012 Feb 20, 423(2): 134-142

Hines HB. Microbial proteomics using mass spectrometry. Methods in Molecular Biology 2012, 881: 159-186

Hoke CH, Pace-Templeton J, Pittman P, Malinoski FJ, Gibbs P, Ulderich T, Mathers M, Fogtman B, Glass P, Vaughn DW. US Military contributions to the global response to pandemic Chikungunya. Vaccine 2012 Oct 19, 30(47): 6713 - 6720

Hu X, Legler PM, Khavrutskii I, Scorpio A, Compton JR, Robertson KL, Friedlander AM, Wallqvist A. Probing the Donor and Acceptor Substrate Specificity of the gamma-Glutamyl Transpeptidase. Biochemistry 2012 Feb 14, 51(6): 1199-1212

Iversen PL, Warren TK, Wells JB, Garza NL, Mourich DV, Welch LS, Panchal RG, Bavari S. Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections. Viruses 2012 Nov, 4(11): 2806-2830

Jiang J, You BJ, Liu E, Apte A, Yarina TR, Myers TE, Lee JS, Francesconi SC, O'Guinn ML, Tsertsvadze N, Vephkhvadze N, Babuadze G, Sidamonidze K, Kokhreidze M, Donduashvili M, Onashvili T, Ismayilov A, Agayev N, Aliyev M, Muttalibov N, Richards AL. Development of three quantitative real-time PCR assays for the detection of Rickettsia raoultii Rickettsia slovaca and Rickettsia aeschlimannii and their validation with ticks from the country of Georgia and the Republic of Azerbaijan. Ticks and Tick-Borne Diseases 2012 Dec, 3(5-6): 326-330

Jing X, Robinson HR, Heffron JD, Popham DL, Schubot FD. The catalytic domain of the germination-specific lytic transglycosylase SleB from Bacillus anthracis displays a unique active site topology. Proteins: Structure, Function and Bioinformatics 2012 Oct: 80(10): 2469 - 2475

Johnston SC, Lin KL, Connor JH, Ruthel G, Goff A, Hensley LE. In vitro inhibition of monkeypox virus production and spread by Interferon-beta. Virology Journal 2012 Jan 6, 9: 5

Kalb SR, Baudys J, Rees JC, Smith TJ, Smith LA, Helma CH, Hill K, Kull S, Kirchner S, Dorner MB, Dorner BG, Pirkle JL, Barr JR. De novo subtype and strain identification of botulinum neurotoxin type B through toxin proteomics. Analytical & Bioanalytical Chemistry 2012 Apr, 403(1): 215-26

Kalb SR, Baudys J, Webb RP, Wright P, Smith TJ, Smith LA, Fernandez R, Raphael BH, Maslanka SE, Pirkle JL, Barr JR. Discovery of a novel enzymatic cleavage site for botulinum neurotoxin F5. FEBS Letters 2012 Jan 20, 586(2): 109-115

Kissner TL, Ruthel G, Alam S, Mann E, Ajami D, Rebek M, Larkin E, Fernandez S, Ulrich RG, Ping S, Waugh DS, Rebek J, Saikh KU. Therapeutic inhibition of pro-inflammatory signaling and toxicity to staphylococcal enterotoxin B by a synthetic dimeric BB-loop mimetic of MyD88. PLoS One 2012 7(7): e40773

Kota KP, Benko JG, Mudhasani R, Retterer C, Tran JP, Bavari S, Panchal RG. High content image based analysis identifies cell cycle inhibitors as regulators of ebola virus infection. Viruses 2012 Sept 25, 4(10): 1865 - 1877

Krakauer T. PI3K/Akt/mTOR a pathway less recognized for staphylococcal superantigen-induced toxicity. Toxins 2012 Nov 15, 4(11): 1343-1366

Krakauer T, Buckley M. Intranasal rapamycin rescues mice from staphylococcal enterotoxin B-induced shock. Toxins 2012 Sept, 4(9): 718-728

Krishnan A, Miller EH, Herbert AS, Ng M, Ndungo E, Whelan SP, Dye JM, Chandran K. Niemann-Pick C1 (NPC1)/NPC1-like1 Chimeras define sequences critical for NPC1's function as a Filovirus entry receptor. Viruses 2012 Nov, 4(11): 2471-2484

Kugelman JR, Lee MS, Rossi CA, McCarthy SE, Radoshitzky SR, Dye JM, Hensley LE, Honko A, Kuhn JH, Jahrling PB, Warren TK, Whitehouse CA, Bavari S, Palacios G. Ebola Virus Genome Plasticity as a Marker of Its Passaging History: A Comparison of In Vitro Passaging to Non-Human Primate Infection. PLoS One, 7(11): e50316

Kumar G, Kumaran D, Ahmed SA, Swaminathan S. Peptide inhibitors of botulinum neurotoxin serotype A: Design inhibition cocrystal structures structure-activity relationship and pharmacophore modeling. Acta Crystallographica Section D: Biological Crystallography 2012 May; 68(5): 511-520

Kvitko BH, Cox CR, DeShazer D, Johnson SL, Voorhees KJ, Schweizer HP. phi X216 a P2-like bacteriophage with broad Burkholderia pseudomallei and B, mallei strain infectivity. BMC Microbiology 2012 Dec 7, 12: 289

Lebeda FJ, Dembek ZF, Adler M. Kinetic and reaction pathway analysis in the application of botulinum toxin a for wound healing. Journal of Toxicology 2012, 2012: 159726

Lindsey CY, Powell BS, Bolt CR, Brown JE, Adamovicz JJ. Validation of quantitative ELISAs for measuring anti-yersinia pestis F1 and V antibody concentrations in nonhuman primate sera. Journal of Immunoassay & Immunochemistry 2012 Jan; 33 (1): 91-113

Louie A, VanScoy BD, Brown DL, Kulawy RW, Heine HS, Drusano GL. Impact of spores on the comparative efficacies of five antibiotics for treatment of Bacillus anthracis in an in vitro hollow fiber pharmacodynamic model. Antimicrobial Agents and Chemotherapy 2012 Mar, 56(3): 1229-1239

Louie A, VanScoy BD, Heine HS, Liu W, Abshire T, Holman K, Kulawy R, Brown DL, Drusano GL. Differential effects of linezolid and ciprofloxacin on toxin production by Bacillus anthracis in an in Vitro pharmacodynamic system. Antimicrobial Agents and Chemotherapy 2012 Mar, 56(1): 513-517

McLain DE, Lewis BS, Chapman JL, Wannemacher RW, Lindsey CY, Smith LA. Protective Effect of Two Recombinant Ricin Subunit Vaccines in the New Zealand White Rabbit Subjected to a Lethal Aerosolized Ricin Challenge: Survival Immunological Response and Histopathological Findings. Toxicological Sciences 2012 Mar, 126(1): 72-83

Miller EH, Obernosterer G, Raaben M, Herbert AS, Deffieu MS, Krishnan A, Ndungo E, Sandesara RG, Carette JE, Kuehne A,I Ruthel G, Pfeffer SR, Dye JM, Whelan SP, Brummelkamp TR, Chandran K. Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO Journal 2012 Apr 18 31(8): 1947-1960

Mire CE, Miller AD, Carville A, Westmoreland SV, Geisbert JB, Mansfield KG, Feldmann H, Hensley LE, Geisbert TW. Recombinant Vesicular Stomatitis Virus Vaccine Vectors Expressing Filovirus Glycoproteins Lack Neurovirulence in Nonhuman Primates. PLoS Neglected Tropical Diseases 2012 Mar, 6(3): e1567

Misasi J, Chandran K, Yang JY, Considine B, Filone CM, Cote M, Sullivan N, Fabozzi G, Hensley L, Cunningham J. Filoviruses Require Endosomal Cysteine Proteases for Entry but Exhibit Distinct Protease Preferences. Journal of Virology 2012 Mar, 86(6): 3284-3292

Mizanur RM, Gorbet J, Swaminathan S, Ashraf Ahmed S. Inhibition of catalytic activities of botulinum neurotoxin light chains of serotypes A B and E by acetate sulfate and calcium. International Journal of Biochemistry and Molecular Biology 2012, 3( 3 ): 313-321

Mou S, Cote CK, Worsham PL. Cytotoxic necrotizing factor is an effective immunogen in a Yersinia pseudotuberculosis aerosol mouse model. Advances in Experimental Medicine and Biology 2012, 954: 179-181

Mukherjee J, Tremblay JM, Leysath CE, Ofori K, Baldwin K, Feng XC, Bedenice D, Webb RP, Wright PM, Smith LA, Tzipori S, Shoemaker CB. A Novel Strategy for Development of Recombinant Antitoxin Therapeutics Tested in a Mouse Botulism Model. PLoS One 2012, 7(1): e29941

Narayanan A, Kehn-Hall K, Senina S, Lundberg L, Van Duyne R, Guendel I, Das R, Baer A, Bethel L, Turell M, Hartman AL, Das B, Bailey C, Kashanchi F. Curcumin inhibits rift valley fever virus replication in human cells. Journal of Biological Chemistry 2012 Sept 28, 287(40): 33198-33214

Ngundi MM, Meade BD, Little SF, Quinn CP, Corbett CR, Brady RA, Burns DL. Analysis of defined combinations of monoclonal antibodies in anthrax toxin neutralization assays and their synergistic action. Clinical and Vaccine Immunology 2012 May, 19(5): 731-739

Nygaard RM, Golden JW, Schiff LA. Impact of host proteases on reovirus infection in the respiratory tract. Journal of Virology 2012 Jan, 86(2): 1238-1243

Olal D, Kuehne AI, Bale S, Halfmann P, Hashiguchi T, Fusco ML, Lee JE, King LB, Kawaoka Y, Dye JM, Saphire EO. Structure of an Antibody in Complex with Its Mucin Domain Linear Epitope That Is Protective against Ebola Virus. Journal of Virology 2012 Mar, 86(5): 2809-2816

Olinger GG, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, Hiatt E, Hume SD, Johnson AK, Morton J, Pauly M, Whaley KJ, Lear CM, Biggins JE, Scully C, Hensley L, Zeitlin L. Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques. Proceedings of the Naitonal Academy of Sciences of the USA. 2012 Oct 30, 109(44): 18030-18035

Opsenica I, Filipovic V, Nuss JE, Gomba LM, Opsenica D, Burnett JC, Gussio R, Solaja BA, Bavari S. The synthesis of 25-bis(4-amidinophenyl)thiophene derivatives providing submicromolar-range inhibition of the botulinum neurotoxin serotype A metalloprotease. European Journal of Medicinal Chemistry 2012 July 53: 374-379

Panchal RG, Geller BL, Mellbye B, Lane D, Iversen PL, Bavari S. Peptide Conjugated Phosphorodiamidate Morpholino Oligomers Increase Survival of Mice Challenged with Ames Bacillus anthracis. Nucleic Acid Therapeutics 2012 Oct, 22 (5): 316-322

Panchal RG, Reid SP, Tran JP, Bergeron AA, Wells J, Kota KP, Aman J, Bavari S. Identification of an antioxidant small-molecule with broad-spectrum antiviral activity. Antiviral Research 2012 Jan, 93(1): 23-9

Pegoraro G, Bavari S, Panchal RG. Shedding light on filovirus infection with high-content imaging. Viruses 2012 Aug, 4(8): 1354-71

Pelin M, Sosa S, Della Loggia R, Poli M, Tubaro A, Decorti G, Florio C. The cytotoxic effect of palytoxin on Caco-2 cells hinders their use for in vitro absorption studies. Food and Chemical Toxicology 2012 Feb: 50(2): 206-211

Powell BS, Lazarev AV, Carlson G, Ivanov AR, Rozak DA. Pressure cycling technology in systems biology. Methods in Molecular Biology 2012 881: 27-62

Radoshitzky SR, Kuhn JH, de Kok-Mercado F, Jahrling PB Bavari S. Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses. Expert Opinion on Drug Discovery 2012 July 7(7): 613-32

Reed C, Steele KE, Honko A, Shamblin J, Hensley LE, Smith DR. Ultrastructural study of Rift Valley fever virus in the mouse model. Virology 2012 Sept 15 431(1-2): 58-70

Reid StP, Shurtleff AC, Bavari S. Emerging therapeutic options against filoviruses. Drugs of the Future 2012 May 37(5): 343-351

Reinbold-Wasson DD, Sardelis MR, Jones JW, Watts DM, Fernandez R, Carbajal F, Pecor JE, Calampa C, Klein TA, Turell MJ. Determinants of Anopheles Seasonal Distribution Patterns Across a Forest to Periurban Gradient near Iquitos Peru. American Journal of Tropical Medicine and Hygiene 2012 Mar, 86(3): 459-463

Reisler RB, Gibbs PH, Danner DK, Boudreau EF. Immune interference in the setting of same-day administration of two similar inactivated alphavirus vaccines: Eastern equine and western equine encephalitis. Vaccine 2012 Nov 26, 30 (50): 7271-7277

Reisler RB, Smith LA. The need for continued development of ricin countermeasures. Advances in Preventive Medicine 2012: 149737

Ridnour LA, Barasch KM, Windhausen AN, Dorsey TH, Lizardo MM, Yfantis HG, Lee DH, Switzer CH, Cheng RYS, Heinecke JL, Brueggemann E, Hines HB, Khanna C, Glynn SA, Ambs S, Wink DA. Nitric oxide synthase and breast cancer: Role of TIMP-1 in NO-mediated Akt activation. PLoS One 2012, 7(9): e44081

Romero R, Soto E, Berry SM, Hassan SS, Kusanovic JP, Yoon BH, Edwin S, Mazor M, Chaiworapongsa T. Blood pH and gases in fetuses in preterm labor with and without systemic inflammatory response syndrome. Journal of Maternal-Fetal and Neonatal Medicine 2012 July, 25(7): 1160-70

Ross TM, Bhardwaj N, Bissel SJ, Hartman AL, Smith DR. Animal models of Rift Valley fever virus infection. Virus Research 2012 Mar, 163(2): 417-423

Safronetz D, Ebihara H, Feldmann H, Hooper JW. The Syrian hamster model of hantavirus pulmonary syndrome. Antiviral Research 2012 Sept, 95(3): 282-92

Sampath R, Mulholland N, Blyn LB, Massire C, Whitehouse CA, Waybright N, Harter C, Bogan J, Miranda MS, Smith D, Baldwin C, Wolcott M, Norwood D, Kreft R, Frinder M, Lovari R, Yasuda I, Matthews H, Toleno D, Housley R, Duncan D, Li F, Warren R, Eshoo MW, Hall TA, Hofstadler SA, Ecker DJ. Comprehensive biothreat cluster identification by PCR/electrospray-ionization mass spectrometry. PLoS One 2012 7(6): e36528

Samy RP, Gopalakrishnakone P, Stiles BG, Girish KS, Swamy SN, Hemshekhar M, Tan KS, Rowan EG, Sethi G, Chow VTK. Snake venom phospholipases A(2): A novel tool against bacterial diseases. Current Medicinal Chemistry 2012 Dec, 19(36): 6150-6162

Samy RP, Rajendran P, Li F, Anandi NM, Stiles BG, Ignacimuthu S, Sethi G, Chow VTK. Identification of a novel Calotropis procera protein that can suppress tumor growth in breast cancer through the suppression of NF-kappa B pathway. PLoS One 2012 Dec, 7(12): e48514

Schmaljohn C, Mandl CW. The interface of animal and human vaccines. Current Opinion in Virology 2012 June 2(3): 306-308

Schmaljohn CS, Smith LA, Friedlander AM. Military vaccines in today's environment. Human Vaccines & Immunotherapeutics 2012 Aug, 8(8): 1126-1128

Shea A, Wolcott M, Daefler S, Rozak DA. Biolog phenotype microarrays. Methods in Molecular Biology 2012, 881: 331-373

Shipley MA, Koehler JW, Kulesh DA, Minogue TD. Comparison of nucleic acid extraction platforms for detection of select biothreat agents for use in clinical resource limited settings. Journal of Microbiological Methods 2012 Oct, 91(1): 179 - 183

Shurtleff AC, Biggins JE, Keeney AE, Zumbrun EE, Bloomfield HA, Kuehne A, Audet JL, Alfson KJ, Griffiths A, Olinger GG, Bavari S. Standardization of the filovirus plaque assay for use in preclinical studies. Viruses 2012 Dec, 4(12): 3511 -3530

Shurtleff AC, Garza N, Lackemeyer M, Carrion Jr, R, Griffiths A, Patterson J, Edwin SS, Bavari S. The impact of regulations safety considerations and physical limitations on research progress at maximum biocontainment. Viruses 2012 Dec, 4(12): 3932-3951

Shurtleff AC, Nguyen TL, Kingery DA, Bavari S. Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design. Expert Opinion on Drug Discovery 2012 Oct, 7(10): 935- 954

Silva LP, Vanzile M, Bavari S, Aman JMJ, Schriemer DC. Assembly of Ebola virus matrix protein VP40 is regulated by latch-like properties of N and C terminal tails. PLoS One 2012 7(7): e39978

Smith DR, Bird BH, Lewis B, Johnston SC, McCarthy S, Keeney A, Botto M, Donnelly G, Shamblin J, Albarino CG, Nichol ST, Hensley LE. Development of a Novel Nonhuman Primate Model for Rift Valley Fever. Journal of Virology 2012 Feb, 86 (4): 2109-2120

Sobarzo A, Perelman E, Groseth A, Dolnik O, Becker S, Lutwama JJ, Dye JM, Yavelsky V, Lobel L, Marks RS. Profiling the native specific human humoral immune response to Sudan Ebola virus strain Gulu by chemiluminescence enzyme-linked immunosorbent Assay. Clinical and Vaccine Immunology 2012 Nov, 19(11): 1844-1852

Switzer CH, Cheng RY, Ridnour LA, Murray MC, Tazzari V, Sparatore A, Del Soldato P, Hines HB, Glynn SA, Ambs S, Wink DA. Dithiolethiones inhibit NF-κB activity via covalent modification in human estrogen receptor-negative breast cancer. Cancer Research 2012 May 1; 72(9): 2394-2404

Thomas D, Naughton J, Cote C, Welkos S, Manchester M, Young JAT. Delayed Toxicity Associated with Soluble Anthrax Toxin Receptor Decoy-Ig Fusion Protein Treatment. PLoS One 2012 7(4): e34611

Toth S, Brueggmann EE, Oyler GA, Smith LA, Hines HB, Ahmed SA. Tyrosine phosphorylation of botulinum neurotoxin protease domains. Frontiers in Pharmacology 2012, 3: 102

Turell MJ. Members of the culex pipiens complex as vectors of Viruses. Journal of the American Mosquito Control Association 2012 Apr, 28(4 Suppl): 123-126

Varga JJ, Vigil A, DeShazer D, Waag DM, Felgner P, Goldberg JB. Distinct human antibody response to the biological warfare agent Burkholderia mallei. Virulence 2012 Oct, 3(6): 510-514

Wagner L, Verma A, Meade BD, Reiter K, Narum DL, Brady RA, Little SF, Burns DL. Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant. Clinical and Vaccine Immunology 2012 Sept, 19(9): 1465-1473

Warren TK, Shurtleff AC, Bavari S. Advanced morpholino oligomers: a novel approach to antiviral therapy. Antiviral Research 2012 Apr, 94(1): 80-8

Weinstein SA, Stiles BG. Recent perspectives in the diagnosis and evidence-based treatment of Mycoplasma genitalium. Expert Review of Anti-infective Therapy 2012 Apr 10(4): 487-99

Whitehouse CA, Kesterson KE, Duncan DD, Eshoo MW, Wolcott M. Identification and characterization of Francisella species from natural warm springs in Utah USA. Letters in Applied Microbiology 2012 Apr, 54(4): 313-324

Wigelsworth DJ, Ruthel G, Schnell L, Herrlich P, Blonder J, Veenstra TD, Carman RJ, Wilkins TD, Guy TVN, Pauillac S, Gibert M, Sauvonnet N, Stiles BG, Popoff MR, Barth H. CD44 Promotes Intoxication by the Clostridial Iota-Family Toxins. PLoS One 2012, 7(12): e51356

Woo HJ Reifman J. A quantitative quasispecies theory-based model of virus escape mutation under immune selection. Proceedings of the National Academy of Sciences of the USA 2012 Aug 7,109(32): 12980-12985

Worsham, PL, Mou S, Cote CK, Fritz D. Virulence of Yersinia pseudotuberculosis in aerosol models. Advances in Experimental Medicine and Biology 2012, 954: 217-222

Yeager John J, Facemire P, Dabisch PA, Robinson CG, Nyakiti D, Beck K, Baker R, Pitt MLM. Natural History of Inhalation Melioidosis in Rhesus Macaques (Macaca mulatta) and African Green Monkeys (Chlorocebus aethiops.) Infection and Immunity 2012 Sept, 80(9): 3332-3340

Zamolo VA, Valenti G, Venturelli E, Chaloin O, Marcaccio M, Boscolo S, Castagnola V, Sosa S, Berti F, Fontanive G, Poli M, Tubaro A, Bianco A, Paolucci F, Prato M. Highly sensitive electrochemiluminescent nanobiosensor for the detection of palytoxin. ACS Nano 2012 Sept. 25, 6(9): 7989-7997

Zumbrun EE, Abdeltawab NF, Bloomfield HA, Chance TB, Nichols DK, Harrison PE, Kotb M, Nalca A. Development of a murine model for aerosolized ebolavirus infection using a panel of recombinant inbred mice. Viruses 2012 Dec, 4(12): 3468-3493

Zumbrun EE, Bloomfield HA, Dye JM, Hunter TC, Dabisch PA, Garza N,L Bramel NR, Baker RJ, Williams RD, Nichols DK, Nalca A. A characterization of aerosolized sudan virus infection in African green monkeys cynomolgus macaques and rhesus macaques. Viruses 2012 Oct 15, 4(10): 2115 - 2136

Akhvlediani T, Ellis MW, Rivard R, Zenaishvili O, Battafarano DJ, Hepburn MJ. A review of the English and Russian language literature on the osteoarticular manifestations of brucellosis infection. Current Rheumatology Reviews 2011, 7(3): 263-271.

Badger CV, Richardson JD, DaSilva RL, Richards MJ, Josleyn MD, Dupuy LC, Hooper JW, Schmaljohn CS. Development and application of a flow cytometric potency assay for DNA vaccines. Vaccine 2011 Sept 9, 29(39): 6728-6735

Bahta M, Lountos GT, Dyas B, Kim SE, Ulrich RG, Waugh DS, Burke TR. Utilization of nitrophenylphosphates and oxime-based ligation for the development of nanomolar affinity inhibitors of the Yersinia pestis outer protein H (YopH) phosphatase. Journal of Medicinal Chemistry 2011 Apr 28; 54(8): 2933-43

Basu A; Li B; Mills DM; Panchal RG; Cardinale SC; Butler MM; Peet NP; Majgier-Baranowska H; Williams JD; Patel I; Moir DT; Bavari S; Ray R; Farzan MR; Rong LJ; Bowlin TL. Identification of a small-molecule entry inhibitor for filoviruses. Journal of Virology 2011 Apr, 85(7): 3106-3119

Bondugula R, Wallqvist A, Lee MS. Can computationally designed protein sequences improve secondary structure prediction? Protein Engineering Design & Selection 2011 May; 24(5): 455-61

Bozue J, Mou S, Moody KL, Cote CK, Trevino S, Fritz D, Worsham P. The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis. Microbial Pathogenesis 2011 June; 50(6): 314-21

Bradfute SB, Bavari S. Correlates of Immunity to Filovirus Infection. Viruses 2011 July, 3(7): 982-1000

Bradfute SB, Dye JM, Bavari S. Filovirus vaccines. Human Vaccines 2011 June; 7 (6): 701-711

Bradfute SB, Stuthman KS, Shurtleff AC, Bavari S. A STAT-1 knockout mouse model for Machupo virus pathogenesis. Virology Journal 2011 June 14; 8: 300

Brett PJ; Burtnick MN; Heiss C; Azadi P; DeShazer D; Woods DE; Gherardini FC. Burkholderia thailandensis oacA mutants facilitate the expression of Burkholderia mallei-like O polysaccharides. Infection and Immunity 2011 Feb, 79(2): 961-969

Burke RL, Vest KG, Eick AA, Sanchez JL, Johns MC, Pavlin JA, Jarman RG, Mothershead JL, Quintana M, Palys T, Cooper MJ, Guan J, Schnabel D, Waitumbi J, Wilma A, Daniels C, Brown ML, Tobias S, Kasper MR, Williams M, Tjaden JA, Oyofo B, Styles T, Blair PJ, Hawksworth A, Montgomery JM, Razuri H, Laguna-Torres A, Schoepp RJ, Norwood DA, MacIntosh VH, Gibbons T, Gray GC, Blazes DL, Russel, KL. Department of Defense influenza and other respiratory disease surveillance during the 2009 pandemic. BMC Public Health 2011 Mar 4; 11 (Suppl. 2): S6

Burtnick MN; Brett PJ; Harding SV; Ngugi SA; Ribot WJ; Chantratita N; Scorpio A; Milne TS; Dean RE; Fritz DL; Peacock SJ; Prior JL; Atkins TP; Deshazer D. The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei. Infection and Immunity 2011 Apr, 79(4): 1512-25

Cardellina JH, Vieira RC, Eccard V, Skerry J, Montgomery V, Campbell Y, Roxas-Duncan V, Leister W, Leclair CA, Maloney DJ, Padula D, Pescitelli G, Khavrutskii I, Hu X, Wallqvist A, Smith LA. Separation of betti reaction produt enantiomers: Absolute configuration and inhibition of botulinum neurotoxin A. ACS Medicinal Chemistry Letters 2011 May 12; 2(5): 396-401

Cardinale SC, Butler MM, Ruthel G, Nuss J, Wanner LM, Li B, Pai RP, Peet NP, Bavari S, Bowlin TL. Novel benzimidazole inhibitors of botulinum neurotoxin/A display enzyme and cell-based potency. Botulinum Journal 2011 2(1): 16-29

Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, Kuehne AI, Kranzusch PJ, Griffin AM, Ruthel G, Dal Cin P, Dye JM, Whelan SP, Chandran K, Brummelkamp TR. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 2011 Sept 15, 477(7364): 340-43

Carman RJ, Stevens AL, Lyerly MW, Hiltonsmith MF, Stiles BG, Wilkins TD. Clostridium difficile binary toxin (CDT) and diarrhea. Anaerobe 2011 Aug, 17(4): 161-165

Cashman KA; Smith MA; Twenhafel NA; Larson RA; Jones KF; Allen RD; Dai D; Chinsangaram J; Bolken TC; Hruby DE; Amberg SM; Hensley LE; Guttieri MC. Evaluation of Lassa antiviral compound ST-193 in a guinea pig model. Antiviral Research 2011 Apr, 90(1): 70-9

Chanturia G, Birdsell DN, Kekelidze M, Zhgenti E, Babuadze G, Tsertsvadze N, Tsanava S, Imnadze P, Beckstrom-Sternberg SM, Beckstrom-Sternberg JS, Champion MD, Sinari S, Gyuranecz M, Farlow J, Pettus AH, Kaufman EL, Busch JD, Pearson T, Foster JT, Vogler AJ, Wagner DM, Keim P. Phylogeography of Francisella tularensis subspecies holarctica from the country of Georgia. BMC Microbiology 2011 June 17; 11: 139

Chappell MG; Koeller CA; Hall Shannan I. Differences in Postsurgical Recovery of CF1 Mice after Intraperitoneal implantation of radiotelemetry devices through a midline or flank surgical approach. Journal of the American Association for Laboratory Animal Science - JAALAS 2011, 50(2): 227-37

Choe H, Jemielity S, Abraham J, Radoshitzky SR, Farzan M. Transferrin receptor 1 in the zoonosis and pathogenesis of New World hemorrhagic fever arenaviruses. Current Opinion in Microbiology 2011 Aug, 14(4): 476-482

Choksi KB, Nuss JE, DeFord JH, Papaconstantinou J. Mitochondrial electron transport chain functions in long-lived Ames dwarf mice. Aging (Albany NY). 2011 Aug;3(8):754-67

Clemens KA;, Larsen LB; Zhang MA ; Kuznetsov YC;, Bilanchone VA;, Randall AD; Harned AF; DaSilva RF; Nagashima KF; McPherson AB; Baldi PC; Sandmeyer, SA. The TY3 Gag3 spacer controls intracellular condensation and uncoating. Journal of Virology 2011 Apr, 85(7): 3055-3066

Compton JR; Legler PM; Clingan BV; Olson MA; Millard CB. Introduction of a disulfide bond leads to stabilization and crystallization of a ricin immunogen. Proteins 2011 Apr, 79(4): 1048-1060

Cote M, Misasi J, Ren T, Bruchez A, Lee K, Filone CM, Hensley L, Li Q, Ory D, Chandran K, Cunningham J. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 2011 Sept 15, 477(7364): 344-48

Cote CK, Welkos SL, Bozue J. Key aspects of the molecular and cellular basis of inhalational anthrax. Microbes and Infection 2011 Dec, 13(14-15): 1146-55

Dabisch PA; Kline J. Symp IIId Respiration Measures and Toxicology Affect assessment in the primate: Mechanisms of injury and physiological responses from selected biological agents. International Journal of Toxicology 2011 Feb, 30(1): 118 (31st Annual Meeting of the American-College-of-Toxicology Baltimore, MD, 7-11 Nov 2010)

Dias JM, Kuehne AI, Abelson DM, Bale S, Wong AC, Halfmann P, Muhammad MA, Fusco ML, Zak SE, Kang E, Kawaoka Y, Chandran K, Dye JM, Saphire EO. A shared structural solution for neutralizing ebolaviruses. Nature Structural & Molecular Biology 2011 Nov 20; 18(12): 1424-7

Dower K, Rubins KH, Hensley LE, Connor JH. Development of Vaccinia reporter viruses for rapid, high content analysis of viral function at all stages of gene expression. Antiviral Research 2011 July; 91(1): 72-80

Dupuy LC, Richards MJ, Ellefsen B, Chau L, Luxembourg A, Hannaman D, Livingston BD, Schmaljohn CS. A DNA vaccine for Venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates. Clinical and Vaccine Immunology 2011 May; 18(5): 707-16

Dux MP; Huang JC; Barent R; Inan M; Swanson ST; Sinha J; Ross JT; Smith LA; Smith TJ; Henderson I; Meagher MM. Purification of a recombinant heavy chain fragment C vaccine candidate against botulinum serotype C neurotoxin [rBoNTC(H-c)] expressed in Pichia pastoris. Protein Expression and Purification 2011 Feb, 75(2): 177-185

Embers ME; Doyle LA; Whitehouse CA; Selby EB; Chappell M; Philipp MT. Characterization of a Moraxella species that causes epistaxis in macaques. Veterinary Microbiology 2011 Jan 27, 147(3-4): 367-375

Ergunay K, Whitehouse CA, Ozkul A. Current status of human arboviral diseases in Turkey. Vector-Borne and Zoonotic Diseases 2011; 11(6): 731-741

Fernandez S, Cisney ED, Hall SI, Ulrich RG. Nasal immunity to staphylococcal toxic shock is controlled by the nasopharynx-associated lymphoid tissue. Clinical and Vaccine Immunology 2011 Apr; 18(4): 667-75

Fernandez S, Cisney ED, Tikhonov AP, Schweitzer B, Putnak RJ, Simmons M, Ulrich RG. Antibody recognition of the Dengue virus proteome and implications for development of vaccines. Clinical and Vaccine Immunology 2011 Apr; 18(4): 523-32

Froude JW, Stiles B, Pelat T, Thullier P. Antibodies for biodefense. mAbs 2011 Nov; 3(6): 517-27

Garcia-Rodriguez C; Geren IN; Lou J; Conrad F; Forsyth C; Wen, W; Chakraborti S; Zao H; Manzanarez G; Smith TJ; Brown J; Tepp WH; Liu N; Wijesuriya S; Tomic MT; Johnson EA; Smith LA; Marks JD. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin. Protein Engineering Design & Selection 2011 Mar, 24(3): 321-331

Geisbert TW, Bailey M, Hensley L, Asiedu C, Geisbert J, Stanley D, Honko A, Johnson J, Mulangu S, Pau MG, Custers J, Vellinga J, Hendriks J, Jahrling P, Roederer M, Goudsmit J, Koup R, Sullivan NJ. Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against Ebolavirus challenge. Journal of Virology 2011 May; 85(9): 4222-33

Gibert M; Monier MN; Ruez R; Hale ML; Stiles BG; Benmerah A; Johannes L; Lamaze C; Popoff MR. Endocytosis and toxicity of clostridial binary toxins depend on a clathrin-independent pathway regulated by Rho-GDI. Cellular Microbiology 2011 Jan, 13(1): 154-170

Goff A, Mucker E, Raymond J, Fisher R, Bray M, Hensley L, Paragas J. Infection of cynomolgus macaques with a recombinant monkeypox virus encoding green fluorescent protein. Archives of Virology 2011 Oct, 156(10): 1877-1881

Goff AJ; Chapman J; Foster C; Wlazlowski C; Shamblin J; Lin K; Kreiselmeier N; Mucker E; Paragas J; Lawler J; Hensley L. A novel respiratory model of infection with monkeypox virus in cynomolgus macaques. Journal of Virology 2011 May, 85(10): 4898-909 PMID: 21389129

Golden JW, Hooper JW. The strategic use of novel smallpox vaccines in the post-eradication world. Expert Review of Vaccines 2011 July, 10(7): 1021-1035

Golden JW, Zaitseva M, Kapnick S, Fisher RW, Mikolajczyk MG, Ballantyne J, Golding H, Hooper JW. Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease. Virology Journal 2011 Sept 20, 8: 441

Goodchild SA, Dooley H, Schoepp RJ, Flajnik M, Lonsdale SG. Isolation and characterisation of Ebolavirus-specific recombinant antibody fragments from murine and shark immune libraries. Molecular Immunology 2011 Sept, 48 (15-16): 2027-2037

Goodin JL; Powell BS; Enama JT; Raab RW; McKown RL; Coffman GL; Andrews GP. Purification. and characterization of a recombinant Yersinia pestis V-F1 "Reversed" fusion protein for use as a new subunit vaccine against plague. Protein Expression and Purification 2011 Mar 2011, 76(1): 136-44

Grant-Klein RJ, Altamura LA, Schmaljohn CS. Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses. Virus Research 2011 Dec, 162(1-2): 148-61

Grove JN, Branco LM, Boisen ML, Muncy IJ, Henderson LA, Schieffellin JS, Robinson JE, Bangura JJ, Fonnie M, Schoepp RJ, Hensley LE, Seisay A, Fair JN, Garry RF. Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: Case Report. Virology Journal 2011 June 20, 8: 314

Gunther S, Feldmann H, Geisbert TW, Hensley LE, Rollin PE, Nichol ST, Stroher U, Artsob H, Peters CJ, Ksiazek TG, Becker S, ter Meulen J, Olschlager S, Schmidt-Chanasit J, Sudeck H, Burchard GD, Schmiedel S. Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany. Journal of Infectious Diseases 2011 Nov; 204(Suppl 3): S785-S790

Guo HT; Pan XB; Mao RC; Zhang XC; Wang LJ; Lu XY; Chang JH; Guo JT; Passic S; Krebs FC; Wigdahl B; Warren TK; Retterer CJ; Bavari S; Xu XD; Cuconati A; Block TM. Alkylated porphyrins have broad antiviral activity against Hepadnaviruses, Flaviviruses, Filoviruses, and Arenaviruses. Antimicrobial Agents and Chemotherapy 2011 Feb, 55(2): 478-486

Hale M; Oyler G; Swaminathan S; Ahmed SA. Basic tetrapeptides as potent intracellular inhibitors of type a botulinum neurotoxin protease activity. Journal of Biological Chemistry 2011 Jan 21, 286(3): 1802-11

Hammerbeck CD, Hooper JW. T cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome. Journal of Virology 2011 Oct, 85(19): 9929-44

Hensley LE, Alves DA, Geisbert JB, Fritz EA, Reed C, Larsen T, Geisbert TW. Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques. Journal of Infectious Diseases 2011 Nov, 204 (Suppl 3): S1021-31

Hensley LE, Smith MA, Geisbert JB, Fritz EA, Daddario-Dicaprio KM, Larsen T, Geisbert TW. Pathogenesis of Lassa fever in cynomolgus macaques. Virology Journal 2011 May 6; 8: 205

Honsell G, De Bortoli M, Boscolo S, Dell'Aversano C, Battocchi C, Fontanive G, Penna A, Berti F, Sosa S, Yasumoto T, Ciminiello P, Poli M, Tubaro A. Harmful Dinoflagellate Ostreopsis cf. ovata Fukuyo: Detection of Ovatoxins in Field Samples and Cell lmmunolocalization Using Antipalytoxin Antibodies. Environmental Science and Technology 2011 Aug 15, 45(16): 7051-7059

Huang IC; Bailey CC; Weyer JL; Radoshitzky SR; Becker MM; Chiang JJ; Brass AL; Ahmed AA; Chi XL; Dong LA; Longobardi LE; Boltz D; Kuhn JH; Elledge SJ; Bavari S; Denison MR; Choe H; Farzan M. Distinct patterns of IFITM-mediated restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus. PloS Pathogens 2011 Jan, 7(1): e1001258

Ibrahim SM, Aitichou M, Hardick J, Blow J, O'Guinn ML, Schmaljohn C. Detection of Crimean-Congo hemorrhagic fever, Hanta, and sandfly fever viruses by real-time RT-PCR. Methods in molecular biology 2011; 665: 357-368

Iranpour M, Turell MJ, Lindsay LR. Potential for Canadian mosquitoes to transmit rift valley fever virus 1. Journal of the American Mosquito Control Association 2011 Dec; 27(4): 363-369

Janelidze N, Jaiani E, Lashkhi N, Tskhvediani A, Kokashvili T, Gvarishvili T, Jgenti D, Mikashavidze E, Diasamidze R, Narodny S, Obiso R, Whitehouse CA, Huq A, Tediashvili M. Microbial water quality of the Georgian coastal zone of the Black Sea. Marine Pollution Bulletin 2011 Mar; 62(3): 573-80

Jenkins A; Cote C; Twenhafel N; Merkel T; Bozue J; Welkos S. Role of purine biosynthesis in Bacillus anthracis pathogenesis and virulence. Infection and Immunity 2011 Jan, 79(1): 153-66

Kalb SR; Baudys J; Egan C; Smith TJ; Smith LA; Pirkle JL; Barr JR. Different substrate recognition requirements for cleavage of synaptobrevin-2 by Clostridium baratii and Clostridium botulinum type F neurotoxins. Applied and Environmental Microbiology 2011 Feb, 77(4): 1301-1308

Kalb SR, Santana WI, Geren IN, Garcia-Rodriguez C, Lou JL, Smith TJ, Marks JD, Smith LA, Pirkle JL, Barr JR. Extraction and inhibition of enzymatic activity of botulinum neurotoxins/B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies. BMC Biochemistry 2011 Nov 15; 12: 58

Keshtkar-Jahromi M, Kuhn JH, Christova I, Bradfute SB, Jahrling PB, Bavari, S. Crimean-Congo hemorrhagic fever: Current and future prospects of vaccines and therapies. Antiviral Research 2011 May; 90(2): 85-92

Kim HC, Klein TA, Kang HJ, Gu SH, Moon SS, Baek LJ, Chong ST, O'Guinn ML, Lee JS, Turell MJ, Song JW. Ecological surveillance of small mammals at Dagmar North Training Area, Gyeonggi Province, Republic of Korea, 2001-2005. Journal of Vector Ecology 2011 June; 36(1): 42-54

Kim SE, Bahta M, Lountos GT, Ulrich RG, Burke TR, Waugh DS. Isothiazolidinone (IZD) as a phosphoryl mimetic in inhibitors of the Yersinia pestis protein tyrosine phosphatase YopH. Acta Crystallographica Section D: Biological Crystallography 2011 July; 67(7): 639-645

Kiris E, Nuss JE, Burnett JC, Kota KP, Koh DC, Wanner LM, Torres-Melendez E, Gussio R, Tessarollo L, Bavari S. Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery. Stem Cell Research 2011 May; 6(3): 195-205

Kissner TL, Moisan L, Mann E, Alam S, Ruthel G, Ulrich RG, Rebek M, Rebek J, Saikh KU. A Small Molecule That Mimics the BB-loop in the Toll Interleukin-1 (IL-1) Receptor Domain of MyD88 Attenuates Staphylococcal Enterotoxin B-induced Pro-inflammatory Cytokine Production and Toxicity in Mice. Journal of Biological Chemistry 2011 Sept 9, 286(36): 31385-31396

Kissner TL; Ruthel G; Alam S; Ulrich RG; Fernandez S; Saikh KU. Activation of MyD88 signaling upon Staphylococcal Enterotoxin binding to MHC class II molecules. PLoS One 2011 Jan 20, 6(1): e15985

Kissner TL, Ruthel G, Cisney ED, Ulrich RG, Fernandez S, Saikh KU. MyD88-dependent pro-inflammatory cytokine response contributes to lethal toxicity of staphylococcal enterotoxin B in mice. Innate Immunity 2011 Oct, 17(5): 451-462

Klein TA, Kang HJ, Gu SH, Moon S, Shim S-H, Park YM, Lee S-Y, Kim H-C, Chong S-T, O'Guinn M, Lee JS, Turell MJ, Song J-W. Hantaan virus surveillance targeting small mammals at Dagmar North Training Area, Gyeonggi Province, Republic of Korea, 2001-2005. Journal of Vector Ecology 2011 Dec; 36(2): 373-381

Koehler JW, Dupuy LC, Garrison AR, Beitzel BF, Richards MJ, Ripoll DR, Wallqvist A, Teh SY, Vaewhongs AA, Vojdani FS, Padgett HS, Schmaljohn CS. Novel plant-derived recombinant human interferons with broad spectrum antiviral activity. Antiviral Research 2011 Dec, 92(3): 461-9

Konduru K, Bradfute SB, Jacques J, Manangeeswaran M, Nakamura S, Morshed S, Wood SC, Bavari S, Kaplan GG. Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice. Vaccine 2011 Apr 5; 29(16): 2968-77

Kortepeter MG, Lawler JV, Honko A, Bray M, Johnson JC, Purcell BK, Olinger GG, Rivard R, Hepburn MJ, Hensley LE. Real-time Monitoring of Cardiovascular Function in Rhesus Macaques Infected With Zaire ebolavirus. Journal of Infectious Diseases 2011 Nov; 204(Suppl 3): S1000-S1010

Kuhn JH, Dodd LE, Wahl-Jensen V, Radoshitzky SR, Bavari S, Jahrling PB. Evaluation of perceived threat differences posed by filovirus variants. Biosecurity and Bioterrorism 2011 Dec; 9(4): 361-371

Lee MS, Olson MA. Comparison of two adaptive temperature-based replica exchange methods applied to a sharp phase transition of protein unfolding-folding. Journal of Chemical Physics 2011 June 28; 134(24): 244111

Leslie T, Whitehouse CA, Yingst S, Baldwin C, Kakar F, Mofleh J, Hami AS, Mustafa L, Omar F, Ayazi E, Rossi C, Noormal B, Ziar N, Kakar R. Outbreak of gastroenteritis caused by Yersinia pestis in Afghanistan. Epidemiology and Infection 2011 May 11; 139(5): 728-35

Li B, Cardinale SC, Butler MM, Pai R, Nuss JE, Peet NP, Bavari S, Bowlin TL. Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors. Bioorganic & Medicinal Chemistry 2011 Dec 15; 19(24): 7338-48

Little SF; Webster WM; Fisher DE. Monoclonal antibodies directed against protective antigen of Bacillus anthracis enhance lethal toxin activity in vivo. FEMS Immunology and Medical Microbiology 2011 June, 62 (1): 11-22

Lofts LL; Wells JB; Bavari S; Warfield KL. Key genomic changes necessary for an in vivo lethal mouse Marburgvirus variant selection process. Journal of Virology 2011 Apr, 85(8): 3905-3917

Lonsway DR, Urich SK, Heine HS, McAllister SK, Banerjee SN, Schriefer ME, Patel JB. Comparison of Etest method with reference broth microdilution method for antimicrobial susceptibility testing of Yersinia pestis. Journal of Clinical Microbiology 2011 May; 49(5): 1956-60

Louie A; Heine HS; VanScoy B; Eichas A; Files K; Fikes S; Brown DL; Liu W; Kinzig-Schippers M; Sorgel F; Drusano GL. Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance. Antimicrobial Agents and Chemotherapy 2011 Feb, 55(2): 822-830

Louie A, VanScoy B, Liu WG, Kulawy R, Brown D, Heine HS, Drusano GL. Comparative efficacies of candidate antibiotics against Yersinia pestis in an in vitro pharmacodynamic model. Antimicrobial Agents and Chemotherapy 2011 June; 55(6): 2623-2628

Lutomiah JL, Koka H, Mutisya J, Yalwala S, Muthoni M, Makio A, Limbaso S, Musila L, Clark JW, Turell MJ, Kioko E, Schnabel D, Sang RC. Ability of Selected Kenyan Mosquito (Diptera: Culicidae) Species to Transmit West Nile Virus Under Laboratory Conditions. Journal of Medical Entomology 2011 Nov; 48(6): 1197-1201

Macdonald TE, Helma CH, Shou Y, Valdez YE, Ticknor LO, Foley BT, Davis SW, Hannet, GE, Kelly-Cirino CD, Barash JR, Arnon SS, Lindström M, Korkeala H, Smith LA, Smith TJ, Hill KK. Analysis of Clostridium botulinum serotype E strains by using multilocus sequence typing, amplified fragment length polymorphism, variable-number tandem-repeat analysis, and botulinum neurotoxin gene sequencing. Applied and Environmental Microbiology 2011 Dec; 77(24): 8625-8634

Majumdar S, Ford BM, Mar KD, Sullivan VJ, Ulrich RG, D'Souza AJ. Evaluation of the effect of syringe surfaces on protein formulations. Journal of Pharmaceutical Sciences 2011 July; 100(7): 2563-2573

McLain DE, Horn TL, Detrisac CJ, Lindsey CY, Smith LA. Progress in Biological Threat Agent Vaccine Development: A repeat-dose toxicity study of a recombinant ricin toxin A-chain (rRTA) 1-33/44-198 vaccine (RVEc) in male and female New Zealand White Rabbits. International Journal of Toxicology 2011 Mar; 30(2): 143-52

Meagher MM, Seravalli JG, Swanson ST, Ladd RG, Khasa YP, Inan M, Harner JC, Johnson SK, Van Cott K, Lindsey C, Wannemacher R, Smith LA. Process Development and cGMP Manufacturing of a Recombinant Ricin Vaccine: an Effective and Stable Recombinant Ricin A-Chain Vaccine-RVEc (TM). Biotechnology Progress 2011 July-Aug, 27(4): 1036-1047

Mease LE, Coldren RL, Musila LA, Prosser T, Ogolla F, Ofula VO, Schoepp RJ, Rossi CA, Adungo N. Seroprevalence and distribution of arboviral infections among rural Kenyan adults: A cross-sectional study. Virology Journal 2011 July 27, 8:371

Michelow IC; Lear C; Scully C; Prugar LI; Longley CB; Yantosca LM; Ji X; Karpel M; Brudner M; Takahashi K; Spear GT; Ezekowitz RAB; Schmidt EV; Olinger GG. High-dose mannose-binding lectin therapy for Ebola virus infection. Journal of Infectious Diseases 2011 Jan 15, 203(2): 175-179

Miller EH, Harrison JS, Radoshitzky SR, Higgins CD, Chi X, Dong L, Kuhn JH, Bavari S, Lai JR, Chandran K. Inhibition of Ebola virus entry by a C-peptide targeted to endosomes. Journal of Biological Chemistry 2011 May 6; 286(18): 15854-61

Montgomery VA, Smith LA. Diagnostic and Possible Therapeutic Application of a Monoclonal Antibody (14G8) Directed Against botulinum Type C Neurotoxin. Hybridoma 2011 June; 30(3): 209-16

Morrill JC, Peters CJ. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent Rift Valley fever virus. Journal of Infectious Diseases 2011 July 15; 204(2): 229-236

Mustafa ML, Ayazi E, Mohareb E, Yingst S, Zayed A, Rossi CA, Schoepp RJ, Mofleh J, Fiekert K, Akhbarian Z, Sadat H, Leslie T. Crimean-Congo hemorrhagic fever, Afghanistan, 2009. Emerging Infectious Diseases 2011 Oct, 17(10): 1940-1941

Nalca A; Nichols DK. Rabbitpox: A model of airborne transmission of smallpox. Journal of General Virology 2011 Jan, 92(Pt 1): 31-5

Narayanan A, Popova T, Turell M, Kidd J, Chertow J, Popov SG, Bailey C, Kashanchi F, Kehn-Hall K. Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection. PLoS One 2011 May 18; 6(5): e20354

Nderitu L; Lee JS; Omolo J; Omulo S; O'Guinn ML; Hightower A; Mosha F; Mohamed M; Munyua P; Nganga Z; Hiett K; Seal B; Feikin DR; Breiman RF; Njenga MK. Sequential Rift Valley fever outbreaks in eastern Africa caused by multiple lineages of the virus. Journal of Infectious Diseases 2011 Jan 15, 203(5): 655-665

Okinaka RT, Price EP, Wolken SR, Gruendike JM, Chung WK, Pearson T, Xie G, Munk C, Hill KK, Challacombe J, Ivins BE, Schupp JM, Beckstrom-Sternberg SM, Friedlander A, Keim P. An attenuated strain of Bacillus anthracis (CDC 684) has a large chromosomal inversion and altered growth kinetics. BMC Genomics 2011 Sept 30; 12: 477

O'Leary VB, Ovsepian SV, Raghunath A, Huo Q, Lawrence GW, Smith L, Dolly JO. Innocuous full-length botulinum neurotoxin targets and promotes the expression of lentiviral vectors in central and autonomic neurons. Gene Therapy 2011 July, 18(7): 656-665

Olson MA, Chaudhury S, Lee MS. Comparison Between Self-Guided Langevin Dynamics and Molecular Dynamics Simulations for Structure Refinement of Protein Loop Conformations. Journal of Computational Chemistry 2011 Nov 15, 32(14): 3014-3022

Opsenica I; Burnett JC; Gussio R; Opsenica D; Todorovic N; Lanteri CA; Sciotti RJ; Gettayacamin M; Basilico N; Taramelli D; Nuss JE; Wanner L; Panchal RG; Solaja BA; Bavari S. A Chemotype That inhibits three unrelated pathogenic targets: The Botulinum Neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus. Journal of Medicinal Chemistry 2011 Mar 10, 54(5): 1157-1169

Ou W, Delisle J, Konduru K, Bradfute S, Radoshitzky SR, Retterer C, Kota K, Bavari S, Kuhn JH, Jahrling PB, Kaplan G, Wilson CA. Development and characterization of rabbit and mouse antibodies against ebolavirus envelope glycoproteins. Journal of Virological Methods 2011 June; 174(1-2): 99-109

Pang Y-P, Park JG, Wang S, Vummenthala A, Mishra RK, McLaughlin JE, Di R, Kahn JN, Tumer NE, Janosi L, Davis J, Millard CB. Small-molecule inhibitor leads of Ribosome-inactivating proteins developed using the doorstop approach. PLoS One 2011 Mar 24; 6(3): e17883

Pawlowski DR; Metzger DJ; Raslawsky A; Howlett A; Siebert G; Karalus RJ; Garrett S; Whitehouse CA. Entry of Yersinia pestis into the viable but nonculturable state in a low-temperature tap water microcosm. PLoS One 2011 Mar 16, 6(3): e17585

Phoolcharoen W, Dye JM, Kilbourne J, Piensook K, Pratt WD, Arntzen CJ, Chen Q, Mason HS, Herbst-Kralovetz MM. A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge. Proceedings of the National Academy of Science USA 2011 Dec 20; 108(51): 20695-700

Porter A, Phillips G, Smith L, Erwin-Cohen R, Tammariello R, Hale M, DaSilva L. Evaluation of a ricin vaccine candidate (RVEc) for human toxicity using an in vitro vascular leak assay. Toxicon 2011 July; 58(1): 68-75

Powell BS, Cybulski RJ. Inactivation and Extraction of Bacterial Spores for Systems Biological Analysis. IN: Edited by Ivanov AR, Lazarev AV. Sample Preparation in Biological Mass Spectrometry, 2011, Springer, New York, p.941-977

Radoshitzky SR, Longobardi LE, Kuhn JH, Retterer C, Dong L, Clester JC, Kota K, Carra J, Bavari S. Machupo virus glycoprotein determinants for human transferrin receptor 1 binding and cell entry. PloS One 2011; 6(7): e21398

Radoshitzky SR, Warfield KL, Chi XL, Dong L, Kota K, Bradfute SB, Gearhart JD, Retterer C, Kranzusch PJ, Misasi JN, Hogenbirk MA, Wahl-Jensen V, Volchkov VE, Cunningham JM, Jahrling PB, Aman MJ, Bavari S, Farzan M, Kuhn JH. Ebolavirus Delta-Peptide Immunoadhesins Inhibit Marburgvirus and Ebolavirus Cell Entry. Journal of Virology 2011 Sept, 85(17): 8502-8513

Rasko DA, Worsham PL, Abshire TG, Stanley ST, Bannan JD, Wilson MR, Langham RJ, Decker RS, Jiang L, Read TD, Phillippy AM, Salzberg SL, Pop M, Van Ert MN, Kenefic LJ, Keim PS, Fraser-Liggett CM, Ravel J. Bacillus anthracis comparative genome analysis in support of the Amerithrax investigation. Proceedings of the National Academy of Science USA 2011 Mar 22; 108(12): 5027-32

Raymond J, Bradfute S, Bray M. Filovirus Infection of STAT-1 Knockout Mice. Journal of Infectious Diseases 2011 Nov; 204(Suppl 3): S986-S990

Reed DS, Lackemeyer MG, Garza NL, Sullivan LJ, Nichols DK. Aerosol exposure to Zaire ebolavirus in three nonhuman primate species: differences in disease course and clinical pathology. Microbes and Infection 2011 Oct, 13(11): 930-936

Rubins KH; Hensley LE; Relman DA; Brown PO. Stunned silence: Gene expression programs in human cells infected with Monkeypox or Vaccinia Virus. PLoS One 2011 Jan 18, 6(1): e15615

Rusnak JM; Gibbs P; Boudreau E; Clizbe DP; Pittman P. Immunogenicity and safety of an inactivated Rift Valley fever vaccine in a 19-year study. Vaccine 2011 Apr 12, 29(17): 3222-9

Ruthel G, Burnett JC, Nuss JE, Wanner LM, Tressler LE, Torres-Melendez E, Sandwick SJ, Retterer CJ, Bavari S. Post-Intoxication Inhibition of Botulinum Neurotoxin Serotype A within Neurons by Small-Molecule, Non-Peptidic Inhibitors. Toxins 2011 Mar, 3(3): 207-17

Samy RP, Stiles BG, Gopalakrishnakone P, Chow VT. Antimicrobial Proteins from Snake Venoms: Direct Bacterial Damage and Activation of Innate Immunity Against Staphylococcus aureus Skin Infection. Current Medicinal Chemistry 2011 Nov 1; 18(33): 5104-13

Samy RP, Thwin MM, Stiles BG, Bow H, Chow VT, Gopalakrishnakone P. Therapeutic potential of peptides with neutralizing ability towards the venom and toxin (CaTx-I) of crotalus adamanteus. Current Topics Medicinal Chemistry 2011; 11(20): 2540-55

Shabman RS, Leung DW, Johnson J, Glennon N, Gulcicek EE, Stone KL, Leung L, Hensley L, Amarasinghe GK, Basler CF. DRBP76 Associates With Ebola Virus VP35 and Suppresses Viral Polymerase Function. Journal of Infectious Diseases 2011 Nov; 204(Suppl 3): S911-S918

Sharma A; Gupta P; Glass PJ; Parker MD; Maheshwari RK. Safety and protective efficacy of INA-inactivated Venezuelan equine encephalitis virus: Implication in vaccine development. Vaccine 2011 Jan 29, 29(5): 953-959

Sheng ZM, Chertow DS, Ambroggio X, McCall S, Przygodzki RM, Cunningham RE, Maximova OA, Kash JC, Morens DM, Taubenberger JK. Autopsy series of 68 cases dying before and during the 1918 influenza pandemic peak. Proceedings of the National Academy of Sciences of the USA 2011 Sept 27, 108(39): 16416-16421

Shultz LD, Brehm MA, Bavari S, Greiner DL. Humanized mice as a preclinical tool for infectious disease and biomedical research. Annals of the New York Academy of Sciences 2011 Dec, 1245: 50-54

Shurtleff AC, Warren TK, Bavari S. Nonhuman primates as models for the discovery and development of ebolavirus therapeutics. Expert Opinion on Drug Discovery 2011 Mar; 6 (3): 233-250

Simpson-Holley M; Kedersha N; Dower K; Rubins KH; Anderson P; Hensley LE; Connor JH. Formation of antiviral cytoplasmic granules during Orthopoxvirus infection. Journal of Virology 2011 Feb, 85(4): 1581-1593

Sullivan NJ, Hensley L, Asiedu C, Geisbert TW, Stanley D, Johnson J, Honko A, Olinger G, Bailey M, Geisbert JB, Reimann KA, Bao S, Rao S, Roederer M, Jahrling PB, Koup RA, Nabel GJ. CD8(+) cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates. Nature Medicine 2011 Sept, 17(9): 1128-1131

Swietnicki W, Carmany D, Retford M, Guelta M, Dorsey R, Bozue J, Lee MS, Olson MA. Identification of Small-Molecule Inhibitors of Yersinia pestis Type III Secretion System YscN ATPase. PLoS One 2011 May 18; 6(5): e19716

Terra JK, France B, Cote CK, Jenkins A, Bozue JA, Welkos SL, Bhargava R, Ho C-L, Mehrabian M, Pan C, Lusis AJ, Davis RC, LeVine SM, Bradley KA. Allelic variation on murine chromosome 11 modifies host inflammatory responses and resistance to bacillus anthracis. PLoS Pathogens 2011 Dec, 7 (12): e1002469

Tubaro A, Del Favero G, Beltramo D, Ardizzone M, Forino M, De Bortoli M, Pelin, M, Poli M, Bignami G, Ciminiello P, Sosa S. Acute oral toxicity in mice of a new palytoxin analog: 42-Hydroxy-palytoxin. Toxicon 2011 Apr; 57(5): 755-63

Turell M, Davé K, Mayda M, Parker Z, Coleman R, Davé S, Strickman D. Wicking assay for the rapid detection of rift valley fever viral antigens in mosquitoes (diptera: Culicidae). Journal of Medical Entomology 2011 May; 48(3): 628-33

Vernati G; Edwards WH; Rocke TE; Little SF; Andrews GP. Antigenic profiling of Yersinia pestis infection in the Wyoming coyote (Canis Latrans). Journal of Wildlife Diseases 2011 Jan, 47(1): 21-29

Wahl-Jensen V, Cann JA, Rubins KH, Huggins JW, Fisher RW, Johnson AJ, de Kok-Mercado F, Larsen T, Raymond JL, Hensley LE, Jahrling PB. Progression of Pathogenic Events in Cynomolgus Macaques Infected with Variola Virus. PLoS One 2011 Oct; 6 (10): e24832

Wanja E, Parker Z, Rowland T, Turell MJ, Clark JW, Davé K, Davé S, Sang R. Field evaluation of a wicking assay for the rapid detection of rift valley fever viral antigens in mosquitoes1. Journal of the American Mosquito Control Association 2011 Dec; 27 (4): 370-375

Weinstein SA, Stiles BG. A review of the epidemiology, diagnosis and evidence-based management of Mycoplasma genitalium. Sexual Health 2011 June; 8(2): 143-158

Welkos S, Cote CK, Hahn U, Shastak O, Jedermann J, Bozue J, Jung G, Ruchala P, Pratikhya P, Tang T, Lehrer RI, Beyer W. Humanized theta-Defensins (Retrocyclins) Enhance Macrophage Performance and Protect Mice from Experimental Anthrax Infections. Antimicrobial Agents and Chemotherapy 2011 Sept 11, 55(9): 4238-4250

Williamson ED, Packer PJ, Waters EL, Simpson AJ, Dyer D, Hartings J, Twenhafel N, Pitt MLM. Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague. Vaccine 2011 June 24, 29(29-30): 4771-4777

Wink DA, Hines HB, Cheng RYS, Switzer CH, Flores-Santana W, Vitek MP, Ridnour LA, Colton CA. Nitric oxide and redox mechanisms in the immune response. Journal of Leukocyte Biology 2011; 89(6): 873-891

Wolfe LL, Shenk TM, Powell B, Rocke TE. Assessment of a Recombinant F1-V Fusion Protein Vaccine Intended to Protect Canada Lynx (Lyns Canadensis) from Plague. Journal of Wildlife Diseases 2011 Oct; 47(4): 888-892

Wu SJ, Eiben CB, Carra JH, Huang I, Zong D, Liu PX, Wu CT, Nivala J, Dunbar J, Huber T, Senft J, Schokman R, Smith MD, Mills JH, Friedlander AM, Baker D, Siegel JB. Improvement of a Potential Anthrax Therapeutic by Computational Protein Design. Journal of Biological Chemistry 2011 Sept 16, 286(37): 32586-32592

Yakes BJ, DeGrasse SL, Poli M, Deeds JR. Antibody characterization and immunoassays for palytoxin using an SPR biosensor. Analytical and Bioanalytical Chemistry 2011 July; 400(9): 2865-2869

Yen JY, Garamszegi S, Geisbert JB, Rubins KH, Geisbert TW, Honko A, Xia Y, Connor JH, Hensley LE. Therapeutics of Ebola Hemorrhagic Fever: Whole-Genome Transcriptional Analysis of Successful Disease Mitigation. Journal of Infectious Diseases 2011 Nov; 204(Suppl 3): S1043-S1052

Zeitlin L, Pettitt J, Scully C, Bohorova N, Kim D, Pauly M, Hiatt A, Ngo L, Steinkellner H, Whaley KJ, Olinger GG. Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant. Proceedings of the National Academy of Science USA 2011 Dec 20; 108(51): 20690-4

Zumbrun EE, Friedman HM. An attenuated HSV-1 live virus vaccine candidate that is replication competent but defective in epithelial cell-to-cell and neuronal spread. Birkhauser Advances in Infectious Diseases 2011, 3: 223-236

Akhvlediani T; Clark DV; Chubabria G; Zenaishvili O; Hepburn MJ. The changing pattern of human brucellosis: Clinical manifestations, epidemiology, and treatment outcomes over three decades in Georgia. BMC Infectious Diseases 2010; 10: 346

Alkhalil A, Hammamieh R, Hardick J, Ichou MA, Jett M, Ibrahim S. Gene expression profiling of monkeypox virus-infected cells reveals novel interfaces for host-virus interactions. Virology Journal 2010 Jul, 7: 173

Allton DR; Rivard RG; Connolly PA; McCall S; Durkin MM; Boyd TM; Flanagan JP; Wheat LJ; Hospenthal DR. Detection of Latin American strains of Histoplasma in a murine model by use of a commercially available antigen test. Clinical and Vaccine Immunology 2010 May; 17(5): 802-6

Alves DA; Bell TM; Benton C; Rushing EJ; Stevens EL. Giant Thoracic Schwannoma in a Rhesus Macaque (Macaca mulatta). Journal of the American Association for Laboratory Animal Science 2010; 49(6): 868-72

Alves DA, Glynn AR, Steele KE, Lackemeyer MG, Garza NL, Buck JG, Mech C, Reed DS. Aerosol exposure to the angola strain of Marburg virus causes lethal viral Hemorrhagic Fever in cynomolgus macaques. Veterinary Pathology 2010 Sept, 47(5): 831-851

Andrews GP; Vernati G; Ulrich R; Rocke TE; Edwards WH; Adamovicz JJ. Identification of in vivo-induced conserved sequences from Yersinia pestis during experimental plague infection in the rabbit. Vector-Borne Zoonotic Diseases 2010 Oct; 10(8): 749-56

Beitzel BF, Bakken RR, Smith JM, Schmaljohn CS. High-resolution functional mapping of the venezuelan equine encephalitis virus genome by insertional mutagenesis and massively parallel sequencing. PLoS Pathogens 2010 Oct, 6(10):e1001146

Bhattacharyya S; Warfield KL; Ruthel G; Bavari S; Aman MJ; Hope TJ. Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology 2010 May 25; 401(1): 18-28

Bishop-Lilly KA; Turell MJ; Willner KM; Butani A; Nolan NME; Lentz SM; Akmal A; Mateczun A; Brahmbhatt TN; Sozhamannan S; Whitehouse CA; Read TD. Arbovirus detection in insect vectors by rapid, high-throughput pyrosequencing. PLOS Neglected Tropical Diseases 2010 Nov; 4(11): e878

Bradfute SB; Swanson PE; Smith MA; Watanabe E; McDunn JE; Hotchkiss RS; Bavari S. Mechanisms and consequences of ebolavirus-induced lymphocyte apoptosis. Journal of Immunology Jan 1 2010, 184(1): 327-35

Branco LM; Grove JN; Geske FJ; Boisen ML; Muncy IJ; Magliato SA; Henderson LA; Schoepp RJ; Cashman KA; Hensley LE; Garry RF. Lassa virus-like particles displaying all major immunological determinants as a vaccine candidate for Lassa hemorrhagic fever. Virology Journal 2010; 7: 279

Branco LM; Grove JN; Moses LM; Goba A; Fullah M; Momoh M; Schoepp RJ; Bausch DG; Garry RF. Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects. Virology Journal 2010; 7: 306

Burke RL; West MW; Erwin-Cohen R; Selby EB; Fisher DE; Twenhafel NA. Alterations in cytokines and effects of dexamethasone immunosuppression during subclinical infections of invasive Klebsiella pneumoniae with hypermucoviscosity phenotype in rhesus (Macaca mulatta) and cynomolgus (Macaca fascicularis) macaques. Comparative Medicine 2010, 60(1): 62-70

Burnett JC; Li B; Pai R; Cardinale SC; Butler MM; Peet NP; Moir D; Bavari S; Bowlin T. Analysis of botulinum neurotoxin serotype A metalloprotease inhibitors: Analogs of a chemotype for therapeutic development in the context of a three-zone pharmacophore. Open Access Bioinformatics 2010 Apr 1; 2010(2): 11-18

Burtnick MN; DeShazer D; Nair V; Gherardini FC; Brett PJ. Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages. Infection and Immunity 2010 Jan; 78(1): 88-99

Butler MM; Williams JD; Peet NP; Moir DT; Panchal RG; Bavari S; Shinabarger DL; Bowlin TL. Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates. Antimicrobial Agents Chemotherapy 2010 Sept; 54(9): 3974-7

Chapman JL, Nichols DK, Martinez MJ, Raymond JW. Animal models of orthopoxvirus infection. Veterinary Pathology 2010 Sept, 47(5): 852-870

Dembek, Z. World-class chem-bio training offered at USAMRIID and USAMRICD. Force Health Protection and Readiness 2010, 5(1): 10

Dabisch PA; Kline J; Lewis C; Yeager J; Pitt MLM. Characterization of a head-only aerosol exposure system for nonhuman primates. Inhalation Toxicology Feb 2010, 22(3): 224-33

Diniz PP; Beall MJ; Omark K; Chandrashekar R; Daniluk DA; Cyr KE; Koterski JF; Robbins RG; Lalo PG; Hegarty BC; Breitschwerdt EB. High prevalence of tick-borne pathogens in dogs from an Indian reservation in northeastern Arizona. Vector-Borne and Zoonotic Diseases 2010 Mar; 10(2): 117-23

Do Y; Koh H; Park CG; Dudziak D; Seo P; Mehandru S; Choi JH; Cheong C; Park S; Perlin DS; Powell BS; Steinman RM. Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague. European Journal Immunology 2010 Oct; 40(10): 2791-6

Drozdowski B; Zhou Y; Kline B; Spidel J; Chan YY; Albone E; Turchin H; Chao Q; Henry M; Balogach J; Routhier E; Bavari S; Nicolaides NC; Sass PM; Grasso L. Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B. Journal of Immune Based Therapies and Vaccines 2010 Dec 21; 8: 9

Dupuy LC, Richards MJ, Reed DS, Schmaljohn CS. Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates. Vaccine Oct 28 2010, 28(46): 7345-50

Eppinger M; Worsham PL; Nikolich MP; Riley DR; Sebastian Y; Mou S; Achtman M; Lindler LE; Ravel J. Genome sequence of the deep-rooted yersinia pestis strain Angola reveals new insights into the evolution and pangenome of the plague bacterium. Journal Bacteriology 2010 Mar; 192(6): 1685-99

Farlow J; Ichou MA; Huggins J; Ibrahim S. Comparative whole genome sequence analysis of wild-type and cidofovir-resistant monkeypoxvirus. Virology Journal 2010 May, 7: 110

Fellows P; Adamovicz J; Hartings J; Sherwood R; Mega W; Brasel T; Barr E; Holland L; Lin W; Rom A; Blackwelder W; Price J; Morris S; Snow D; Hart MK. Protection in mice passively immunized with serum from cynomolgus macaques and humans vaccinated with recombinant plague vaccine (rF1V). Vaccine 2010 Nov 16; 28(49): 7748-56

Felts RL; Narayan K; Estes JD; Shi D; Trubey CM; Fu J; Hartnell LM; Ruthel GT; Schneider DK; Nagashima K; Bess Jr. JW; Bavari S; Lowekamp BC; Bliss D; Lifson JD; Subramaniam S. 3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells. Proceedings of the National Academy of Sciences USA 2010 July 27; 107(30): 13336-41

Fine DL; Jenkins E; Martin SS; Glass P; Parker MD; Grimm B. A multisystem approach for development and evaluation of inactivated vaccines for Venezuelan equine encephalitis virus (VEEV). Journal of Virological Methods 2010 Feb, 163(2): 424-32

Galyov EE; Brett PJ; Deshazer D. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis. Annual Review of Microbiology 2010; 64: 495-517

Geisbert TW; Bailey M; Geisbert JB; Asiedu C; Roederer M; Grazia-Pau M; Custers J; Jahrling P; Goudsmit J; Koup R; Sullivan NJ. Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates. Journal of Virology Oct 2010, 84(19): 10386-94

Geisbert TW; Daddario-Dicaprio KM; Hickey AC; Smith MA; Chan YP; Wang LF; Mattapallil JJ; Geisbert JB; Bossart KN; Broder CC. Development of an acute and highly pathogenic nonhuman primate model of Nipah virus infection. PLOS One 2010; 5(5): e10690

Geisbert TW; Hensley LE; Geisbert JB; Leung A; Johnson JC; Grolla A; Feldmann H. Postexposure treatment of Marburg virus infection. Emerging Infectious Diseases 2010 July; 16(7): 1119-22

Geisbert TW; Lee AC; Robbins M; Geisbert JB; Honko AN; Sood V; Johnson JC; de Jong S; Tavakoli I; Judge A; Hensley LE; MacLachlan I. Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: A proof-of-concept study. Lancet 2010 May 29; 375(9729): 1896-905

Gill SC; Rubino CM; Bassett J; Miller L; Ambrose PG; Bhavnani SM; Beaudry A; Li J; Stone KC; Critchley I; Janjic N; Heine HS. Pharmacokinetic-pharmacodynamic assessment of faropenem in a lethal murine Bacillus anthracis inhalation postexposure prophylaxis model. Antimicrobial Agents Chemotherapy 2010 May; 54(5): 1678-83

Golden JW; Hooper JW. Evaluating the orthopoxvirus type I interferon-binding molecule as a vaccine target in the vaccinia virus intranasal murine challenge model. Clinical and Vaccine Immunology 2010 Nov, 17(11): 1656-65

Grant RJ; Baldwin CD; Nalca A; Zoll S; Blyn LB; Eshoo MW; Matthews H; Sampath R; Whitehouse CA. Application of the Ibis-T5000 pan-Orthopoxvirus assay to quantitatively detect monkeypox viral loads in clinical specimens from macaques experimentally infected with aerosolized monkeypox virus. American Journal of Tropical Medicine and Hygiene Feb 2010, 82(2): 318-23

Grant-Klein RJ; Baldwin CD; Turell MJ; Rossi Cynthia A; Li F; Lovari R; Crowder CD; Matthews HE; Rounds MA; Eshoo MW; Blyn LB; Ecker DJ; Sampath R; Whitehouse CA. Rapid identification of vector-borne flaviviruses by mass spectrometry. Molecular and Cellular Probes Aug 2010, 24 (4): 219-28

Grim CJ; Jaiani E; Whitehouse CA; Janelidze N; Kokashvili T; Tediashvili M; Colwell RR; Huq A. Detection of toxigenic vibrio cholerae O1 in freshwater lakes of the former Soviet Republic of Georgia. Environmental Microbiology Reports 2010 Feb; 2(1): 2-6

Gul N; Smith LA; Ahmed SA. Light chain separated from the rest of the type a botulinum neurotoxin molecule is the most catalytically active form. PloS One 2010 Sept, 5(9): e12872

Guntur VP; Waldrep JC; Guo JJ; Selting K; Dhand R. Increasing P53 protein sensitizes non-small cell lung cancer to paclitaxel and cisplatin in vitro. Anticancer Research 2010 Sept; 30(9): 3557-64

Hakami RM; Ruthel G; Stahl AM; Bavari S. Gaining ground: Assays for therapeutics against botulinum neurotoxin. Trends in Microbiology 2010 Apr; 18(4): 164-72

Heine HS; Bassett J; Miller L; Purcell BK; Byrne WR. Efficacy of Daptomycin against Bacillus anthracis in a murine model of anthrax spore inhalation. Antimicrobial Agents and Chemotherapy Oct 2010, 54(10): 4471-3

Heine HS; Miller L; Halasohoris S; Holman K; Zadeh M. Assessment of Burkholderia Pseudomallei (bp) In Vitro Susceptibility and Efficacy in a Murine-Aerosol Challenge Model for Five Antibiotic Classes. 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, September 12 -15, 2009, 49: 54

Heine HS; Purcell BK; Bassett J; Miller L; Goldstein BP. Activity of Dalbavancin against Bacillus anthracis In Vitro and in a Mouse Inhalation Anthrax Model. Antimicrobial Agents and Chemotherapy Mar 2010, 54(3): 991-6

Hensley LE, Mulangu S, Asiedu C, Johnson J, Honko AN, Stanley D, Fabozzi G, Nichol ST, Ksiazek TG, Rollin PE, Wahl-Jensen V, Bailey M, Jahrling PB, Roederer M, Koup RA, Sullivan NJ. Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species. PLoS Pathog May 2010, 6(5):pe1000904

Hill BJ; Skerry JC; Smith TJ; Arnon SS; Douek DC. Universal and specific quantitative detection of botulinum neurotoxin genes. BMC Microbiology 2010; 10: 267

Kalb SR; Garcia-Rodriguez C; Lou J; Baudys J; Smith TJ; Marks JD; Smith LA; Pirkle JL; Barr JR. Extraction of BoNT/A, /B, /E, and /F with a single; high affinity monoclonal antibody for detection of botulinum neurotoxin by Endopep-MS. PLOS One 2010; 5(8): e12237

Keasey S; Pugh C; Tikhonov A; Chen G; Schweitzer B; Nalca A; Ulrich RG. Proteomic basis of the antibody response to monkeypox virus infection examined in cynomolgus macaques and a comparison to human smallpox vaccination. PLOS One 2010; 5(12): e15547

Kim HC; Lee IY; Chong ST; Richards AL; Gu SH; Song JW; Lee JS; Klein TA.. Serosurveillance of scrub typhus in small mammals collected from military training sites near the DMZ, Northern Gyeonggi-do, Korea;,and analysis of the relative abundance of chiggers from mammals examined. Korean Journal of Parasitology 2010 Sept; 48(3): 237-43

Kissner TL; Cisney ED; Ulrich RG; Fernandez S; Saikh KU. Staphylococcal enterotoxin A induction of pro-inflammatory cytokines and lethality in mice is primarily dependent on MyD88. Immunology 2010 Aug, 130(4): 516-26

Krakauer T. Therapeutic down-modulators of staphylococcal superantigen-induced inflammation and toxic shock. Toxins 2010 Aug; 2(8): 1963-83

Krakauer T; Buckley M; Issaq HJ; Fox SD. Rapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo. Antimicrobial Agents and Chemotherapy Mar 2010, 54(3): 1125-31

Krakauer T; Buckley M; Fisher D. Murine models of staphylococcal enterotoxin B-induced toxic shock. Military Medicine 2010 Nov, 175(11): 917-22

Krakauer T; Buckley M; Fisher D. Proinflammatory mediators of toxic shock and their correlation to lethality. Mediators of Inflammation 2010: 517594

Kranzusch PJ; Schenk AD; Rahmeh AA; Radoshitzky SR; Bavari S; Walz T; Whelan SPJ. Assembly of a functional Machupo virus polymerase complex. Proceedings of the National Academy of Science USA 2010 Nov 16; 107(46): 20069-74

Larkin EA; Stiles BG; Ulrich RG. Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B. PloS One 2010, 5(10): pe13253

Lee MS; Olson MA. Protein folding simulations combining self-guided langevin dynamics and temperature-based replica exchange. Journal of Chemical Theory and Computation 2010 Aug 10; 6(8): 2477-87

Li B; Pai R; Cardinale SC; Butler MM; Peet NP; Moir DT; Bavari S; Bowlin TL. Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors. Journal of Medicinal Chemistry 2010 Mar 11; 53(5): 2264-76

Lin J; Park S; Adamovicz JJ; Hill J; Bliska JB; Cote CK; Perlin DS; Amemiya K; Smiley ST. TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague. Vaccine 2010 Dec 16; 29(2): 357-62

Little SF; Webster WM; Wilhelm H; Fisher D; Norris SLW; Powell BS; Enama J; Adamovicz JJ. Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice. Vaccine Jan 22 2010, 28(4): 934-9

Liu F; Hakami RM; Dyas B; Bahta M; Lountos GT; Waugh DS; Ulrich RG; Burke Jr. TR. A rapid oxime linker-based library approach to identification of bivalent inhibitors of the Yersinia pestis protein-tyrosine phosphatase; YopH. Bioorganic and Medicinal Chemistry Letters 2010 May 1; 20(9): 2813-6

Livingston BD; Little SF; Luxembourg A; Ellefsen B; Hannaman D. Comparative performance of a licensed anthrax vaccine versus electroporation based delivery of a PA encoding DNA vaccine in rhesus macaques. Vaccine 2010 Jan 22; 28(4): 1056-61

Losada L; Ronningf CM; Deshazer D; Woods D; Fedorova N; Kim HS; Shabalina SA; Pearson TR; Brinkac L; Tan P; Nandi T; Crabtree J; Badger J; Beckstrom-Sternberg S; Saqib M; Schutzer SE; Keim P; Nierman WC. Continuing evolution of Burkholderia mallei through genome reduction and large-scale rearrangements. Genome Biology and Evolution 2010; 2(1): 102-16

Lou J; Geren I; Garcia-Rodriguez C; Forsyth C M; Wen W; Knopp K; Brown J; Smith T; Smith LA; Marks JD. Affinity maturation of human botulinum neurotoxin antibodies by light chain shuffling via yeast mating. Protein Engineering Design & Selection 2010 Apr, 23(4): 311-319

Loveless BM; Yermakova A; Christensen DR; Kondig JP; Heine HS; Wasieloski LP; Kulesh DA. Identification of ciprofloxacin resistance by SimpleProbe, High Resolution Melt and Pyrosequencing nucleic acid analysis in biothreat agents: Bacillus anthracis, Yersinia pestis and Francisella tularensis. Molecular and Cellular Probes Jun 2010, 24(3): 154-60

Martin SS; Bakken RR; Lind CM; Garcia P; Jenkins E; Glass PJ; Parker MD; Hart MK; Fine DL. Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB. Vaccine 2010 Jan 22, 28(4): 1031-40

Martin SS; Bakken RR; Lind CM; Garcia P; Jenkins E; Glass PJ; Parker MD; Hart MK; Fine DL. Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus. Vaccine 2010 Apr 19, 28(18): 3143-51

Martinez O; Johnson J; Manicassamy B; Rong L; Olinger GG; Hensley LE; Basler CF. Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition. Cellular Microbiology 2010; 12(2): 148-57

Matchett MR; Biggins DE; Carlson V; Powell B; Rocke T. Enzootic plague reduces black-footed ferret (Mustela Nigripes) survival in Montana. Vector-Borne and Zoonotic Diseases 2010 Jan/Feb; 10(1): 27-35

McGann P; Rozak DA; Nikolich MP; Bowden RA; Lindler LE; Wolcott MJ; Lathigra R. A novel brain heart infusion broth supports the study of common Francisella tularensis serotypes. Journal of Microbiological Methods 2010 Feb; 80(2): 164-171

Michelow IC; Dong M; Mungall BA; Yantosca LM; Lear C; Ji X; Karpel M; Rootes CL; Brudner M; Houen G; Eisen DP; Kinane TB; Takahashi K; Stahl GL; Olinger GG; Spear GT; Ezekowitz RAB; Schmidt EV. A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virus. Journal of Biological Chemistry 2010 Aug 6; 285(32): 24729-39

Mitchell JL; Chatwell N; Christensen D; Diaper H; Minogue TD; Parsons TM; Walker B; Weller SA. Development of real-time PCR assays for the specific detection of Francisella tularensis ssp. tularensis; holarctica and mediaasiatica. Molecular and Cellular Probes 2010 Apr; 24(2): 72-6

Mokrievich AN, Kondakova AN, Valade E, Platonov ME, Vakhrameeva GM, Shaikhutdinova RZ, Mironova RI, Blaha D, Bakhteeva IV, Titareva GM, Kravchenko TB, Kombarova TI, Vidal D, Pavlov VM, Lindner B, Dyatlov IA, Knirel YA. Biological properties and structure of the lipopolysaccharide of a vaccine strain of Francisella tularensis generated by inactivation of a quorum sensing system gene qseC, Biochemistry (Moscow) Apr 2010, 75 (4): p443-451

Moody KL; Driks A; Rother GL; Cote CK; Brueggemann EE; Hines HB; Friedlander AM; Bozue J. Processing, assembly and localization of a Bacillus anthracis spore protein. Microbiology Jan 2010, 156(Pt 1): 174-83

Nalca A, Livingston VA, Garza NL, Zumbrun EE, Frick OM, Chapman JL, Hartings JM. Experimental infection of cynomolgus macaques (Macaca fascicularis) with aerosolized monkeypox virus. PloS One 2010 Sept, 5(9). Pii: e12880

Nalca A, Zumbrun EE. ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile. Drug Design, Development and Therapy 2010 May, 4: 71-9

Natesan M; Ulrich RG. Protein microarrays and biomarkers of infectious disease. International Journal of Molecular Sciences 2010 Dec; 11(12): 5165-83

Nuss JE; Dong Y; Wanner LM; Ruthel G; Wipf P; Gussio R; Vennerstrom JL; Bavari S; Burnett JC. Pharmacophore Refinement Guides the Design of Nanomolar-Range Botulinum Neurotoxin Serotype A Light Chain Inhibitors. ACS Medicinal Chemistry Letters 2010 Oct, 1(7): 301-305

Nuss JE; Ruthel G; Tressler LE; Wanner LM; Torres-Melendez E; Hale ML; Bavari S. Development of cell-based assays to measure botulinum neurotoxin serotype A activity using cleavage-sensitive antibodies. Journal of Biomolecular Screening 2010 Jan, 15(1): 42-51

Nuss JE; Wanner LM; Tressler LE; Bavari S. The osmolyte trimethylamine N-oxide (TMAO) increases the proteolytic activity of botulinum neurotoxin light chains A, B, and E: implications for enhancing analytical assay sensitivity. Journal of Biomolecular Screening 2010 Sep, 15(8): 928-36

O'Guinn ML, Klein TA, Lee JS, Richards AL, Kim Heung-Chul, Ha Si Jung, Shim So Hee, Baek Luck Ju, Song Ki-Joon, Chong Sung-Tae, Turell MJ, Burkett DA, Schuster A, Lee In-Yong, Yi Suk-Hee, Sames WJ, Song Jin-Won. Serological surveillance of scrub typhus, murine typhus, and leptospirosis in small mammals captured at firing points 10 and 60, Gyeonggi province, republic of Korea, 2001-2005. Vector Borne and Zoonotic Diseases Mar 2010, 10(2): 125-33

Opperman TJ; Williams JD; Houseweart C; Panchal RG; Bavari S; Peet NP; Moir DT; Bowlin TL. Efflux-mediated bis-indole resistance in Staphylococcus aureus reveals differential substrate specificities for MepA and MepR. Bioorganic and Medicinal Chemistry 2010 Mar 15; 18(6): 2123-30

Ozkaya E; Dincer E; Carhan A; Uyar Y; Ertek M; Whitehouse CA; Ozkul A. Molecular epidemiology of Crimean-Congo hemorrhagic fever virus in Turkey: Occurrence of local topotype. Virus Research 2010 Apr; 149(1): 64-70

Panchal RG, Kota KP, Spurgers KB, Ruthel G, Tran JP, Boltz RCD, Bavari S. Development of high-content imaging assays for lethal viral pathogens. Journal of Biomolecular Screening Aug 2010, 15(7): 755-65

Pang YP; Davis J; Wang S; Park JG; Nambiar MP; Schmidt JJ; Millard CB. Small molecules showing significant protection of mice against botulinum neurotoxin serotype A. PLOS One 2010; 5(4): e10129

Paranavitana C; Zelazowska E; Dasilva L; Pittman PR; Nikolich M. Th17 cytokines in recall responses against Francisella tularensis in humans. Journal of Interferon and Cytokine Research 2010 July; 30(7): 471-6

Parker MD; Buckley MJ; Melanson VR; Glass PJ; Norwood D; Hart MK. Antibody to the E3 glycoprotein protects mice against lethal venezuelan equine encephalitis virus infection. Journal of Virology 2010 Dec, 84(24): 12683-90

Popova TG; Turell MJ; Espina V; Kehn-Hall K; Kidd J; Narayanan A; Liotta L; Petricoin EF; Kashanchi F; Bailey C; Popov SG. Reverse-phase phosphoproteome analysis of signaling pathways induced by Rift Valley fever virus in human small airway epithelial cells. PLOS One 2010; 5(11): e13805

Pratt WD, Wang D, Nichols DK, Luo M, Woraratanadharm J, Dye JM, Holman DH, Dong JY. Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector. Clinical and Vaccine Immunology Apr 2010, 17(4): 572-81

Radoshitzky SR, Dong L, Chi X, Clester JC, Retterer C, Spurgers K, Kuhn JH, Sandwick S, Ruthel G, Kota K, Boltz D, Warren T, Kranzusch PJ, Whelan SPJ, Bavari S. Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. Journal of Virology Oct 2010, 84(20): 10569-80

Ray N; Whidby J; Stewart S; Hooper JW; Bertolotti-Ciarlet A. Study of Andes virus entry and neutralization using a pseudovirion system. Journal of Virological Methods 2010 Feb; 163(2): 416-23

Reisler RB, Danner DK, Gibbs PH. Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: using PRNT50 as an endpoint for immunogenicity. Vaccine Mar 11 2010, 28(12): 2436-41

Ritchie G; Harvey DJ; Stroeher U; Feldmann F; Feldmann H; Wahl-Jensen V; Royle L; Dwek RA; Rudd PM. Identification of N-glycans from Ebola virus glycoproteins by matrix-assisted laser desorption/ ionisation time-of-flight and negative ion electrospray tandem mass spectrometry. Rapid Communications in Mass Spectrometry 2010 Mar 15; 24(5): 571-85

Rocke TE; Pussini N; Smith SR; Williamson J; Powell B; Osorio JE. Consumption of baits containing raccoon pox-based plague vaccines protects black-tailed prairie dogs (Cynomys ludovicianus). Vector-Borne and Zoonotic Diseases 2010 Jan/Feb; 10(1): 53-8

Ronning CM, Losada L, Brinkac L, Inman J, Ulrich RL, Schell M, Nierman WC, DeShazer D. Genetic and phenotypic diversity in Burkholderia: contributions by prophage and phage-like elements. BMC Microbiology Jul 28 2010, 10: 202

Rooijakkers SHM; Rasmussen SL; McGillivray SM; Bartnikas TB; Mason AB; Friedlander AM; Nizet V. Human transferrin confers serum resistance against Bacillus anthracis. Journal of Biological Chemistry 2010 Sept 3; 285(36): 27609-13

Rowe B, Schmidt JJ, Smith LA, Ahmed SA. Rapid product analysis and increased sensitivity for quantitative determinations of botulinum neurotoxin proteolytic activity. Analytical Biochemistry Jan 15 2010, 396(2): 188-93

Rozak DA, Gelhaus HC, Smith M, Zadeh M, Huzella L, Waag D, Adamovicz JJ. CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols. Journal of Immune Based Therapies and Vaccines 2010, 8(1): 2

Sanders JL; Lawrence C; Nichols DK; Brubaker JF; Peterson TS; Murray KN; Kent ML. Pleistophora hyphessobryconis (Microsporidia)infecting zebrafish Danio rerio in research facilities. Diseases of Aquatic Organisms 2010; 91(1): 47-56

Sang R; Kioko E; Lutomiah J; Warigia M; Ochieng C; O'Guinn M; Lee JS; Koka H; Godsey M; Hoel D; Hanafi H; Miller B; Schnabel D; Breiman RF; Richardson J. Rift Valley fever virus epidemic in Kenya, 2006/2007: The entomologic investigations. American Journal of Tropical Medicine and Hygiene 2010 Aug; 83(2 Suppl.): 28-37

Scorpio A; Chabot DJ; Day WA; Hoover TA; Friedlander AM. Capsule depolymerase overexpression reduces Bacillus anthracis virulence. Microbiology 2010 May, 156(Pt 5): 1459-67

Smith DR, McCarthy S, Chrovian A, Olinger G, Stossel A, Geisbert TW, Hensley LE, Connor JH. Inhibition of heat-shock protein 90 reduces Ebola virus replication. Antiviral Research Aug 2010, 87(2): 187-94

Smith DR; Ogg M; Garrison A; Yunus A; Honko A; Johnson J; Olinger G; Hensley LE; Kinch MS. Development of FGI-106 as a broad-spectrum therapeutic with activity against members of the family Bunyaviridae. Virus Adaptation and Treatment 2010; 2(1): 9-20

Smith DR, Steele KE, Shamblin J, Honko A, Johnson J, Reed C, Kennedy M, Chapman JL, Hensley LE. The pathogenesis of Rift Valley fever virus in the mouse model. Virology Nov 25 2010, 407(2): 256-67

Sobocinski GP; Toy K; Bobrowski WF; Shaw S; Anderson AO; Kaldjian EP. Ultrastructural localization of extracellular matrix proteins of the lymph node cortex: Evidence supporting the reticular network as a pathway for lymphocyte migration. BMC Immunology 2010; 11: 42

Song H; Hwang J; Yi H; Ulrich RL; Yu Y; Nierman WC; Kim HS. The early stage of bacterial genome-reductive evolution in the host. PLOS Pathogens 2010; 6(5): e1000922

Spurgers KB; Alefantis T; Peyser BD; Ruthel GT; Bergeron AA; Costantino JA; Enterlein S; Kota KP; Boltz RCD; Aman MJ; Delvecchio VG; Bavari S. Identification of Essential Filovirion-associated Host Factors by Serial Proteomic Analysis and RNAi Screen. Molecular & Cellular Proteomics 2010 Dec, 9(12): 2690-703

Steele KE. Guest editorial: Special focus on the pathology of biological select agents and toxins in animals and research challenges in biological defense. Veterinary Pathology 2010 Sept, 47(5): 772-773

Steele KE, Twenhafel NA. Review Paper: Pathology of animal models of alphavirus encephalitis. Veterinary Pathology 2010 Sept, 47(5): 790-805

Terra JK; Cote CK; France B; Jenkins AL; Bozue JA; Welkos SL; LeVine SM; Bradley KA. Cutting Edge: Resistance to Bacillus anthracis infection mediated by a lethal toxin sensitive allele of Nalp1b/Nlrp1b. Journal of Immunology 2010 Jan 1; 184(1): 17-20

Thompson J; Hill KK; Smith TJ; Pikis A. The gene CBO0515 from Clostridium botulinum strain Hall A encodes the rare enzyme N5-(carboxyethyl) ornithine synthase, EC 1.5.1.24. Journal of Bacteriology 2010 Feb; 192(4): 1151-55

Tribble DR; Baqar S; Scott DA; Oplinger ML; Trespalacios F; Rollins D; Walker RI; Clements JD; Walz S; Gibbs P; Burg III EF; Moran AP; Applebee L; Bourgeois AL. Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans. Infection and Immunity 2010 Apr; 78(4): 1750-9

Trombley AR, Wachter L, Garrison J, Buckley-Beason VA, Jahrling J, Hensley LE, Schoepp RJ, Norwood DA, Goba A, Fair JN, Kulesh DA. Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses. Am J Trop Med Hyg. May 2010, 82(5):954-60

Turell MJ, Wilson WC, Bennett KE. Potential for North American mosquitoes (Diptera: Culicidae) to transmit rift valley fever virus. Journal of Medical Entomology Sep 2010, 47(5): 884-9

Turell MJ; Dohm DJ; Geden CJ; Hogsette JA; Linthicum KJ. Potential for stable flies and house flies (Diptera: Muscidae) to transmit Rift Valley fever virus. Journal of the American Mosquito Control Association 2010 Dec; 26(4): 445-48

Twenhafel NA. Pathology of inhalational anthrax animal model. Veterinary Pathology 2010 Sept, 47(5): 819-830

Vilensky JA; Gilman S; McCall S. A historical analysis of the relationship between encephalitis lethargica and postencephalitic Parkinsonism: A complex rather than a direct relationship. Movement Disorders 2010 July 15; 25(9): 1116-23

Vilensky JA; Gilman S; McCall S. Does the historical literature on encephalitis lethargica support a simple (direct) relationship with postencephalitic Parkinsonism? Movement Disorders 2010 July 15; 25(9): 1124-30

Walters MS, Mobley HL. Bacterial proteomics and identification of potential vaccine targets. Expert Rev Proteomics. Apr 2010, 7(2):181-4

Warren TK, Warfield KL, Wells J, Enterlein S, Smith M, Ruthel G, Yunus AS, Kinch MS, Goldblatt M, Aman MJ, Bavari S. Antiviral activity of a small-molecule inhibitor of filovirus infection. Antimicrobial Agents and Chemotherapy May 2010, 54(5): 2152-9

Warren TK, Warfield KL, Wells J, Swenson DL, Donner KS, Van Tongeren SA, Garza NL, Dong L, Mourich DV, Crumley S, Nichols DK, Iversen PL, Bavari S. Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nature Medicine Sep 2010, 16(9): 991-4

Warren TK, Warfield KL, Wells J, Swenson D, Lovejoy C, Iversen P, Bavari S. Treatment of highly pathogenic filovirus infections using advanced antisense technology. Retrovirology May 11 2010, 7(Suppl. 1): 16-17

Weiner DB; Sardesai NY; Schmaljohn C. Introduction to DNA vaccines - Las Vegas. Vaccine 2010 Feb 23; 28(8): 1893-6

West GF, Lillibridge SR, Howard RJ, Grabenstein J, Dembek ZF, Dombrowski PA. Federal Practitioner 2010 Apr, 27(Suppl 2): 4-10

Whitehouse CA, Baldwin C, Sampath R, Blyn LB, Melton R, Li F, Hall TA, Harpin V, Matthews H, Tediashvili M, Jaiani E, Kokashvili T, Janelidze N, Grim C, Colwell RR, Huq A. Identification of pathogenic Vibrio species by multilocus PCR-electrospray ionization mass spectrometry and its application to aquatic environments of the former soviet republic of Georgia. Applied and Environmental Microbiology Mar 2010, 76(6): 1996-2001

Whitehouse CA, Keirstead N, Taylor J, Reinhardt JL, Beierschmitt A. Prevalence of hypermucoid Klebsiella pneumoniae among wild-caught and captive vervet monkeys (Chlorocebus aethiops sabaeus) on the island of St. Kitts. Journal of Wildlife Diseases Jul 2010, 46(3): 971-6

Wojciechowski J; Chase-Baldwin K; Wasieloski LP; Padilla S; Vora GJ; Taitt CR. Enhancement of deoxyribonucleic acid microarray performance using post-hybridization signal amplification. Analytica Chim Acta 2010 Oct 29; 679(1-2): 85-90

Wolf MC; Freiberg AN; Zhang T; Akyol-Ataman Z; Grock A; Hong PW; Li J; Watson NF; Fang AQ; Aguilar HC; Porotto M; Honko AN; Damoiseaux R; Miller JP; Woodson SE; Chantasirivisal S; Fontanes V; Negrete OA; Krogstad P; Dasgupta A; Moscona A; Hensley LE; Whelan SP; Faull KF; Holbrook MR; Jung ME; Lee B. A broad-spectrum antiviral targeting entry of enveloped viruses. Proceedings of the National Academy of Sciences USA 2010 Feb 16; 107(7): 3157-62

Xiao X; Zhu Z; Dankmeyer JL; Wormald MM; Fast RL; Worsham PL; Cote CK; Amemiya K; Dimitrov DS. Human anti-plague monoclonal antibodies protect mice from Yersinia pestis in a bubonic plague model. PloS One 2010, 5(10): pe13047

Yee SB; Hatkin JM; Dyer DN; Orr SA; Pitt MLM. Aerosolized Bacillus anthracis infection in New Zealand White Rabbits: Natural history and intravenous levofloxacin treatment. Comparative Medicine 2010; 60(6): 461-8

Yingst SL, Huzella LM, Chuvala L, Wolcott M. A rhesus macaque (Macaca mulatta) model of aerosol-exposure brucellosis (Brucella suis): pathology and diagnostic implications. J Med Microbiol (England) 2010 Jun, 59(Pt 6):724-30

Zakhashvili K; Tsertsvadze N; Chikviladze T; Jghenti E; Bekaia M; Kuchuloria T; Hepburn MJ; Imnadze P; Nanuashvili A. Crimean-Congo hemorrhagic fever in man, Republic of Georgia, 2009. Emerging Infectious Diseases 2010 Aug; 16(8): 1326-8

Zuniga JE; Hammill JT; Drory O; Nuss JE; Burnett JC; Gussio R; Wipf P; Bavari S; Brunger AT. Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A. PLOS One 2010; 5(6): e11378

Alkhalil A; Strand S; Mucker E; Huggins JW; Jahrling PB; Ibrahim SM. Inhibition of monkeypox virus replication by RNA interference. Virology journal 2009, 6: 188

Aman MJ; Kinch MS; Warfield K; Warren T; Yunus A; Enterlein S; Stavale E; Wang P; Chang S; Tang Q; Porter K; Goldblatt M; Bavari S. Development of a broad-spectrum antiviral with activity against Ebola virus. Antiviral research 2009 Sep, 83(3): 245-51

Amemiya K; Meyers JL; Rogers TE; Fast RL; Bassett AD; Worsham PL; Powell BS; Norris SL; Krieg AM; Adamovicz JJ. CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague. Vaccine 2009 Apr 6, 27(16): 2220-9

Baldwin CD, Howe GB, Sampath R, Blyn LB, Matthews H, Harpin V, Hall TA, Drader JJ, Hofstadler SA, Eshoo MW, Rudnick K, Studarus K, Moore D, Abbott S, Janda J, Whitehouse CA. Usefulness of multilocus polymerase chain reaction followed by electrospray ionization mass spectrometry to identify a diverse panel of bacterial isolates. Diagnostic microbiology and infectious disease 2009 Apr, 63(4): 403-8

Burke RL; Whitehouse CA; Taylor JK; Selby EB. Epidemiology of invasive Klebsiella pneumoniae with hypermucoviscosity phenotype in a research colony of nonhuman primates. Comparative medicine 2009 Dec, 59(6): 589-97

Cer RZ; Mudunuri U; Stephens R; Lebeda FJ. IC50-to-K-i: a web-based tool for converting IC50 to K-i values for inhibitors of enzyme activity and ligand binding. Nucleic Acids Research 2009 July 1, 37 (Suppl. S): W441-W445

Coleman RE, Hochberg LP, Swanson KI, Lee JS, McAvin JC, Moulton JK, Eddington DO, Groebner JL, O'Guinn ML, Putnam JL. Impact of phlebotomine sand flies on U.S. military operations at Tallil Air Base, Iraq: 4. Detection and identification of leishmania parasites in sand flies. Journal of Medical Entomology 2009 May; 46(3): 649-63.

Cote CK; Bozue J; Twenhafel N; Welkos SL. Effects of altering the germination potential of Bacillus anthracis spores by exogenous means in a mouse model. Journal of medical microbiology 2009 Jun, 58(Pt 6): 816-25

DiMezzo TL, Ruthel G, Brueggemann EE, Hines HB, Ribot WJ, Chapman CE, Powell BS, Welkos SL. In vitro intracellular trafficking of virulence antigen during infection by Yersinia pestis. PloS One 2009, 4(7): e6281

Dupuy LC, Locher CP, Paidhungat M, Richards MJ, Lind CM, Bakken R, Parker MD, Whalen RG, Schmaljohn CS. Directed molecular evoluation improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine. Vaccine 2009 Jun 24; 27(31): 4152-60.

Dupuy LC; Schmaljohn CS. DNA vaccines for biodefense. Expert review of vaccines 2009 Dec, 8(12): 1739-54

Ezzell JW, Abshire TG, Panchal R, Chabot D, Bavari S, Leffel EK, Purcell B, Friedlander AM, Ribot WJ. Association of Bacillus anthracis Capsule with Lethal Toxin during Experimental Infection. Infection and immunity 2009 Feb, 77(2): 749-755

Friedlander AM; Little SF. Advances in the development of next-generation anthrax vaccines. Vaccine 2009 Nov 5, 27 (Suppl 4): D28-32

Garza NL; Hatkin JM; Livingston V; Nichols DK; Chaplin PJ; Volkmann A; Fisher D; Nalca A. Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model. Vaccine 2009 Sep 4, 27(40): 5496-504

Gelhaus HC; Rozak DA; Nierman WC; Chen D; Mojgan Z; John JV; Ulrich RL; Adamovicz JJ. Exogenous Yersinia pestis quorum sensing molecules N-octanoyl-homoserine lactone and N-(3-oxooctanoyl)-homoserine lactone regulate the LcrV virulence factor. Microbial pathogenesis 2009 May; 46(5): 283-7

Hartman LJ; Selby EB; Whitehouse CA; Coyne SR; Jaissle JG; Twenhafel NA; Burke RL; Kulesh DA. Rapid real-time PCR assays for detection of Klebsiella pneumoniae with the rmpA or magA genes associated with the hypermucoviscosity phenotype: screening of nonhuman primates. Journal of molecular diagnostics 2009 Sep, 11(5): 464-71

Hooper JW; Ferro AM; Golden JW; Silvera P; Dudek J; Alterson K; Custer M; Rivers B; Morris J; Owens G; Smith JF; Kamrud KI. Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates. Vaccine 2009 Dec 11, 28(2): 494-511

Howe GB; Loveless BM; Norwood D; Craw P; Waag D; England M; Lowe JR; Courtney BC; Pitt ML; Kulesh DA. Real-time PCR for the early detection and quantification of Coxiella burnetii as an alternative to the murine bioassay. Molecular and Cellular Probes 2009 June-Aug, 23(3-4): 127-131

Huzella LM, Buckley MJ, Alves DA, Stiles BG, Krakauer T. Central roles for IL-2 and MCP-1 following intranasal exposure to SEB: A new mouse model. Research in veterinary science 2009 Apr, 86(2): 241-7

Jenkins AL; Worsham PL; Welkos SL. A strategy to verify the absence of the pgm locus in Yersinia pestis strain candidates for select agent exemption. Journal of microbiological methods 2009 Jun, 77 (3): 316-9

Kalina WV; Warfield KL; Olinger GG; Bavari S. Discovery of common marburgvirus protective epitopes in a BALB/c mouse model. Virology journal 2009, 6: 132

Keasey SL, Schmid KE, Lee MS, Meegan J, Tomas P, Minto M, Tikhonov AP, Schweitzer B, Ulrich RG. Extensive antibody cross-reactivity among infectious gram-negative bacteria revealed by proteome microarray analysis. Molecular and Cellular Proteomics 2009 May; 8(5): 924-35

Krakauer T; Buckley MJ; Huzella LM; Alves DA. Critical timing, location and duration of glucocorticoid administration rescue mice from superantigen-induced shock and attenuate lung injury. International immunopharmacology 2009 Sep, 9(10): 1168-74

Larkin EA; Carman RJ; Krakauer T; Stiles BG. Staphylococcus aureus: the toxic presence of a pathogen extraordinaire. Current medicinal chemistry 2009, 16(30): 4003-19

Loveless BM, Mucker EM, Hartmann C, Craw PD, Huggins J, Kulesh DA. Differentiation of Variola major and Variola minor variants by MGB-Eclipse probe melt curves and genotyping analysis. Molecular and Cellular Probes 2009 June-August; 23(3-4): 166-70

Ludivico ML; Smith LA; Ahmed SA. Structure-based design of peptide inhibitors of botulinum neurotoxin serotype A proteolytic activity. The Botulinum Journal 2009; 1(3): 297-308

McKinney MD, Moon SJ, Kulesh DA, Larsen T, Schoepp RJ. Detection of viral RNA from paraffin-embedded tissues after prolonged formalin fixation. Journal of clinical virology 2009 Jan, 44(1): 39-42

Natesan M; Cooper MA; Tran JP; Rivera VR; Poli MA. Quantitative detection of staphylococcal enterotoxin B by resonant acoustic profiling. Analytical chemistry 2009 May 15, 81(10): 3896-902

Olinger GG, Biggins JE, Melanson MR, Wahl-Jensen V, Geisbert TW, Hensley EL. Drug targets in infections with Ebola and Marburg viruses. Infectious Disorders Drug Targets 2009 April; 9(2): 191-200

Panchal RG; Ulrich RL; Lane D; Butler MM; Houseweart C; Opperman T; Williams JD; Peet NP; Moir DT; Nguyen T; Gussio R; Bowlin T; Bavari S. Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains. Antimicrobial agents and chemotherapy 2009 Oct, 53(10): 4283-91

Panchal RG; Bradfute SB; Peyser BD; Warfield KL; Ruthel G; Lane D; Kenny TA; Anderson AO; Raschke WC; Bavari S. Reduced levels of protein tyrosine phosphatase CD45 protect mice from the lethal effects of Ebola virus infection. Cell host & microbe 2009 Aug 20, 6(2): 162-73

Panchal RG, Ulrich RL, Bradfute SB, Lane D, Ruthel G, Kenny TA, Iversen PL, Anderson AO, Gussio R, Raschke WC, Bavari S. Reduced expression of CD45 protein-tyrosine phosphatase provides protection against anthrax pathogenesis. Journal of Biological Chemistry 2009 May 8; 284(19): 12874-85

Pittman PR, Liu CT, Cannon TL, Mangiafico JA, Gibbs PH. Immune interference after sequential alphavirus vaccine vaccinations. Vaccine 2009 Aug 6, 27(36): 4879-82

Roxas-Duncan V, Enyedy I, Montgomery VA, Eccard VS, Carrington MA, Lai H, Gul N, Yang DCH, Smith LA. Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A. Antimicrobial agents and chemotherapy 2009 Aug, 53(8): 3478-86

Rushing SR, Saylor ML, Hale ML. Translocation of ricin across polarized human bronchial epithelial cells. Toxicon 2009 Aug; 54(2): 184-191

Rusnak JM, Byrne WR, Chung KN, Gibbs PH, Kim TT, Boudreau EF, Cosgriff T, Pittman P, Kim KY, Erlichman MS, Rezvani DF, Huggins JW. Experience with intravenous ribavirin in the treatment of hemorrhagic fever with renal syndrome in Korea. Antiviral research 2009 Jan, 81(1): 68-76

Schmaljohn C. Vaccines for hantaviruses. Vaccine 2009 Nov 5, 27 (Suppl 4): D61-4

Smith DR; Lee JS; Jahrling J; Kulesh DA; Turell MJ; Groebner JL; O'Guinn ML. Development of field-based real-time reverse transcription-polymerase chain reaction assays for detection of Chikungunya and O'nyong-nyong viruses in mosquitoes. American journal of tropical medicine and hygiene 2009 Oct, 81(4): 679-84

Smith LA. Botulism and vaccines for its prevention. Vaccine 2009 Nov 5, 27(Suppl 4): D33-9

Shanks J; Burtnick MN; Brett PJ; Waag DM; Spurgers KB; Ribot WJ; Schell MA; Panchal RG; Gherardini FC; Wilkinson KD; DeShazer D. Burkholderia mallei tssM encodes a putative deubiquitinase that is secreted and expressed inside infected RAW 264.7 murine macrophages. Infection and Immunity 2009 Apr; 77 (4): 1636-1648

Stahl AM, Adler M, Millard CB, Gilfillan L. Accelerating Botulism Therapeutic Product Development in the Department of Defense. Drug Development Research 2009 June; 70(4, Sp. Iss.): 303-326

Swenson DL; Warfield KL; Warren TK; Lovejoy C; Hassinger JN; Ruthel G; Blouch RE; Moulton HM; Weller DD; Iversen PL; Bavari S. Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection. Antimicrobial agents and chemotherapy 2009 May; 53(5): 2089-99

Taylor BJ; Orr SA; Chapman JL; Fisher DE. Beyond-use dating of extemporaneously compounded ketamine, acepromazine, and xylazine: safety, stability, and efficacy over time. Journal of the American Association for Laboratory Animal Science - JAALAS 2009 Nov, 48(6): 718-26

Taylor SL; Krempel RL; Schmaljohn CS. Inhibition of TNF-alpha-induced activation of NF-kappaB by hantavirus nucleocapsid proteins. Annals of the New York Academy of Sciences 2009 Sep, 1171 (Suppl 1): E86-93

Taylor SL, Frias-Staheli N, Garcia-Sastre A, Schmaljohn CS. Hantaan virus nucleocapsid protein binds to importin alpha proteins and inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappa B. Journal of virology 2009 Feb, 83(3): 1271-9

Toth SI; Smith LA; Ahmed SA. Extreme sensitivity of botulinum neurotoxin domains towards mild agitation. Journal of pharmaceutical sciences 2009 Sep, 98(9): 3302-11

Twenhafel NA, Alves DA, Purcell BK. Pathology of Inhalational Francisella tularensis spp tularensis SCHU S4 infection in African Green Monkeys (Chlorocebus aethiops). Veterinary Pathology 2009 July; 46(4): 698-706

Vaughan JA, Focks DA, Turell MJ. Simulation models examining the effect of Brugian filariasis on dengue epidemics. American journal of tropical medicine and hygiene 2009 Jan, 80(1): 44-50

Warfield KL, Bradfute SB, Wells J, Lofts L, Cooper MT, Alves DA, Reed DK, VanTongeren SA, Mech CA, Bavari S. Development and characterization of a mouse model for Marburg hemorrhagic fever. Journal of Virology 2009 July; 83(13): 6404-15

Webb RP; Smith TJ; Wright P; Brown J; Smith LA. Production of catalytically inactive BoNT/A1 holoprotein and comparison with BoNT/A1 subunit vaccines against toxin subtypes A1, A2, and A3. Vaccine 2009 July 16, 27(33): 4490-4497

Ahmed SA, Smith L, Toth S. Issues in therapeutic development against botulinum neurotoxins (BONT). Toxicon 2008 Jun 1, 51(Suppl. 1): 8

Ahmed S, Olson MA, Ludivico ML, Gilsdorf J, Smith LA. Identification of residues surrounding the active site of type A botulinum neurotoxin important for substrate recognition and catalytic activity. Protein journal Apr 2008, 27(3): 151-62

Asher LVSU, Wahl-Jensen V, Zimmerman M, Larsen T, Hooper JW. Ultrastructural Pathology in Syrian Hamsters Experimentally Infected with Andes Hantavirus. Abstracts of the General Meeting of the American Society for Microbiology 2008, 108 p. 667

Blow JA, Mores CN, Dyer J, Dohm DJ. Viral nucleic acid stabilization by RNA extraction reagent. Journal of virological methods Jun 2008, 150(1-2): 41-4

Bozue J, Mou S, Moody K, van de Wetering C, Cote C, Bassett A, Fritz D, Worsham P. Mutation of phoP in the Fully Virulent CO92 Strain of Yersinia pestis Affects Intracellular Survival in Macrophages and Virulence by Subcutaneous Challenge in a Mouse Model of Infection But Not Virulence by Aerosol Exposure. Abstracts of the General Meeting of the American Society for Microbiology 2008, 108 p. 111

Bradfute SB, Warfield KL, Bavari S. Functional CD8+ T Cell Responses in Lethal Ebola Virus Infection. Journal of immunology Mar 15 2008, 180(6): 4058-66

Cote CK, DiMezzo TL, Banks DJ, France B, Bradley KA, Welkos SL. Early interactions between fully virulent Bacillus anthracis and macrophages that influence the balance between spore clearance and development of a lethal infection. Microbes and infection May 2008, 10(6): 613-9

Cote CK, Bozue J, Moody KL, Dimezzo TL, Chapman CE, Welkos SL. Analysis of a novel spore antigen in Bacillus anthracis that contributes to spore opsonization. Microbiology (Reading, England) Feb 2008, 154(Pt 2): 619-32

Dembek ZF. Preparedness for a CBRNE event. Joint Force Quarterly 2008, 51(4): 52-56

Foster CD, Hunter TC, Gibbs PH, Leffel EK. Whole-body plethysmography in African green monkeys (Chlorocebus aethiops) with and without jackets. Journal of the American Association for Laboratory Animal Science-JAALAS Sep 2008, 47(5): 52-5

Fritz EA, Geisbert JB, Geisbert TW, Hensley LE, Reed DS. Cellular immune response to Marburg virus infection in cynomolgus macaques. Viral immunology Sep 2008, 21(3): 355-63

Golden JW, Hooper JW. Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine. Virology Jul 20 2008, 377(1): 19-29

Golden JW, Josleyn MD, Hooper JW. Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies. Vaccine Jun 25 2008, 26(27-28): 3507-15

Groves SS, Turell MJ, Bailey CL, Morozov VN. Rapid active assay for the detection of antibodies to West Nile virus in chickens. American Journal of Tropical Medicine and Hygiene Jan 2008, 78(1): 63-69

Heine H S, Bassett J, Miller L, Bassett A, Ivins B E, Lehoux D, Arhin F F, Parr T R. Moeck G. Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax. Antimicrobial agents and chemotherapy Sep 2008, 52(9): 3350-7

Hewetson JF, Little SF, Ivins BE, Johnson WM, Pittman PR, Brown JE, Norris SL, Nielsen CJ. An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals. Vaccine Aug 5 2008, 26(33): 4262-6

Hooper JW, Ferro AM, Wahl-Jensen V. Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus. Journal of virology Feb 2008, 82(3): 1332-8

Keener WK, Rivera VR, Cho CY, Hale ML, Garber EAE, Poli MA. Identification of the RNA N-glycosidase activity of ricin in castor bean extracts by an electrochemiluminescence-based assay. Analytical Biochemistry Jul 1 2008, 378(1): 87-89

Kortepeter MG, Martin JW, Rusnak JM, Cieslak TJ, Warfield KL, Anderson EL, Ranadive MV. Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit. Emerging infectious diseases Jun 2008, 14(6): 881-7

Krakauer T, Buckley M. The potency of anti-oxidants in attenuating superantigen-induced proinflammatory cytokines correlates with inactivation of NF-kappaB. Immunopharmacology and immunotoxicology 2008, 30(1): 163-79

Kumaran D, Rawat R, Ahmed SA, Swaminathan S. Substrate binding mode and its implications on drug design for botulinum neurotoxin A. PLos Pathog 2008 Sep 26, 4(9): e1000165

Larkin E, Bashirova A, Hale M, Stiles BG, Ulrich RG. Human Monoclonal Antibodies against Staphylococcus aureus Enterotoxins: Potential Therapeutics? Abstracts of the General Meeting of the American Society for Microbiology 2008, 108 p. 44

Lebeda FJ, Adler M, Erickson K, Chushak Y. Onset dynamics of type A botulinum neurotoxin-induced paralysis. Journal of pharmacokinetics and pharmacodynamics Jun 2008, 35(3): 251-67

Leffel EK, Twenhafel NA, Whitehouse CA. Nosocomial infection of Serratia marcescens may induce a protective effect in monkeys exposed to Bacillus anthracis. Journal of infection Aug 2008, 57(2): 162-4

Little SF, Webster WM, Wilhelm H, Powell B, Enama J, Adamovicz JJ. Evaluation of quantitative anti-F1 IgG and anti-V IgG ELISAs for use as an in vitro-based potency assay of plague vaccine in mice. Biologicals Sep 2008, 36(5): 287-95

McCall S, Vilensky JA, Gilman S, Taubenberger JK. The relationship between encephalitis lethargica and influenza: a critical analysis. Journal of neurovirology May 2008, 14(3): 177-85

Mou S, Bozue J, Moody KS, Cote C, Bassett A, Worsham P. Phage-Shock-Protein Response Is Required for Virulence of Yersinia pestis in Bubonic and Pneumonic Murine Plague Models. Abstracts of the General Meeting of the American Society for Microbiology 2008, 108 p. 111-112

Nalca A, Hatkin JM, Garza NL, Nichols DK, Norris SW, Hruby DE, Jordan R. Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model. Antiviral research Aug 2008, 79(2): 121-7

Nuss JE, Choksi KB, DeFord JH, Papaconstantinou J. Decreased enzyme activities of chaperones PDI and BiP in aged mouse livers. Biochemical and biophysical research communications Jan 11 2008, 365 (2): 355-61

O'Guinn ML, Klein TA, Lee JS, Kim HC, Baek LJ, Chong ST, Turell MJ, Burkett DA, Schuster A, Lee IY, Yi SH, Sames WJ, Song KJ, Song JW. Ecological surveillance of small mammals at Firing Points 10 and 60, Gyeonggi Province, Republic of Korea, 2001-2005. Journal of vector ecology Dec 2008, 33(2): 370-84 (19263858)

Page JE, Murphy WJ. Construction of radiation hybrid panels. Methods in molecular biology 2008, 422:51-64

Parthasarathy N, DeShazer D, England M, Waag DM. Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies (vol 56, pg 329, 2006). Diagnostic Microbiology and Infectious Disease Sept 2008, 62(1): 117

Peyser BD, Irizarry R, Spencer FA. Statistical analysis of fitness data determined by TAG hybridization on microarrays. Methods in molecular biology (Clifton, N.J.) 2008, 416:369-81

Raab R, Swietnicki W. Yersinia pestis YopD 150-287 fragment is partially unfolded in the native state. Protein Expression and Purification Mar 2008, 58(1): 53-60

Rawat R, Ashraf Ahmed S, Swaminathan S. High level expression of the light chain of botulinum neurotoxin serotype C1 and an efficient HPLC assay to monitor its proteolytic activity. Protein Expr Purif 2008 Aug, 60(2): 165-69

Rogers J, Schoepp RJ, Schroeder O, Clements TL, Holland TF, Li JQ, Li J, Lewis LM, Dirmeier RP, Frey GJ, Tan X, Wong K, Woodnutt G, Keller M, Reed DS, Kimmel BE, Tozer EC. Rapid discovery and optimization of therapeutic antibodies against emerging infectious diseases. Protein Engineering Design & Selection Aug 2008, 21,(8): 495-505

Rossi CA, Ulrich M, Norris S, Reed DS, Pitt LM, Leffel EK. Identification of a surrogate marker for infection in the African green monkey model of inhalation anthrax. Infection and immunity Dec 2008, 76(12): 5790-801

Rozak D, Rozak A. Simplicity, function, and legibility in an enhanced ambigraphic nucleic acid notation. BioTechniques May 2008, 44(6): 811-3

Saikh KU, Kissner TL, Nystrom S, Ruthel G, Ulrich RG. Interleukin-15 increases vaccine efficacy through a mechanism linked to dendritic cell maturation and enhanced antibody titers. Clinical and Vaccine Immunology Jan 2008, 15(1): 131-137

Selby E, Hartman L, Whitehouse C, Coyne S, Jaissle J, Twenhafel N , Burke R, Kulesh D. Rapid Real-Time PCR for Detection of Klebsiella pneumoniae and the rmpA Gene Target responsible for the Hypermucoviscosity Phenotype: Comparison with Culture for the Screening of African Green monkeys. Abstracts of the General Meeting of the American Society for Microbiology 2008, 108 p, 720

Shipley MA, Minogue TD. Evaluation of the Fujifilm QuickGene-Mini80 for Nucleic Acid Extraction and Subsequent Detection of Select Biothreat Agents. Abstracts of the General Meeting of the American Society for Microbiology 2008, 108 p. 150

Spik KW, Badger C, Mathiessen I, Tjelle T, Hooper JW, Schmaljohn C. Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters. Vaccine Sep 19 2008, 26(40): 5177-81

Spurgers KB, Sharkey CM, Warfield KL, Bavari S. Oligonucleotide antiviral therapeutics: Antisense and RNA interference for highly pathogenic RNA viruses. Antiviral research Apr 2008, 78(1): 26-36

Swenson DL, Wang D, Luo Min, Warfield KL, Woraratanadharm J, Holman DH, Dong JY, Pratt WD. Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections. Clinical and vaccine immunology Mar 2008, 15(3): 460-7

Turell MJ, Dohm DJ, Mores CN, Terracina L, Wallette DL, Hribar LJ, Pecor JE, Blow JA. Potential for North American mosquitoes to transmit Rift Valley fever virus. Journal of the American Mosquito Control Association Dec 2008, 24(4): 502-7

Turell MJ, Linthicum KJ, Patrican LA, Davies FG, Kairo A, Bailey CL. Vector competence of selected African mosquito (Diptera: Culicidae) species for Rift Valley fever virus. Journal of medical entomology Jan 2008, 45(1) 102-8

Turell MJ, O'Guinn ML, Dohm D, Zyzak M, Watts D, Fernandez R, Calampa C, Klein TA, Jones JW. Susceptibility of Peruvian mosquitoes to eastern equine encephalitis virus. Journal of medical entomology Jul 2008, 45(4): 720-5

Turell MJ, Parker MD. Protection of Hamsters by Venezuelan Equine Encephalitis Virus Candidate Vaccine V3526 against Lethal Challenge by Mosquito Bite and Intraperitoneal Injection. American journal of tropical medicine and hygiene Feb 2008, 78(2): 328-32

Turell MJ, Sardelis MR, Jones JW, Watts DM, Fernandez R, Carbajal F, Pecor JE, Klein TA. Seasonal distribution, biology, and human attraction patterns of mosquitoes (Diptera: Culicidae) in a rural village and adjacent forested site near Iquitos, Peru. Journal of medical entomology Nov 2008, 45(6): 1165-72

Turell MJ, Whitehouse CA, Butler A, Baldwin C, Hottel H, Mores CN. Assay for and replication of Karshi (mammalian tick-borne flavivirus group) virus in mice. American journal of tropical medicine and hygiene Feb 2008, 78(2): 344-7

Twenhafel NA, Whitehouse CA, Stevens EL, Hottel HE, Foster CD, Gamble S, Abbott S, Janda JM, Kreiselmeier N, Steele KE. Multisystemic abscesses in African green monkeys (Chlorocebus aethiops) with invasive Klebsiella pneumoniae--identification of the hypermucoviscosity phenotype. Veterinary pathology Mar 2008, 45(2): 226-31

Waag DM, England MJ, Bolt CR, Williams JC. Low-dose priming before vaccination with the phase I chloroform-methanol residue vaccine against Q fever enhances humoral and cellular immune responses to Coxiella burnetii. Clinical and vaccine immunology Oct 2008, 15(10): 1505-12

Welkos S, Norris S, Adamovicz J. Modified caspase-3 assay indicates correlation of caspase-3 activity with immunity of nonhuman primates to Yersinia pestis infection. Clinical and vaccine immunology Jul 2008, 15(7): 1134-7

Worsham PL, Mou S, Cote C, Lockman H, Fritz D. Cytotoxic Necrotizing Factor (CNF) Contributes to Virulence of Yersinia pseudotuberculosis Strain Yp III in a Murine Pneumonia Model. Abstracts of the General Meeting of the American Society for Microbiology 2008, 108 p. 114

Ahmed SA, Smith L, Toth S. Issues in therapeutic development against botulinum neurotoxins (BONT). Toxicon 2008 Jun 1, 51(Suppl. 1): 8

Ahmed S, Olson MA, Ludivico ML, Gilsdorf J, Smith LA. Identification of residues surrounding the active site of type A botulinum neurotoxin important for substrate recognition and catalytic activity. Protein journal Apr 2008, 27(3): 151-62

Asher LVSU, Wahl-Jensen V, Zimmerman M, Larsen T, Hooper JW. Ultrastructural Pathology in Syrian Hamsters Experimentally Infected with Andes Hantavirus. Abstracts of the General Meeting of the American Society for Microbiology 2008, 108 p. 667

Blow JA, Mores CN, Dyer J, Dohm DJ. Viral nucleic acid stabilization by RNA extraction reagent. Journal of virological methods Jun 2008, 150(1-2): 41-4

Bozue J, Mou S, Moody K, van de Wetering C, Cote C, Bassett A, Fritz D, Worsham P. Mutation of phoP in the Fully Virulent CO92 Strain of Yersinia pestis Affects Intracellular Survival in Macrophages and Virulence by Subcutaneous Challenge in a Mouse Model of Infection But Not Virulence by Aerosol Exposure. Abstracts of the General Meeting of the American Society for Microbiology 2008, 108 p. 111

Bradfute SB, Warfield KL, Bavari S. Functional CD8+ T Cell Responses in Lethal Ebola Virus Infection. Journal of immunology Mar 15 2008, 180(6): 4058-66

Cote CK, DiMezzo TL, Banks DJ, France B, Bradley KA, Welkos SL. Early interactions between fully virulent Bacillus anthracis and macrophages that influence the balance between spore clearance and development of a lethal infection. Microbes and infection May 2008, 10(6): 613-9

Cote CK, Bozue J, Moody KL, Dimezzo TL, Chapman CE, Welkos SL. Analysis of a novel spore antigen in Bacillus anthracis that contributes to spore opsonization. Microbiology (Reading, England) Feb 2008, 154(Pt 2): 619-32

Dembek ZF. Preparedness for a CBRNE event. Joint Force Quarterly 2008, 51(4): 52-56

Foster CD, Hunter TC, Gibbs PH, Leffel EK. Whole-body plethysmography in African green monkeys (Chlorocebus aethiops) with and without jackets. Journal of the American Association for Laboratory Animal Science-JAALAS Sep 2008, 47(5): 52-5

Fritz EA, Geisbert JB, Geisbert TW, Hensley LE, Reed DS. Cellular immune response to Marburg virus infection in cynomolgus macaques. Viral immunology Sep 2008, 21(3): 355-63

Golden JW, Hooper JW. Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine. Virology Jul 20 2008, 377(1): 19-29

Golden JW, Josleyn MD, Hooper JW. Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies. Vaccine Jun 25 2008, 26(27-28): 3507-15

Groves SS, Turell MJ, Bailey CL, Morozov VN. Rapid active assay for the detection of antibodies to West Nile virus in chickens. American Journal of Tropical Medicine and Hygiene Jan 2008, 78(1): 63-69

Heine H S, Bassett J, Miller L, Bassett A, Ivins B E, Lehoux D, Arhin F F, Parr T R. Moeck G. Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax. Antimicrobial agents and chemotherapy Sep 2008, 52(9): 3350-7

Hewetson JF, Little SF, Ivins BE, Johnson WM, Pittman PR, Brown JE, Norris SL, Nielsen CJ. An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals. Vaccine Aug 5 2008, 26(33): 4262-6

Hooper JW, Ferro AM, Wahl-Jensen V. Immune serum produced by DNA vaccination protects hamsters against lethal respiratory challenge with Andes virus. Journal of virology Feb 2008, 82(3): 1332-8

Keener WK, Rivera VR, Cho CY, Hale ML, Garber EAE, Poli MA. Identification of the RNA N-glycosidase activity of ricin in castor bean extracts by an electrochemiluminescence-based assay. Analytical Biochemistry Jul 1 2008, 378(1): 87-89

Kortepeter MG, Martin JW, Rusnak JM, Cieslak TJ, Warfield KL, Anderson EL, Ranadive MV. Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit. Emerging infectious diseases Jun 2008, 14(6): 881-7

Krakauer T, Buckley M. The potency of anti-oxidants in attenuating superantigen-induced proinflammatory cytokines correlates with inactivation of NF-kappaB. Immunopharmacology and immunotoxicology 2008, 30(1): 163-79

Kumaran D, Rawat R, Ahmed SA, Swaminathan S. Substrate binding mode and its implications on drug design for botulinum neurotoxin A. PLos Pathog 2008 Sep 26, 4(9): e1000165

Larkin E, Bashirova A, Hale M, Stiles BG, Ulrich RG. Human Monoclonal Antibodies against Staphylococcus aureus Enterotoxins: Potential Therapeutics? Abstracts of the General Meeting of the American Society for Microbiology 2008, 108 p. 44

Lebeda FJ, Adler M, Erickson K, Chushak Y. Onset dynamics of type A botulinum neurotoxin-induced paralysis. Journal of pharmacokinetics and pharmacodynamics Jun 2008, 35(3): 251-67

Leffel EK, Twenhafel NA, Whitehouse CA. Nosocomial infection of Serratia marcescens may induce a protective effect in monkeys exposed to Bacillus anthracis. Journal of infection Aug 2008, 57(2): 162-4

Little SF, Webster WM, Wilhelm H, Powell B, Enama J, Adamovicz JJ. Evaluation of quantitative anti-F1 IgG and anti-V IgG ELISAs for use as an in vitro-based potency assay of plague vaccine in mice. Biologicals Sep 2008, 36(5): 287-95

McCall S, Vilensky JA, Gilman S, Taubenberger JK. The relationship between encephalitis lethargica and influenza: a critical analysis. Journal of neurovirology May 2008, 14(3): 177-85

Mou S, Bozue J, Moody KS, Cote C, Bassett A, Worsham P. Phage-Shock-Protein Response Is Required for Virulence of Yersinia pestis in Bubonic and Pneumonic Murine Plague Models. Abstracts of the General Meeting of the American Society for Microbiology 2008, 108 p. 111-112

Nalca A, Hatkin JM, Garza NL, Nichols DK, Norris SW, Hruby DE, Jordan R. Evaluation of orally delivered ST-246 as postexposure prophylactic and antiviral therapeutic in an aerosolized rabbitpox rabbit model. Antiviral research Aug 2008, 79(2): 121-7

Nuss JE, Choksi KB, DeFord JH, Papaconstantinou J. Decreased enzyme activities of chaperones PDI and BiP in aged mouse livers. Biochemical and biophysical research communications Jan 11 2008, 365 (2): 355-61

O'Guinn ML, Klein TA, Lee JS, Kim HC, Baek LJ, Chong ST, Turell MJ, Burkett DA, Schuster A, Lee IY, Yi SH, Sames WJ, Song KJ, Song JW. Ecological surveillance of small mammals at Firing Points 10 and 60, Gyeonggi Province, Republic of Korea, 2001-2005. Journal of vector ecology Dec 2008, 33(2): 370-84 (19263858)

Page JE, Murphy WJ. Construction of radiation hybrid panels. Methods in molecular biology 2008, 422:51-64

Parthasarathy N, DeShazer D, England M, Waag DM. Polysaccharide microarray technology for the detection of Burkholderia pseudomallei and Burkholderia mallei antibodies (vol 56, pg 329, 2006). Diagnostic Microbiology and Infectious Disease Sept 2008, 62(1): 117

Peyser BD, Irizarry R, Spencer FA. Statistical analysis of fitness data determined by TAG hybridization on microarrays. Methods in molecular biology (Clifton, N.J.) 2008, 416:369-81

Raab R, Swietnicki W. Yersinia pestis YopD 150-287 fragment is partially unfolded in the native state. Protein Expression and Purification Mar 2008, 58(1): 53-60

Rawat R, Ashraf Ahmed S, Swaminathan S. High level expression of the light chain of botulinum neurotoxin serotype C1 and an efficient HPLC assay to monitor its proteolytic activity. Protein Expr Purif 2008 Aug, 60(2): 165-69

Rogers J, Schoepp RJ, Schroeder O, Clements TL, Holland TF, Li JQ, Li J, Lewis LM, Dirmeier RP, Frey GJ, Tan X, Wong K, Woodnutt G, Keller M, Reed DS, Kimmel BE, Tozer EC. Rapid discovery and optimization of therapeutic antibodies against emerging infectious diseases. Protein Engineering Design & Selection Aug 2008, 21,(8): 495-505

Rossi CA, Ulrich M, Norris S, Reed DS, Pitt LM, Leffel EK. Identification of a surrogate marker for infection in the African green monkey model of inhalation anthrax. Infection and immunity Dec 2008, 76(12): 5790-801

Rozak D, Rozak A. Simplicity, function, and legibility in an enhanced ambigraphic nucleic acid notation. BioTechniques May 2008, 44(6): 811-3

Saikh KU, Kissner TL, Nystrom S, Ruthel G, Ulrich RG. Interleukin-15 increases vaccine efficacy through a mechanism linked to dendritic cell maturation and enhanced antibody titers. Clinical and Vaccine Immunology Jan 2008, 15(1): 131-137

Selby E, Hartman L, Whitehouse C, Coyne S, Jaissle J, Twenhafel N , Burke R, Kulesh D. Rapid Real-Time PCR for Detection of Klebsiella pneumoniae and the rmpA Gene Target responsible for the Hypermucoviscosity Phenotype: Comparison with Culture for the Screening of African Green monkeys. Abstracts of the General Meeting of the American Society for Microbiology 2008, 108 p, 720

Shipley MA, Minogue TD. Evaluation of the Fujifilm QuickGene-Mini80 for Nucleic Acid Extraction and Subsequent Detection of Select Biothreat Agents. Abstracts of the General Meeting of the American Society for Microbiology 2008, 108 p. 150

Spik KW, Badger C, Mathiessen I, Tjelle T, Hooper JW, Schmaljohn C. Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters. Vaccine Sep 19 2008, 26(40): 5177-81

Spurgers KB, Sharkey CM, Warfield KL, Bavari S. Oligonucleotide antiviral therapeutics: Antisense and RNA interference for highly pathogenic RNA viruses. Antiviral research Apr 2008, 78(1): 26-36

Swenson DL, Wang D, Luo Min, Warfield KL, Woraratanadharm J, Holman DH, Dong JY, Pratt WD. Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections. Clinical and vaccine immunology Mar 2008, 15(3): 460-7

Turell MJ, Dohm DJ, Mores CN, Terracina L, Wallette DL, Hribar LJ, Pecor JE, Blow JA. Potential for North American mosquitoes to transmit Rift Valley fever virus. Journal of the American Mosquito Control Association Dec 2008, 24(4): 502-7

Turell MJ, Linthicum KJ, Patrican LA, Davies FG, Kairo A, Bailey CL. Vector competence of selected African mosquito (Diptera: Culicidae) species for Rift Valley fever virus. Journal of medical entomology Jan 2008, 45(1) 102-8

Turell MJ, O'Guinn ML, Dohm D, Zyzak M, Watts D, Fernandez R, Calampa C, Klein TA, Jones JW. Susceptibility of Peruvian mosquitoes to eastern equine encephalitis virus. Journal of medical entomology Jul 2008, 45(4): 720-5

Turell MJ, Parker MD. Protection of Hamsters by Venezuelan Equine Encephalitis Virus Candidate Vaccine V3526 against Lethal Challenge by Mosquito Bite and Intraperitoneal Injection. American journal of tropical medicine and hygiene Feb 2008, 78(2): 328-32

Turell MJ, Sardelis MR, Jones JW, Watts DM, Fernandez R, Carbajal F, Pecor JE, Klein TA. Seasonal distribution, biology, and human attraction patterns of mosquitoes (Diptera: Culicidae) in a rural village and adjacent forested site near Iquitos, Peru. Journal of medical entomology Nov 2008, 45(6): 1165-72

Turell MJ, Whitehouse CA, Butler A, Baldwin C, Hottel H, Mores CN. Assay for and replication of Karshi (mammalian tick-borne flavivirus group) virus in mice. American journal of tropical medicine and hygiene Feb 2008, 78(2): 344-7

Twenhafel NA, Whitehouse CA, Stevens EL, Hottel HE, Foster CD, Gamble S, Abbott S, Janda JM, Kreiselmeier N, Steele KE. Multisystemic abscesses in African green monkeys (Chlorocebus aethiops) with invasive Klebsiella pneumoniae--identification of the hypermucoviscosity phenotype. Veterinary pathology Mar 2008, 45(2): 226-31

Waag DM, England MJ, Bolt CR, Williams JC. Low-dose priming before vaccination with the phase I chloroform-methanol residue vaccine against Q fever enhances humoral and cellular immune responses to Coxiella burnetii. Clinical and vaccine immunology Oct 2008, 15(10): 1505-12

Welkos S, Norris S, Adamovicz J. Modified caspase-3 assay indicates correlation of caspase-3 activity with immunity of nonhuman primates to Yersinia pestis infection. Clinical and vaccine immunology Jul 2008, 15(7): 1134-7

Worsham PL, Mou S, Cote C, Lockman H, Fritz D. Cytotoxic Necrotizing Factor (CNF) Contributes to Virulence of Yersinia pseudotuberculosis Strain Yp III in a Murine Pneumonia Model. Abstracts of the General Meeting of the American Society for Microbiology 2008, 108 p. 114

Amemiya K, Meyers JL, Deshazer D, Riggins RN, Halasohoris S, England M, Ribot W, Norris SL, Waag DM. Detection of the host immune response to Burkholderia mallei heat-shock proteins GroEL and DnaK in a glanders patient and infected mice. Diagnostic microbiology and infectious disease Oct 2007, 59 (2): 137-47

Bashaw J, Norris S, Weeks S, Trevino S, Adamovicz JJ, Welkos S. Development of in vitro correlate assays of immunity to infection with Yersinia pestis. Clinical and vaccine immunology-CVI May 2007, 14 (5): 605-16

Bozue J, Moody KL, Cote CK, Stiles BG, Friedlander AM, Welkos SL, Hale ML. Bacillus anthracis spores of the bclA mutant exhibit increased adherence to epithelial cells, fibroblasts, and endothelial cells but not to macrophages. Infection and immunity Sep 2007, 75 (9): 4498-505

Bozue J, Cote CK, Moody KL, Welkos SL.Fully virulent Bacillus anthracis does not require the immunodominant protein BclA for pathogenesis. Infection and immunity Jan 2007, 75 (1): 508-11

Bradfute SB, Braun DR, Shamblin JD, Geisbert JB, Paragas J, Garrison A, Hensley LE, Geisbert TW. Lymphocyte death in a mouse model of Ebola virus infection. Journal of infectious diseases Nov 15 2007, 196 (Suppl 2): S296-304

Carra JH, McHugh CA, Mulligan S, Machiesky LM, Soares AS, Millard CB. Fragment-based identification of determinants of conformational and spectroscopic change at the ricin active site. BMC structural biology 2007, 7: 72

Carra JH, Wannemacher RW, Tammariello RF, Lindsey CY, Dinterman RE, Schokman RD, Smith LA. Improved formulation of a recombinant ricin A-chain vaccine increases its stability and effective antigenicity. Vaccine May 22 2007, 25 (21): 4149-58

Cashman KA, Smith M, Guttieri M, Jones F, Allen R, Dai D, Bolken T, Hruby D, Amberg S. Evaluation of the Antiviral Efficacy of Small Molecule Compound ST-193 in a Guinea Pig Lassa Virus Lethal Challenge Model. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy, 2007, 47 p237

Coster TS, Wolf MK, Hall ER, Cassels FJ, Taylor DN, Liu CT, Trespalacios FC, DeLorimier A, Angleberger DR, McQueen CE. Immune response, ciprofloxacin activity, and gender differences after human experimental challenge by two strains of enterotoxigenic Escherichia coli. Infection and immunity Jan 2007, 75 (1): 252-9

Coyne SR, Ulrich MP. Comparison of the Whatman FTA elute and the modified Qiagen DNA Mini kit for isolating PCR-amplifiable DNA. Abstracts of the 107th General Meeting of the American Society for Microbiology, 2007, p191

Dembek ZF, Kortepeter MG, Pavlin JA.Discernment between deliberate and natural infectious disease outbreaks. Epidemiology and infection Apr 2007, 135 (3): 353-71

Dembek ZF, Smith LA, Rusnak JM. Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities. Disaster Med Public Health Prep Nov 2007, 1 (2):122-34

Dembek, ZF, Anderson EL. Food, Waterborne, and Agricultural Diseases. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Army Medical Center. 2007: 21-38.

Dembek ZF, Pavlin JA, Kortepeter MG. Epidemiology of Biowarfare and Bioterrorism. In: Dembek ZF ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA., Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 39-68

Dembek ZF, Smith LA, Rusnak JM. Botulinum Toxin. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 337-353

Demmin GL. Biosurety. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 543-558

Deshazer D. Virulence of clinical and environmental isolates of Burkholderia oklahomensis and Burkholderia thailandensis in hamsters and mice. FEMS microbiology letters Dec 2007, 277 (1): 64-9

Fair J, Jentes E, Inapogui A, Kourouma K, Goba A, Bah A, Tounkara M, Coulibaly M, Garry RF, Bausch DG. Lassa virus-infected rodents in refugee camps in Guinea: A looming threat to public health in a politically unstable region VECTOR-BORNE AND ZOONOTIC DISEASES. Sum 2007, 7 (2): 167-171

Fritz DL England MJ, Miller L, Waag DM. Murine models of aerosol-acquired tularemia caused by type A and type B Francisella tularensis. Abstracts of the 107th General Meeting of the American Society for Microbiology, 2007, p104

Gamble CS, Jacobsen KO, Leffel EK, Pitt ML. Use of a low-concentration heparin solution to extend the life of central venous catheters in African green monkeys (Chlorocebus aethiops). Journal of the American Association for Laboratory Animal Science May 2007, 46 (3): 58-60

Garrison AR, Alakbarova S, Kulesh DA, Shezmukhamedova D, Khodjaev S, Endy TP, Paragas J. Development of a TaqMan minor groove binding protein assay for the detection and quantification of Crimean-Congo hemorrhagic fever virus. American journal of tropical medicine and hygiene Sep 2007, 77 (3): 514-20

Geisbert TW, Daddario-DiCaprio KM, Geisbert JB, Young HA, Formenty P, Fritz EA, Larsen T, Hensley LE. Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2. Journal of infectious diseases Nov 15 2007, 196 (Suppl 2): S372-81

Gelhaus HC, Rozak DA, Nierman WC, Chen D, Ulrich RL, Adamovicz JJ. Yersinia pestis type III secretion is negatively regulated by N-octanoyl homoserine lactone Abstracts of the 107th General Meeting of the American Society for Microbiology, 2007, p121

Goff A, Twenhafel N, Garrison A, Mucker E, Lawler J, Paragas J. In vivo imaging of cidofovir treatment of cowpox virus infection. Virus Research Sep 2007, 128 (1-2): 88-98

Goodin JL, Nellis DF, Powell BS, Vyas VV, Enama JT, Wang LC, Clark PK, Giardina SL, Adamovicz JJ, Michiel DF.
Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague. Protein expression and purification May 2007, 53 (1): 63-79

Gregory BC, Waag DM. Glanders. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 121-146

Heine HS, Bassett J, Miller L, Hartings JM, Ivins BE, Pitt ML, Fritz D, Norris SL, Byrne WR.
Determination of antibiotic efficacy against Bacillus anthracis in a mouse aerosol challenge model. Antimicrobial agents and chemotherapy Apr 2007, 51 (4): 1373-9

Heine HS, Bassett J, Miller L, Bassett A, Parr T R, Moeck G. Efficacy of oritavancin in a murine model of Bacillus anthracis spore inhalation anthrax. Abstracts of the 107th General Meeting of the American Society for Microbiology, 2007, p23

Heine HS, Louie A, Sorgel F, Bassett J, Miller L, Sullivan LJ, Kinzig-Schippers M, Drusano GL. Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague. Journal of infectious diseases Sep 1 2007, 196 (5): 782-7

Heine HS; Miller L; Bassett J; Halasohoris S; Eiznhamer D A; Xu ZQ; Leski M; Flavin MT. Antimicrobial Activity of Cethromycin, a Novel Ketolide, Tested against a Diverse Collection of Francisella tularensis Strains. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy, 2007, 47 p210

Heine H; Rubino CM; Bassett J; Miller L; Ambrose PG; Bhavnani SM; Forrest A; Drusano GL; Beaudry A; Li J; Janjic N; Gill SC. Pharmacokinetic-Pharmacodynamic (PK-PD) Assessment of Faropenem (FAR) in a Lethal Murine-Bacillus anthracis (BA) Inhalation Post-Exposure Prophylaxis Model. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy, 2007, 47 p34

Henchal EA, Ludwig GV, Whitehouse CA, Scherer JM. Laboratory Identification of Biological Threats. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 391-414

Hensley LE, Stevens EL, Yan SB, Geisbert JB, Macias WL, Larsen T, Daddario-DiCaprio KM, Cassell GH, Jahrling PB, Geisbert TW. Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. Journal of infectious diseases Nov 15 2007, 196 (Suppl 2): S390-9

Hepburn MJ, Friedlander AM, Dembek ZF. Tularemia. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 167-184

Hooper JW, Golden JW, Ferro AM, King AD. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine Feb 26 2007, 25 (10): 1814-23

Huebner KD, Martin JW. Consequence Management: The National and Local Response. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 415-442

Huebner KD, Wannemacher, Jr. RW, Stiles BG, Popoff MR, Poli MA. Additional Toxins of Clinical Concern. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 355-389

Jahrling PB, Geisbert JB, Swearengen JR, Larsen T, Geisbert TW. Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates. Journal of infectious diseases Nov 15 2007, 196 (Suppl 2): S400-3

Jahrling PB, Huggins JW, Ibrahim MS, Lawler JV, Martin JW. Smallpox and Related Orthopoxviruses. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 215-240

Jahrling PB, Marty AM, Geisbert TW. Viral Hemorrhagic Fevers. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 271-310

Kende M, Tan X, Wlazlowski C, Williams R, Lindsey C, Del Giudice G. Enhancement of intranasal vaccination with recombinant chain A ricin vaccine (rRV) in mice by the mucosal adjuvants LTK63 and LTR72. Vaccine Apr 20 2007, 25 (16): 3219-27

Kondig JP, Turell MJ, Lee JS, O'Guinn ML, Wasieloski LP Jr. Genetic analysis of South American eastern equine encephalomyelitis viruses isolated from mosquitoes collected in the Amazon Basin region of Peru. American journal of tropical medicine and hygiene Mar 2007, 76 (3): 408-16

Koterski J, Twenhafel N, Porter A, Reed DS, Martino-Catt S, Sobral B, Crasta O, Downey T, DaSilva L. Gene expression profiling of nonhuman primates exposed to aerosolized Venezuelan equine encephalitis virus. FEMS immunology and medical microbiology Dec 2007, 51 (3): 462-72

Krakauer T, Stephens J, Buckley M, Tate M. Superantigen-induced cytokine release from whole-blood cell culture as a functional measure of drug efficacy after oral dosing in nonhuman primates. Research in veterinary science Oct 2007, 83 (2): 182-7

Krakauer T. Small nonpeptide inhibitors of staphylococcal superantigen-induced cytokine production andToxic shock. In: Kotb M Fraser JD ed. Superantigens: Molecular Basis for Their Role in Human Diseases, Washington, DC: American Society of Microbiology, 2007: 229-244

Larsen T, Stevens EL, Davis KJ, Geisbert JB, Daddario-DiCaprio KM, Jahrling PB, Hensley LE, Geisbert TW. Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus. Journal of infectious diseases Nov 15 2007, 196 (Suppl 2): S323-8

Lindsey CY, Richardson JD, Brown JE, Hale ML. Intralaboratory validation of cell-free translation assay for detecting ricin toxin biological activity. Journal of AOAC International Sep-Oct 2007, 90 (5): 1316-25

Little SF, Ivins BE, Webster WM, Norris SL, Andrews GP. Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine. Vaccine Apr 12 2007, 25 (15): 2771-7

Lofts LL, Ibrahim MS, Negley DL, Hevey MC, Schmaljohn AL. Genomic differences between guinea pig lethal and nonlethal Marburg virus variants Journal of Infectious Diseases Nov 15 2007, 196 (Suppl 2): S305-S312

Martin JW, Christopher GW, Eitzen, Jr. EM. History of Biological Weapons: From Poisoned Darts to Intentional Epidemics. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 1-20

Mores CN, Turell MJ, Dohm DJ, Blow JA, Carranza MT, Quintana M. Experimental transmission of West Nile virus by Culex nigripalpus from Honduras. Vector borne and zoonotic diseases (Larchmont, N.Y.) Summer 2007, 7 (2): 279-84

Nalca A, Whitehouse CA. Crimean-Congo hemorrhagic fever virus infection among animals. In: Ergonul O, Whitehouse CA ed. Crimean-Congo Hemorrhagic Fever: A Global Perspective, Netherlands: Springer, 2007: 155-165

Poli MA, Rivera VR, Neal DD, Baden DG, Messer SA, Plakas SM, Dickey RW, Said KE, Flewelling L, Green D, White J. An electrochemiluminescence-based competitive displacement immunoassay for the type-2 brevetoxins in oyster extracts. Journal of AOAC International Jan-Feb 2007, 90 (1): 173-8

Poli MA, Roy C, Huebner KD, Franz DR, Nancy K, Jaax NK. Ricin. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 323-335

Powell BS, Enama JT, Ribot WJ, Webster W, Little S, Hoover T, Adamovicz JJ, Andrews GP. Multiple asparagine deamidation of Bacillus anthracis protective antigen causes charge isoforms whose complexity correlates with reduced biological activity. Proteins Aug 1 2007, 68 (2): 458-79

Purcell PK, Hoover DL, Friedlander DL. Brucellosis. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 185-198

Purcell BK, Worsham PL, Friedlander AM. Anthrax. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 69-90

Reed DS, Lackemeyer MG, Garza NL, Norris S, Gamble S, Sullivan LJ, Lind CM, Raymond JL. Severe encephalitis in cynomolgus macaques exposed to aerosolized Eastern equine encephalitis virus. Journal of infectious diseases Aug 1 2007, 196 (3): 441-50

Reed DS, Mohamadzadeh M. Status and challenges of filovirus vaccines. Vaccine Mar 1 2007, 25 (11): 1923-34

Rozak DA, Gelhaus H, Nierman WC, Chen D, Ulrich RL, Adamovicz JJ. Francisella tularensis Schu S4 virulence genes are differently regulated by pH and temperature. Abstracts of the 107th General Meeting of the American Society for Microbiology, 2007: p122

Rusnak JM, Boudreau EF, Hepburn MJ, Martin JW, Bavari S. Medical Countermeasures. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 465-513

Schell MA, Ulrich RL, Ribot WJ, Brueggemann EE, Hines HB, Chen D, Lipscomb L, Kim HS, Mrázek J, Nierman WC, Deshazer D. Type VI secretion is a major virulence determinant in Burkholderia mallei Molecular Microbiology Jun 2007, 64 (6): 1466-1485

Shipley M, Jaissle J, Ulrich M. Sonication methods for disrupting Bacillus anthracis sterne and ames spores. Abstracts of the 107th General Meeting of the American Society for Microbiology, 2007, p19

Silvestri LS, Ruthel G, Kallstrom G, Warfield KL, Swenson DL, Nelle T, Iversen PL, Bavari S, Aman MJ. Involvement of vacuolar protein sorting pathway in Ebola virus release independent of TSG101 interaction. Journal of infectious diseases Nov 15 2007, 196 (Suppl 2): S264-70

Smith LA, Rusnak JM. Botulinum neurotoxin vaccines: past, present, and future. Critical reviews in immunology 2007, 27 (4): 303-18

Smith TJ, Hill KK, Foley BT, Detter JC, Munk AC, Bruce DC, Doggett NA, Smith LA, Marks JD, Xie G, Brettin TS. Analysis of the Neurotoxin Complex Genes in Clostridium botulinum A1-A4 and B1 Strains: BoNT/A3, /Ba4 and /B1 Clusters Are Located within Plasmids. PLoS ONE 2007, 2 (12): e1271

Steele KE, Reed DS, Glass PJ, Hart MK, Ludwig GV, Pratt WD, Parker MD, Smith JF. Alphavirus Encephalitides. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 241-270

Stephenson JE, Anderson AO. Ethical and Legal Dilemmas in Biodefense Research. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 559-577

Stevens EL, Twenhafel NA, MacLarty AM, Kreiselmeier N. Corynebacterial necrohemorrhagic cystitis in two female macaques. Journal of the American Association for Laboratory Animal Science-JAALAS Nov 2007, 46 (6): 65-9

Turell MJ, Lee JS, Richardson JH, Sang RC, Kioko EN, Agawo MO, Pecor J, O'Guinn ML. Vector competence of Kenyan Culex zombaensis and Culex quinquefasciatus mosquitoes for Rift Valley fever virus. Journal of the American Mosquito Control Association Dec 2007, 23(4): 378-82

Turell MJ. Role of ticks in the transmission of Crimean-Congo hemorrhagic fever virus. In: Ergonul O, Whitehouse CA ed. Crimean-Congo Hemorrhagic Fever: A Global Perspective, Netherlands: Springer, 2007: 143-154

Twenhafel NA, Leffel E, Pitt ML. Pathology of inhalational anthrax infection in the african green monkey. Veterinary pathology Sep 2007, 44 (5): 716-21

Ulrich RG, Wilhelmsen CL, Krakauer TD. Staphylococcal Enterotoxin B and Related Toxins. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 311-322

Vietri NJ, Deshazer D. Melioidosis. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 147-166

Waag DM Coxiella burnetii: host and bacterial responses to infection. Vaccine Oct 16 2007, 25 (42): 7288-95

Waag DM. Q Fever. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 199-213

Wahl-Jensen V, Chapman J, Asher L, Fisher R, Zimmerman M, Larsen T, Hooper JW. Temporal analysis of Andes virus and Sin Nombre virus infections of Syrian hamsters. Journal of virology Jul 2007, 81 (14): 7449-62

Warfield KL, Swenson DL, Olinger GG, Kalina WV, Aman MJ, Bavari S. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge. Journal of infectious diseases Nov 15 2007, 196 (Suppl 2): S430-7

Warfield KL, Posten NA, Swenson DL, Olinger GG, Esposito D, Gillette WK, Hopkins RF, Costantino J, Panchal RG, Hartley JL, Aman MJ, Bavari S. Filovirus-like particles produced in insect cells: immunogenicity and protection in rodents. Journal of infectious diseases Nov 15 2007, 196 (Suppl 2): S421-9

Warfield KL, Swenson DL, Olinger GG, Kalina WV, Viard M, Aitichou M, Chi X, Ibrahim S, Blumenthal R, Raviv Y, Bavari S, Aman MJ. Ebola virus inactivation with preservation of antigenic and structural integrity by a photoinducible alkylating agent. Journal of infectious diseases Nov 15 2007, 196 (Suppl 2): S276-83

Warfield KL, Alves DA, Bradfute SB, Reed DK, VanTongeren S, Kalina WV, Olinger GG, Bavari S. Development of a model for marburgvirus based on severe-combined immunodeficiency mice. Virology journal 2007; 4: 108

Whitehouse CA. Risk groups and control measures for Crimean-Congo hemorrhagic fever. In: Ergonul O, Whitehouse CA ed. Crimean-Congo Hemorrhagic Fever: A Global Perspective, Netherlands: Springer, 2007: 273-280

Whitehouse CA, Baldwin C, Wasieloski L, Kondig J, Scherer J. Molecular identification of the biowarfare simulant Serratia marcescens from a 50-year-old munition buried at Fort Detrick, Maryland. Military medicine Aug 2007, 172 (8): 860-3

Whitehouse CA, Hottel HE. Comparison of five commercial DNA extraction kits for the recovery of Francisella tularensis DNA from spiked soil samples. Molecular and cellular probes Apr 2007, 21 (2): 92-6

Whitehouse CA, Schmaljohn AL, Dembek ZF. Emerging Infectious Diseases and Future Threats. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 579-607

Wilhelmsen CL, Hawley RJ. Biosafety. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 515-541

Worsham PL, McGovern TW, Vietri NJ, Friedlander AM. Plague. In: Dembek ZF, ed. Medical Aspects of Biological Warfare, rev ed. Falls Church, VA: Office of the Surgeon General United States Army and Washington, DC: Borden Institute, Walter Reed Medical Center. 2007: 91-119

Aldis JW, Kortepeter MG, Rusnak JM. 2006. Reaction after smallpox vaccination. Am Fam Physician 74:145-147.

Amemiya K, Meyers JL, Trevino SR, Chanh TC, Norris SL, Waag DM. 2006. Interleukin-12 induces a Th1-like response to Burkholderia mallei and limited protection in BALB/c mice. Vaccine 24:1413-1420.

Bedwell DW, Wolcott MJ, Newell SW, Carpenter J, Chuvala LJ, Scherer JM. 2006. Identification and differentiating of Francisella tularensis by automated ribotyping. Abstracts of the 106th General Meeting of the American Society for Microbiology, p629.

Bode EA, Chase CJ, Payne RR, Gibson C, Norwood DA, Scherer JM, Geyer JA, Wasieloski LP. 2006. Fragmentation utility of target DNA for microarray hybridization. Abstracts of the 106th General Meeting of the American Society for Microbiology, p630.

Christensen DR, Hartman LJ, Loveless BM, Frye MS, Shipley MA, Bridge DL, Richards MJ, Kaplan RS, Garrison J, Baldwin CD, Kulesh DA, Norwood DA. 2006. Detection of biological threat agents by real-time PCR: comparison of assay performance on the R.A.P.I.D., the LightCycler, and the Smart Cycler platforms. Clin Chem 52:141-145.

Daddario-DeCaprio KM, Geisbert TW, Stroher U, Geisbert JB, Grolla A, Fritz EA, Fernando L, Kagan E, Jahrling PB, Hensley LE, Jones SM, Feldmann H. 2006. Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet 367:1399-1404.

Fuller CL, Brittingham KC, Hepburn MJ, Martin JW, Pettit PL, Pittman PR, Bavari S. 2006. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination. Letter to the editor. J Allergy Clin Immunol 117:1186-1188.

Geisbert TW, Hensley LE, Kagan E, Yu EZ, Geisbert JB, Daddario-Decaprio K, Fritz EA, Jahrling PB, McClintock K, Phelps JW, Lee AC, Judge A, Jeffs LB, Maclachlan I. 2006. Postexposure protection of guinea pigs against a lethal Ebola virus challenge is conferred by RNA interference. J Infect Dis 193:1650-1657.

Gilsdorf J, Gul N, Smith LA. 2006. Expression, purification, and characterization of Clostridium botulinum type B light chain. Protein Expr Purif 46:256-267.

Hepburn MJ, Kortepeter MG, Pittman PR, Boudreau EF, Mangiafico JA, Buck PA, Norris SL, Anderson EL. 2006. Neutralizing antibody response to booster vaccination with the 17d yellow fever vaccine. Vaccine 24:2843-2849.

Hepler RW, Kelly R, McNeely TB, Fan H, Losada MC, George HA, Woods A, Cope LD, Bansal A, Cook JC, Zang G, Cohen SL, Wei X, Keller PM, Leffel E, Joyce JG, Pitt L, Schultz LD, Jansen KU, Kurtz M. 2006. A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection. Vaccine 24:1501-1514.

Hooper JW, Custer DM, Smith J, Wahl-Jensen V. 2006. Hantaan/Andes virus DNA vaccine elicits a broadly cross-reactive neutralizing antibody response in nonhuman primates. Virology 347:208-216.

Jiang G, Joshi B, Peek LJ, Brandau DT, Huang J, Ferriter MS, Woodley WD, Ford BM, Mar KD, Mikszta JA, Huang CR, Ulrich R, Harvey NG, Middaugh CR, Sullivan VJ. 2006. Anthrax vaccine powder formulations for nasal mucosal delivery. J Pharm Sci 95:80-96.

Jones T, Adamovicz JJ, Cyr SL, Bolt CR, Bellerose N, Pitt LM, Lowell GH, Burt DS. 2006. Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection. Vaccine 24:1625-1632.

Kalina WV, Anderson ML, Gershwin LJ. 2006. Alternaria aerosol during a bovine respiratory syncytial virus infection alters the severity of subsequent re-infection and enhances IgE production. Comp Immunol Microbiol Infect Dis 29:138-156.

Kende M, Del Guidice G, Rivera N, Hewetson J. 2006. Enhancement of intranasal vaccination in mice with deglycosylated chain A ricin by LTR72, a novel mucosal adjuvant. Vaccine 24:2213-2221.

Krakauer T, Buckley M. 2006. Dexamethasone attenuates staphylococcal enterotoxin B-induced hypothermic response and protects mice from superantigen-induced toxic shock. Antimicrob Agents Chemother 50:391-395.

Kuhn JH, Radoshitzky SR, Guth AC, Warfield KL, Li W, Vincent MJ, Towner JS, Nichols ST, Bavari S, Choe H, Aman MJ, Farzan M. 2006. Conserved receptor-binding domains of lake Victoria marburgvirus and zaire ebolavirus bind a common receptor. J Biol Chem 281:15951-15958.

Lawler JV, Endy TP, Hensley LE, Garrison A, Fritz EA, Lesar M, Baric RS, Kulesh DA, Norwood DA, Wasieloski LP, Ulrich MP, Slezak TR, Vitalis E, Huggins JW, Jahrling PB, Paragas J. 2006. Cynomolgus macaque as an animal model for severe acute respiratory syndrome. PLoS Med 3:e194.

Lee MS, Olson MA. 2006. Calculation of absolute protein-ligand binding affinity using path and endpoint approaches. Biophys J 90:864-877.

Little SF, Ivins BE, Webster WM, Fellows PF, Pitt MLM, Norris SL, Andrews GP. 2006. Duration of protection of rabbits after vaccination with Bacillus anthracis recombinant protective antigen vaccine. Vaccine 24:2530-2536.

Merino I, Thompson JD, Millard CB, Schmidt JJ, Pang YP. 2006. Bis-imidazoles as molecular probes for peripheral sites of the zinc endopeptidase of botulinum neurotoxin serotype A. Bioorg Med Chem 14:3583-3591.

Meyers JL, Worsham PL, Powell B, Norris SL, Krieg AM, Adamovicz JJ, Amemiya K. 2006. CpG ODNs enhance the efficacy of the Yersinia pestis F1-V vaccine assessed by parenteral and aerosol challenges in a BALB/c murine model for plague. Abstracts of the 106th General Meeting of the American Society for Microbiology, p241.

Mohamadzadeh M, Coberley SS, Olinger GG, Kalina WV, Ruthel G, Fuller CL, Swenson DL, Pratt WD, Kuhns DB, Schmaljohn AL. 2006. Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses. J Virol 80:7235-7244.

Moody KL, Cote CK, Blank TE, Friedlander AM, Bozue JA. 2006. Ccpa of B-anthracis affects catabolite repression, sporulation and germination, but not virulence. Abstracts of the 106th General Meeting of the American Society for Microbiology, p81.

Moody KL, Parthasarathy N, Friedlander AM, Driks A, Bozue JA. 2006. Biochemical analysis of Bacillus anthracis spores from fully virulent Strains. Abstracts of the 106th General Meeting of the American Society for Microbiology, p194.

Mudunuri U, Stephens R, Bruining D, Liu D, Lebeda FJ. 2006. botXminer: mining biomedical literature with a new web-based application. Nucleic Acids Res 34:W748-W752.

Muehlenbein MP, Cogswell FB, James MA, Koterski J, Ludwig GV. 2006. Testosterone correlates with Venezuelan equine encephalitis virus infection in macaques. Virol J 3:19.

Palacios G, Briese T, Kapoor V, Jabado O, Liu Z, Venter M, Zhai J, Renwick N, Grolla A, Geisbert TW, Drosten C, Towner J, Ju J, Paweska J, Nichol ST, Swanepoel R, Feldmann H, Jahrling PB, Lipkin WI. 2006. MassTag polymerase chain reaction for differential diagnosis of viral hemorrhagic fever. Emerg Infect Dis 12:692-695.

Park JG, Sill PC, Makiyi EF, Garcia-Sosa AT, Millard CB, Schmidt JJ, Pang Y-P. 2006. Serotype-selective, small-molecule inhibitors of the zinc endopeptidase of botulinum neurotoxin serotype A. Biorg Med Chem 14:395-408.

Pittman PR, Norris SL, Barrera Oro JG, Bedwell D, Cannon TL, McKee Jr KT. 2006. Patterns of antibody response in humans to the anthrax vaccine adsorbed (AVA) primary (six-dose) series. Vaccine 24:3654-3660.

Powell B. 2006. Analyzing vaccines: vaccines are complicated mixtures that provide analytical challenges. Chem Engin News 84:52-54.

Reed DS, Martinez MJ. 2006. Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague. Vaccine 24:2383-2389.

Ribot WJ, Powell BS, Ivins BE, Little SF, Johnson WM, Hoover TA, Norris SL, Adamovicz JJ, Friedlander AM, Andrews GP. 2006. Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits. Vaccine 24:3469-3476.

Ribot WJ, Ulrich RL. 2006. The animal pathogen-like type III secretion system is required for the intracellular survival of Burkholderia mallei within J774.2 macrophages. Infect Immun 74:4349-4353.

Rivera VR, Gamez FJ, Keener WK, White JA, Poli MA. 2006. Rapid detection of Clostridium botulinum toxins A, B, E, and F in clinical samples, selected food matrices, and buffer using paramagnetic bead-based electrochemiluminescence detection. Anal Biochem 353:248 - 256.

Salierno JD, Snyder NS, Murphy AZ, Poli M, Hall S, Baden D, Kane AS. 2006. Harmful algal bloom toxins alter c-Fos protein expression in the brain of killifish, Fundulus heteroclitus. Aqua Toxicol 78:350-357.

Santi L, Giritch A, Roy CJ, Marillonnet S, Klimyuk V, Gleba Y, Webb R, Arntzen CJ, Mason HS. 2006. Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. Proc Natl Acad Sci USA 103:861-866.

Spik K, Shurtleff A, McElroy AK, Guttieri MC, Hooper JW, Schmaljohn C. 2006. Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus. Vaccine 24:4657-4666.

Sullivan NJ, Geisbert TW, Geisbert JB, Shedlock DJ, Xu L, Lamoreaux L, Jerome H, Custers HV, Popernack PM, Yang Z-Y, Pau MG, Roederer M, Koup RA, Goudsmit J, Jahrling PB, Nabel GJ. 2006. Immune protection of nonhuman primates against Ebola virus with single low-dose adenovirus vectors encoding modified GSs. PLoS Med 3:865 - 873.

Trevino SR, Permenter AR, England MJ, Parsatharathy N, Gibbs PH, Waag DM, Chanh TC. 2006. Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge. Infect Immun 74:1958-1961.

Turell MJ, Dohm DJ, Fernandez R, Calampa C, O'Guinn ML. 2006. Vector competence of Peruvian mosquitoes (Diptera: Culicidae) for a subtype IIIC virus in the Venezuelan equine encephalomyelitis complex isolated from mosquitoes captured in Peru. J Am Mosq Control Assoc 22:70-75.

Turell MJ, Mores CN, Dohm DJ, Komilov N, Paragas J, Lee JS, Shermuhemedova D, Endy TP, Kodirov A, Khodjaev S. 2006. Laboratory transmission of Japanese encephalitis and west Nile viruses by molestus form of Culex pipiens (Diptera: Culicidae) collected in Uzbekistan in 2004. J Med Entomol 43:296-300.

Ulrich MP, Christensen DR, Coyne SR, Craw PD, Henchal EA, Sakai SH, Swenson D, Tholath J, Tsai J, Weir AF, Norwood DA. 2006. Evaluation of the Cepheid GeneXpert® system for detecting Bacillus anthracis. J Appl Microbiol 100:1011-1016.

Ulrich MP, Norwood DA, Christensen DR, Ulrich RL. 2006. Using real-time PCR to specifically detect Burkholderia mallei. J Med Microbiol 55:551-559.

Ulrich RL, Ulrich MP, Schell MA, Kim HS, DeShazer D. 2006. Development of a polymerase chain reaction assay for the specific identification of Burkholderia mallei and differentiation from Burkholderia pseudomallei and other closely related Burkholderiaceae. Diagn Microbiol Infect Dis 55:37-45.

Vietri NJ, Purcell BK, Lawler JV, Leffel EK, Rico P, Gamble CS, Twenhafel NA, Ivins BE, Heine HS, Sheeler R, Wright ME, Friedlander AM. 2006. Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax. Proc Natl Acad Sci USA (epub ahead of print).

Waag DM, McCluskie MJ, Zhang N, Krieg AM. 2006. A CpG oligonucleotide can protect mice from a low aerosol challenge dose of Burkholderia mallei. Infect Immun 74:1944-1448.

Wang D, Raja NU, Trubey CM, Juompan LY, Luo M, Woraratanadharm J, Deitz SB, Yu H, Swain BM, Moore KM, Pratt WD, Hart MK, Dong JY. 2006. Development of a cAdVax-based bivalent ebola virus vaccine that induces immune responses against both the Sudan and Zaire species of Ebola virus. J Virol 80:2738-2746.

Wang D, Schmaljohn AL, Raja NU, Trubey CM, Juompan LY, Luo M, Deist SB, Yu H, Woraratanadharm J, Holman DH, Moore KM, Swain BM, Pratt WD, Dong JY. 2006. De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses. Vaccine 24:2975-2986.

Warfield KL, RG Panchal, MJ Aman, S Bavari. 2006. Antisense treatments for biothreat agents. Curr Opin Mol Ther 8:93-103.

Warfield KL, Swenson DL, Olinger GG, Nichols DK, Pratt WD, Blouch R, Stein DA, Aman MJ, Iverson PL, Bavari S. 2006. Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers. MPLoS Pathog 2:5-9.

Yu Y, Kim HS, Chua HH, Lin CH, Sim SH, Lin D, Derr A, Engels R, DeShazer D, Birren B, Nierman WC, Tan P. 2006. Genomic patterns of pathogen evolution revealed by comparison of Burkholderia pseudomallei, the causative agent of melioidosis, to avirulent Burkholderia thailandensis. BMC Microbiol 6:1-17.

Aitichou M, Saleh SS, McElroy AK, Schmaljohn C, Ibrahim MS. 2005. Identification of Dobrava, Hantaan, Seoul, and Puumala viruses by one-step real-time RT-PCR. J Virol Meth 124:21-26.

Anderson AO, Shaw S. 2005. Conduit for privileged communications in the lymph node. Immunity 22:3-7.

Arndt JW, Gu J, Jaroszewski L, Schwarzenbacher R, Hanson MA, Lebeda FJ, Stevens RC. 2005. The structure of the neurotoxin-associated protein HA33/A from Clostridium botulinum suggests a reoccurring beta-trefoil fold in the progenitor toxin complex. J Mol Biol 346:1083-1093.

Blank TE, Carpenter BM, Chabot DJ, Peterson SN, Friedlander AM. 2005. Deletions in the chromosome of the carbosap vaccine strain of Bacillus Anthracis. Abstracts of the 105th General Meeting of the American Society for Microbiology, p217.

Bozue JA, Parthasarathy N, Phillips LR, Cote CK, Fellows PF, Mendelson I, Shafferman A, Friedlander A. 2005. Construction of a rhamnose mutation in Bacillus anthracis affects adherence to macrophages but not virulence in guinea pigs. Microb Pathogen 38:1-12.

Bray M, Geisbert TW. 2005. Ebola virus: the role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic fever. Int J Biochem Cell Biol 37:1560-1566.

Brittingham KC, Ruthel G, Panchal RG, Fuller CL, Ribot WJ, Hoover TA, Young HA, Anderson AO, Bavari S. 2005. Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis. J Immunol 174:5545-5552.

Burnett JC, Schmidt JJ, McGrath CF, Nguyen TL, Hermone AR, Panchal RG, Vennerstrom JL, Kodukula K, Zaharevitz DW, Gussio R, Bavari S. 2005. Conformational sampling of the botulinum neurotoxin serotype A light chain: implications for inhibitor binding. Bioorg Med Chem 13:333-341.

Christensen DR, Ulrich MP. 2005. Comparison of the QIAGEN BioRobot EZ1 and the roche MagNA pure compact automated extraction instruments. Abstracts of the 105th General Meeting of the American Society for Microbiology, p135.

Coyne SR, Shipley MA, Ulrich MP. 2005. Evaluation of the imigene BPE reagent system for extracting PCR-amplifiable DNA from whole blood samples. Abstracts of the 105th General Meeting of the American Society for Microbiology, p156.

Crosland RD, Fitch RW, Hines HB. 2005. Characterization of beta-leptinotarsin-h and the effects of calcium flux antagonists on its activity. Toxicon 45:829-841.

Elson CO, Dertzbaugh MT. 2005. Mucosal adjuvants, p 967-986. In J Mestecky, ME Lamm, W Strober, J Bienenstock, et al. (ed), Mucosal Immunology, 3rd edition, chapter 54, Academic Press, NY.

Gibson CM, Ulrich MP. 2005. Comparison of sonication methods for cell disruption of Bacillus anthracis Sterne spores. Abstracts of the 105th General Meeting of the American Society for Microbiology, p488.

Glynn A, Roy CJ, Powell BS, Adamovicz JJ, Freytag LC, Clements JD. 2005. Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigens. Infect Immun 73:5256-61.

Goodin JL, Raab RW, McKown RL, Coffman GL, Powell BS, Enama JT, Ligon JA, Andrews GP. 2005. Yersinia pestis outer membrane type III secretion protein YscC: expression, purification, characterization, and induction of specific antiserum. Protein Expr Purif 40:152-163.

Hartman LJ, Coyne SR, Norwood DA. 2005. Development of a novel internal positive control for Taqman�-based assays. Mol Cell Probes 19:51-59.

Hepburn M, Coyne SR, Norwood DA, Ulrich MP. 2005. Rapid diagnostic techniques for detecting Francisella tularensis live vaccine strain from whole blood and swab samples. Abstracts of the 105th General Meeting of the American Society for Microbiology, p136

Kallstrom, G, Warfield KL, Swenson DL, Mort S, Panchal RG, Ruthel G, Bavari S, Aman MJ. 2005. Analysis of Ebola virus and VLP release using an immunocapture assay. J Virol Methods 127:1-9.

Krakauer T, Chen X, Howard OMZ, Young HA. 2005. Triptolide attenuates endotoxin- and staphylococcal exotoxin-induced T-cell proliferation and production of cytokines and chemokines. Immunopharmacol Immunotoxicol 27:53-56.

Lee MS, Salsbury Jr FR, Olson MA. 2005. An efficient hybrid explicit/implicit solvent method for biomolecular simulations. J Comput Chem 25:1967-1978.

Mohamadzadeh M, Olson S, Kalina WV, Ruthel G, Demmin GL, Warfield KL, Bavari S, Klaenhammer TR. 2005. Lactobacilli activate human dendritic cells that skew T cells toward T helper1 polarization. Proc Natl Acad Sci USA 102:2880-2885.

Panchal RG, Halverson K, Ribot W, Lane D, Kenny T, Abshire TG, Ezzell JW, Hoover TA. 2005. Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity. J Biol Chem 280:10834-10839.

Paragas J, Blatt LM, Hartmann C, Huggins JW, Endy TP. 2005. Interferon alfacon 1 is an inhibitor of SARS-corona virus in cell-based models. Antivir Res 66:99-102.

Pittman PR, Leitman SF, Barrera Oro JG, Norris SL, Marano NM, Ranadive M, Sink BS, McKee Jr KT. 2005. Protective antigen (PA) and toxin neutralization (TNA) antibody patterns in anthrax vaccinees undergoing plasmapheresis. Clin Diag Lab Immunol 12:713-722.

Pittman PR, Norris SL, Coonan KM, McKee Jr KT. 2005. An assessment of health status among medical research volunteers who served in Project Whitecoat program at Fort Detrick, Maryland. Mil Med 170:183-187.

Powell BS, Andrews GP, Enama JT, Jendrek S, Bolt C, Worsham P, Pullen JK, Ribot W, Hines H, Smith L, Heath DG, Adamovicz JJ. 2005. Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague. Biotechnol Prog 21:1490-510.

Reed DS, Lind CM, Lackemeyer MG, Sullivan LJ, Pratt WD, Parker MD. 2005. Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus. Vaccine 23:3139-3147.

Roy CJ, Warfield KL, Welcher BC, Gonzales RF, Larsen T, Hanson J, David CS, Krakauer T, Bavari S. 2005. Human leukocyte antigen-DQ8 transgenic mice: a murine model to examine the toxicity of aerosolized staphylococcal enterotoxin B. Infect Immun 73:2452-2460.

Ruthel G, Demmin GL, Kallstrom G, Javid MP, Badie SS, Will AB, Nelle T, Schokman R, Nguyen TL, Carra JH, Bavari S, Aman MJ. 2005. Association of Ebola virus matrix protein VP40 with microtubules. J Virol 79:4709-4719.

Schmidt JJ, Stafford RG. 2005. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity. Biochemistry 44:4067-4073.

Shipley MA, Coyne SR, Craw PD, Ulrich MP. 2005. Evaluation of the DNA/RNA protect (TM) additive for nucleic acid preservation in diagnostic samples. Abstracts of the 105TH General Meeting of the American Society for Microbiology, p135.

Swenson DL, Warfield KL, Negley DL, Schmaljohn A, Aman MJ, Bavari S. 2005. Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections. Vaccine 23:3033-3042.

Swietnicki W, Powell BS, Goodin J. 2005. Yersinia pestis Yop secretion protein F: purification, characterization, and protective efficacy against bubonic plague. Protein Expr Purif 42:166-72.

Turell MJ, Dohm DJ, Sardelis MR, O'Guinn ML, Andreadis TG, Blow JA. 2005. An update on the potential of North American mosquitoes (Diptera: Culicidae) to transmit West Nile virus. J Entomol 42:57-62.

Ulrich RL, Amemiya K, Waag DM, Roy CJ, DeShazer D. 2005. Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice. Vaccine 23:1986-1992.

Vogel P, Kell WM, Fritz DL, Parker MD, Schoepp RJ. 2005. Early events in the pathogenesis of eastern equine encephalitis virus in mice. Am J Pathol 37:159-171.

Carr K, HenchalEA , Wilhelmsen C, Carr B. 2004. Implementation of biosurety systems in a department of defense medical research laboratory. Biosecur Bioterror 2:1-16.

Hale ML, Marvaud J-C, Popoff MR, Stiles BG. 2004. Detergent-resistant membrane microdomains facilitate Ib oligomerization formation and biological activity of Clostridium perfringens iota toxin. Infect Immun 72: 2186-2193.

Hartings JM, Roy CJ. 2004. The automated bioaerosol exposure system: preclinical platform development and a dosimetry application with nonhuman primates. J Pharmacol Toxicol Methods 49:39-55.

Hensley LE, Fritz EA, Jahrling PB, Geisbert TW. 2004. Interferon-beta 1a and SARS coronavirus replication. Emerg Infect Dis 10:317-319.

Hering D, Thompson W, Hewetson J, Little S, Norris S, Pace-Templeton J. 2004. Validation of the anthrax lethal toxin neutralization assay. Biologicals 32:17-27.

Hevey M, Negley D, Schmaljohn A. 2004. Characterization of monoclonal antibodies to Marburg virus (strain Musoke) glycoprotein and identification of two protective epitopes. Virology 314:350-357.

Hooper JW, Thompson E, Wilhelmsen C, Zimmerman M, Ait-Ichou M, Steffan S, Schmaljohn CS, Schmaljohn AL, Jahrling PB. 2004. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J Virol 78:4433-4443.

Hurtle W, Bode E, Kulesh DA, Kaplan RS, Garrison J, Bridge D, House M, Frye MS, Loveless B, Norwood D. 2004. Detection of the Bacillus anthracis gyrA gene by using a minor groove binder probe. J Clin Microbiol 42:179-185.

Lebeda FJ. 2004. BOTDB: a database resource for the clostridial neurotoxins. Mov Disord 19:S35-S41.

Jarrett CO, Sebbane F, Adamovicz JJ, Andrews GP, Hinnebusch BJ. 2004. A flea-borne transmission model to evaluate vaccine efficacy against naturally acquired bubonic plague. Infect Immun 72:2052-2056.

Kulesh DA, Baker RO, Loveless B, Norwood D, Zwiers SH, Mucker E, Hartmann C, Herrera R, Miller D, Christensen D, Wasieloski Jr LP, Huggins J, Jahrling PB. 2004. Smallpox and pan-orthopox virus detection by real-time 3'-minor groove binder TaqMan assays on the roche LightCycler and the Cepheid smart Cycler platforms. J Clin Microbiol 42:601-609.

Little SF, Ivins BE, Fellows PF, Pitt MLM, Norris SLW, Andrews GP. 2004. Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine. Vaccine 22:422-430.

Matyas GR, Rao M, Pittman PR, Burge R, Robbins IE, Wassef NM, Thiverge B, Alving CR. 2004. Detection of antibodies to squalene III. Naturally occurring antibodies to squalene in humans and mice. J Immunol Methods 286:47-67.

O’Guinn ML, Lee JS, Kondig JP, Fernandez R, Carbajal F. 2004. Field detection of eastern equine encephalitis virus in the Amazon Basin region of Peru using reverse transcription-polymerase chain reaction adapted for field identification of arthropod-borne pathogens. Am J Trop Med Hyg 70:164-171.

Panchal RG, Hermone AR, Nguyen TL, Wong TY, Schwarzenbacher R, Schmidt J, Lane D, McGrath C, Turk BE, Burnett J, Aman MJ, Little S, Sausaville EA, Zaharevitz DW, Cantley LC, Liddington RC, Gussio R, Bavari S. 2004. Identification of small molecule inhibitors of anthrax lethal toxin. Nat Struct Mol Biol 11:67-72.

Panchal RG, Ruthel G, Kenny TA, Kallstrom GH, Lane D, Badie SS, Li L, Bavari S, Aman MJ. 2004. In vivo oligomerization and raft localization of Ebola VP40 during vesicular budding. Proc Natl Acad Sci 100:15936-15941.

Reed DS, Lind CM, Sullivan LJ, Pratt WD, Parker MD. 2004. Aerosol infection of cynomolgus macaques with enzootic strains of Venezuelan equine encephalitis viruses. J Infect Dis 189:1013-1017.

Rusnak J, Boudreau E, Bozue J, Pettit P, Ranadive M, Kortepeter M. 2004. An unusual inhalational exposure to Bacillus anthracis in a research laboratory. Letter to the editor, J Occup Environ Med 46:313-314.

Ruthel G, Ribot WJ, Bavari S, Hoover TA. 2004. Time-lapse confocal imaging of development of Bacillus anthracis in macrophages. J Infect Dis 189:1313-1316.

Smith LA, Jensen MJ, Montgomery VA, Brown DR, Ahmed SA, Smith TJ. 2004. Roads from vaccines to therapies. Mov Disord 19:S48-S52.

Swenson DL, Warfield KL, Kuehl K, Larsen T, Hevey MC, Schmaljohn A, Bavari S, Aman MJ. 2004. Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein. FEMS Immunol Med Microbiol 40:27-31.

Ulrich RL, DeShazer D. 2004. Type III secretion: a virulence factor delivery system essential for the pathogenicity of Burkholderia mallei. Infect Immun 72:1150-1154.

Welkos SL, Cote CK, Rea KM, Gibbs PH. 2004. A microtiter fluorometric assay to detect the germination of Bacillus anthracis spores and the germination inhibitory effects of antibodies. J Microbiol Meth 56;253-265.

Ahmed SA, McPhie P, Smith LA. 2003. Autocatalytically fragmented light chain of botulinum A neurotoxins is enzymatically active. Biochemistry 42:12539-12549.

Aman MJ, Bosio CM, Burnett JC, Schmaljohn A, Bavari S. 2003. Molecular mechanisms of filovirus cellular trafficking. Microbes Infect 5:639-649.

Boles JW, Pitt ML, LeClaire RD, Gibbs PH, Torres E, Dyas B, Ulrich RG, Bavari S. 2003. Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity. Clin Immunol 108:51-59.

Boles JW, Pitt MLM, LeClaire RD, Gibbs PH, Ulrich RG, Bavari S. 2003. Correlation of body temperature with protection against staphylococcal enterotoxin B exposure and use in determining vaccine dose-schedule. Vaccine 11:2791-2796.

Bosio CM, Aman MJ, Grogan C, Hogan R, Ruthel G, Negley D, Mohamazadeh M, Bavari S, Schmaljohn A. 2003. Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. J Infect Dis 188:1630-1638.

Burnett JC, Schmidt JJ, Stafford RG, Panchal RG, Nguyen TL, Hermone AR, Vennerstrom JL, McGrath CH, Lane DL, Sausville EA, Zaharevitz DW, Gussio R, Bavari S. 2003. Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity. Biochem Biophys Res Commun 310:84-93.

Carra JH, Welcher BC, Schokman RD, David CS, Bavari S. 2003. Mutational effects on protein folding stability and antigenicity: The case of streptococcal pyrogenic exotoxin A. Clin Immunol 108:60-68.

Cieslak TJ, Henretig FM. 2003. Bioterrorism. Pediatrics Ann 32:154-165.

Cuff L, Ulrich RG, Olson MA. 2003. Prediction of the multimeric assembly of staphylococcal enterotoxin A with cell-surface protein receptors. J Molec Graph Model 21:473-486.

Custer DM, Thompson E, Schmaljohn CS, Ksiazek TG, Hooper JW. 2003. Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine. J Virol 77:9894-9905.

DaSilva L, Cote D, Roy C, Martinez M, Duniho S, Pitt ML, Downey T, Dertzbaugh M. 2003. Pulmonary gene expression profiling of inhaled ricin. Toxicon 41:813-822.

Dekonenko A, Yakimenko V, Ivanov A, Morozov V, Nikitin P, Khasanova S, Dzagurova T, Tkachenko E, Schmaljohn CS. 2003. Genetic similarity of Puumala viruses found in Finland and western Siberia and of the mitochondrial DNA of their rodent hosts suggests a common evolutionary origin. Infect Gen Evol 3:245-257.

Geisbert TW, Hensley LE, Larsen T, Young HA, Reed DS, Geisbert JB, Scott DP, Kagan E, Jahrling PB, Davis KJ. 2003. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: Evidence that dendritic cells are early and sustained targets of infection. Am J Pathol 163:2347-2370.

Geisbert TW, Jahrling PB. 2003. Towards a vaccine against Ebola virus. Exp Rev Vaccines 2:777-789.

Geisbert TW, AM Marty, Jahrling PB. 2003. Viral hemorrhagic fevers, pp 221-242, In MJ Roy (ed), Physician’s Guide to Terrorist Attack, Chapter 16, Human Press, Totowa NJ.

Geisbert TW, Young HA, Jahrling PB, Davis KJ, Kagan E, Hensley LE. 2003. Mechanisms underlying coagulation abnormalities in Ebola hemorrhagic fever: Overexpression of tissue factor in primate monocytes/macrophages is a key event. J Infect Dis 188:1618-1629.

Geisbert TW, Young HA, Jahrling PB, Davis KJ, Larsen T, Kagan E, Hensley L. 2003. Pathogenesis of Ebola hemorrhagic fever in primate models: Evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells. Am J Pathol 163:2371-2382.

Guttieri MC, Liang M. 2003. Human antibody production using insect-cell expression systems, pp 269-299. In BKC Lo (ed), Methods in Molecular Biology, vol 248, Antibody Engineering: Methods and Protocols, Humana Press, Totowa NJ.

Guttieri MC, Sinha T, Bookwalter C, Liang M, Schmaljohn CS. 2003. Cassette vectors for conversion of Fab fragments into full-length human IgG1 monoclonal antibodies by expression in stably transformed insect cells. Hybridoma Hybridomics 22:135-145.

Hart MK. 2003. Vaccine research efforts for filoviruses. Int J Parasitol 33:583-595.

Hooper JW, Custer DM, Thompson E. 2003. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates. Virology 306:181-195.

Hurtle W, Bode E, Kaplan RS, Garrison J, Kearney B, Shoemaker D, Henchal E, Norwood D. 2003. Use of denaturing high-performance liquid chromatography to identify Bacillus anthracis by analysis of the 16S - 23S rRNA interspacer region and gyrA gene. J Clin Microbiol 41:4758-4766.

Hurtle W, Lindler L, Fan W, Shoemaker D, Henchal E, Norwood D. 2003. Detection and identification of ciprofloxacin-resistant Yersinia pestis by denaturing high-performance liquid chromatography. J Clin Microbiol 41:3273-3283.

Ibrahim MS, Kulesh DA, Saleh SS, Damon IK, Esposito JJ, Schmaljohn A, Jahrling PB. 2003. Real-time PCR assay to detect smallpox virus. J Clin Microbiol 41:3835-3839.

Jarrett CD. 2003. Lessons learned: The “pale horse” bioterrorism response exercise. Disaster Management Response 1:114-118

Jeddeloh JA, Fritz DL, Waag DM, Hartings JM, Andrews GP. 2003. Biodefense-driven murine model of pneumonic melioidosis. Infect Immun 71:584-587.

Jendrek S, Little SF, Hem S, Mitra G, Giardina S. 2003. Evaluation of the compatibility of a 2nd generation recombinant anthrax vaccine with aluminum-containing adjuvants. Vaccine 21:3011-3008.

Jensen MJ, Smith TJ, Ahmed SA, Smith LA. 2003. Expression, purification, and efficacy of the type A botulinum neurotoxin catalytic domain fused to two translocation domain variants. Toxicon 41:691-701.

Krakauer T. 2003. Measurement of proinflammatory cytokines and T-cell proliferative response in superantigen-activated human peripheral blood mononuclear cells. Methods Mol Biol 314:137-149.

Krakauer T, Buckley M. 2003. Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced inflammatory cytokines and chemokines. Antimicrob Agents Chemother 47:3630-3633.

Krakauer T, Chen X, Howard OM, Young HA. 2003. RNAse protection assay for the study of the differential effects of therapeutic agents in suppressing staphylococcal enterotoxin B-induced cytokines in human peripheral blood mononuclear cells. Methods Mol Bio 314:151-164.

Krakauer T, Stiles BG. 2003. Staphylococcal enterotoxins, toxic shock syndrome toxin-1, and streptococcal pyrogenic exotoxins: Some basic biology of bacterial superantigens. Recent Devel Infect Dis 1:1-27.

Lee JS, AG Hadjipanayis, SL Welkos. 2003. Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge. Infect Immun 71:1491-1496.

Marklund LA. 2003. Patient care in a biological safety level-4 (BSL-4) environment. Critical Care Nursing, Clinics of North America 15:245-255.

Markotic A, Hensley L, Geisbert T, Spik K, Schmaljohn C. 2003. Hantaviruses induce cytopathic effects and apoptosis in continuous human embryonic kidney cells. J Gen Virol 84:2197-2202.

Mellquist-Riemenschneider JL, Garrison AR, Geisbert JB, Heidebrink KD, Jahrling PB, Schmaljohn CS. 2003. Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for Ebola virus in guinea pigs. Virus Res 92:187-193.

Morrill JC, Peters CJ. 2003. Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys. Vaccine 21:21-23.

Nalca A, Fellows PF, Whitehouse CA. 2003. Vaccines and animal models for arboviral encephalitides. Antivir Res 60:153-174.

Nelson EL, Prieto D, Alexander TG, Pushko P, Lofts LA, Rayner JO, Kamrud KI, Fralish B, Smith JF. 2003. Venezuelan equine encephalitis replicon immunization overcomes intrinsic tolerance and elicits effective anti-tumor immunity to the 'self' tumor-associated antigen, neu in a rat mammary tumor model. Breast Canc Res Treat 82:169-183.

Poli MA. 2003. Foodborne marine biotoxins, pp 445-448. In MD Miliotis and JW Bier (ed) International Handbook on Foodborne Toxins, Marcel Dekker, Inc.

Pratt WD, Davis NL, Johnston RE, Smith JF. 2003. Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: Testing in animal models. Vaccine 21:3854-3862.

Read TD, Peterson SN, Tourasse N, Baillie LW, Paulsen IT, Nelson KE, Tettelin H, Fouts DE, Eisen JA, Gill SR, Holtzapple EK, Okstad OA, Helgason E, Rilstone J, Wu M, Kolonay JF, Beanan MJ, Dodson RJ, Brinkac LM, Gwinn M, DeBoy RT, Madpu R, Daugherty SC, Durkin AS, Haft DH, Nelson WC, Peterson JD, Pop M, Khouri HM, Radune D, Benton JL, Mahamoud Y, Jiang L, Hance IR, Weidman JF, Berry KJ, Plaut RD, Wolf AM, Watkins KL, Nierman WC, Hazen A, Cline R, Redmond C, Thwaite JE, White O, Salzberg SL, Thomason B, Friedlander AM, Koehler TM, Hanna PC, Kolsto AB, Fraser CM. 2003. The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature 423:81-86.

Riemenschneider J, Garrison A, Geisbert J, Jahrling P, Hevey M, Negley D, Schmaljohn A, Lee J, Hart MK, Vanderzanden L, Custer D, Bray M, Ruff A, Ivins B, Bassett A, Rossi C, Schmaljohn C. 2003. Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus. Vaccine 21:4071-4080.

Rivera VR, Merrill GA, White JA, Poli MA. 2003. An enzymatic electrochemiluminescence assay for the lethal factor of anthrax. Anal Biochem 321:125-130.

Roy CJ, Baker R, Washburn K, Bray M. 2003. Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challenge. Antimicrob Agents Chemother 47:2933-2937.

Roy CJ, Hale M, Hartings J, Duniho S, Pitt L. 2003. Impact of inhalation exposure modality and particle size on the respiratory deposition of ricin in BALB/c mice. Inhal Toxicol 15:619-638.

Roy CJ, Thorne PS. 2003. Exposure to particulates, microorganisms, b-(1-3)-glucans, and endotoxins during soybean harvesting. AIHA J 64:487-495.

Saikh KU, Dyas B, Kissner T, Ulrich RG. 2003. CD56+-T-cell responses to bacterial superantigens and immune recognition of attenuated vaccine. Clin Diag Lab Immunol 10:1065-1073.

Saikh KU, Lee JS, Kissner TL, Dyas B, Ulrich RG. 2003. Toll-like receptor and cytokine expression patterns of CD56+ T cells are similar to natural killer cells in response to infection with Venezuelan equine encephalitis virus replicons. J Infect Dis 188:1562-1570.

Sardelis MR, Turell MJ, Andre RG. 2003. Experimental transmission of St. Louis encephalitis virus by Ochlerotatus j japonicus. J Am Mosq Contr Asso 19:159-162.

Schmidt JJ, Stafford RG. 2003. Fluorigenic substrates for the protease activities of botulinum neurotoxins, serotypes A, B, and F. Appl Environ Microbiol 69:297-303.

Swietnicki W, Barnie AM, Dyas BK, Ulrich RG. 2003. Zinc binding and dimerization of Streptococcus pyogenes pyrogenic exotoxin C are not essential for T-cell stimulation. J Biol Chem 14:9885-9895.

Turell MJ, Bunning M, Ludwig GV, Ortman B, Chang J, Speaker T, Spielman A, McLean R, Komar N, Gates R, McNamara T, Creekmore T, Farley L, Mitchell CJ. 2003. DNA vaccine for West Nile virus infection in fish crows (Corvus ossifragus). Emerg Infect Dis 9:1077-1081.

Turell MJ, O'Guinn ML, Navarro R, Estrada-Franco JG. 2003. Vector competence of Mexican and Honduran mosquitoes (Diptera:Culicidae) for enzootic (IE) and epizootic (IC) strains of Venezuelan equine encephalomyelitis virus. J Med Entomol 40:306-310.

Turell MJ, O'Guinn ML, Parker MD. 2003. Limited potential for mosquito transmission of genetically engineered, live-attenuated western equine encephalitis virus vaccine candidates. Am J Trop Med Hyg 68:218-221.

Turell MJ, O'Guinn ML, Wasieloski Jr LP, Lee, H-W Cho, Kim H-C, Burkett DA, Mores CN, Coleman RE, Klein TA. 2003. Isolation of Japanese encephalitis W-Jand Getah viruses from mosquitoes (Diptera: Culicidae) collected near Camp Greaves, Gyonggi Province, Republic of Korea, 2000. J Med Entomol 40:580-584.

Vogel P, Fritz DL. 2003. Cardiomyopathy associated with angiomatous pheochromocytoma in a rhesus macaque (Macaca mulatta). Vet Pathol 40:468-473.

Warfield KL, Bosio CM, Welcher BC, Deal EM, Mohamadzadeh M, Schmaljohn A, Aman MJ, Bavari S. 2003. Ebola virus-like particles protect from lethal Ebola infection. Proc Natl Acad Sci 10:1073.

Wasserman GM, Grabenstein JD, Pittman PR, Rubertone MV, Gibbs PP, Wang LX, Golder LGB. 2003. Analysis of adverse events after anthrax immunization in U.S. medical personnel. J Occup Environ Med 45:222-233.

Amemiya K, Bush GV, DeShazer D, Waag DM. 2002. Nonviable Burkholderia mallei induces a mixed Th1- and Th2-like cytokine response in BALB/c mice. Infect Immun 70:2319-2325.

Bavari S, Bosio CM, Wiegand E, Ruthel G, Will AB, Geisbert TW, Hevey M, Schmaljohn C, Schmaljohn A, Aman MJ. 2002. Lipid raft microdomains: A gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med 195:593-602.

Blow JA, Turell MJ, Walker ED, Silverman AL. 2002. Post-bloodmeal diuretic shedding of hepatitis B virus by mosquitoes (Diptera:Culicidae). J Med Entomol 39:605-612.

Bray M, M Martinez, D Kefauver, M West, C Roy. 2002. Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir. Anim Res 54:129-142.

Bray M, Paragas J. 2002. Experimental therapy of filovirus infections. Antivir Res 54:1-17.

Bray M, Raymond JL, Geisbert T, Baker RO. 2002. 3-deazaneplanocin A induces massively increased interferon–A production in Ebola virus-infected mice. Antiviral Res 55:151-159.

DaSilva L, Welcher BC, Ulrich RG, Aman MJ, David CS, Bavari S. 2002. Humanlike immune response of human leukocyte antigen – DR3 transgenic mice to staphylococcal enterotoxins: A novel model for superantigen vaccines. J Infect Dis 185:1754-1760.

Dohm DJ, O'Guinn ML, Turell MJ. 2002. Effect of environmental temperature on the ability of Culex pipiens (Diptera:Culicidae) to transmit West Nile virus. J Med Entomol 39:221-225.

Dohm DJ, Sardelis MR, Turell MJ. 2002. Experimental vertical transmission of West Nile virus by Culex pipiens (Diptera: Culicidae). J Med Entomol 39:640-644.

Fellows PF, MK Linscott, JS Little, P Gibbs, BE Ivins. 2002. Anthrax vaccine efficacy in golden Syrian hamsters. Vaccine 20:1421-1424.

Friedlander AM, Welkos SL, Ivins BE. 2002. Anthrax vaccines, pp 32-60. In Koehler TM (ed.) Current Topics in Microbiology and Immunology, Vol 271, Anthrax. Springer-Verlag, Berlin, Germany.

Fritz DL, Dubey JP. 2002. Pathology of Sarcocystis neurona in interferon gamma knockout mice. Vet Pathol 39:137-140.

Geisbert TW, Hensley LE, Geisbert JB, Jahrling PB. 2002. Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections. Virology 293:15-19.

Geisbert TW, Pushko P, Anderson K, Smith J, Davis KJ, Jahrling PB. 2002. Evaluation in nonhuman primates of vaccine against Ebola virus. Emerg Infect Dis 8:503-507.

Gibb TR, Norwood DA, Woolen N, Henchal EA. 2002. Viral replication and host gene expression in alveolar macrophages infected with Ebola virus (Zaire strain). Clin Diag Lab Immunol 9:19-27.

Hale ML, Margolin SB, Krakauer T, Roy CJ, Stiles BG. 2002. Pirfenidone blocks the in vitro and in vivo effects of staphylococcal enterotoxin B. Infect Immun 70:2989-2994.

Hart MK, Del Giudice RA, Korch Jr GW. 2002. Absence of mycoplasma contamination in the anthrax vaccine. Emerg Infect Dis 8:94-95.

Hart MK, Lind C, Bakken R, Robertson M, Tammariello RF, Ludwig GV. 2002. Onset and duration of protective immunity to IA/B and IE strains of Venezuelan equine encephalitis virus in vaccinated mice. Vaccine 20:616-622.

Hensley LE, Young HA, Jahrling P, Geisbert TW. 2002. Proinflammatory response during Ebola virus infection of primate models: Possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett 80:169-179.

Holt RK, Walker BK, Ruff AL. 2002. Horizontal transmission of recombinant vaccinia virus in strain 13 guinea pigs. Contemp Topics Lab Anim Sci 41:57-60.

Hoover TA, Culp DW, Vodkin MH, Wiliams JC, Thompson HA. 2002. Chromosomal DNA deletions explain phenotypic characteristics of two antigenic variants, phase II and RSA 514 (crazy), of the Coxiella burnetii nine mile strain. Infect Immun 70:6726-6733.

Hurtle W, Shoemaker D, Henchal E, Norwood D. 2002. Denaturing HPLC for identifying bacteria. Biotechniques 33:1-5.

Kanesa-Thasan N, Putnak JR, Mangiafico JA, Saluzzo JE, Ludwig GV. 2002. Short report: Absence of protective neutralizing antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines. Am J Trop Med Hyg 66:113-114.

Kende M, Yan C, Hewetson J, Frick MA, Rill WL, Tammariello R. 2002. Oral immunization of mice with ricin toxoid vaccine encapsulated in polymeric microspheres against aerosol challenge. Vaccine 20:1681-1691.

Krakauer T. 2002. Stimulant-dependent modulation of cytokines and chemokines by airway epithelial cells: Cross talk between pulmonary epithelial and peripheral blood mononuclear cells. Clin Diag Lab Immunol 9:126-131.

LeClaire RD, Hunt RE, Bavari S. 2002. Protection against bacterial superantigen staphylococcal enterotoxin B by passive vaccination. Infect Immun 70:2278-2281.

Lee JS, DyasBK , Nystrom SS, Lind CM, Smith JF, Ulrich RG. 2002. Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon. J Infect Dis 185:1192-1196.

Lindsey CY, LA Smith, MW West, JW Boles, JE Brown. 2002. Evaluation of a botulinum fragment C-based ELISA for measuring the humoral immune response in primates. Biologicals 31:17-24.

Lòpez KR, Gibbs PH, Reed DS. 2002. A comparison of body temperature changes due to the administration of ketamine-acepromazine and tiletamine-zolazepam anesthetics in cynomolgus macaques. Comtemp Topics 41:47-50.

Ludwig GV, Calle PP, Mangiafico JA, Raphael BL, Danner DK, Hile JA, Clippinger TL, Smith JF, Cook RA, McNamara T. 2002. An outbreak of West Nile virus in a New York City captive wildlife population. Am J Trop Med Hyg 67:67-75.

Mangiafico JA, CA Rossi, GV Ludwig. 2002. Short report: Isolation and identification of Venezuelan equine encephalitis virus from a human in Panama. Am J Trop Med Hyg 67:112-113.

Marklund LA. 2002. Transporting patients with lethal contagious infections. Int J Trauma Nurs 8:51-53.

McElroy AK, Bray M, Reed DS, Schmaljohn CS. 2002. Andes virus infection of cynomolgus macaques. J Infect Dis 186:1706-1712.

Meissner F, Maruyama T, Frentsch M, Hessell AJ, Rodrigues LL, Geisbert TW, Jahrling PB, Burton DR, Parren PW. 2002. Detection of antibodies against the four serotypes of Ebola virus in sera from any species using a novel antibody-phage indicator assay. Virology 300:236-243.

Noah DL, Crowder HR. 2002. Biological terrorism against animals and humans: A brief review and primer for action. J Am Vet Med Asso 221:40-43.

O'Guinn ML, Turell MJ. 2002. Effect of triethylamine on the recovery of selected South American alphaviruses, flaviviruses, and bunyaviruses from mosquito (Diptera:Culicidae) pools. J Med Entomol 39:806-808.

Olson MA, Armendinger TL. 2002. Free-energy contributions to complex formation between botulinum neurotoxin type B and synaptobrevin fragment. Prot Eng 15:739-743.

Parren PW, Geisbert TW, Maruyama T, Jahrling PB, Burton DR. 2002. Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody. J Virol 76:6408-6412.

Pittman PR, Gibbs PR, Cannon TL, Friedlander AM. 2002. Anthrax vaccine: Short-term safety experience in humans. Vaccine 20:972-978.

Pittman PR, Hack D, Mangiafico J, Gibbs P, McKee Jr KT, Friedlander AM, Sjogren MH. 2002. Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid. Vaccine 20:2107-2115.

Pittman PR, Kim-Ahn G, Pifat DY, Coonan K, Gibbs P, Little SF, Templeton-Pace JG, Myers R, Parker GW, Friedlander AM. 2002. Anthrax vaccine: Immunogenicity and safety of a dose-reduction, route-change comparison study in humans. Vaccine 20:1412-1420.

Poli MA, VR Rivera, D Neal. 2002. Sensitive colorimetric capture ELISAs for Clostridium botulinum neurotoxin serotypes E and F. Toxicon 40:797-802.

Reed DS, Smoll J, Gibbs P, Little SF. 2002. Mapping of antibody responses to the protective antigen of Bacillus anthracis by flow cytometric analysis. Cytometry 49:1-7.

Sardelis MR, Dohm DJ, Pagac B, Andre RG, Turell MJ. 2002. Experimental transmission of eastern equine encephalitis virus by Ochlerotatus j. japonicus (Diptera:Culicidae). J Med Entomol 39:480-484.

Sardelis MR, Turell MJ, O'Guinn ML, Andre RG, Roberts DR. 2002. Vector competence of three North American strains of Aedes albopictus for West Nile virus. J Med Entomol 38:284-289.

Sardelis MR, Turell MJ, Andre RG. 2002. Laboratory transmission of LaCrosse virus by Ochlerotatus j. japonicus (Diptera: Culicidae). J Med Entomol 39:635-639.

Smee DF, Sidwell RW, Kefauver D, Bray M, Huggins JW. 2002. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses. Antimicrob Agents Chemother 46:1329-1335.

Stiles BG, Blöcker D, Hale ML, Guentthof MA, Barth H. 2002. Clostridium botulinum C2 toxin: Binding studies with fluorescence-activated cytometry. Toxicon 40:1135-1140.

Stiles BG, Hale ML, Marvaud J-C, Popoff MR. 2002. Clostridium perfringens iota toxin: Characterization of the cell-associated iota b complex. Biochem J 367:801-808.

Turell MJ, Morril JC, Rossi CA, Gad AM, Cope SE, Clements TL, Arthur RR, Wasieloski LP, Dohm DJ, Nash D, Hassan MM, Hassan AN, Morsy ZS, Presley SM. 2002. Isolation of West Nile and Sindbis viruses from mosquitoes collected in the Nile Valley of Egypt during an outbreak of Rift Valley fever. J Med Entomol 39:248-250.

Turell MJ, O'Guinn ML, Dohm DJ, Webb Jr JP, Sardelis MR. 2002. Vector competence of Culex tarsalis from Orange County, California, for West Nile virus. Vector Borne Zoonotic Dis 2:193-196.

Turell MJ, Sardelis MR, O'Guinn ML, Dohm DJ. 2002. Potential vectors of West Nile virus in North America. Curr Top Microbiol Immunol 267:241-252.

Turell MJ, Spring AR, Miller MK, Cannon CE. 2002. Effect of holding conditions on the detection of West Nile viral RNA by reverse transcriptase-polymerase chain reaction from mosquito (Diptera:Culicidae) pools. J Med Entomol 39:1-3.

Weeks S, Hill J, Friedlander A, Welkos S. 2002. Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis. Mcrob Pathogen 32:227-237.

Welcher BC, Carra JH, DaSilva L, Hanson J, David CS, Aman MJ, Bavari S. 2002. Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: Implications for development of vaccines and therapeutics. J Infect Dis 186:501-510.

Welkos S, Friedlander A, Weeks S, Little S, Mendelson I. 2002. In-vitro characterization of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody. J Med Microbiol 51:821-831.

Welkos SL, Pitt MLM, Martinez M, Friedlander AM, Vogel P, Tammariello R. 2002. Determination of the virulence of the pigmentation-deficient and pigmentation-/plasminogen activator-deficient strains of Yersinia pestis in non-human primate and mouse models of pneumonic plague. Vaccine 20:2206-2214.

Woods DE, Jeddeloh JA, Fritz DL, DeShazer D. 2002. Burkholderia thailandensis E125 harbors a temperate bacteriophage specific for Burkholderia mallei. J Bacteriol 184:4003-4017.

Ahmed SA, Byrne MP, Jensen M, Hines HB, Brueggeman E, Smith LA. 2001. Enzymatic autocatalysis of botulinum A neurotoxin. J Prot Chem 20:221-231.

Blow JA, MJ Turell, Silverman AL, Walker ED. 2001. Stercorarial shedding and transtadial transmission of hepatitis B virus by common bed bugs (Hemiptera: Cimicidae). J MeD Entomol 38:694-700.

Bray M. 2001. The role of type 1 interferon response in the resistance of mice to filovirus infection. J Gen Virol 82:1365-1373.

Bray M, Hatfill S, Hensley L, Huggins JW. 2001. Haematological, biochemical and coagulation changes in mice, guinea-pigs and monkeys infected with a mouse-adapted variant of Ebola Zaire virus. J Comp Pathol 125:243-253.

Cieslak TJ. 2001. Medical consequences of biological warfare: The ten commandments of management. Mil Med 166:11-12.

Coffman JD, Zhu J, Roach JM, Bavari S, Ulrich RG, Giardina SL. 2001. Production and purification of a recombinant staphylococcal enterotoxin B vaccine candidate expressed in Escherichia coli. Prot Expr Purif 24:302-312.

Culpepper RC, Pratt WD. 2001. Advances in medical biological defense technology. Clin Lab Med 21:679-689.

DeShazer D, Waag DM, Fritz DL, Woods DE. 2001. Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence factor. Microb Pathogen 30:253-269.

Dohm DJ, Turell MJ. 2001. Effect of incubation at overwintering temperatures on the replication of West Nile virus in New York Culex pipiens (Diptera:Culicidae). J Med Entomol 38:462-464.

Erwin JL, DaSilva LM, Bavari S, Little SF, Friedlander AM, Chanh TC. 2001. Macrophage-derived cell lines do not express proinflammatory cytokines after exposure to Bacillus anthracis lethal toxin. Infect Immun 69:1172-1177.

Fellows PF, Linscott MK, Ivins BE, Pitt MLM, Rossi CA, Gibbs PH, Friedlander AM. 2001. Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine 19:3241-3247.

Gibb TR, Norwood DA, Woolen N, Henchal EA. 2001. Development and evaluation of a fluorogenic 5'-nuclease assay to detect and differentiate between Ebola Zaire and Ebola Sudan. J Clin Microbiol 39:4125-4130.

Gibb TR, Bray M, Geisbert TW, Steele KE, Kell WM, Davis KJ, Jaax NK. 2001. Pathogenesis of experimental Ebola Zaire virus infection in BALB/c mice. J Comp Pathol 125:233-242.

Hale ML. 2001. Microtiter-based assay for evaluating the biological activity of ribosome-inactivating proteins. Pharmacol Toxicol 88:255-260.

Hale ML, Campbell TA, Campbell YG, Fong SE, Stiles BG. 2001. Development of a time-resolved immunofluorometric assay for quantitation of mucosal and systemic antibody responses. J Immunol Meth 257:83-92.

Hart MK, Lind C, Bakken R, Robertson M, Tammariello R, Ludwig GV. 2001. Onset and duration of protective immunity to IA/B and IE strains of Venezuelan equine encephalitis virus in vaccinated mice. Vaccine 20:616-622.

Hawley RJ, Pittman PR, Nerges JA. 2001. Maximum containment for researchers exposed to biosafety level 4 agents, pp 35-53. In JY Richmond (ed), Anthology of Biosafety: II, Publication committee of the American Biological Safety Association, Mundalein, IL.

Hawley RJ, Eitzen Jr EM. 2001. Protection against biological warfare agents, pp 1161-1167. In SS Block (ed), Disinfection, Sterilization, and Preservation, Lippincott Williams & Wilkins, Philadelphia PA.

Hawley RJ. 2001. Biosafety training - a practical, realistic, and reasonable approach. The Loop, newsletter of the National Registry of Microbiologists. 27:2-3.

Hawley RJ, Eitzen Jr EM. 2001. Biological weapons - a primer for microbiologists. Ann Rev Microbiol 55:235-253.

Henchal EA, Teska JD, Ludwig GV, Shoemaker DR, Ezzell JW. 2001. Current laboratory methods for biological threat agent identification. Clin Lab Med 21:661-678.

Hevey M, Negley D, VanderZanden L, Tammariello RF, Geisbert J, Schmaljohn C, Smith JF, Jahrling PB, Schmaljohn AL. 2001. Marburg virus vaccines: Comparing classical and new approaches. 20:586-593.

Hooper JW, Li D. 2001. Vaccines against hantaviruses, pp 171-191. In CS Schmaljohn, ST Nichol (ed), Current Topics in Microbiology and Immunology, Vol 256, Springer-Verlag, Berlin.

Hooper JW, Custer DM, Thompson E, Schmaljohn CS. 2001. DNA vaccination with the Hantaan virus M gene protects hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in rhesus monkeys. J Virol 75:8469-8477.

Hooper JW, Larsen T, Custer DM, Schmaljohn CS. 2001. A lethal disease model for hantavirus pulmonary syndrome. Virology 289:6-14.

Kortepeter MG, Krauss MR. 2001. Tuberculosis infection after humanitarian assistance, Guantanamo Bay, 1995. Mil Med 166:116-120.

Kortepeter MG, Cieslak TJ, Eitzen Jr EM. 2001. Bioterrorism. J Environ Hlth 63:21-24.

Krakauer T. 2001. Suppression of endotoxin- and staphylococcal exotoxin-induced cytokines and chemokines by a phospholipase C inhibitor in human peripheral blood mononuclear cells. Clin Diag Lab Immunol 8:449-453.

Krakauer T, Russo C. 2001. Serum cytokine levels and antibody response to influenza vaccine in the elderly. Immunopharmacol Immunotoxicol 1:35-41.

Krakauer T, Li BQ, Young HA. 2001. The flavonoid baicalin inhibits staphylococcal superantigen-induced inflammatory cytokines and chemokines. FEBS Lett 500:52-55.

LeClaire RD, Bavari S. 2001. Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality. Antimicrob Agents Chemother 45:460-463.

Lee JS, Pushko P, Parker MD, Dertzbaugh MT, Smith LA, Smith JF. 2001. Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system. Infect Immun 69:5709-5715.

Ludwig GV, Turell MJ, Vogel P, Kondig JP, Kell W, Smith JF, Pratt WD. 2001. Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice. Am J Trop Med Hyg 64:49-55.

Marty AM, Conran RM, Kortepeter MG. 2001. Recent challenges in infectious diseases. Biological pathogens as weapons and emerging endemic threats. Clin Lab Med 21:411-420.

Marvaud J-C, Smith T, Hale ML, Popoff MR, Smith LA, Stiles BG. 2001. Clostridium perfringens iota-toxin: Mapping of receptor binding and LA docking domains on LB. Infect Immun 69:2435-2441.

O'Quinn AL, Wiegand EM, Jeddeloh JA. 2001. Burkholderia pseudomallei kills the nematode Caenorhabditis elegans using an endotoxin-mediated paralysis. Cell Microbiol 3:381-393.

Olson MA. 2001. Electrostatic effects on the free-energy balance in folding a ribosome-inactivating protein. Biophys Chem 91:219-229.

Olson MA. 2001. Calculations of free-energy contributions to protein-RNA complex stabilization. Biophys J 81:1841-1853.

Pastel RH. 2001. Collective behaviors: Mass panic and outbreaks of multiple unexplained symptoms. Mil Med 166:44-46.

Pastel RH, Mulvaney J. 2001. Fear of radiation in U.S. military medical personnel. Mil Med 166:80-82.

Pitt MLM, Little SF, Ivins BE, Fellows P, Barth J, Hewetson JF, Gibbs P, Dertzbaugh M, Friedlander AM. 2001. In vitro correlate of immunity in a rabbit model of inhalational anthrax. Vaccine 19:4768-4773.

Pittman PR, Mangiafico JA, Rossi CA, Cannon TL, Gibbs PH, Parker GW, Friedlander AM. 2001. Anthrax vaccine: Increasing intervals between the first two doses enhances antibody response in humans. Vaccine 19:213-216.

Pless DD, Torres ER, Reinke EK, Bavari S. 2001. High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A. Infect Immun 69:570-574.

Poli MA, FJ Lebeda. 2001. An overview of clostridial toxins, pp 293-304. In EJ Massaro (ed), Handbook of Neurotoxicology, Humana Press Inc, Totowa, NJ.

Pushko P, Geisbert J, Parker M, Jahrling P, Smith J. 2001. Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses. J Virol 75:11677-11685.

Pushko P, Bray M, Ludwig GV, Parker D, Schmaljohn A, Sanchez A, Jahrling PB, Smith JF. 2001. Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine 19:142-153.

Sardelis MR, Turell MJ. 2001. Ochlerotatus j. japonicus in Frederick County, Maryland: Discovery, distribution, and vector competence for West Nile virus. J Am Mosq Control Asso 17:137-141.

Sardelis MR, Turell MJ, Dohm DJ, O'Guinn ML. 2001. Vector competence of selected North American Culex and Coquillettidia mosquitoes for West Nile virus. Emerg Infect Dis 7:1018-1022.

Schmidt JJ, Stafford RG, Millard CB. 2001. High throughput assays for botulinum neurotoxin proteolytic activity: serotypes A, B, D, and F. Anal Biochem 296:130-137.

Smee DF, Bray M, Huggins JW. 2001. Intracellular phosphorylation of carbocyclic 3-deazaadenosine, an anti-Ebola virus agent. Antivir Chem Chemother 12:251-258.

Smith DR, Rossi CA, Kijek TM, Henchal EA, Ludwig GV. 2001. Comparison of dissociation-enhanced lanthanide fluorescent immunoassays to enzyme-linked immunosorbent assays for detection of staphylococcal enterotoxin B, Yersinia pestis-specific F1 antigen, and Venezuelan equine encephalitis virus. Clin Diag Lab Immunol 8:1070-1075.

Srinivasan A, Kraus CN, DeShazer D, Becker PM, Dick JD, Spacek L, Bartlett JG, Byrne WR, Thomas DL. 2001. Glanders in a military research microbiologist. N Eng J Med 345:256-258.

Steele KE, Stabler K, VanderZanden L. 2001. Cutaneous DNA vaccination against Ebola virus by particle bombardment: Histopathology and alteration of CD3-positive dendritic epidermal cells. Vet Pathol 38:203-215.

Steele K, Crise B, Kuehne A, Kell W. 2001. Ebola virus glycoprotein demonstrates differential cellular localization in infected cell types of nonhuman primates and guinea pigs. Arch Pathol Lab Med 125:625-630.

Stiles BG, Garza AR, Ulrich RG, Boles JW. 2001. Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model. Infect Immun 69:2031-2036.

Turell MJ, O'Guinn ML, Dohm DJ, Jones JW. 2001. Vector competence of North American mosquitoes (Diptera:Culicidae) for West Nile virus. J Med Entomol 38:130-134.

Turell MJ, Sardelis MR, Dohm DJ, O'Guinn ML. 2001. Potential North American vectors of West Nile virus. Ann NY Acad Sci 951:317-324.

Welkos SL, Little SF, Friedlander A, Fritz D, Fellows P. 2001. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology 147:1677-1685.

Wilson JA, Hart MK. 2001. Protection from Ebola virus mediated by cytotoxic T-lymphocytes specific for the viral nucleoprotein. J Virol 75:2660-2664.

Wilson JA, Bray M, Bakken R, Hart MK. 2001. Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins. Virology 286:384-390.

Wilson JA, Bosio CM, Hart MK. 2001. Ebola virus: The search for vaccines and treatments. Cell Mol Life Sci 58:1826-1841.

Zaucha GM, Jahrling PB, Geisbert TM, Swearengen JR, Hensley L. 2001. The pathology of experimental aerosolized monkeypox virus infection in cynomolgus monkeys (Macaca fascicularis). Lab Invest 81:1581-1600

Bray M, Driscoll J, Huggins JW. 2000. Treatment of lethal Ebola virus infection with a single dose of an A-adenosyl-L-homocysteine hydrolase inhibitor. Antivir Res 45:135-147.

Bray M, Martinez M, Smee DF, Kefauver D, Thompson E, Huggins JW. 2000. Cidofovir (HPMPC) protects mice against lethal aerosol or intranasal cowpox virus challenge. J Infect Dis 181:10-19.

Byrne MP, Titball R, Holley J, Smith LA. 2000. Fermentation, purification, and efficacy of a recombinant vaccine candidate against botulinum neurotoxin type F from Pichia pastoris. Protein Expression Purif 18:327-337.

Cieslak TJ, Christopher GW, Kortepeter MG, Rowe JR, Pavlin JA, Culpepper RC, Eitzen Jr EM. 2000. Immunization against potential biological warfare agents. Clin Infect Dis 30:843-850.

Cieslak TJ, Eitzen Jr EM. 2000. Bioterrorism: Agents of concern. J Pub Hlth Manage Prac 6:19-29.

Clayton J, Middlebrook JL. 2000. Vaccination of mice with DNA encoding a large fragment of botulinum neurotoxin serotype A. Vaccine 18:1855-1862.

Geisbert TW, Hensley LE, Gibb TR, Steele KE, Jaax NK, Jahrling PB. 2000. Apoptosis induced in vitro and in vivo during infection by Ebola and Marburg viruses. Lab Invest 80:171-186.

Gilligan K, Shipley M, Stiles B, Hadfield TL, Ibrahim MS. 2000. Identification of Staphylococcus aureus enterotoxins A and B genes by PCR-ELISA. Molec Cell Probes 14:71-78.

Hail AS, Rossi CA, Ludwig GV, Ivins BE, Tammariello RF, Henchal EA. 1999. Comparison of noninvasive sampling sites for early detection of Bacillus anthracis spores from rhesus monkeys after aerosol exposure. Milit Med 164:833-837.

Hooper JW, Custer DM, Schmaljohn CS, Schmaljohn AL. 2000. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge. Virology 266:329-339.

Jahrling PB, Zaucha GM, Huggins JW. 2000. Countermeasures to the reemergence of smallpox virus as a agent of bioterrorism, pp 187-200. In WM Scheld, WA Craig, JM Hughes, Emerging Infections 2000, ASM Press, Washington DC.

Kijek TM, Rossi CA, Moss D, Parker RW, Henchal EA. 2000. Rapid and sensitive immunomagnetic electrochemiluminescent detection of staphylococcal enterotoxin B. J Immunol Meth 236:9-17.

Krakauer T. 2000. Coordinate suppression of superantigen-induced cytokine production and T-cell proliferation by a small non-peptidic inhibitor of class II major histocompatibility complex and CD4 interaction. Antimicrob Agents Chemother 44:1067-1069.

Macintyre AG, Christopher GW, Eitzen Jr E, Gum R, Weir S, DeAtley C, Tonat K, Barbera JA. 2000. Weapons of mass destruction events with contaminated casualties. Effective planning for health care facilities. JAMA 283:242-249.

Martinez MJ, Bray MP, Huggins JW. 2000. A mouse model of aerosol-transmitted orthopoxviral disease: Morphology of experimental aerosol-transmitted orthopox viral disease in a cowpax virus-BALBlc mouse system. Arch Pathol Lab Med 124:362-377.

McClain DJ, Summers P, Harrison S, Schmaljohn AL, Schmaljohn CS. 2000. Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine. J Med Virol 60:77-85.

Meyer BC, Schmaljohn C. 2000. Accumulation of terminally deleted RNAs may play a role in Seoul virus persistence. J Virol 74:1321-1331.

Meyer BC, Schmaljohn C. 2000. Persistent hantavirus infections: Characteristics and mechanisms. Trends Microbiol 8:61-67.

Montgomery VA, Makuch RS, Brown JE, Hack DC. 2000. The immunogenicity in humans of a botulinum type F vaccine. Vaccine 18:728-735.

Poli MA, Musser SM, Dickey RW, Eilers PP, Hall S. 2000. Neurotoxic shellfish poisoning and brevetoxin metabolites: A case study from Florida. Toxicon 38:981-993.

Sheets JT, Rossi CA, Kearney BJ, Moore GE. 1999. Evaluation of a commercial enzyme-linked immunosorbent assay (ELISA) for detection of Borrelia burgdorferi exposure in dogs. J Am Vet Med Asso 216:1418-1422.

Stiles BG, Hale ML, Marvaud J-C, Popoff MR. 2000. Clostridium perfringens iota toxin: Binding studies and characterization of cell surface receptor by fluorescence-activated cytometry. Infect Immun 68:3475-3484.

Turell MJ, O'Guinn M, Oliver J. 2000. Potential for New York mosquitoes to transmit West Nile virus. Am J Trop Med Hyg 62:413-414.

Ulrich RG. 2000. Evolving superantigens of Staphylococcus aureus. FEMS Immunol Med Microbiol 27:1-7.

Vaughan JA, Trpis M, Turell MJ. 1999. Brugia malayi microfilariae (Nematoda:Filaridae) enhance the infectivity of Venezuelan equine encephalitis virus to Aedes mosquitoes (Diptera:Culicidae). J Med Entomol 36:758-763.

Vlach KD, Stiles BG, Boles JW. 2000. Telemetric evaluation of temperature and physical activity as predictors of mortality in a murine model of staphylococcal enterotoxic shock. Comp Med 50:160-166.

Wilson JA, Hevey M, Bakken R, Guest S, Bray M, Schmaljohn AL, Hart MK. 2000. Epitopes involved in antibody-mediated protection from Ebola virus. Science 287:1664-1666.